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Summary 
Porcine reproductive and respiratory syndrome viruses (PRRSV) cause the most 
economically significant disease of swine. The emergence of highly pathogenic 
strains and the limitations of current vaccines pose significant challenges to PRRS 
control. An improved understanding of pathogenesis is needed to support the 
development of improved vaccines. Experimental infection with virulent PRRSV-1 
subtype 3 strains is associated with enhanced immune responses, which have 
been attributed to the more effective viral clearance compared to ‘typical’ PRRSV-
1 subtype 1 strains. Previous ex vivo data has also shown that this increased 
virulence correlates with a broader cell tropism for cells of the myeloid lineage. The 
causation of this correlation was investigated by assessing whether European 
PRRSV-1 strains can infect dendritic cells (DC), which are not canonically a target 
cell.  A staining strategy was optimised to enrich and phenotype blood-derived DC 
(BDC) subsets. Infection experiments demonstrated that BDC were not 
susceptible, and that cytokine responses in enriched BDC culture were suppressed 
by inoculation of subtype 3 strain Lena. Further characterisations of host responses 
instead used monocyte-derived macrophages (MΦ) and DC. Functional assays 
determined that pro-inflammatory responses were increased by subtype 3 strain 
SU1-Bel more than subtype 1 strains, including modulation of surface activation 
markers, ability to prime allogeneic T cell proliferation, and secretion of 
inflammatory cytokines; Lena, however, did not induce pro-inflammatory cytokine 
responses but decreased endocytic and phagocytic capacity. This trend was 
validated by transcriptomic analysis of infected monocyte-derived MΦ, which 
identified putative genes of interest for future studies, including pattern recognition 
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receptors. Inflammasome treatments suggested that SU1-Bel primed 
inflammasome activation and that subtype 3 strain replication was decreased by 
inflammasome inhibition, proportionately increasing MΦ viability. Finally, 
preliminary trials of a novel macrophage cell line demonstrated its utility for further 
investigation of the mechanistic basis for the enhanced virulence of PRRSV-1 
subtype 3 strains.   
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Chapter 1 : Introduction 
1.1 Porcine Reproductive and Respiratory Syndrome  
Porcine reproductive respiratory syndrome (PRRS) is responsible for significant 
losses in pig herds causing infertility and miscarriage in sows, and pneumonia in 
juvenile pigs. PRRS was recognised in the late 1980s, with initial disease names 
corresponding with the range of clinical signs (reviewed by Christianson, 1994). 
Clinical presentation of PRRS varies significantly in severity depending on both the 
age of animal and the strain of infecting virus. Sows may present with anorexia, 
dyspnoea, cyanosis, reduced farrowing rates, late stage abortions, and stillborn 
mummified piglets  (Iowa State University, 2015). PRRS causes major financial 
losses in swine herds globally; loss predictions in the USA have increased from 
$560m (Neumann et al., 2005) to $664m per annum (Holtkamp et al., 2012), far 
more than other swine diseases that have warranted eradication. Recent European 
studies suggest losses per sow are continuing, despite now-widespread 
administration of live attenuated vaccines (De Paz, 2015; Nieuwenhuis et al., 
2012). These losses are particularly significant in China and Southeast Asia where 
pork is the primary source of animal protein and population growth is creating 
increasing demand (He et al., 2016; Oh and See, 2012). The causative agent, 
PRRS virus (PRRSV) was identified in Europe 28 years ago (Wensvoort et al., 
1991), and one year later in the USA (Benfield et al., 1992). PRRSV-infected piglets 
may show stunted growth and be susceptible to opportunistic viral and bacterial 
co-infections such as porcine circovirus type 2 (PCV-2), swine influenza virus, 
classical swine fever (CSF) (Blome et al., 2017), Aujeszky’s disease/pseudorabies 
virus, Haemophilus species or Mycoplasma hyopneumoniae. The clinical signs 
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caused by these co-infections with PRRSV is broadly known as the porcine 
respiratory disease complex (PRDC) (Galán-Relaño et al., 2015).  
The aetiological agent, PRRSV, initially infects alveolar macrophages (AMΦ) within 
the lungs, before dissemination through the blood to infect MΦ in lymphoid, non-
lymphoid and placental tissues. The infection of alveolar and intravascular MΦ 
causes alveolar infiltration, which can lead to interstitial pneumonia and lesions in 
the lungs, as well inflammation in lymph nodes, cardiac tissue, and brain (Iowa 
State University, 2015; Zeman et al., 1993). Virus has also been detected in the 
bone marrow, liver, and kidneys (Huong Giang et al., 2016). Symptoms may recur 
in several month long cycles in larger herds due to sows farrowing at different 
times, new sows being introduced (Linhares et al., 2015), and artificial insemination 
due to the persistence of PRRSV in semen (Christopher-Hennings et al., 2001; 
Schulze et al., 2013) and oocytes (Bureau et al., 2005). Low pathogenicity strains 
may not be apparent clinically, especially in the absence of secondary infections, 
and as such farmers may only become aware of an infection if the abortion rate 
increases significantly (abortion rates above 6% are often the first noticeable 
hallmark of PRRS), by which time it is possible the infection has spread to other 
farms. 
The majority of PRRSV-1 strains are broadly considered less pathogenic than 
PRRSV-2 strains. Highly pathogenic PRRSV-2 strains emerged in China in 2006 
(HP-PRRSV-2), forming a novel isolated clade capable of inducing sustained fever 
and mortality in pigs of all ages, regardless of co-infection status. This resulted in 
major economic losses, millions of cases, and hundreds of thousands of deaths of 
pigs (X. Li et al., 2017; Tian et al., 2007; Zhao et al., 2015). These highly pathogenic 
strains spread rapidly and only a few years after identification of PRRSV in the 
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region have now become the predominant strains circulating in Southeast Asia 
(Tornimbene et al., 2015).  
Pathogenic PRRSV-1 strains were first recognised in subtype 3 Belarusian isolates 
Lena and SU1-Bel (Karniychuk et al., 2010; Morgan et al., 2013; Weesendorp et 
al., 2013a), but pathogenic PRRSV-1.1 strains have since been isolated in Belgium 
(13V091) (Frydas et al., 2015), Austria (AUT14-440) (Sinn et al., 2016), and Italy 
(PR40) (Canelli et al., 2017; Ferrari et al., 2018), as well as subtype 2 Belarusian 
strain BOR59 (Stadejek et al., 2017) and Chinese PRRSV-1 (Chen et al., 2017). 
PRRSV-1.3 Lena, an Eastern European subtype 3 strain reported in 2010 
(Karniychuk et al., 2010), has been shown experimentally to induce fever and a 
100-fold increase in viraemia over the prototype LP-PRRSV-1 Lelystad strain, as 
well as inducing an earlier antibody response (Weesendorp et al., 2016). Another 
Belarussian PRRSV-1.3 strain, SU1-Bel, has been characterised to cause 
significant clinical signs and pathology in the lungs and lymph nodes compared to 
British field strains, despite more rapid viral clearance and lower viraemia (Morgan 
et al., 2014, 2013; Salguero et al., 2015). 
 PRRS virus diversity 
PRRSV exists as two discrete species: Betaarterivirus suid 1 (PRRSV-1, 
classically European origin) and Betaarterivirus suid 2 (PRRSV-2, classically North 
American origin), in the monotypic subgenera Europbartevirus and 
Ampobartevirus, respectively (Siddell et al., 2019). Both are within the genus 
Betaarterivirus, subfamily Variarterivirinae, family Arteriviridae, order Nidovirales. 
PRRSV taxonomy has been reclassified several times since its identification 30 
years ago; between 1996 and 2016 the Arteriviridae family contained only the 
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Arterivirus genus, consisting of four species: the genus type-species equine 
arteritis virus (EAV), lactate dehydrogenase-elevating virus (LaDV), simian 
haemorrhagic fever virus, and PRRSV as two genotypes of a single species 
(Pringle, 1996). The 2016 ICTV update (Kuhn et al., 2016) split PRRSV genotypes 
into PRRSV-1 and PRRSV-2 species within the new Rodarterivirus genus, along 
with LaDV-1 and -2, remaining within the Arteriviridae family (Siddell and Knowles, 
2016). Between 2016 and 2019, PRRSV-1 and -2 were assigned to the novel 
genus Porartevirus, with LaDV and the newly identified rat arterivirus-1. The 
Porartevirus genus was removed with the introduction of Betaarterivirus 
nomenclature and introduction of individual subgenera (Siddell et al., 2019). Both 
PRRSV species likely share a common ancestor with EAV, circulating for some 
time before identification (Forsberg et al., 2001). Emergence may have occurred 
after transmission from horses, with similarities in myelotropism to prior-identified 
members of the family Arteriviridae, such as the genus Equarterivirus (Bryans et 
al., 1957). 
PRRSV possess a non-segmented genome made up of capped and 
polyadenylated positive sense RNA, with a total length of ~15kb. The RNA genome 
is packaged within a 45 nm diameter capsid comprised of nucleocapsid (N) protein, 
itself encapsulated by a ~60 nm diameter plasma membrane. The virus produces 
10 open reading frames (ORFs), of which ORF1 is the largest, accounting for 
approximately 60% of the viral genome (Figure 1.1). ORF1a and ORF1b encode 
poly-proteins 1a & 1ab, respectively, via frameshift-mediated translational 
reprogramming. These poly-proteins autoproteolytically cleave to produce non-
structural proteins (NSPs): ORF1a produces NSP1 papain-like protein domains α 
and β, NSP2 chymotrypsin-like cysteine-protease domain, which contains a 
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hypervariable region, the most diverse domain of PRRSV-1 and PRRSV-2 
(Kvisgaard et al., 2013; Tian et al., 2007), and the NSP4 chymotrypsin-like serine-
protease domain. ORF1b encodes the RNA-dependent RNA polymerase catalytic 
SDD domain, the CP2 zinc-finger, and helicase (Dea et al., 2000; Drew et al., 1995; 
Fang and Snijder, 2010; Meulenberg et al., 1993). ORFs 2-7 respectively encode 
5 glycoslyated  membrane-associated proteins: GP2a, pore-forming envelope (E) 
protein, GP3, GP4, GP5, and GP5a; unglycoslyated M protein; and N protein 
(Meulenberg et al., 1993; Wissink et al., 2005). ORFs 3 and 4 are the most diverse 
of the structural proteins, whereas ORFs 6 and 7 are the least varied (Kvisgaard 
et al., 2013), likely due to their indispensable function in capsid formation. 
 
Figure 1.1. PRRSV genome structure.  Schematic representation of the open reading 
frames (ORF) encoding non-structural and structural proteins. Polyprotein-derived non-
structural proteins are numbered underneath ORF1a and 1b. Papain-like cysteine 
proteases (P) and serine protease (S) cleave the polyprotein at the sites indicated by 
arrows of corresponding colour. HVR indicates the highly variable region within nsp2; TM 
indicates transmembrane regions; TF indicates trans-frame expression. ORF1b encodes 
RNA-dependent RNA polymerase (R), multinuclear zinc-binding domain (Z), RNA helicase 
(H), and NendoU endoribonuclease (Ne). Structural proteins respectively expressed from 
subgenomic mRNA encoded by ORFs 2–7: GP2, E, GP3, GP4, GP5, GP5a, M, and N, 
and the 3’ polyA tail. Figure used with permission from Annual Review of Animal 
Biosciences (Lunney et al., 2016). 
PRRSV-1 subtypes are determined by the length of ORF7; the encoded N protein 
is between 124-132 amino acids in length, including the C terminus (Stadejek et 
al., 2013). PRRSV-1 subtype 1 (PRRSV-1.1) originated in Western Europe and is 
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the dominant subtype in Europe, whereas PRRSV-1 subtypes 2, 3, (Stadejek et 
al., 2006) and most recently 4 (Stadejek et al., 2013) (PRRSV-1.2, -1.3, -1.4) have 
emerged in Eastern Europe and Russia; geographical restrictions  that correlate 
with movement of animals in trading blocs in the 1980s and 1990s (Forsberg et al., 
2002; Stadejek et al., 2013). ORF5 is reported to show extensive recombination 
and antigen selection pressure, and is therefore typically used to identify 
breakpoints in phylogenies (Lee et al., 2017; Martín-Valls et al., 2014). Despite the 
use of ORF7 to determine subtype and ORF5 to determine phylogenies, ORF3 has 
been demonstrated to exhibit the most variation in length (Dortmans et al., 2019). 
Using ORF5 instead of ORF7 can cluster PRRSV-1 subtypes more closely by 
geographical isolation than subtype. For example, Russian subtype 1 strains 
cluster by ORF5  closely to subtype 2, and subtype 3 separates subtypes 2 and 1; 
using ORF7 clusters Russian subtype 1 strains between subtypes 1 and 3 (Rappe 
et al., 2016). 
Each PRRSV species consists of subtypes which each show quasi-species 
variation (Brar et al., 2014; Lu et al., 2014). To date, all PRRSV circulating in the 
UK, and all PRRSV-1 in China and South Korea, are PRRSV-1.1 (Guo et al., 2018). 
PRRSV-2 is split into 9 major lineages distributed globally, with a reduced presence 
in Europe relative to PRRSV-1 (Shi et al., 2010).  Highly pathogenic strains have 
recently emerged alongside lowly pathogenic strains within geographical isolation, 
such as Italian PRRSV-1.1 PR40 (Canelli et al., 2017; Ferrari et al., 2018), Belgian 
PRRSV-1.1 13V091 (Frydas et al., 2015), and Russian PRRSV-1.2 strain BOR59 
(Stadejek et al., 2017). Interestingly, European PRRSV-1.1 strains have also 
emerged that are highly similar to South Korean PRRSV-1 strains (Sinn et al., 
2016), highlighting the diversity of PRRSV-1. Whilst PRRSV-1 predominates in 
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continental Europe, PRRSV-2 is also present, which is  the reverse of the Americas 
and Asia where PRRSV-2 is predominant (Chen et al., 2006; Iowa State University, 
2015; Tian et al., 2007, 2007).  
Genetic variation has increased dramatically since initial identification of PRRSV-
1 in 1991 (Wensvoort et al., 1991) due to the absence of a viral RdRp associated 
exoribonuclease enzyme (Forsberg et al., 2001), which regulates the proof-reading 
of large RNA virus genomes, such as Coronaviridae (Nga et al., 2011), another 
major family of order Nidovirales. Ancestral strains  from both species circulate 
alongside recent divergent strains in pig herds, indicating heavy diversification 
(Forsberg et al., 2002; Frossard et al., 2013; Kvisgaard et al., 2014), (Figure 1.2). 
This is due to both recombination, particularly characterised in PRRSV-2 (Martín-
Valls et al., 2014; Zhao et al., 2015), and substitution rates that are high even 
relative to other positive sense RNA viruses, as frequent as 3.8x10-3 mutations per 
site per year (Frossard et al., 2013; Hanada et al., 2005; Jenkins et al., 2002; 
Murtaugh et al., 2010).  
  
 
Figure 1.2. Phylogenetic analysis of PRRSV-1 and PRRSV-2 ORF5 sequences. 
Constructed using the neighbour-joining method, with evolutionary distances computed 
using the maximum composite likelihood method. Kindly provided by Dr Jean-Pierre 
Frossard, Animal and Plant Health Agency, Addlestone, UK.  
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 PRRSV cellular tropism and replication cycle 
A range of host receptors have been identified as beneficial to PRRSV infection: 
CD163 (cellular scavenger receptor) (Calvert et al., 2007), siglec-1 (CD169; 
sialoadhesin) and siglec-10 (Xie et al., 2018), CD151 (tetraspanin) (L. Zhang et al., 
2016), vimentin (Kim et al., 2006), and heparan sulphate (Delputte et al., 2005, 
2002). PRRSV GP2, GP3, and GP4 form a heterotrimer which binds CD163 
(Figure 1.3). This interaction is stabilised by the binding of CD169 by the GP5 and 
M protein heterodimer. Envelope (E) protein, a hydrophobic viroporin, is essential 
for infectivity and aids localisation of nascent GP2/3/4 heterotrimers into the viral 
envelope during replication (Wissink et al., 2005).  
Scavenger receptor cysteine rich region (SRCR) 5 is the critical domain of CD163 
for binding of GP2 (Burkard et al., 2017; Guo et al., 2019). The adaptation to 
MARC-145 infectivity is contingent on a triple amino acid change in GP2 (Xie et al., 
2019). Myosin, heavy chain 9, non-muscle (MYH9) interacts with CD163 SRCR1-
4 for endosomal fusion and egress to the cytoplasm (Hou et al., 2019). As a 
phagocytosis receptor, Siglec-1 (CD169) is co-expressed by myeloid cells that 
express CD163. Intact Siglec-1 is not essential to in vivo infection with North 
American PRRSV-2 KS-06 (Prather et al., 2013), however PRRSV-1.1 Lelystad 
infection is completely blocked in vitro by monoclonal antibodies (mAbs) (Duan et 
al., 1998; Van Breedam et al., 2010) that have since been confirmed as being 
specific to Siglec-1 (Delputte et al., 2011). Siglec-10 is a related protein that in 
normal homeostasis binds CD52 (Clark and Cooke, 2013), which has been 
demonstrated to be used by PRRSV-1.3 to invade the epithelial layer of ex vivo 
cultures (Frydas et al., 2013), however, this utilisation has since been 
characterised as lower affinity/less preferential than Siglec-1 (Xie et al., 2018). 
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PRRSV-1 and PRRSV-2 strains assessed by the authors did not present a readily-
apparent trend in Siglec preference correlating with geographical or temporal 
emergence, nor pathogenicity.  
The ORF that transcribes E protein is derived from bicistronic sub-genomic mRNA 
which is conserved throughout Nidovirales, however, variation in the start codon 
alters the naming convention between species; in PRRSV ORF2a encodes GP2 
and ORF2b encodes E protein, whereas the inverse is true in EAV and SHFV 
(Vatter et al., 2014). E protein’s ion channel-like role is associated with un-coating 
and viral genome delivery into the cytoplasm (Lee and Yoo, 2006). Despite the 
inverted genomic position of GP2 and E protein, function and post-translational 
modifications are conserved between arteriviruses; a myristoylation site is reported 
to enhance replication but not infection (Du et al., 2010). 
 
 
Figure 1.3. PRRSV glycoprotein complex. Schematic model of PRRSV envelope 
glycoprotein complex and interaction with host CD163. Figure used with permission from 
Annual Review of Animal Biosciences (Lunney et al., 2016). 
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Virus binding occurs within 60 minutes, undergoing internalisation by clathrin 
mediated endocytosis, before egress from vesicles into the cytoplasm within 5 
hours (Nauwynck et al., 1999). Low pH is reported to induce PRRSV exit of the 
early endosome (Kreutz and Ackermann, 1996); the protease cathepsin E is 
connected to endosomal exit, which has an optimal functional pH of 6.0 (Misinzo 
et al., 2008; Nauwynck et al., 1999). 
The RdRp encoded by ORF1b creates PRRSV dsRNA in replication complexes, 
which localise with the endoplasmic reticulum (W. Zhang et al., 2018) (summarised 
in Figure 1.4). PRRSV NSP2 modulates mTOR, the PI3Kinase involved in 
numerous cell proliferation signalling pathways, to hijack the ER, halting translation 
both dependent and independent of eIF2α, the eukaryotic tRNA initiation factor (Li 
et al., 2018). Disruption to the ER has been demonstrated to result in unfolded-
protein response pathology, illustrated in a porcine foetal liver-derived AMΦ cell 
line (W.-Y. Chen et al., 2018). 
Recombinant EAV expressing PRRSV GP5 and M has been demonstrated to 
retain EAV-associated tropism of the BHK-21 cell line and did not gain the capacity 
to infect porcine AMΦ, suggesting that the essential role of the GP5-M heterodimer 
is not the initial binding of viral entry (Lu et al., 2012; Tian et al., 2012). Virions 
produced in the ER are encapsidated in the Golgi apparatus before transporting to 
the cell surface by exocytosis, as is recycled heparan sulphate, (Giantsos-Adams 
et al., 2013). Heparan sulphate, which plays a role in PRRSV binding, is cleaved 
by heparanase to release nascent PRRSV virions from the cell surface; 
heparanase is induced by cathepsin and nuclear factor Kappa-B (NF-κB), which 
has been demonstrated to be upregulated by classical (pre-2006) Chinese 
PRRSV-2 (Guo et al., 2017).  
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Figure 1.4. PRRSV replication cycle. RTC denotes replication and transcription complexes 
where negative sense RNA is synthesised as an intermediate to single-strand full-length 
and subgenomic negative sense RNAs. Positive sense subgenomic RNA is then 
synthesised to produce structural virion proteins. These are packaged into nucleocapsid 
(N) are internalised in the membrane envelope when exocytosed and budded from the 
host cell membrane. Figure used with permission from Annual Review of Animal 
Biosciences (Lunney et al., 2016). 
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1.2 Control of PRRS 
 Control through farming practices 
Biosecurity during animal and personnel movement is a critical factor in 
maintaining a PRRS-free status (Rathkjen and Dall, 2017; Valdes-Donoso et al., 
2016).  Herd closure and rollover is an effective but costly method, halting 
introduction of replacement gilts into a herd for six months, reducing the 
susceptible population thus interrupting the transmission cycle (Corzo et al., 2010). 
Animal re-introduction is more frequent where multi-site farming is practised: 
weaner producers, nurseries, growers, and finishers are often separated in North 
America, whereas farms in Europe more traditionally, but not exclusively, follow a 
“farrow to finish” practise in a single site. Transport of live animals has increased 
in Europe in line with political changes and increasing trade between Central and 
Western Europe in the previous 3 decades (Balka et al., 2018). Serological testing 
and removal of seropositive animals can be used to successfully eliminate PRRSV 
at the herd level, with relative success using oral fluid samples to survey for 
infection (Biernacka et al., 2016; Kittawornrat et al., 2014). Detecting the presence 
of anti-PRRSV N protein-specific antibodies has proven an effective tool in PRRSV 
screening; at least four N protein domains have been identified as highly antigenic 
(Kvisgaard et al., 2013; Lurchachaiwong et al., 2008). False negatives are an 
inherent risk associated with newly emerged strains due to potential variation in 
PRRSV nucleotide sequence, however, reverse transcription quantitative real time 
polymerase chain reaction (RT-qPCR) has proven to be a powerful tool, especially 
when combined with degenerate primers (Drigo et al., 2014).  
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PRRS diagnostics traditionally use oral fluids as the sample source to detect 
Mycoplasma hyopneumoniae, influenza virus, PCV-2 and PRRSV, with saliva 
collections being pooled at the pen-level or farm-level as desired (Hernandez-
Garcia et al., 2017; Prickett et al., 2008a, 2008b). Fluids derived from processing 
fluids of docked tails and testicles have recently been demonstrated as a viable 
source (Lopez, 2018); these fluids have also been applied to bacteria including 
Mycoplasma hyopneumoniae (Vilalta et al., 2019). Tissue processing fluids may 
therefore be a streamlined source of material for bulk screening of multiple 
pathogens within a herd, making use of tissues which are otherwise wasted; 
however, tail docking is being phased out in EU nations (De Briyne et al., 2018). 
Alternative sources of diagnostic sample include faecal matter, which was used to 
isolate one of the highly pathogenic 2006 outbreak PRRSV-2 strains  (WUH4) 
(Song et al., 2012); isolating from faecal matter is not widely reported, therefore it 
is likely not a robust source of viable diagnostic sample. 
 PRRSV control by vaccination 
Vaccination is widely used in an attempt to control PRRSV and reduce production 
losses, but with limited success (Linhares et al., 2015; Rose et al., 2015). There 
are currently two types of commercial vaccine available; modified live vaccines 
(MLV) and inactivated vaccines (Kimman et al., 2009). Whilst safe, inactivated 
vaccines are only efficacious against closely related strains and thus may be at 
best considered as autogenous vaccines or boosters of pre-existing immunity 
(Charerntantanakul, 2012; Karniychuk et al., 2012; Kim et al., 2011; Vanhee et al., 
2009). MLVs have been shown to be effective against homologous strains of 
PRRSV but against heterologous strains these vaccines show variable efficacy, 
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therefore farmers theoretically need to expose their herds to a multivalent 
attenuated vaccine to gain sufficient cross-protection (Huang and Meng, 2010; 
Kimman et al., 2009). MLV are widely used but eradication from chronically 
infected herds has proved elusive thus far (Linhares et al., 2015; Rose et al., 2015). 
As described previously, PCR-based diagnostics cannot differentiate newly 
infected animals from animals previously vaccinated by MLV. More significantly, 
MLV may be shed from immunised animals and there is a risk of subsequent 
reversion to virulence and recombination with field strains (Huang and Meng, 2010; 
Kimman et al., 2009; Opriessnig et al., 2002).  For example, vaccination in 
Denmark with PRRSV-2 MLV Amervac led to disease outbreaks with virulent 
revertant strains which persist to this day (Nielsen et al., 2001), and Chinese 
PRRSV-2 strains reported shortly before emergence of HP-PRRSV-2 were shown 
to be closely related to vaccine strains (Chen et al., 2006). Recombination of MLV 
and field strains has been reported multiple times, including in the UK where only 
Porcilis is used (Frossard et al., 2013), and in France where a field strain was 
derived from two separate MLV (Eclercy et al., 2019). In China, both PRRSV-1.1 
and PRRSV-2 strains have recombined with vaccine strains, resulting in novel 
strains that are more pathogenic than their parental strains (Chen et al., 2017; 
Dong et al., 2018). Pigs have been shown to be better protected against PRRSV-
1.3 by prior infection with heterologous field strains than immunisation with 
commercial MLV, suggesting a need for greater immunogenicity of vaccine strains, 
while preserving the inherent advantage of MLV of minimal clinical signs post-
vaccination (Larcher et al., 2019). Inoculating with homologous field strains instead 
of MLV is often part of the herd closure protocol in the US (reviewed by Corzo et 
al. 2010), increasing subsequent herd immunity at the initial expense of average 
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daily weight gain, which is the primary metric for achieving slaughter weight as 
rapidly as possible.  
 New approaches to PRRS control by recombinant methods 
Variation in permissiveness to PRRS has been reported to vary between pig 
breeds in Europe and China (Kapetanovic et al., 2013a; Meng et al., 2018; Reiner 
et al., 2010). Genetic predispositions exist in pig breeds (Pena et al., 2019); for 
example, GBP5 variants have been described to correlate with resilience to 
PRRSV in large scale in vivo studies in the USA (Dekkers et al., 2017; Kommadath 
et al., 2017). To date, three groups have described recombinant modification of 
CD163 with a view to eliminating in vivo susceptibility to PRRSV-1 and PRRSV-2 
by modifying or deleting SRCR5. CD163 was modified by the introduction of frame 
shifts to truncate SRCR5, which resulted in lower expression of CD163 in all 
animals and increased haptoglobin circulation in serum (Wells et al., 2017); this 
carries concerns of maintaining healthy homeostasis, although no complications 
were reported. Resistance to PRRSV-1 was complete, but AMΦ from modified 
animals remained susceptible to PRRSV-2. The same group also modified SRCR5 
to human SRCR8, which again removed susceptibility to PRRSV-1, and reduced 
but did not complete abrogate susceptibility to PRRSV-2. Furthermore, beyond 
research purposes, transgenic animals may be more controversial than knockout 
animals to introduce to the global meat market. A second group reported deletion 
of SRCR5 using CRISPR/Cas9 targeted within the SRCR5 exon, with resistance 
to both PRRSV-1 and PRRSV-2, (Burkard et al., 2017) and resistance to PRRSV-
1.2 confirmed in vivo (Burkard et al., 2018). CD163 expression was comparable to 
non-modified animals in AMΦ and MoMΦ in vitro; MoMΦ were also screened for 
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normal expression of MΦ markers CD14, CD172a, CD151, CD203a, CD16, and 
CD169, which were all expressed consistently between wild type, heterozygous, 
and ΔSRCR5 animals. A third group has used SRCR5 deletion to remove 
susceptibility to PRRSV-2 in challenged F0 Liang Guang Small Potted pigs and 
Large White pigs (Guo et al., 2019); Burkard et al. used F1 Large White pigs, and 
Wells et al. did not report the breed of pig used, nor specify if heterozygotes were 
crossed. Guo et al. reported nuclear transfer before transfer of embryos into Large 
White sows, however it is not clear if this is the step that increased deletion 
frequency relative to the animals described by Burkard et al. 
Recombinant approaches have also been applied to make more efficient MLV. 
Mosaic viruses have been made by combining ORFs from different isolates, which 
is a more controlled version of the recombination reported in circulating strains 
(Martín-Valls et al., 2014). These have been demonstrated to increase cross-
protection compared to conventional vaccines (Cui et al., 2019). Consensus 
viruses are an alternative recombinant approach that utilises a codon optimisation 
approach at each amino acid rather than each complete ORF; consensus viruses 
have been demonstrated to provide heterologous protection between North 
American PRRSV-2 subclades (Vu et al., 2015). The consensus sequence induced 
comparable viraemia and clinical signs to heterologous challenge, however, after 
attenuating the consensus-sequence strain by passaging through MARC-145, its 
characteristic heterologous protection remained while inducing reduced lung 
pathology, viraemia, and seroconversion. 
Alternative control methods to modification of virus and host are therapeutics. 
Recombinant mAbs are an expensive as a therapeutic, but have proven effective 
in the field of human autoimmunity therapy; 60 therapeutic mAbs were undergoing 
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clinical trials in the US in 2018 alone (Singh et al., 2018). Passive immunisation 
has been increasingly revisited where vaccines are absent. Passive protection has 
been induced by transfer of serum from PRRSV recovered pigs, with sterile 
protection reported (Lopez et al., 2007). Whereas administration of tissue culture 
propagated mAbs requires large scale bioreactors, anti-swine influenza mAbs have 
been induced by adenovirus vectors and direct injections of DNA plasmids 
encoding mAb sequences (Welles et al., 2018; Yamazaki et al., 2018). Alternative 
vectors include mRNA to encode conventional mAbs (reviewed by (Schlake et al., 
2019) and recombinant peptide-mAb fusions to increase presentation of peptides 
bound to Fc receptors (Ja et al., 2005). Isolation of B cell clones reactive to PRRSV 
has recently been described in animals exposed to Chinese PRRSV-2, cross-
reacting with four Chinese HP-PRRSV-2 (Li et al., 2019) and within animals 
sequentially exposed to attenuated Spanish PRRSV-1.1, British PRRSV-1.1, 
pathogenic PRRSV-1.3, and North American PRRSV-1.2 as a source of anti-
PRRSV antibodies (Goldeck et al., 2019). The former study reported cloning the 
heavy and light chain of variable regions from single-sorted B cells in PRRSV 
infected pigs, with reported production of bi-specific GP4-GP5 binding mAbs. 
As well as recombinant animals, viruses, and mAbs, recombinant approaches have 
been applied to subunit vaccines. Supplementing feed with viral antigen has been 
demonstrated to be effective in PCV-2, using freeze-dried yeast expressing cap 
protein to deliver antigen, with a reduction in viraemia of challenged animals in 
vaccinated pigs (Patterson et al., 2015). A comparable strategy has been applied 
to PRRS using Taiwanese PRRSV-2 isolate ORF5 sequence (Deng et al., 2015). 
GP5 was expressed in banana plants, as an expression system that can be directly 
consumed by pigs (Chan et al., 2013). Viral load was significantly reduced in feed-
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vaccinated pigs in lungs, tonsil, spleen and bronchial lymph node tissue, however, 
viral load in serum was a similar order of magnitude in vaccinated animals 1 week 
after autogenous challenge. This suggests that shedding of challenged animals 
would continue to be a factor, which combined with the absence of clinical scores 
in this study, suggests that efficacy against heterologous strains may be low. 
The limitations of current vaccines means that new vaccines are required to more 
effectively control PRRSV; in order to identify more effective approaches the 
immune responses to PRRSV infection must be better understood. 
 
1.3 Porcine immune responses 
 Adaptive responses to PRRSV 
PRRSV-specific T and B cells undergo clonal expansion after migration of APC 
from the lungs to lymph nodes (Thepen et al., 1993), of which AMΦ are the most 
abundant in the lungs. Lymph nodes proximal to the lungs are known to be heavily 
inflamed during PRRSV infection (Morgan et al., 2014). This may also correlate 
with migration of AMΦ which have phagocytosed infected cell debris; DC have 
been demonstrated to increase in lymph node homing after phagocytosis of 
apoptotic tumour cells (Bertho et al., 2005). It is not certain whether MΦ are 
migrating after infection in the lungs or whether MΦ are infected after spread of 
virus, as the lymphatics have not been directly collected to quantify cell-free virus; 
this approach has been proven in cattle but is limited in swine (Vrieling et al., 2012). 
Antibody responses are generally delayed in pigs with PRRS, with virus-
neutralising antibody (nAb) production taking at least 3 weeks to emerge, 
dissipating by 8 weeks post infection, despite persistent non-neutralising 
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antibodies against N, and against NSPs after clearance of virus approximately 18 
weeks after infection (Figure 1.5). Titres of nAb when measurable are often lower 
than those elicited by other viral infections (Meier et al., 2003; Yoon et al., 1994). 
Resolution of viraemia may therefore precede the appearance of nAbs and low 
levels of virus replication can be found in lungs and lymphoid tissues in the 
presence of nAb  (Murtaugh and Genzow, 2011). Antibody responses have been 
reported to be induced more rapidly in experimental infection by strains with 
increased viraemia, such as PRRSV-1.3 Lena (Weesendorp et al., 2014a, 2013a). 
A shortfall of nAb response is generally thought to contribute to the inability to 
induce sterile immunity to PRRS in the field, however a degree of heterologous 
neutralisation has been described from infected pig sera, with partial reactivity 
described against both PRRSV-1 and -2 (Robinson et al., 2015), with an 
unexpectedly low threshold of nAb required to prevent viraemia in homologous 
infection (Lopez et al., 2007); the latter work followed up successful demonstration 
of passive transfer-induced immunity (Lopez and Osorio, 2004). Despite the 
apparent success of nAbs isolated from sera in certain literature, there has not 
been published progress in creating efficient therapeutics targeting a conserved 
epitope. Collectively, these observations suggest that PRRSV has evolved 
strategies to modulate the B cell response to evade the induction of protective 
nAbs. This may be achieved via the glycan shielding of neutralising epitopes and/or 
the promotion of B cell responses against non-neutralising decoy epitopes 
(Darwich et al., 2010). In numerous Danish isolates (Kvisgaard et al., 2013) ORF7 
contained a linear B-cell epitope (An et al., 2005) and four T-cell epitopes (Díaz et 
al., 2009); if the presence of these epitopes was deleterious it is unlikely that they 
would be conserved. 
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Figure 1.5. Adaptive immune responses to PRRSV over time. Representative viral load in 
serum is represented for typical strains with faster (purple lines) and slower (blue dashed 
line) clearance. Humoral responses are resolved into neutralising (NAb) and antibody to 
non-structural (nsp), N and GP5 proteins. Cell mediated immunity (CMI) responses do not 
peak until infection is persistent, with IFN-γ responses initially by NK and γδ T cells, and 
later by αβ T cells. Figure used with permission from Annual Review of Animal Biosciences 
(Lunney et al., 2016). 
Antigen-specific CD8+ cytotoxic T cells destroy cells presenting corresponding 
intracellular-derived viral antigen on MHC I, reducing the reservoir of cells 
containing replicative virus. Although PRRSV infection is known to result in virus-
specific T cell responses detectable in the blood after 7-14 days, few studies have 
conducted an in-depth analysis of the PRRSV-specific T cell response. An early 
study found that PRRSV infection induced PRRSV-specific proliferative CD4+ T 
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cell responses measured in an in vitro assay as well as in vivo by delayed-type 
hypersensitivity response (DTH) (Bautista and Molitor, 1997). However, a more 
recent study indicates that CD8+ T cells are the predominant population expanded 
by infection, indicating substantial priming of CD8+ responses against PRRSV 
(Costers et al., 2009). A recent study showed that PRRSV-1 SU1-Bel strain 
induced a stronger IFN-γ response than other PRRSV-1 strains, which was 
associated with enhanced clearance of the virus in the absence of neutralising 
antibody (Morgan et al., 2013). Both CD4+ and CD8+ T cells contribute to PRRSV-
specific IFN-γ responses (Mokhtar et al., 2016, 2014);  in pigs, unlike humans and 
mice, memory T cells are recognised as CD4+CD8+. While IFN-γ is known to inhibit 
PRRSV replication (Bautista and Molitor, 1999; Rowland et al., 2001), cytotoxic 
killing of infected cells by CD8+ T cells likely represents an additional important 
effector mechanism in vivo (Morgan et al., 2013). Consistent with an important 
direct role of CD8+ T cells in PRRSV control, CD8+ T cells are the dominant T cell 
population infiltrating the lungs during resolution of PRRSV infection (Samsom, de 
Bruin et al. 2000).  
Subversion of the adaptive immune responses has also, at least in the context of 
PRRSV-2 infection, been associated with the induction of immunosuppressive 
regulatory T cells (Tregs).  Tregs are induced by IL-10 and TGF-β. Natural Tregs 
are thymus derived and antigen independent, whereas induced Tregs are antigen-
specific and the result of interactions with DCs and co-stimulation with IL-10 and 
TGF-β (Josefowicz et al., 2012). PRRSV-2 infection is associated with IL-10 and 
TGF-β production and with Treg counts positively correlating with viraemia (Silva-
Campa et al., 2012). Induced Tregs have been suggested to physiologically be the 
result of a prolonged immune stimulation, in order to reduce chronic inflammation 
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and prevent auto-immune disorders (Walker et al., 2005). It has been suggested 
that induced Tregs are likely to be a feature of chronic PRRSV-1 infections where 
a sustained immune reaction can be measured, and that an increased 
inflammatory immune response is associated with increased pathology (Morgan et 
al., 2013; Salguero et al., 2015). PRRSV-1 has been shown to infect and replicate 
in MoDC but not induce Tregs (Silva-Campa et al., 2010, 2009), whereas PRRSV-
2 is able to significantly increase Tregs in vitro and in vivo (Wongyanin et al., 2010). 
 Innate responses to PRRSV 
Antigen-presenting cells (APC) play an important role in connecting the innate and 
adaptive immune systems by detecting pathogens with a host of pattern 
recognition receptors (PRR). In literature conventional DC (cDC) are professional 
APCs found at the interface to pathogen entry and can increase or decrease 
lymphocyte activity against antigens, through both stimulatory or tolerogenic 
mechanisms. Conventional presentation of intracellular peptides derived from 
infections is achieved by the ubiquitous MHC I molecule interacting with the T cell 
receptor. The function of APC is specialised in that expression of MHC II enables 
presentation of exogenous antigen to CD4+ T helper cells. Furthermore, APC are 
capable of cross-presentation, processing foreign peptides via the endogenous 
MHC I pathway, enabling presentation of exogenous antigen to somatic cells; this 
interaction is enhanced with cytotoxic T lymphocytes by the T cell co-receptor CD8. 
CD1a enables presentation of amphipathic lipid antigens to NKT cells (Barral and 
Brenner, 2007), and mannose receptors play a role in taking up soluble antigen by 
endosomal rather than lysosomal pathways (Burgdorf et al., 2010, 2010), and 
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immunomodulatory stimulation by triggering CTLA4 on CD8 T cells (Schuette et 
al., 2016). 
During any viral infection type I interferon (IFN) production is an early innate 
immune response to contain and reduce viral load. PRRs integral to detection of 
microbe associated molecular patterns (MAMPs), such as PRRSV proteins and 
RNA, include membrane-bound toll-like receptors (TLRs), and cytoplasmic RIG-I-
like receptors (RLRs) and NOD-like receptors (NLRs). Fc receptors and active 
complement component receptors play roles in cell priming and indirect recognition 
of PRRSV via interactions with virus or cells opsonised by Abs or complement. 
RLRs, as well as MDA5, are RNA helicases which recognise dsRNA which forms 
in PRRSV replication complexes. MDA5 activates mitochondrial antiviral-signalling 
protein (MAVS), which when aggregated induces dimerization of IFN regulatory 
factors (IRFs) 3 and 7 (Hou et al., 2011). IRFs are transcription factors for type I 
IFN-α and -β. Type I IFN in turn activates numerous interferon stimulated genes 
(ISGs) to increase anti-viral responses in an autocrine and paracrine fashion 
(reviewed by Crosse et al., 2018) (summarised in Figure 1.6). IRFs are also 
activated by TLR-3 and -4 via the MyD88 adaptor protein transducing signal via IL-
1 receptor-associated kinases (IRAKs) and TNF receptor associated factor 3 
(TRAF3). IRAK interaction with TRAF6, rather than TRAF3, leads to transcription 
factors CREB, AP1 and NF-κB translocation to the nucleus via phosphorylation by 
TAK1 complexed with adaptor proteins TAB2 and TAB3 (Cheung et al., 2004; 
Shinohara et al., 2016); CREB and AP1 are contingent on p38 and JNK, 
respectively, whereas NF-κB is contingent on IκB kinases (IKKs). IKKs and IRAK 
are also activated by the IL-1 receptor, which is triggered by extracellular IL-1, 
released by pyroptotic cells. 
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Figure 1.6. Summary of PRR pathways. TLR, RLR, NLR, and cytosolic nucleic acid 
sensors are involved in mediating responses to infection via direct detection of MAMPs; 
signal transduction pathways converge in both inflammasome activation and increased 
transcription factor expression for antiviral and pro-inflammatory cytokines, leading to 
autocrine and paracrine positive feedback. Figure used with permission from Nature 
Immunology Reviews (Cao, 2016). 
1.3.2.1 Ontogeny of the mononuclear phagocyte system  
The mononuclear phagocyte system (MPS) is comprised of circulating and tissue-
resident populations of APC; monocytes, MΦ and dendritic cells DC. Stimulating 
monocytes with growth factors to a DC or MΦ phenotype is an established model 
for T cell proliferation (Pozzi et al., 2005) and autologous vaccines in oncology 
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(Nesselhut et al., 2015), however, DC and MΦ are often referred to in literature 
without factoring in their origin. It has been demonstrated that the lung niche can 
be colonised in a self-renewing fashion by monocytes derived from the yolk sac, 
bone marrow or foetal liver (Ginhoux and Guilliams, 2016; Röszer, 2018; Y. Zhao 
et al., 2018), however, in normal homeostasis MΦ resident to the liver, brain, 
epidermis, and lung are seeded by an erythro-myeloid progenitor distinct from 
haematopoietic stem cells (Gomez Perdiguero et al., 2015). Monocytes are the 
precursor to certain resident MΦ in the intestines, dermis and heart, but are 
typically only recruited into tissues following inflammation due to injury or infection, 
where the milieu created by cytokine and other immunomodulatory factors drive 
monocyte differentiation to MΦ- or DC-like phenotypes (Ginhoux and Jung, 2014). 
MΦ response to LPS is reported to vary between compartmental origin; PCA of 
transcriptomic data from MΦ generated in vitro from bone marrow or peripheral 
blood monocytes cluster away from AMΦ isolated by lung lavage; both LPS 
stimulated and untreated AMΦ cluster away from bone-marrow derived and 
monocyte-derived MΦ, which each cluster together into groups of stimulated and  
untreated cells (Kapetanovic et al., 2013a). Furthermore, MoDC are associated 
with an inflammatory response in vivo; monocyte differentiation occurs after 
migration into tissues from the peripheral blood, following a chemokine gradient, 
which occur in response to damage or infection (Campbell et al., 2011). 
Monocytes and MΦ share a haematopoietic myeloid progenitor with DC. 
Haematopoietic stem cells colonize the thymus, spleen and populate the bone 
marrow (BM), which serves as the reservoir for adult haematopoiesis. Steady-state 
DC retain expression of CD34 when differentiating from the common DC 
progenitor, unlike most terminally differentiated cells, and develop dependent on 
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stimulation by the myeloid growth factor Flt3 (Balan et al., 2014; Karsunky et al., 
2003). Flt3 receptor is expressed by DC precursors and circulating DC, but not DC 
differentiated from monocytes or bone marrow culture by GM-CSF treatment, nor 
any other leukocytes; Flt3 is therefore a robust marker for “true” DC (Guzylack-
Piriou et al., 2010). DC are traditionally viewed as the most efficient at lymphocyte 
stimulation (Guidos et al., 1984; Pozzi et al., 2005). 
1.3.2.2 Mononuclear phagocyte system subsets and roles 
During maturation, cDC readily initiate micropinocytosis to process soluble 
antigens and phagocytosis for particulate antigens, while mature cDC migrate, 
following chemokine gradients, to lymphoid tissue to interact with T cells. Two 
functionally discrete cDC populations have been described: cDC1, which express 
XCR1, TLR3 and 8, produce IL-12 and are highly efficient at cross-presenting 
exogenous antigen to CD8+ T cells; and cDC2, which express high levels of MHC 
class II and are most efficient at inducing CD4+ Th2 responses (Merad et al., 2013). 
Plasmacytoid DC (pDC) abundantly produce type I IFN  in response to MAMP 
stimulation (Fitzgerald-Bocarsly et al., 2008; Summerfield et al., 2003a). pDC may 
additionally complement cDC MHC class I and II presentation of antigenic peptides 
(Villadangos and Schnorrer, 2007), however, the lymphocyte proliferation capacity 
of pDC is reportedly lower than cDC (Edwards et al., 2017).  The anti-viral role of 
porcine pDC is further supported by high expression of TLR3 and TLR7 assessed 
in tonsil-resident populations, relative to cDC and CD14+ cells (Soldevila et al., 
2018). Porcine pDC are described to show lesser capacity to stimulate T cells than 
cDC, and are professional interferon producing cells that recognise PRRSV 
infected macrophages (García-Nicolás et al., 2016). 
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Principle component analysis of porcine genes has demonstrated that monocytes 
and monocyte-derived cells cluster away from porcine BDC subsets (Auray et al., 
2016; Edwards et al., 2017), supporting previous findings in sheep, mice, and 
humans (Tang-Huau et al., 2018; Vu Manh et al., 2015). Lung parenchyma derived 
MoDC have been reported to express multiple chemokine receptors comparably to 
cDC1 and cDC2, but cluster more closely to MoMΦ and AMΦ for expression of 
colony stimulating factor 1-receptor, phagocytosis regulator MerTK, Fcγ receptor 
CD64, and lack steady-state DC marker Flt3 (Bordet et al., 2018b; Maisonnasse 
et al., 2016), suggesting an intermediate niche for MoDC in vivo. Despite this 
functional separation, BDC share a haematopoietic myeloid progenitor with 
monocytes and MΦ. MoDC are widely used in the literature as a model for DC in 
context of both myelotropic virus infection and antigen presentation, including the 
clinical setting, using antigen-loaded autologous ex vivo MoDC as a cancer 
immunotherapy (Huber et al., 2018), and in chronic viral infections such as HIV (da 
Silva et al., 2018) and hepatitis (Chen et al., 2005). 
1.3.2.3 Orthologous populations in pigs (and other species) 
MΦ responses to LPS are more related in humans and pig than between pig and 
mouse or human and mouse (Kapetanovic et al., 2012). Orthologous populations 
of cDC have been aligned across human, mouse and pig using XCR1 and CD172a 
(Dutertre et al., 2014); these markers have been applied to cattle (K. Li et al., 2017), 
chickens (Vu Manh et al., 2014), and horses (Ziegler et al., 2016), with minor 
variations in strategy as availability of key reagents varies between species. 
Porcine DC subsets have been defined in blood as: pDC, CD4+ CD135+ CD172a+ 
CD123+ CD303+; cDC1, CD135+ CD14- CD172alow CADM1+ wCD11R1+; and cDC2, 
CD135+ CD14- CD172a+ CADM1+ CD115+. Functional studies have confirmed their 
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role as orthologous to DC subsets in other species, and microarrays have 
confirmed their genetic distance from monocyte-derived cells (Auray et al., 2016; 
Edwards et al., 2017). 
Porcine peripheral monocytes pre-differentiation have not been described to 
entirely match the classical/non-classical monocyte phenotyping described in 
humans and mice; the most differentially expressed genes in freshly isolated 
monocytes cluster strongly into CD14lowCD163high and CD14highCD163low 
populations, whereas a CD14-CD163-CD16+ also exists (Kapetanovic et al., 
2013a).  
MoMΦ activation and polarization in vitro are reported to present M1 and M2 
phenotypes in vitro comparably to isolated MΦ polarised in vivo, (Cui et al., 2018; 
Ruytinx et al., 2018). M1 are broadly associated with pro-inflammatory microbial 
defence, whereas M2 are associated with anti-inflammatory tissue homeostasis, 
with differences in their migratory properties as well as expression of key surface 
proteins such as MHC (Italiani and Boraschi, 2014). Deriving M1 and M2 MΦ from 
monocytes in humans has recently been expanded from the CD14-CD16 
dichotomy of classical/intermediate/non-classical peripheral monocyte populations 
by resolution of chemokine co-receptor (CCR)2 and MHC II within a CD64+CD86+ 
population, and a CD33low population within a CD86+CD64low population (Ong et 
al., 2019). 
1.3.2.4 Porcine antigen-presenting cell interactions with PRRSV 
The essential PRRSV entry receptor, CD163, is associated with antigen uptake by 
phagocytosis, and is therefore expressed by MΦ, Langerhans cells, and to a lesser 
extent cDC-like subsets (Marquet et al., 2014; Piriou-Guzylack and Salmon, 2008). 
Porcine peripheral blood cDC1, cDC2 and pDC in pigs have been recently 
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described, using alternative markers to those described in humans and mice 
(Auray et al., 2016; Edwards et al., 2017). Lung-derived DC (Bordet et al., 2018a). 
Human blood DC populations have been further characterised by single cell 
transcriptomics, with multiple CD163+ populations identified as efficiently inducing 
CD4 and CD8 T cell proliferation (Villani et al., 2017). There are limited ex vivo or 
in vitro studies to support or refute cDC permissiveness to PRRSV. Limited studies 
of pDC have suggested that these cells are resistant to PRRSV infection but 
activate in response to detection of PRRSV in susceptible neighbouring cells more 
efficiently than cell-free virus (Baumann et al., 2013; García-Nicolás et al., 2016). 
PRRSV-1 infected lung DC have been described previously (Pröll et al., 2017), 
however, these lung-derived DCs are described to be cultured until becoming 
confluent, suggesting they are actively proliferating and therefore may not be 
terminally differentiated. Furthermore, isolation of cells in this publication referred 
to a previous paper (Loving et al., 2007), wherein cells were isolated by CD11c 
expression alone and subsequently characterised as CD14+, which alongside 
microscopy images, suggesting that these cells are more akin to monocyte-derived 
cells than steady-state DC, as described above. A comprehensive study on 
PRRSV-1 modulation of ex vivo cDC was published during the course of my own 
infection experiments. Bordet et al. (2018) demonstrated that lung parenchyma 
derived cDC1 and cDC2 are not susceptible to PRRSV-1.3 Lena nor PRRSV-1.1 
strains Lelystad and 13V091, lowly and highly pathogenic PRRSV-1.1 strains 
respectively. Lena, however, induced anti-viral cytokine responses in cDC1. 
In vitro generated monocyte-derived cells are an established model for PRRSV 
infection (Rodríguez-Gómez et al., 2015; Silva-Campa et al., 2010; Singleton et al., 
2016); bone marrow and monocyte-derived DC are permissive to PRRSV infection, 
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despite their lower CD163 expression than MΦ (Chamorro et al., 2004; Singleton 
et al., 2016). Bordet et al. (2018a) demonstrated that porcine lung parenchyma 
MoDC are susceptible to PRRSV-1 in vivo. MoMΦ activation to M1 and M2 
phenotypes has previously been described as manipulating the susceptibility to 
PRRSV-1 and -2, with IFN-γ induced M1 showing significantly reduced infection 
rates 20 hpi by PRRSV-1.1, an effect not observed in highly pathogenic PRRSV-
1.3 Lena (García-Nicolás et al., 2014a). Combining activating cytokine IFN-γ and 
LPS has been reported to reduce replication of Lena, an effect that was observable 
at 24 hpi onwards and not 16 hpi (Singleton et al., 2016). Both reports did not 
observe these differences in IL-4 treated M2 MoMΦ, despite lower CD163 
expression in M2. Enhanced replication is a characteristic shared by highly 
pathogenic PRRSV-1.3 Lena and highly pathogenic PRRSV-2 subgroup 4 strains, 
but not PRRSV-1.3 SU1-Bel (Morgan et al., 2013; Weesendorp et al., 2014a; K. 
Zhao et al., 2018). Treatment by MoMΦ with alternative activation cytokines has 
demonstrably reduced permissiveness to a range of PRRSV-1 strains, apparently 
reducing pathogenic strain replication to a lesser extent than low pathogenicity 
strains (Ogno et al., 2019a). 
In vitro PRRSV replication in AMΦ is shown to be inhibited by both type I (IFN-α & 
β) (Albina et al., 1998) and type II (IFN-γ) interferons (Bautista and Molitor, 1999). 
This is countered in part by PRRSV mediated immune evasion mechanisms 
targeting both interferon and NF-κB signalling pathways (Fu et al., 2012; Van Reeth 
et al., 1999). In vitro studies have shown that PRRSV deploys multiple proteins to 
modulate innate immune responses. Both non–structural proteins (NSP1, NSP2, 
NSP4 and NSP11) and the nucleocapsid (N) protein have all been shown to 
modulate innate immune response signalling pathways (Sun et al., 2012). NSP1 
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interferes with the IRF3-mediated IFN production in the nucleus and the NF-κB-
mediated pathway in the cytoplasm and may modulate the type I IFN response 
through its interaction with feedback inhibitors of the JAK-STAT pathway. NSP2 is 
involved in the blocking of IFN regulatory factor 3 (IRF-3) activation. NSP4 
suppresses NF-κB-mediated IFN-β production and NSP11 functions as an 
endoribonuclease, inhibiting the RIG-I induced type I IFN response by degrading 
IFN-ß promoter stimulator-1 (IPS-1) mRNA (Luo et al., 2008).  This inhibits dsRNA-
mediated IRF-3 nuclear translocation (Subramaniam et al., 2010). Chen et al. 
(2010) demonstrated that NSP-1β also blocks nuclear translocation of STAT1, 
which blocks downstream signalling for all IFN production. 
European PRRSV-1.3 and Asian HP-PRRSV-2 strains are associated with 
increased pro-inflammatory cytokine expression (IL1-α, IL-6, TNF-α, IL-10 and 
IFN-γ) in infected pig lungs compared with low pathogenicity strains (Liu et al., 
2010; Morgan et al., 2014; Weesendorp et al., 2013a; Xiao et al., 2010; L. Zhang 
et al., 2013), which correlates with observed inflammation and tissue/organ 
damage. In vivo studies of PRRSV-1.3 Lena compared to prototype Lelystad 
demonstrated that Lena upregulated of IL-1β, IFN-α, IL-10, IL-12, and IFN-γ mRNA 
in blood around 7 dpi in infected animals, with TNF-α being further up-regulated in 
PRRSV-1 infected pigs (Weesendorp et al., 2016, 2014b).  A related study 
compared PRRSV-1.3 SU1-Bel to a British field strain and attenuated Spanish 
strain. IFN-γ and IL-1β secretion from bronchoalveolar lavage fluid (BALF) cells 
showed a significant positive correlation with the gross pathology scores following 
PRRSV-1.3 infection. Conversely, the expression of IL-10 by BALF cells showed a 
significant negative correlation with pathology. SU1-Bel was reported to present 2-
fold lower viraemia than low pathogenicity Lelystad, despite severe pathology, 
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whereas Lena was described by Weesendorp et al. to present significantly 
elevated viraemia compared to low pathogenicity strains. That viraemia can vary 
so widely among pathogenic PRRSV-1 strains suggests mechanisms other than 
enhanced viral replication, such as an exacerbated inflammatory immune reaction, 
are responsible for the enhanced tissue pathology associated with these strains. 
Pyroptosis is a form of lytic cell death, unlike apoptosis, which leads to blebbing of 
membrane-bound bodies, mediated by the inflammasome. Caspases are 
proteolytic enzymes that serve roles in apoptotic and pyroptotic death pathways; 
the former of which has been reported in response to PRRSV infection (Costers et 
al., 2008; Kavanová et al., 2017a; Labarque et al., 2003), and the latter of which 
has been described in limited PRRSV-2 studies (J. Li et al., 2015; K. Zhang et al., 
2013). Caspase-1 cleaves pro-IL-1β, pro-IL-18 and gasdermin to their active forms; 
the absence of pore-forming gasdermin blocks pyroptotic cytokine secretion, and 
has been reported to instead lead to apoptosis (reviewed by Tsuchiya et al., 2019). 
Caspase-1 is cleaved to its active form by the inflammasome molecule, sometimes 
referred to as the pyroptosome in literature, which is named for their scaffold 
protein; NLRP, AIM2, NLRC. The inflammasome components co-localise in the 
cytoplasm and not with any cell organelles (Wang et al., 2013). NACHT, leucine 
rich regions (LRR), and pyrin domain (PYD) domains-containing protein 3 (NLRP3) 
inflammasome oligomerises with apoptosis-associated speck-like protein 
containing a CARD (ASC) to become its active heptameric form (summarised in 
Figure 1.7). In normal homeostasis the pro-inflammatory response induced by 
NLRP3 enables a protective inflammatory response to aid recruitment of 
leukocytes to damaged sites, however, pathology can be induced by excessive 
activation of the inflammasome (reviewed by Yu et al., 2017), including by gain of 
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function mutations in autoimmunity (Hoffman et al., 2001). Activating damage 
associated molecular patterns (DAMPs) include extracellular ATP, urate crystals, 
or pore-forming toxins. Environmental DAMPs in human health include diesel 
particles, demonstrated to cause lung infiltration by leukocytes in mice (Provoost 
et al., 2011), and in the livestock industry particulates in pig housing have been 
described to induce NLRP3 mediated oxidative stress (Tang et al., 2019).  
PRRSV-2 has been reported to induce IL-1β secretion by activating the 
inflammasome. Murine bone marrow-derived Flt3+MHC IIhigh DC are reported to be 
negative for NLRP3, while CD209a+ DC that do not share the pre-cDC progenitor 
(therefore akin to MoDC) were reported to express the inflammasome molecule 
NLRP3 (Erlich et al., 2019); the authors therefore suggested that the 
inflammasome is restricted to MΦ and monocyte-derived cells. However, porcine 
cDC1 have been demonstrated to express NLRP3 (Auray et al., 2016). This 
conflicts with human literature, where more variants of inflammasome-forming 
NLRs exist, with distribution appearing to be broader (Jha et al., 2017; Kummer et 
al., 2007). Pigs have been reported to lack the NLRC4 and NAIP genes, whereas 
they are present in mice and humans (Dawson et al., 2017; Sakuma et al., 2017). 
Responses in porcine bone marrow-derived MΦ and PBMC to NLRP3 MAMPs has 
been described to induce IL-1β (Kim et al., 2014). NEK7 has been described as an 
NLRP3-specific adapter; NEK7 interacts with NLRP3, but not the other 
inflammasome sensors NLRC4 or absent in melanoma (AIM2), therefore NEK7 is 
likely conserved within pigs. 
A range of viruses have been described to interact with the inflammasome, either 
as part of the replication cycle or as part of the effective host response. Severe 
acute respiratory syndrome (SARS)-coronavirus (CoV) E protein has been 
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described to activate NLRP3, leading to pulmonary oedema (Nieto-Torres et al., 
2015). Hepatitis C virus RNA is reported to activate the NLRP3 inflammasome in 
a dose-dependent manner, but it was unclear in the report if this confers a 
replicative advantage (Chen et al., 2014). In mice, NLRP3 activation has been 
described as protective in influenza A infection, aiding viral clearance and reducing 
mortality (Allen et al., 2009). A similar beneficial effect of NLRP3 has been 
described in rabies virus infection, wherein infected bone marrow-derived DC 
produce IL-1β only in response to live infectious virus, and IL-1 receptor deficient 
mice presented more pathology when infected (Lawrence et al., 2013). PRRSV-2 
RNA is reported to be directly detected via the PRR dead-box helicase 19A 
(DDX19A) in AMΦ (J. Li et al., 2015). The authors demonstrated that DDX19A 
directly bound HP-PRRSV-2 HuN4 (2006 Chinese outbreak strain) RNA but did 
not directly bind synthetic MAMP analogues such as Poly I:C. HP-PRRSV-2 strains 
SDA2 and HuN4 induced IL-1β and TNF-α to comparable levels as LPS priming 
and ATP treatment, unlike the comparatively lower virulence 1995 prototype 
Chinese PRRSV-2 strain CH-1a, and the MARC-145 attenuated variant of HuN4. 
DDX19A knockdown was shown to reduce HuN4 replication, suggesting that 
inducing pyroptosis confers a replicative advantage to pathogenic PRRSV. 
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Figure 1.7. Summary of the NLRP3 inflammasome signalling pathway. Priming by MAMPs 
and pro-inflammatory cytokines leads to increased expression of inflammasome 
components. Subsequent PAMPs and DAMPs inducing potassium efflux and calcium 
influx leads to oligomerisation of inflammasome components and formation of the 
complete inflammasome. Active inflammasome matures IL-1β, leading to inflammatory 
cytokine release and pyroptosis. Figure used with permission from Nature Immunology 
Reviews (Swanson et al., 2019). 
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1.4 Research question & objectives 
Since there was limited information available on the susceptibility and interactions 
of PRRSV with porcine DC subsets, this project aimed to address this and test the 
underlying hypothesis that increased PRRSV-1 pathogenicity is associated with an 
enhanced capacity to infect and dysregulate DC subset function. The project 
focussed on PRRSV-1 due to its endemicity in Europe and the UK and utilised 
PRRSV-1 strains whose virulence have recently been characterised in vivo.   
The primary aim was initially to assess susceptibility of BDC to PRRSV-1.3 strains 
to determine whether expanded myeloid tropism is responsible for the increased 
pathology observed in vivo. This was expanded to characterise further MΦ and 
monocyte-derived subsets, both as model APC and as permissive cells relevant to 
in vivo infection, to identify responses evoked or modulated differentially by 
PRRSV-1.3.  
To test these hypotheses, the following specific objectives were investigated:  
Chapter three: 
1. To optimise enrichment and phenotyping strategies for BDC subsets.    
2. To assess BDC susceptibility to PRRSV-1.1 and -1.3 strains and resultant 
cytokine responses. 
Chapter four: 
1. To characterise permissiveness and replication kinetics of PRRSV-1.1 and 
PRRSV-1.3 strains in ex vivo AMΦ and in vitro generated MoMΦ and 
MoDC.  
2. To characterise activation states and functional responses to MoMΦ and 
MoDC infection with to PRRSV-1.1 and -1.3 strains.  
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Chapter five: 
1. To evaluate the significance of inflammasome activation in pro-inflammatory 
cytokine induction by PRRSV-1.3 infection   
2. To compare the modulation of the transcriptomes of MoMΦ infected by 
PRRSV-1.3 strains Lena and SU1-Bel  
3. To characterise novel cell lines for future application in characterising 
PRRSV-1.3 pro-inflammatory activation 
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Chapter 2 : Materials & methods 
2.1 Ethics statement 
Porcine lungs and whole blood were collected from 3 week old PIC 
359/Camborough 23 cross-bred piglets from an isolated, high-health pig farm. 
Tissues were collected in accordance with the UK Animals (Scientific Procedures) 
Act 1986 under Project Licence number PPL 70/7725 and animals euthanised 
under Schedule 1 by personal license holders by barbiturates overdose; blood was 
collected during subsequent exsanguination. Blood was obtained from adult 
animals of the inbred Babraham herd in the same manner, courtesy of the Animal 
Plant and Health Agency (APHA), Addlestone, UK. In addition, adult pig blood was 
purchased from a local meat wholesaler; blood was collected by staff during 
exsanguination after electrical stunning.  
 
2.2 PRRSV-1 infection 
 PRRSV-1 strains 
Six European PRRSV-1 strains were included in this study. Two western European 
PRRSV-1.1 strains previously attenuated by MARC-145 adaptation (DV and 
Olot/91), two British PRRSV-1.1 field strains (H2 and 215-06), both characterised 
as lowly pathogenic, and two Belarusian PRRSV-1.3 field strains (Lena and SU1-
Bel), both characterised as highly pathogenic. All PRRSV-1 strains used in this 
study were kindly provided by Dr Jean-Pierre Frossard, Virology Department, 
APHA. DV is a commercially available vaccine strain, closely related to the 
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prototype European PRRSV-1 strain Lelystad virus-Ter Huurne (hereafter referred 
to as Lelystad). DV has previously been tested in controlled in vivo studies, where 
no viraemia was detected (Morgan, 2013). Olot/91 is a Spanish isolate that has 
been passaged through MARC-145, but retains myeloid tropism (Plana Duran et 
al., 1997; Plana et al., 1992). H2 was isolated from the serum of an adult sow in 
North Humberside, UK, in 1991 (Lewis et al., 2010). 215-06 was isolated in 2006 
from the serum of a post-weaning piglet showing signs of wasting and poor 
condition on a farm in Sussex, UK. Subtype 3 strain SU1-Bel was isolated from 
lung tissue homogenate of a 30-day old piglet pig from Belarus in 2010 (Morgan et 
al., 2013). Subtype 3 strain Lena was isolated from a Belarusian farm with 
reproductive and respiratory failure (Karniychuk et al., 2010). The relatedness of 
these strains is summarised in Figure 2.1, including prototype strain Lelystad as a 
reference.  
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Figure 2.1. Phylogenetic relationship between PRRSV-1 strains used in monocyte-derived 
cell infection studies. Full genome alignments of 52 full genome sequences were 
conducted in MEGA6 using ClustalW and the neighbour-joining method. The optimal tree 
with the sum of branch length = 3.697 is shown. The tree is drawn to scale, with branch 
lengths in the same units as those of the evolutionary distances used to infer the 
phylogenetic tree; evolutionary distances are in the units of the number of base 
substitutions per site. Where publicly available, the GenBank accession code for each 
strain of interest is listed in parentheses. Phylogenetic tree kindly provided by Dr Jean-
Pierre Frossard, Virology Department, APHA. 
 
 PRRSV-1 propagation 
Tissue culture adapted strains Olot/91 and DV were propagated in MARC-145 cells 
(provided by Jean-Pierre Frossard, APHA; accession # CVCL_4540), an African 
green monkey kidney epithelial cell line derived from the MA-104 line. MARC-145 
cells were maintained in Dulbecco’s modified Eagle media with Glutamax (DMEM; 
Thermo Fisher Scientific, Paisley, UK) supplemented with 100 U/mL penicillin and 
100 µg/mL streptomycin (1x Pen/Strep; Thermo Fisher Scientific) and 10% heat-
inactivated foetal bovine serum (FBS; APS Life Sciences Group, Barnet UK) 
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referred to as cDMEM, incubated at 37°C in 5% CO2. PRRSV-1 field strains were 
propagated in AMΦ cultured in Roswell Park Memorial Institute Glutamax medium 
(RPMI-1640, Thermo Fisher Scientific), supplemented in the same way as cDMEM 
(cRPMI). MARC-145 were cultured at 2x106 cells/T75 flask and AMΦ cultured at 
1x106 cells/well in 24 well plates. Both cell types were seeded the day before 
inoculation at a multiplicity of infection (MOI) = 0.1 and incubated for 48 hours at 
37°C in 5% CO2. Supernatant was removed and cells lysed in residual volume by 
freeze-thaw twice at -80°C. The lysed cells were washed with the culture 
supernatant, collected and clarified by centrifugation at 500 x g for 15 minutes at 
4°C, aliquoted and stored at -80°C. Mock virus supernatants were prepared in the 
same way but with inoculation of media containing no virus. Throughout cell culture 
and infection cells were inspected to monitor viability and morphology using a DMi1 
(Leica) inverted microscope, using objectives lenses with a total magnification of 
40X, 100X and 400X. 
All strains were passaged twice to obtain an infectious master-stock; this 
corresponded with passage 4 of 215-06 and SU1-Bel isolates, whereas all other 
strains were received with an unspecified number of prior passages. 
 Virus titre assessment by immunohistochemistry peroxidase assay 
Immunoperoxidase (IPX) staining is an established assay system for quantifying 
viral titres. Cytopathic effect (CPE) caused by PRRSV can be unclear in low MOI 
conditions (during end-point dilution of virus) and cell death, particularly of primary 
cells such as AMΦ, can be confused with CPE caused by virus infection. As AMΦ 
were not cultured with complete cell-to-cell contact, as epithelial cell lines, discrete 
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plaques were additionally difficult to assess. Assessment of staining of the serially 
diluted infection series by HRP-based immunohistochemistry allowed accurate 
identification of individual infected cells to determine the end-point dilution at which 
infection is detectable. Staining of infected MARC-145 and AMΦ, dependent on 
the strain tested, was carried out 3 days after infection using a modified version of 
the method described by van der Linden et al. (2003). Cell monolayers were 
seeded the day before infection; 2x104 MARC-145 cells/well or 1x105 AMΦ/well. 
10-fold serial dilutions of virus suspension were added to a minimum of 4 replicate 
wells per dilution of in Nunclon Delta tissue culture-treated 96 well flat-bottom 
plates (Thermo Fisher Scientific) and incubated for 72 hours before IPX staining. 
Cell monolayers were fixed and permeabilised with a solution of 0.1% Triton X-100 
(Sigma-Aldrich, Poole, UK), 2% paraformaldehyde (PFA; Affymetrix UK, High 
Wycombe, UK) in pH 7.0-7.3, phosphate buffered saline without supplementation 
of magnesium and calcium (PBS; Central Services Unit, The Pirbright Institute). 
Cell monolayers were washed three times before and after fixation and between 
all staining steps using PBS containing 0.2% Tween20 (PBSt). A pan-PRRSV 
specific anti-nucleocapsid (N protein) 1AC7 monoclonal antibody (mAb) (Ingenasa, 
Madrid, Spain) diluted 1:1600 in PBSt was added to cells which were then 
incubated for 1 hour at room temperature (RT). After washing, horseradish 
peroxidase (HRP) conjugated polyclonal rabbit anti-mouse immunoglobulin 
secondary antibody (Agilent Technologies, Stockport, UK) was diluted 1:800 in 
PBSt and added to cells and incubated for 1 hour at RT. Cells were washed and 
freshly prepared 3,3’-diaminobenzidine (DAB) Peroxidase Substrate Kit with Nickel 
(Vector Laboratories, Peterborough, UK) was added to the cells per manufacturer’s 
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recommendations. Cells were incubated for 5-10 minutes at RT (depending on 
rapidity of staining development), inspected at 2 minute intervals until black 
cytosolic colour development was observed, then washed once with water. Plates 
were inspected using an inverted microscope and cells deemed PRRSV-infected 
by the presence of black cytosolic staining, counting the number of positive wells 
within each virus dilution. Virus titres were calculated as 50% tissue culture 
infectious dose (TCID50) using the Spearman-Karber method (Hamilton et al., 
1977) and converted to log10 before analysing titres.  
 In vitro PRRSV-1 infection 
Cells were seeded in 100 µL volumes in 96 well plates at the same density as 
TCID50 assays; 2x104 cells/well MARC-145 and CΔ2+ cells, 1x105 cells/well AMΦ, 
monocytes, and enriched blood-derived dendritic cells. Flat bottom plates were 
used when fluorescent microscopy or immunohistochemistry was the method of 
assessment, whereas round bottom plates were used when cells were to be 
resuspended for flow cytometric staining. Unless otherwise stated, cells were 
seeded the day before infection (approximately 24 hours). At the time of inoculation 
75 µL of culture media was aspirated before addition of 100 µL of inocula diluted 
in the appropriate complete media to yield the specified MOI. Inoculated cells were 
incubated at 37°C for 90 minutes before removal. Inocula were washed by 
aspirating and replacing 100 µL media twice, topping up to 100 µL in complete 
media before returning cells to 37°C for the specified time-interval; the 90 minute 
inoculation time was included in the total time-interval.  
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 Virus stock confirmation by Sanger sequencing of ORF5 
PRRSV-1 strains were sequenced to confirm their identity and to screen for genetic 
drift which could have been introduced during prior passaging. Phylogenetic 
analyses tree generation are courtesy of Dr Jean-Pierre Frossard, APHA, UK. 
RNA was extracted from virus stock supernatant by TRIzol phase separation, 
mixing 400 µL of supernatant with 400 µL of TRIzol Reagent (Qiagen) to and 
resting at RT for 5 minutes to lyse virus particles. 200 µL of chloroform was added 
and vortexed, for a ratio of 2 parts TRIzol, 2 parts sample, and 1 part chloroform. 
This mixture was centrifuged at 16000 x g for 15 minutes at 4°C in a pre-cooled 
micro-centrifuge. The upper aqueous phase containing RNA was aspirated, taking 
care not to collect or disrupt the interphase of proteins or the lower phase. The 
aqueous phase was mixed with an equal volume of molecular grade ethanol and 
added in 700 µL volumes to a Monarch Total RNA Extraction (NEB, Hitchin, UK) 
spin column, following manufacturer’s instructions, eluting in 50 µL pre-warmed 
molecular grade water. Extracted RNA was quantified by nanodrop and 9 µL taken 
to RT-PCR using a SuperScript IV kit (Thermo Fisher Scientific) per manufacturer’s 
instructions, using random hexamers. A thermocycler was used for annealing at 
65°C for 5 minutes, holding at 4°C until the RT master-mix was ready. The RT-
PCR step incubated for 10 minutes each at 23°C, 55°C, 80°C, before holding at 
10°C. cDNA was stored at -20°C or taken to PCR immediately. 25 µL reaction 
volumes were prepared for PCR, using Q5 polymerase (NEB) and ORF5-spanning 
primers as described in (Kvisgaard et al., 2013): TGAGGTGGGCTACAACCATT 
forward primer, ACAAAAAATCTTGCTAGCCT reverse primer. The reverse primer 
was predicted to be fully complementary to Olot/91 but mismatch SU1-Bel and 
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Lena in 3 positions, therefore the published primers were tested alongside primers 
adjusted to be 100% complementary to the SU1-Bel reference sequence 
(KP889243); the published mismatching primer pair was found to have greater 
PCR efficiency than using the adjusted reverse primer. PCR reactions were run on 
a thermocycler following a 60°C 1 minute incubation before 30 cycles of 98°C 10 
seconds, 67°C 30 seconds, 72°C 20 seconds, before a final 5 minutes at 72°C, 
holding at 10°C. PCR products were gel purified using 1% agarose TAE (Thermo 
Fisher Scientific) gel including SYBR safe (Invitrogen), run with 1kb Hyperladder 
(Invitrogen) at 70V for 40 minutes. The gel was visualised in a UV transilluminator 
and the 600bp band excised. DNA was isolated from the excised gel using a 
Monarch Gel Extraction kit (NEB) per manufacturer’s instructions, eluting in elution 
buffer pre-warmed to 37°C. Purified DNA was diluted in molecular grade water to 
5 ng/µL and send to Source Biosciences (Cambridge) for Sanger sequencing. 
Sequencing files were aligned to reference sequences using VectorNTI v11.5.4 
(Invitrogen).  
PRRSV-1 strains Olot/91, 215-06, and SU1-Bel P3, P4A and P4B were prepared 
for sequencing myself, whereas Lena, H2 and DV were processed and sequenced 
by APHA’s proprietary sequencing service in collaboration with Jean-Pierre 
Frossard. 
 Phylogenetic analysis 
Phylogenetic trees presenting relatedness of whole genome sequences and 
ORF2b sequences were kindly shared by Dr Jean-Pierre Frossard. Optimal trees 
were presented with sum length specified in individual figure legends. Evolutionary 
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history was inferred using the neighbour-joining method (Saitou and Nei, 1987). If 
greater than 70%, the percentage of replicate trees in which the associated taxa 
clustered together in the bootstrap test (1000 replicates) are shown next to the 
branches  (Felsenstein, 1985). Trees were drawn to scale, with branch lengths in 
the same units as those of the evolutionary distances used to infer the phylogenetic 
tree. The evolutionary distances were computed using the Kimura 2-parameter 
method (Kimura, 1980) and are in the units of the number of base substitutions per 
site. The rate variation among sites was modelled with a gamma distribution (shape 
parameter = 0.66). The analysis full genome analysis involved 52 full genome 
nucleotide sequences and ORF2b involved 51 sequences, conducted in MEGA6 
(Tamura et al., 2013). The following strains included in the figures were 
unpublished sequences: 13V91 (Belgium), 215-06 (UK), 87129-13 (UK), 91110-14 
(UK), H2 (UK). 
 ORF2b amino acid alignment 
The amino acid sequences of ORF2b from the strains Lelystad (JF802085), DV 
(KJ127878), Olot/91 (KF203132), H2 (genome not public), 215-06 (genome not 
public), Lena (JF802085), and SU1-Bel (KP889243) were #aligned with the 
ClustalW algorithm (Thompson et al., 1994), using MegAlign Version 13.0 
DNASTAR (Madison, WI.). The alignment was conducted by and kindly shared by 
Dr Jean-Pierre Frossard. 
 Chemical inactivation of PRRSV-1 
Beta-propiolactone (BPL), a cyclic ether, was added at 1/10,000 volume of virus 
stock volume, i.e. 0.2 µL BPL per 2 mL virus, double contained, incubated on roller 
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at 4°C overnight, before transfer to 37°C for 2 hours to hydrolyse/inactivate residual 
toxic BPL. After this time BPL-treated stocks were treated in an identical fashion to 
infectious stocks, stored at -80°C, and titrated by IPX to confirm absence of 
infectivity and inactivation of BPL. 
2.3 Tissue culture & primary cell isolation 
 Immortal cell lines 
MARC-145 cells were used for propagation of PRRSV-1 Olot/91 and DV. MARC-
145 cell cultures, in cDMEM, were routinely passaged every 3-4 days at 90% 
confluency using a 1:4 ratio. Cell culture media was removed, washed twice in PBS 
and detached by incubation with 0.05% trypsin-EDTA (Thermo Fisher Scientific) at 
37°C for 2 minutes.  
CΔ2+ cells were kindly shared by Professor Dirk Werling, Royal Veterinary 
College, UK. They are reported to be a MoMΦ-like cell line, generated by 
repeatedly passaging spontaneously-immortalised monocytes cultured in the 
presence of M-CSF. Cells were passaged in the same manner as MARC-145 cells, 
cultured in cRPMI containing 50 ng/mL recombinant human M-CSF (R&D 
Systems). 
Porcine Max Planck Institute cells (poMPI) were shared by Dr Gyorgy Fejer at the 
University of Plymouth. Non-transformed, primary, continuously growing, GM-CSF 
dependent tissue macrophages were established from embryonic pig liver and 
spleen tissues using protocols described in mice (Fejer et al., 2013). poMPI were 
cultured in cRPMI containing 10 ng/mL GM-CSF (R&D Systems) and not 
passaged; cells were resuspended by incubation in 5 mM EDTA/PBS at 37°C for 
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30 minute before seeding 1x105 cells/well in 96 well plates for infection 
assessments.  
 Porcine alveolar macrophage isolation and culture 
Broncho-alveolar lavage cells, which are highly enriched (>90%) for macrophages 
and hereafter referred to as AMΦ, were obtained from piglets post-mortem. The 
thoracic cavity was opened to remove the pulmonary and cardiac organs with the 
trachea clamped. The lungs were repeatedly filled with 20 mL sterile cRPMI and 
gently massaged, and the lavage fluid decanted into sterile Falcon tubes. The 
collected fluid was often initially red due to contaminating red blood cells, which 
paled as collection continued. The lavage typically yielded a total volume of 500 
mL. Collected cells were washed by centrifugation at 500 ×g for 5 min at 4°C, 
pooled into 2 Falcon tubes, and washed again. The cell pellets were suspended in 
10mL red blood cell lysis buffer (BioLegend, London, UK) and incubated at RT for 
5 minutes before washing twice in PBS. Viable cell densities were determined by 
counting cells diluted 1:10 with Trypan Blue using a haemocytometer. AMΦ were 
cryopreserved as described previously at a density of 4x107/mL. Viability of cells 
and assessment of susceptibility to PRRSV-1 (which is recognised in the literature 
as varying between individual animals, regardless of the PRRSV-naïve status of 
the farm) was tested on an animal-by-animal basis by resuscitating frozen cells 
then determining the infectious titre of a previously titred virus stock in parallel with 
a previously used AMΦ stock. Cell stocks that showed limited susceptibility were 
discarded. 
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 Peripheral blood mononuclear cell isolation 
Peripheral blood mononuclear cells (PBMC) were isolated from blood collected 
from adult and juvenile pigs. Blood was anti-coagulated by collection directly into 
either equal volume Alsever’s Solution (Sigma-Aldrich) or heparin to a final 
concentration of 25 U/mL (Wockhardt, Wrexham, UK). Heparinised blood was 
mixed 1:1 with PBS before layering whereas Alsever’s-treated blood was layered 
directly. 30 mL of treated blood was layered over 20 mL of RT 1.083 g/mL 
Histopaque (Sigma-Aldrich) and centrifuged for 30 min at 1200 x g at RT with no 
brake. PBMC were harvested from the Histopaque-plasma interface and washed 
by filling the remaining Falcon tube volume with sterile PBS and centrifuging for 5 
minutes at 500 x g at 4°C, brake on, and then pouring off the supernatant. The cell 
pellet was re-suspended in 10mL red blood cell lysis buffer (BioLegend) and 
incubated at RT for 5 minutes before washing twice as previous. Cell density was 
determined by counting cells mixed 1:5 with Trypan Blue using a haemocytometer, 
taking care to not count platelets. Cells were re-suspended in the appropriate 
volume of 2% FBS, 1 mM EDTA (Sigma-Aldrich) in PBS (MACS buffer) for cell 
enrichment or cryopreserved as described above. 
 Enrichment of blood-derived cells by magnetic associated cell sorting  
2.3.4.1 Monocyte enrichment and culture 
PBMC were resuspended in mouse anti-human CD14 conjugated microbeads (10 
L/107cells, Miltenyi Biotec, Bisley, UK) and incubated at RT for 15 minutes. After 
two washes with 50 mL of PBS supplemented with 2% FBS (PBS/2% FBS), cells 
were resuspended in MACS buffer (2.5x108 cells/mL), passed through a 100 µm 
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cell strainer to eliminate clumps and applied to a MACS LS column on a midiMACS 
magnet (Miltenyi Biotec). Columns were washed twice with 3 mL of MACS buffer 
then cells eluted into a fresh 15 mL Falcon tube by purging cells in 5 mL of MACS 
buffer. 
Monocytes were seeded at 1x106/mL in cRPMI containing either 50 ng/mL 
recombinant human M-CSF (Miltenyi Biotec) to drive MoMΦ differentiation or 10 
ng/mL recombinant porcine GM-CSF and 10 ng/mL recombinant porcine IL-4 (both 
R&D Systems, Abingdon, UK) to drive MoDC differentiation. Monocytes were 
cultured for 6 days before subsequent use in assays as the differentiated cell types. 
Subsequent infections and treatments included replenishment of cRPMI without 
growth factors. 
2.3.4.2 Dendritic cell enrichment and culture 
PBMC were resuspended of lymphocyte lineage antibodies: CD3, CD8α, CD21 or 
IgG (H+L), each diluted at the dilution factor specified (Table 2.1), in a total volume 
of 250 µL/107 cells. Cells were incubated at RT for 15 minutes, washed, re-
suspended in anti-human CD14 conjugated microbeads and anti-biotin conjugated 
microbeads (both at 10 L/107cells, Miltenyi Biotec) at RT for 15 minutes, washed, 
and applied through a 100 µm strainer to a pre-equilibrated LD column. The column 
flow-through (CD3-CD8α-Ig-CD14- enriched BDC) and two washes of 2 mL MACS 
buffer were collected and washed in 2% FBS/PBS before resuspending at the 
appropriate density for cell seeding. Enriched BDC were cultured in Glutamax 
IMDM (Gibco) containing 1x Pen/Strep, 10% FBS and 10 ng/mL recombinant 
porcine IL-3, kindly provided by Kirsten Morris, CSIRO Biosecurity Flagship, 
Australian Animal Health Laboratory, Geelong, Australia (BDC media).  
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 Cryopreservation and resuscitation of cell stocks 
Cryopreserved cell stocks were maintained for both primary cells and immortal cell 
lines. Cells were centrifuged at 500 x g for 5 minutes, supernatant was removed 
and the cells resuspended at a maximum density of 4x107 cells/mL in 10% dimethyl 
sulfoxide (DMSO) (Sigma-Aldrich) in heat-inactivated FBS (freezing media). 
Cryovials (Nalgene Cryoware, Fisher Scientific, UK) were placed in a Nalgene Mr. 
Frosty freezing container containing 100% isopropanol (VWR International, 
Lutterworth, UK) and transferred to -80°C freezers for 24 hours before transferring 
to the vapour phase of liquid nitrogen storage. Cryopreserved cells were thawed 
rapidly in a water bath at 37°C then transferred to a Falcon tube of pre-warmed 
cDMEM or cRPMI and washed by centrifugation at 500 x g for 5 minutes. The 
supernatant was then discarded and cells resuspended in 10 mL complete media. 
Cells were then counted using Trypan blue as described above, and the cells 
resuspended in the necessary volume of pre-warmed corresponding media at the 
required seeding density. 
 
2.4 Flow cytometry 
Cells were resuspended before staining: 0.05% trypsin to detach MARC-145, 5 
mM EDTA in PBS for adherent monocyte-derived cells and AMΦ, PBS only for 
non-adherent primary cells (lymphocytes).  Resuspended cells were washed in 
PBS before staining to removal residual media or resuspension agent. To assess 
viability, cells were stained with Zombie Near Infra-Red fixable amine reactive dye 
(BioLegend) in 50 µL staining volume for 15 minutes at room temperature in the 
dark and then washed twice with PBS supplemented with 1% FBS and 0.09% 
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sodium azide (FACS buffer). All washes included adding 150 µL FACS buffer for 
surface staining or Permeabilisation/Wash buffer (P/W buffer) (BioLegend) for 
intracellular staining and centrifugation at 900 x g for 2 minutes. Cells were stained 
with primary mAbs specific for surface markers diluted in FACS buffer 
simultaneously with Zombie staining, washed twice with FACS buffer, then when 
relevant, anti-isotype secondary mAbs incubated for 15 minutes at room 
temperature. After all mAb incubations, cells were washed twice in FACS buffer, 
fixed in 4% PFA (ChemCruz) for 10 minutes, and either resuspended in FACS 
buffer and stored at 4°C or if staining intracellularly washed twice in P/W buffer. 
Intracellular stains were conducted in the same fashion as surface stains, diluting 
mAbs and washing in P/W buffer instead of FACS buffer. After staining cells were 
re-fixed in 4% PFA for 10 minutes and resuspended in FACS buffer and stored at 
4°C until they were run on a flow cytometer. All cells were assessed using either a 
MACSQuant Analyzer 10 (Miltenyi Biotec) or an LSR Fortessa (BD Biosciences). 
mAbs described in Table 2.1 and Table 2.2 were titrated on PBMC (co-staining 
with viability dye) to determine their optimal working dilutions in a 50 µL staining 
volume. All primary and secondary antibody titrations were carried out as two-fold 
serial dilutions on PBMC to ascertain the optimal staining resolution to prevent 
artificial spread of fluorescence in both negative and positive populations. Non-
specific staining was increasingly relevant to multi-parameter panels due to the 
requirement for compensation calculations to control for spectral overlap of 
fluorophores. The working concentration of all antibodies was determined by 
titrating onto PBMC and a stain index calculated using the formula: 
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(𝑀𝐹𝐼 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛) − (𝑀𝐹𝐼 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛)
(2 × 𝑟𝑆𝐷 𝑀𝐹𝐼 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛)
 
The stain index working dilution was used when changes in MFI were employed to 
assess relative expression per cell of the corresponding marker. When mAbs were 
used to phenotype and resolve populations without assessing expression intensity, 
working concentrations were decreased to reduce spectral overlap and 
background. All flow cytometry analysis was conducted using FlowJo Version 10 
(BD); all percentages indicate the percentage of the parent gate for populations of 
interest. 
  
Luke PM Johnson   Chapter 2 
 
 
 
54 
 
Table 2.1. Primary antibodies used for flow cytometric analysis. 
Target Clone Isotype Conjugate 
Dilution 
factor 
Supplier 
Zombie 
dead cell stain 
NA NA 
Aqua/Near-
IR 
1000 BioLegend 
CD3 PPT3 Mouse IgG1 Biotin 1000 AbCam 
CD8α 76-2-11 
Mouse 
IgG2a 
Biotin 600 AbCam 
CD21 BB6-11C9-6 Mouse IgG1 Biotin 5000 Ab-Direct 
CD14 REA599 Human IgG1 PE-Vio770 50 Miltenyi Biotec 
CD172a 74-22-15A 
Mouse 
IgG2b 
PE 1000 
BD 
Biosciences 
CADM1 3E1 Chicken IgY - 100 Caltag 
CD1a 04-07-76 
Mouse 
IgG2a 
FITC 25 Ab Online 
CD4 74-12-4 
Mouse 
IgG2b 
PerCP-
Cy5.5 
50 
BD 
Biosciences 
CD11c 3A8 Mouse IgG1 - 100 INRA # 
MHC II DR MSA3 
Mouse 
IgG2a 
- 100 Kingfisher 
CD16 G7 Mouse IgG1 PE 100 Bio-Rad 
CD163 2A10/11 Mouse IgG1 - 1000 Bio-Rad 
CD203a PM18-7 Mouse IgG1 - 500 Bio-Rad 
IgM Polyclonal Goat IgG - 20 
Cambridge 
Biosciences 
IgGH+L Polyclonal Goat IgG Biotin 5000 
Cambridge 
Biosciences 
IgGFc Polyclonal Goat IgG FITC 1600 
Cambridge 
Biosciences 
Ig κ+λ (IgL) 
Pooled 
monoclonal 
Mouse IgG1 - 40 
Celtic 
Diagnostics 
SWC8 MIL3 Mouse IgM - 10 
Central 
Services; 
Pirbright 
PRRSV N SDOW-17A Mouse IgG1 - 1000 RTI 
#CD11c mAb 3A8 kindly provided by Dr Isabelle Schwartz-Cornil at Institut National de la 
Recherche Agronomique (INRA), France. NA: amine reactive dye, not a mAb. 
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Table 2.2. Secondary antibodies used for flow cytometric analysis. 
Target Clone Isotype Conjugate 
Dilution 
factor 
Supplier 
Chicken IgY Polyclonal Goat IgG 
Alexa Fluor 
(AF)405 
10 AbCam 
Chicken IgY Polyclonal 
Donkey 
IgG 
BV421 50 Stratech 
Mouse IgG1 RMG1-1 Rat IgG BV421 500 BioLegend 
Mouse IgG1 RMG1-1 Rat IgG AF488 500 BioLegend 
Mouse IgG2a RMG2a-62 Rat IgG AF647 500 BioLegend 
Mouse IgG2b RMG2b-1 Rat IgG1κ PE 200 
Southern 
Biotech 
Biotin NA NA 
Streptavidin 
Brilliant Violet 
(BV)605 
100 BioLegend 
Biotin NA NA 
Streptavidin  
BV650 
500 BioLegend 
Biotin NA NA 
Streptavidin  
BV421 
500 BioLegend 
Mouse IgM RMM-1 Rat IgG2a APC-Cy7 20 BioLegend 
Mouse IgG1 NA NA 
APC Zenon 
conjugation kit 
Varied † 
Thermo Fisher 
Scientific 
† Optimal dilutions were determined by titration of the corresponding mAb conjugated with 
Zenon. 
NA: Reagents were not mAbs; biotin binds streptavidin covalently, Zenon dyes amine 
residues directly. 
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2.5 Confocal microscopy 
All cultures were carried out in 24 well plates at 5x105 cells/well at a density of 
5x105/mL. Before seeding cells, cover slips were sterilised in 70% ethanol for 10 
minutes at room temperature and washed three times in PBS. All incubations were 
conducted at RT, in the dark after addition of fluorescent reagents.  
At the end-time of the experiment, supernatant was aspirated and cells washed 
twice with 1 mL PBS. Fixation and permeabilisation was conducted with 500 
µL/well of 4% PFA containing 0.1% Triton X-100 for 15 minutes before washing 
twice with PBS. Cells were blocked with 0.1% bovine serum albumin in PBS 
(PBS/BSA) for 30 minutes, washed once with PBS and 100 µL primary antibody 
added per well diluted 1:1000 in PBS/BSA. After 30 minutes cells were washed 3 
times in PBS and 100 µL/well secondary antibody added; secondary antibody 
diluted in PBS/BSA containing Flash Phalloidin Red 594 (BioLegend) was 
incubated at RT for 10 minutes before washing 3 times. Cover slips were washed 
by dipping once in ultra-pure water, excess water removed and inverted onto 
Vectashield (Vector Laboratories) mounting media on glass slides (Thermo Fisher 
Scientific). Coverslips were sealed with clear nail varnish and stored at 4°C in the 
dark until imaged, within 1 week of staining. Images were collected using a Leica 
DM6000B microscope with LAS AF software (Leica Microsystems, Milton Keynes, 
UK). Composites images were created using the Fiji distribution of ImageJ 1.52p 
(NIH, USA). 
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Table 2.3. Antibodies and dyes used for confocal microscopy in this project. 
Target Clone Isotype Conjugate 
Dilution 
factor 
Supplier 
PRRSV N 
protein 
SDOW17-
A 
Mouse IgG1 - 1000 RTI 
PRRSV NSP7 1AH2 Mouse IgG1 - 500 Ingenasa † 
Anti-mouse 
IgG1 
RMG1-1 Rat IgG1κ AF647 500 BioLegend 
Flash Phalloidin 
Red 594 
NA NA AF594 50 BioLegend 
 
2.6 Secreted cytokine quantification by enzyme-linked 
immunosorbent assay (ELISA) 
 Sandwich ELISA 
Porcine Duoset ELISA kits (R&D Systems) were used to quantify IL-1β, TNF-α, IL-
8, and IL-10 following manufacturer’s protocol. Blocks were carried out using 4% 
milk powder instead of 1% BSA. TMB (Thermo Fisher Scientific) was used as the 
substrate and stop solution was 1M (2N) sulphuric acid (H2SO4) diluted from an 
18M stock (Sigma-Aldrich). 
 Luminex - multiplex magnetic bead based ELISA 
Cytokine & Chemokine 9-Plex Porcine ProcartaPlex Panel 1 (Thermo Fisher 
Scientific) was used following the manufacture’s protocol and samples analysed 
using a Bio-Plex 200 (Bio-Rad, Watford, UK). Fluorescence data was interpolated 
using ProCartaPlex Analyst software v1.0.  
Luke PM Johnson   Chapter 2 
 
 
 
58 
 
2.7 Endocytosis and phagocytosis assays 
To assess endocytosis, ovalbumin was used with two different conjugates. A direct 
AF647 tag was used to assess all uptake (Ovalbumin, Alexa Fluor 647 Conjugate; 
Thermo Fisher Scientific), and ovalbumin labelled with BODIPY FL (detected in the 
FITC/AF488 channel) was used to detect fluorescence post-proteolysis of 
endocytosed ovalbumin (DQ Ovalbumin - Special Packaging; Thermo Fisher 
Scientific). 2.0 µm microspheres (FluoSpheres Carboxylate-Modified 
Microspheres, red fluorescent; Thermo Fisher Scientific) were used to assess 
phagocytosis, detected in the PE channel. 
To mature MoDC when comparing OVA and OVA-DQ, media was replenished  
hours before infection with cRPMI containing 20 ng/mL recombinant porcine TNF-
α protein (Bio-Techne, Abingdon, UK), 10 ng/mL IFN-α (Cambridge Bioscience, 
Cambridge, UK). As treated controls in endocytosis and phagocytosis assays 
MoMΦ were treated with 100 ng/mL LPS (Sigma-Aldrich) and MoDC with 100 
ng/mL synthetic TLR9 ligand CpG ODN 2007 (Invivogen) for 24 hours, 
commencing from the addition of inocula. Cell priming used 100 ng/mL LPS from 
E. coli O111:B4.  
AMΦ and monocyte-derived cells were seeded in duplicate plates as previously 
described. Control plates were pre-cooled at 4°C for 30 minutes prior to transferring 
on ice and adding the OVA-DQ and microspheres. Microspheres and OVA-DQ 
were added in cRPMI on top of culture supernatant. 2 microspheres per cell were 
added for 3 hours, whereas OVA-DQ was added at a final concentration of 50 
µg/mL for 1 hour. At the end time of each assay, experimental and control plates 
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were washed in ice cold PBS before resuspending as previously described for flow 
cytometric staining. 
2.8 Allogeneic and mixed leukocyte reaction proliferation assays 
Mixed leukocyte reactions of whole PBMC were conducted to assess the strongest 
allogeneic response combination of animals out of 6 tested. Of these 6 PBMC 
batches tested, 1 responder and 3 stimulator animals were selected for allogeneic 
reactions of enriched monocyte-derived cells and responder lymphocytes, seeding 
monocyte-derived cells from the responder animal as an autologous control. 
Monocyte-derived cells were cultured for 6 days to differentiate as previously 
described. PBMC proliferation was assessed using Tag It-Violet (BioLegend) 
diluted to 5 mM in PBS, staining cells at a density of 1x107/mL for 20 minutes at 
37°C in the dark (using a humidified incubator). After the staining incubation cells 
were topped up to 50 mL in cRPMI, incubated for a further 10 mins at 37°C, washed 
twice by spinning at 500 x g at replacing the media, resuspend in 10mL cRPMI, 
resuspend lymphocytes at 6x106/mL, seeded 100 µL/well. 
2.9 Inflammasome modulating molecules 
Lyophilised MCC950 and nigericin (both from Invivogen, Paris, France) were 
resuspended in DMSO and absolute ethanol, respectively, per manufacturer’s 
protocol and stored at -80°C. Final concentrations and duration of treatment in 
media varied between experiments and are described in the text. LPS priming of 
AMΦ and MoMΦ was at a final concentration of 1 µg/mL in complete media for 3 
hours; alternative treatment concentrations are specified in figure legends. 
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2.10 RNA-Seq transcriptomics 
 RNA isolation 
RNA was extracted using TRIzol treatment of infected cells in situ in round bottom 
96 well plates (Nunclon Delta treated; Thermo Fisher Scientific). Supernatants 
were taken and cells washed gently with PBS by aspirating before adding 100 µL 
TRIzol Reagent (Qiagen) to wells and incubating at room temperature for 5 minutes 
to lyse cells and virus particles. Quadruplicate wells were pooled and additional 
TRIzol added if necessary to a total volume of 800 µL. TRIzol phase separation 
was carried out as described previously (2.2.4 ). The upper phase was collected 
as previously described and mixed with an equal volume of molecular grade 
ethanol and added in 700 µL volumes to a Monarch Total RNA Extraction (NEB) 
spin column, following manufacturer’s instructions, including on-column DNase 
treatment, and eluting in 50 µL pre-warmed nuclease-free water containing 0.1 mM 
EDTA. 
This strategy was compared to taking the aqueous phase forward to an alcohol 
precipitation strategy or to RNeasy spin columns (Qiagen), following the 
manufacturer’s protocol from the addition of supernatant to column onwards. The 
alcohol precipitation strategy commenced from the aspiration of the aqueous 
phase. An equal volume of isopropyl alcohol (Sigma) and 1 µL GlycoBlue 
Coprecipitant (Thermo Fisher Scientific) was added to each aspirate, vortexed, and 
incubated on ice for 10 minutes. The tubes were centrifuged at 15000 x g at 10 
minutes at 4°C. Supernatant was aspirated and discarded and 1 mL 70% molecular 
grade ethanol added. Samples were vortexed and centrifuged as previous. 
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Supernatant was aspirated and discarded and the RNA pellet allowed to air dry at 
RT. The RNA was resolubilised in 20 µL nuclease-free water and stored at -80°C. 
In all cases isolated RNA was assessed by Qubit RNA BR kit (Thermo Fisher 
Scientific) and BioAnalyser 2100 (Agilent). RNA taken to library preparations were 
RIN greater than 9. 
 RNA library generation and sequencing 
RNA-Seq Library preparation was carried out by The Pirbright Institute Sequencing 
Unit.  Total RNA was checked for quality using a Bioanalyser 2100 RNA Pico kit 
(Agilent, San Diego, CA) and quantitated using a Qubit (Life Technologies) and 
normalised for a 200 ng input per sample.  Total RNA was enriched for mRNA 
using the NEBNEXT polyA enrichment module (NEB, Ipswich, MA).  The enriched 
mRNA was the subjected to sequencing library preparation using a NEBNext 
directional Ultra II RNA-Seq kit (NEB, Ipswich, MA).  Library QC was performed 
using the Bioanalyser 2100 DNA 1000 kit and Qubit, prior to pooling.  Library pools 
were quantified using a NEBNEXT Illumina library quantitation kit (NEB) before 
being diluted and loaded onto a High output 150 cycle NextSeq reagent cartridge 
v2.5 and flow cell (Illumina, San Diego, CA) on a 1x150 cycle sequencing run. 
Approximately 60 – 80 million reads were generated per sample. 
 Transcriptomics analysis 
Analysis was conducted on a collaborative basis by the Bioinformatics Group at 
The Pirbright Institute. The in-house workflow consisted of primary and secondary 
analysis. Reads were first aligned to the genomic reference and transcriptome with 
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an analysis workflow similar to that originally used to analyse the data produced by 
the GEUVADIS consortium (Lappalainen et al., 2013). Briefly, reads were 
subjected to several stages of mapping – (i) alignment to the reference genome, 
Sus scrofa 11.1 (unpublished, (The Swine Genome Sequencing Consortium, 
2017)) (ii) alignment to the reference transcriptome, Sus scrofa 11.1.95 (Warr et 
al., 2019) (iii) de-novo split mapping step, in order to capture novel introns possibly 
not present in the original annotation (iv) alignment to an extended annotation 
derived from the introns present in the annotation provided for stage ii and the 
introns derived from the de-novo step iii. Mapping was performed with the GEM 
mapper (Marco-Sola et al., 2012). The alignments obtained from all the steps were 
subsequently merged, eliminating replications and keeping the set of alignments 
having the best score. Reads in each pair were mapped separately, and the 
alignments for each end were subsequently paired. In order to determine counts, 
reads were assigned a weight of 1/(number of alignments with the best score). The 
method aimed to strike a good balance between sensitivity and specificity, 
optimising sensitivity by reconstructing unannotated splice forms via the de-novo 
intron detection step. Specificity is increased by controls on the de-novo step – rare 
introns which are not supported by multiple reads were filtered out, reducing the 
problem of spurious mappings which shows up when reads are mapped one by 
one. 
Secondary analysis was performed using R (R Core Team, 2013). Differential 
expression analysis was performed with edgeR (Robinson et al., 2010). Three two-
way comparisons were performed, namely SU1-Bel versus Mock, Lena versus 
Mock, and SU1-Bel versus Lena. Preliminary exploratory data analysis was 
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conducted by generating MDS plots of leading log-fold changes. Annotation was 
performed using the biomaRt package (Durinck et al., 2009, 2005). The gene 
names present in the tables were translated to the closest human orthologue via 
BioMart. A subset of significantly differentially expressed genes (those with 
absolute log-fold change >1 and Benjamini-Hochberg corrected p-value (FDR) < 
0.05) was subsequently analysed for each two-way comparison, in order to 
establish the existence of over-represented pathways or gene sets in the 
differentially expressed subsets. Analysis was performed with the clusterProfiler R 
package (Yu et al., 2012) and related packages (Yu et al., 2015; Yu and He, 2016). 
Databases used in order to establish over-representation were GO (Ashburner et 
al., 2000; The Gene Ontology Consortium, 2019) and Reactome (Croft et al., 
2014). To generate heat maps mixOmics (Rohart et al., 2017) and HTSFilter (Rau 
et al., 2013) were used. Venn diagrams were generated using the online tool Venny 
2.0 (Oliveros, 2007). 
 
2.11 Statistics 
GraphPad Prism 8.1.2 (GraphPad Software, La Jolla, California, USA) was used 
to carry out Two-Way ANOVA with Tukey’s multiple comparison tests when two 
independent variables were included such as multiple infection strains at time-
intervals, or multiple infection strains with and without additional treatment. One-
Way ANOVA was used to conduct T tests used when a single variable was present 
such as a single time-point infections comparing strains. Numbers of biological and 
technical replicates are specified in individual figure legends.  
Luke PM Johnson   Chapter 3 
 
 
 
64 
 
Chapter 3 : Optimisation of blood dendritic cell isolation and 
culture to enable assessment of PRRSV-1 susceptibility 
3.1 Aims & rationale 
In vivo characterisation of highly pathogenic PRRSV-1.3 strain SU1-Bel reported a 
rapid inflammatory response and enhanced viral clearance compared to lowly 
pathogenic PRRSV-1.1 field strains (Morgan et al., 2013). AMΦ are the canonical 
primary target of PRRSV, however, virus dissemination to the lymph nodes leads 
to systemic infection and inflammation, including persistence in secondary 
lymphoid tissues. Lung infiltration by T cells and accumulation of infected MΦ in 
the interfollicular area of the mediastinal lymph node is increased in pigs infected 
with SU1-Bel compared to PRRSV-1.1 field strain 215-06 and attenuated strain 
Olot/91, despite lower viral load in the lymph nodes and bronchoalveolar lavage 
fluid (García-Nicolás et al., 2015; Morgan et al., 2013). This suggested that 
inflammation mediated cell migration is the cause of disease in highly pathogenic 
strains, rather than an increase in viral cellularity or rate of replication. 
Immunohistochemistry has demonstrated that MΦ are absent in control animals 
and transiently more abundant in the lymph nodes in line with viraemia, supporting 
migration of cells post infection. This would provide an intracellular route of virus 
transport to the lymph nodes, which is further supported by previous findings that 
infected cells migrating to the lymph nodes led to apoptosis in neighbouring cells, 
and local tissue inflammation, therefore spreading inflammation systemically from 
the initial site of infection in the lungs (Rodríguez-Gómez et al., 2014).  
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Susceptibility of MΦ to PRRSV is attributed to expression of phagocyte scavenger 
receptor CD163, which is integral to virus internalisation and indispensable to 
susceptibility in vivo (Burkard et al., 2017). Frydas et al. (2013) reported a wider 
tropism of the highly virulent PRRSV-1.3 strain Lena to cells lacking virus 
attachment receptor Siglec-1, which facilitated the invasion of the epithelial layer 
of an ex vivo nasal mucosa explant culture via infection of CD163+Siglec-1- cells. 
Given the restricted myelotropism of PRRSV and the increased infection of 
monocyte-derived DC by Lena compared to Lelystad, the unidentified 
CD163+CD169- cells reported by Frydas et al. (2013) may be steady state DC. DC 
are members of the mononuclear phagocytic family sharing a common 
haematopoietic myeloid progenitor with MΦ and monocytes. DC serve as the 
bridge between innate and adaptive immunity, responsible for presentation of 
antigen leading to the activation of cognate naïve T cells in secondary lymphoid 
organs. Two distinct cDC subsets are associated with cross-presentation to CD8 
T cells and Th1 activation (cDC1) or Th2 and Th17 activation (cDC2), therefore 
broadly categorised as promoting adaptive immune responses against intracellular 
pathogens and extracellular pathogens, respectively. pDC are comparatively lower 
expressers of T cell priming molecules but are key producers of cytokines involved 
in anti-viral responses and regulation of T cell tolerance (Dutertre et al., 2014; 
Guilliams et al., 2014).  
pDC have previously been described as refractory to PRRSV infection but initiate 
a strong anti-viral response only when co-cultured with PRRSV infected monocyte-
derived MΦ (Baumann et al., 2013; García-Nicolás et al., 2016). The hypothesis 
that the unconfirmed Lena susceptible cell type being steady-state cDC would 
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correlate with DC being a major myeloid cell type that migrates to the lymph nodes 
from sites of infection where they interact with neighbouring cells, potentially 
transporting PRRSV as putatively reported in MΦ. Whether DC are found to uptake 
PRRSV by direct infection or by phagocytosis of infected apoptotic cells, migration 
of virus containing DC could lead to the enhanced systemic pro-inflammatory 
response observed in vivo during infection by SU1-Bel. Increased PRRSV-
experienced DC in the lymph nodes would also correlate with the role of cDC in T 
cell activation and the enhanced T cell lung infiltration (García-Nicolás et al., 2015), 
responses and clearance of SU1-Bel both reported in vivo (Morgan et al., 2013). 
Literature confirming CD163 expression within steady state DC was limited at the 
outset of this project: Langerhans cells (Piriou-Guzylack and Salmon, 2008), cDC-
like skin derived DC (Marquet et al., 2014), and a subpopulation of bone marrow 
derived cells expressing DC marker Flt3+ (Guzylack-Piriou et al., 2010) were all 
reported to express CD163. Orthologous porcine DC populations were not yet 
agreed in the literature, with preliminary reports from (Vu Manh et al., 2015) and 
work published after the commencement of this PhD confirming these populations 
(Edwards et al., 2017). Subsequent work in swine has reported low levels of CD163 
in cDC2 from blood (Auray et al., 2016) and no expression of CD163 on lung-
derived DC (Maisonnasse et al., 2016). Recently, human blood DC populations 
have been further characterised by single cell transcriptomics, with multiple 
CD163+ populations identified as efficiently inducing CD4 and CD8 T cell 
proliferation (Villani et al., 2017). 
DC isolated from peripheral blood (BDC) are an established and accessible form 
of DC, which are widely used in human studies and more recently used to study 
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porcine DC (Auray et al., 2016; Edwards et al., 2017). The accessibility of blood-
derived steady state DC over tissue-derived DC is a distinct advantage as a model 
system, both for the numbers of available PBMC from culled swine and the reduced 
processing of PBMC compared to lung or lymphoid tissue improving cell viability. 
Using BDC as a model system, this chapter aimed to test the hypothesis that the 
reported in vivo enhanced viral clearance and pro-inflammatory responses induced 
by infection with highly pathogenic SU1-Bel and Lena is, in-part, due to tropism 
towards at least one DC subset. BDC expression of CD163 was assessed following 
adaptation of the enrichment and phenotyping strategies of Edwards et al. (2017), 
Auray et al. (2016) and Deloizy et al. (2016) before characterisation of BDC 
susceptibility and cytokine responses to PRRSV-1.  
This chapter addressed the following specific primary objectives: 
1. To compare and optimise BDC enrichment strategies  
2. To optimise phenotyping strategies for BDC subsets  
3. To assess BDC susceptibility to PRRSV-1.1 and -1.3 strains 
4. To characterise BDC cytokine responses to PRRSV-1 
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3.2 Optimisation of BDC enrichment and culture  
 Immunophenotyping strategy 
Porcine BDC comprise subpopulations orthologous to human BDC as 
characterised by Auray et al. (2016) and Edwards et al. (2017), both using similar 
but not identical strategies to define DC subsets. To assess BDC subsets ex vivo 
for permissiveness to PRRSV-1 infection, the cells require sufficient enrichment to 
enable accurate detection by flow cytometry; this technique is preferential to 
immunofluorescent microscopy due to the ability to identify multiple rare 
populations simultaneously using multiple parameters to confirm population 
phenotypes. Flow cytometric analysis and cell sorting requires antibodies against 
surface proteins on BDCs, however, the lack of discriminatory markers means that 
multiple markers are required to discriminate BDC subsets from each other as well 
as the myeloid and lymphoid cell types that are present within PBMC populations, 
as summarised in Table 3.1. 
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Table 3.1. Expected surface marker distribution in porcine peripheral blood mononuclear 
cells to discriminate BDC populations based on published literature 
 Cell surface marker expression* 
Marker cDC1 cDC2 pDC Monocytes Lymphocytes Neutrophils 
Lineage 
(CD3, CD8α, 
CD21) 
- - - - +/++ - 
CD14 - - - + - low 
CD172a + ++ + ++ - + 
CD11c + + - ++ - + 
CD4 - - ++ - +/- - 
CD1a - + - +/- - - 
CADM1 + + - +/- - - 
SWC8 - † - † - † - +/- + 
CD163 - - † - +/- - +/- 
* Corresponding surface markers indicated as “-” for no expression, “+” for positive 
expression, “++” for comparably higher expression, and “+/-” for a mixture of positive and 
negative cells within a given population. † Corresponding surface maker expression to be 
confirmed on this cell type due to limited or conflicting literature. 
The first priority was therefore to optimise the staining panel to enable BDC 
identification/phenotyping. A combination of biotinylated monoclonal antibodies 
(mAbs) for lymphoid lineage cells (lineage+ cells) was used to stain the majority of 
lymphocytes that are present in PBMC i.e. CD3 (pan-T cell), CD8α (NK cell and 
CTL) and CD21 (B cells), using a single streptavidin conjugated fluorophore to 
detect them simultaneously.  
Based on the distribution of these markers, an initial phenotyping panel was 
designed to identify BDC subsets and assess enrichment strategies (Table 3.2). In 
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the initial flow cytometric staining panel, CADM1 expression was assessed in the 
AF405 channel, allocating the brighter marker AF647 to interchangeable markers 
of interest, with a view to subsequently using anti-PRRSV N mAb in the 
AF647/APC channel. Forward scatter area (FSC) correlates with size and side 
scatter area (SSC) correlates with granularity. As with fluorophore signal detection, 
FSC and SSC values are relative within each sample and affected by cytometer 
detector voltage changes. Aggregated cells were excluded from all analyses by 
plotting the collected FSC-height value against the calculated FSC-area value 
(Figure 3.1 A), excluding all cells that have a greater area than height. Based on 
back-gating positive populations from single-colour mAb titrations and pilot multi-
colour experiments, relative FSC-SSC was associated with particular cell types: 
FSCmedSSChigh cells were typically neutrophils, FSClowSSClow cells were typically 
lymphocytes, and FSChighSSCmed cells were monocytes. Monocytes and 
lymphocytes overlap in SSC properties more than neutrophils, which are typically 
distinct from both monocytes and lymphocytes in both whole blood and PBMC. 
BDC fall within a similar region to monocytes, therefore to facilitate downstream 
gating, cells which are highly unlikely to overlap with BDC are excluded to improve 
resolution of down-stream gating (Figure 3.1 C). When CD14 was detected using 
a PE-Vio770 conjugated mAb it was plotted against viability dye for live/dead 
gating, instead of using FSC, in order to increase confidence in compensation 
between the amine reactive dye emitting in the APC-Cy7 channel and the CD14 
conjugated PE-Vio770 emitting in the PE-Cy7 channel. A slight increase in the 
background level of Zombie staining can be observed on CD14+ cells, due to the 
increased size of monocytes compared to lymphocytes; the background of larger 
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cells is increased due to an increase of surface proteins present which the amine 
reactive viability dye binds. When PE-Vio770 was not used, FSC was plotted 
against Zombie dye in order to control for cell size against Zombie-background and 
to confirm the expected trend that Zombie+ cells are reduced in size compared to 
the same cell type when intact. 
 
Table 3.2. Flow cytometric staining panel used to assess the enrichment of BDC from 
PBMC. 
  Marker Tag Clone 
 
1 Viability 
Near IR 
(APC-Cy7) 
NA 
L
in
e
a
g
e
 
2 
CD3 Biotin PPT3 
CD8α Biotin 76-2-11 
CD21 Biotin BB6-11C9.6 
Streptavidin BV650 NA 
 3 CD14 PE-Vio770 REA599 
 4 CD172a PE 74-22-15A 
 5 CD4 PerCP-Cy5.5 74-12-4 
 6 CD1a FITC 04-07-76 
 
7 
CADM1 None 3E1 
 Anti-IgY AF405 Goat polyclonal 
 
8 
CD163/CD11c None 2A10/3A8 
 Anti-IgG1 AF647 RMG1-1 
 
The gating strategy to identify cDC1, cDC2 and pDC was initially trialled using 
stained PBMC. Excluding cell aggregates with a non-linear height-area ratio 
(Figure 3.1 A) and dead cells staining above background for amine reactive Zombie 
dye, which therefore have decreased membrane integrity, (Figure 3.1 B)  were the 
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initial steps in every flow cytometry analysis presented in this thesis. Excluding 
contaminating FSCmedSSChigh neutrophils and FSClowSSClow lymphocytes was a 
standard step unless otherwise specified for all subsequent BDC enrichment 
analyses in this chapter (Figure 3.1 C). Lymphocytes were then removed from 
analysis by gating on CD172a+ cells, excluding cells positive for any of the markers 
included in the lineage cocktail (Figure 3.1 D). Lineage- cells were then assessed 
for CD14 to resolve and exclude monocytes (Figure 3.1 E), before final analysis of 
BDC subsets by CD1a and CD4 (Figure 3.1 F), where the three populations 
described in (Edwards et al., 2017) are observable: cDC2 (CD1a+CD4-), pDC 
(CD1a-CD4+) and cDC1 (CD1a-CD4-).  
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Figure 3.1. Core gating strategy for BDC demonstrated on PBMC. Porcine PBMC were 
isolated by density gradient centrifugation, stained and analysed by multi-parameter flow 
cytometry to identify BDC subsets. Following exclusion of doublets (A), dead (B) SSChigh 
and FSClow cells (C); lineage+ cells (D) and CD172ahighCD14+ monocytes (E), the 
distribution of BDC subsets was assessed by CD1a and CD4 expression and defined as: 
CD4−CD1a− cDC1, CD4−CD1a+ cDC2 and CD4+CD1a− pDC (F) (Edwards et al., 2017). 
Representative data from technical replicates (n=3) of a biological singlet are shown. 
The rarity of BDC subpopulations makes them difficult to discriminate from other 
myeloid cells in PBMC without enrichment, adding a technical difficulty as well as 
the logistical problem of scale; significant numbers of PBMC require analysing to 
detect sufficient BDC. The analysis strategy described was therefore taken forward 
onto PBMC enriched for the identified BDC populations. 
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 Enrichment strategy – positive and negative selection 
Magnetic microbeads and MACS columns were used to enrich BDC populations 
from PBMC by either removing the cells of interest (positive selection) or depleting 
unwanted cells to indirectly enrich the cells of interest (negative selection). 
Emulating protocols carried out by Auray et al. (2016) and Edwards et al. (2017), 
anti-CD14 mAb conjugated microbeads were first used to deplete monocytes from 
PBMC before either positively or negatively selecting DC. CD14- PBMC collected 
from the flow-through of an LD column were and either stained with a CD172a mAb 
and anti-IgG1 Ab conjugated microbeads for positive selection, or, a cocktail of 
biotinylated mAbs binding the same lymphocyte markers in the phenotyping 
cocktail used in Figure 3.1. Anti-biotin Ab conjugated microbeads were used to 
bind the cocktail of biotinylated primary mAbs to deplete these cells in an LD 
column. This depletion strategy is an adaptation of the CD3 depletion reported by 
Auray et al. (2016), with a view to sufficiently deplete non-BDC that infection culture 
is feasible without the requirement for FACSorting, which may directly stress cells 
and increases processing time that cells are in neither whole blood nor optimal 
culture media. The negative selection approach was also expanded by reducing 
the time cells spent on columns by combining the anti-CD14 microbead and anti-
biotin microbead incubations and simultaneously deplete CD14 and lymphocytes, 
obtaining a comparable efficiency. 
Enriched BDCs were stained with the multicolour flow cytometric panel and their 
enrichment assessed, anticipating a significant increase in frequencies with some 
contaminating cells remaining. In order to assess enrichments, a comparably large 
number of events was collected, which would not be viable in the case of assessing 
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individual cultured wells of cells in subsequent infection experiments. Enriched 
CD172alow lineage- DCs within FSChighSSClow cells in Figure 3.2 presents 
representative analysis of positively and negatively selected enrichments, 
demonstrating an increased proportion of the BDC populations. 
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Figure 3.2. Enriching BDC from PBMC by positive and negative selection based 
MACSorting strategies. BDC were enriched from freshly isolated PBMC by CD14 depletion 
followed by lymphocyte “lineage” depletion (Negative selection) or CD14 depletion 
followed by CD172a selection (Positive selection). Enriched populations were stained 
immediately post-enrichment and analysed by flow cytometry. Data presented are pre-
gated on live singlets excluding FSClowSSChigh cells (not shown). Following exclusion of 
lineage+ and CD172a- cells (A) and CD14+ cells (B), the distribution of BDC subsets was 
assessed by CD1a and CD4 expression (C). Representative data are shown for PBMC 
pre-enrichment (top row), BDC post-enrichment by negative selection (middle row), and 
BDC post-enrichment by positive selection (bottom row). Representative data from 
technical replicates (n=2) of a biological singlet are shown. 
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The positive and negative selection strategies shown in Figure 3.2 A demonstrate 
a comparable proportion of CD172a+lineage- cells, which was a significantly altered 
composition but comparable percentage to CD172a+lineage- cells present in pre-
enrichment PBMC. Interestingly, back gating showed that CD172a- cells that were 
more abundant in the negatively depleted strategy were lymphocytes which were 
unstained with the lineage cocktail, suggesting that the depletion of stained cells 
was successful and that the remaining cells were not detected by the lineage 
markers. These unstained cells are also present in PBMC and positively selected 
enriched BDC, with a small proportion of lineage+ cells retained in the column in 
the positive selection strategy. Both strategies clearly reduced lineage+ cells 
compared to PBMC. Taking the CD172a+lineage- cells forward, the vast majority 
of these cells in PBMC are CD14+ monocytes, whereas the opposite is true in the 
CD14 depleted samples – as described above, in both selection strategies CD14 
was depleted using anti-CD14 conjugated microbeads, therefore the comparable 
depletion fits expectations. Analysing the subsets of DC by CD1a and CD4 as 
demonstrated in Figure 3.1, the proportion of CD1a+ cells referred to here as cDC2 
was comparable between PBMC and positively selected enriched BDC, whereas 
a lower proportion was present in negatively enriched BDC. Rather than a poor 
enrichment of CD1a+ cells this appears to be due to enhanced enrichment of 
CD172alowCD1a- cells and CD172a+CD4+ pDC; positive selection of CD172a was 
thought to risk excluding CD172alow cDC1, as reported by Auray et al. (2016). The 
reduced distribution of CD172alow cells shown in positively selected cells (Figure 
3.2 B) may be due to reduced anti-IgG1 microbead binding of cells with lesser 
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expression of CD172a, exacerbated by the degree of labelling of microbead 
conjugated Ab to each primary mAb. 
CD172a (also known as signal regulating protein-α, SIRPα) binds its ligand CD47, 
causing inhibitory signalling to prevent phagocytosis of CD47-expressing cells 
(Barclay, 2009). Antibody binding of CD172a could carry the potential risk of 
artefactual cell responses by activating or blockading this receptor (Weiskopf et al., 
2014), increasing the preference for negative selection as the primary enrichment 
strategy. 
PBMC stocks were cryopreserved from the animal used in this experiment and 
enrichment repeated one week later using thawed cells and the single column 
depletion protocol. Very few viable BDC were found within the depleted flow-
through but viable lymphocytes and monocytes were observed in the positive cell 
fraction eluted from the column (data not shown), suggesting that BDC do not 
survive cryopreservation or are sufficiently stressed to not survive the enrichment 
protocol; either case rendered working from frozen PBMC stocks impractical 
therefore all data presented in this chapter are from freshly isolated PBMC. 
 Culture conditions to preserve BDC viability 
To improve BDC viability in culture, experiments were conducted to test media 
conditions. Enriched BDC were cultured in RPMI, the standard media used for 
culturing primary myeloid cells, and IMDM, an enriched complex media that is used 
for sensitive cell lines such as hybridomas and haematopoietic progenitors. 
Additional macronutrients in IMDM compared to RPMI include a second potassium 
source in nitrate form, sodium, selenium, alanine, and pyruvic acid. Both media 
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contained HEPES and phenol red to buffer and facilitate visual assessment of pH, 
respectively.  Recombinant porcine IL-3 was included in all cultures in order to 
preserve viability of pDC as initially reported by (Summerfield et al., 2003b) and 
further characterised by phenotyping distribution of IL-3R (CD123) (Auray et al., 
2016). IL-3 was kindly shared by Kirsten Morris, Commonwealth Scientific and 
Industrial Research Organisation, South Geelong, Australia.  
Assessment of cells after 18 hours in culture, showed consistently higher viability 
of enriched BDC cultures with IMDM than RPMI (Table 3.3). The enriched BDC 
population (CD172a+lineage-) also made up a greater proportion of live cells in the 
IMDM cultures, suggesting that the reduction in overall viability in the RPMI 
cultures correlates with the decreased viability of the enriched BDC. The addition 
of recombinant porcine GM-CSF was also compared. GM-CSF drives monocyte 
and granulocyte proliferation from progenitor cells and is widely used in literature 
as a growth factor when differentiating monocytes to a dendritic cell-like phenotype 
(MoDC), as well as being implicated in steady-state DC development with Flt3, a 
major growth factor that is detectable on the surface of porcine BDC (Guzylack-
Piriou et al., 2010; Karsunky et al., 2003; van de Laar et al., 2012). 
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Table 3.3. Viability of enriched BDC in RPMI and IMDM supplemented with GM-CSF.  
Culture medium* 
% Live 
cells 
% Live BDC 
% CD1a+ 
live BDC 
IMDM 
+ GM-CSF 
43.5 45.8 1.57 
IMDM 46.8 46.4 1.74 
RPMI  
+ GM-CSF 
15.5 10.2 0.79 
RPMI 27.7 18.5 1.24 
* Enriched BDC were cultured in IMDM or RPMI, with or without supplementary 10 ng/mL 
GM-CSF, for 18 hours before collecting cells and staining with a minimal version of the 
BDC enrichment QC panel including amine reactive viability dye. 
 
No changes were observed in the overall viability nor in the CD1a+ cDC2 subset 
distribution when culturing with GM-CSF; within the RPMI cultures the absence of 
GM-CSF correlated with the highest proportion of live BDC, which did not match 
the findings of (Summerfield et al., 2003b). While this experiment was performed 
at a small scale the trend supported the use of IMDM instead of RPMI and did not 
support the need for GM-CSF supplementation. BDC media used subsequently 
therefore refers to IMDM supplemented with IL-3, alongside “standard” 
supplements 10% FBS and 1x Pen/Strep. 
 Further characterisation of surface markers to improve the BDC 
subset phenotyping strategy 
Markers beyond CD1a and CD4 were tested with a view to improving resolution of 
BDC subsets from PBMC. CD11c, an integrin associated with myeloid cells, was 
reported to be detected with a novel porcine-reactive mAb by Deloizy et al. (2016). 
CADM1 is an adhesion molecule found on a wide array of cells that is reported to 
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be expressed to differential levels on DC subsets, enabling resolution of cDC1 and 
cDC2  populations using a mAb that cross-reacts with artiodactyls (Vu Manh et al., 
2015). Testing these reagents was necessary to prioritise markers to include in the 
BDC phenotyping panel, as analysis strategies vary in literature between groups: 
Auray et al. (2016) assessed CD1a and CD4 within subsets determined by CADM1 
and CD172a; Edwards et al. (2017) assessed CADM1 expression within subsets 
first determined by CD1a and CD4 expression; Deloizy et al. (2016) resolved cDC2 
by CD1a staining and cDC1 by CADM1 staining. These parameters were therefore 
characterised in lymphocytes, cDC1, cDC2, and monocytes to assess staining 
resolution for application to both phenotyping analysis and as a potential MACS 
enrichment reagent. In this analysis CD14 was detected by biotinylated mAb 
alongside previous lineage markers CD3, CD8α and CD21; CD172a+lineage+ cells 
were therefore classified as monocytes. 
Staining of PBMC (Figure 3.3 A) and enriched BDC (Figure 3.1 B) illustrate 
FSChighSSClow live cells as described previously. DC were separated by CD1a and 
CD4 staining as before (Figure 3.1 C), with each cDC subset further analysed by 
CADM1 expression. The gating applied to Figure 3.3 D and E was applied to panel 
F, in order to assess whether comparable cDC1 and cDC2 populations are 
resolvable using CADM1 and CD172a without the prior assessment of CD1a. The 
decision to regard the CADM1- portions of both cDC1 and cDC2 as contaminants 
was informed by (Deloizy et al., 2016; Vu Manh et al., 2015). This was also 
validated by back-gating the CADM1+ and CADM1- populations against FSC and 
SSC and observing that CADM1- cells classified as cDC1 by negative CD1a 
staining were in fact often contaminating neutrophils (data not shown). CD4+ pDC 
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were also assessed for CADM1 expression within panel F, and did not overlap with 
CADM1+ population (gating not shown; illustrated in subsequent analysis). 
The CD172a+lineage+ monocytes and CD172a-lineage+ lymphocytes abundant in 
pre-enrichment PBMC and lineage- lymphocytes present in BDC enriched samples 
are shown alongside BDC subsets when analysing CD11c distribution in Figure 
3.3 H to assess whether this marker aids population resolution, using the same 
strategy to assess CD172a to provide a side-by-side comparison of the two 
“myeloid” markers alongside CADM1. CD172a+lineage+ monocytes expressed 
CD11c more abundantly than any other population assessed, in a comparable 
staining pattern to CD172a. A subset of lineage- lymphocytes (light blue) were 
CD11c+, the cause of which was not readily apparent at the time of initial analysis; 
however, in subsequently published literature, B cell populations were confirmed 
to express variants of CD11 (Braun et al., 2017). Lineage+ lymphocytes (dark blue) 
appeared to highly express CD11c, however, this was due to staining of the anti-
CD3 mAb by the anti-IgG1 secondary mAb used to detect CD11c; CD3 and CD11c 
were the only IgG1 mAbs used in this stain. pDC were found to express CD172a, 
CD11c, and CADM1 in a comparable distribution to CD1a-, therefore CD4 was 
considered essential to retain positive identification of this subset. 
Using CD1a to discriminate cDC1 (orange populations) and cDC2 (red 
populations), it was observed that CADM and CD172a expression was able to 
discriminate these cDC1 and cDC2 populations without the use of CD1a (green 
populations). In the histogram of cDC1 (orange), the event count of CD11c- masks 
the CD11c+CADM1+ population, whereas the cDC2 (red) populations are more 
consistent between gating strategies. The difference in CD11c expression between 
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cDC1 and cDC2 was less than that of CD172a expression, therefore using CD11c 
against CADM1 to phenotype these populations without CD172a was not viable; 
CD172a remained the more relevant parameter to combine with CADM1. The 
summary of CADM1 expression in PBMC populations (Figure 3.3 I) suggests that 
lineage- lymphocytes are a contributing contaminant to the CADM1- populations 
observed within CD1a+ cDC2 gating and CD1a- cDC1 gates. Assessment of cDC2 
and cDC1 using CD172a and CADM1 without CD1a (green populations) removes 
this contamination from the subset gating and downstream analysis. 
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Figure 3.3. CD11c and CADM1 distribution on populations enriched from PBMC. PBMC 
and BDC subsets enriched by negative selection were analysed for CADM1 and CD172a 
expression. Monocytes (grey) and lineage+ lymphocytes (dark blue) were defined in PBMC 
before enrichment (A); lineage- lymphocytes (light blue) defined in PBMC after BDC 
enrichment (B); DC defined in B were resolved as CD1a- cDC1 (orange), CD1a+ cDC2 
(red), and CD4+ pDC (purple) (C); CD1a- and CD1a+ cDC populations were further 
assessed for expression of CADM1 (D) and (E), respectively; events in panel C are 
presented assessing CADM1 (F), applying the gating strategies from D and E (light green 
and dark green respectively). The named coloured populations defined in A - F are 
summarised for expression of CD172a (G), CD11c (H) and CADM1 (I), histogram y axes 
normalised to modal counts for each population. The distribution of CD172a, CD11c, and 
CADM1 support that cDC populations determined by expression of CD1a contain mixed 
populations expressing varying degrees of CD172a and CADM1, whereas cDC 
populations determined by expression of CADM1 are homogeneous for expression of 
CD1a and CD172a. Representative data from technical replicates (n=2) of a biological 
singlet are shown. 
 
Despite its utility to confirm in this instance that cDC2 gating by CADM1 selected 
a separate population to monocytes, CD11c staining resolution was deemed not 
sufficient to replace the CD172a and CD1a phenotyping strategy. CADM1 provided 
additional confidence and resolution in cDC subsets and was therefore deemed an 
effective gating parameter. With this confirmation in place, BDC subsets and 
monocytes were next assessed for CD163 expression with the addition of CADM1 
and not CD11c (Figure 3.4). The accurate detection of CD163+ BDC required prior 
exclusion of a small population of lineage+CD163+ events (data not shown), as the 
anti-IgG1 secondary mAb used to label the CD163 primary mAb also bound the 
IgG1 anti-CD3 mAb. All other antibodies in the panel were not IgG1 and showed 
no background staining by this secondary mAb. CD1a+ BDC (cDC2) contained 
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three populations: CD172alowCADM1-CD163-, CD172a+CADM1+CD163- and 
CD172a+CADM1+CD163low (Figure 3.4F). The former population may be 
lymphocytes that are carried through from the lineage+ exclusion gate when 
attempting to include CD172alow cells which are CADM1+CD1a-CD163-; overlap of 
CD172alow populations and CD172a- lymphocytes was observable throughout 
experiments. Similarly, a small population of CD163lowCADM1+ cells in the 
monocyte upper-right quadrant closely resemble the distribution observed in the 
CD1a+ cDC2 population, suggesting this is another instance of overlap in upstream 
gating due to comparable CD172a expression. The current panel resolution meant 
total separation of these gates was not possible, therefore it was reliant on efficient 
enrichment. Figure 3.4 G and H demonstrates that the CD4+ pDC are CADM1low 
and CD172a expression overlaps with both CD172alow and CD172a+ cDC 
populations. 
The relative expression of CD163 can be observed by the dot plots in Figure 3.4 
D, F, H, K and M, and by using the median fluorescent intensity of the 
corresponding populations: lower right quartile of Figure 3.4 K (monocytes) and M 
(AMΦ), and the upper right quartile of Figure 3.4 F (cDC2). Peripheral monocytes 
are reported to typically express low levels of CD163 which elevate after culture 
with MΦ or DC growth factors (Fairbairn et al., 2013; Philippidis et al., 2004). The 
intensity of CD163 staining in cDC2 was 30-fold lower than in monocytes, and 
almost 100-fold lower than AMΦ stained simultaneously as a positive control for 
CD163 expression; these AMΦ were stained immediately after cryo-resuscitation 
rather than after overnight culture, when PRRSV-1 is unable to infect effectively, 
so it is expected that this is a conservative assessment of AMΦ CD163 expression.  
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Figure 3.4. Phenotyping of enriched BDC subsets for CD163 expression, using CD1a and 
CADM1 to validate populations. Negatively selected lineage- BDC were resolved from 
CD14+ monocytes (A), grouped into cDC1, cDC2 and pDC subsets by CD1a and CD4 
expression (B), and further assessed by expression of CADM1 (C, E, G) and CD163 (D, 
F, H). Monocytes in pre-enrichment PBMC, gated by CD14 expression (I), were similarly 
assessed by expression of CD172a, CADM1 (J) and CD163 (K). AMΦ were 
simultaneously assessed to compare relative expression of CD172a, CADM1 (L) and 
CD163 (M). The CADM1+CD172a+ gate presented in E is identical to that used in J, to 
compare overlap in these populations following this strategy; the CD163 and CADM1 
quadrant gates presented in D are identical in F, H, K and M. Representative data from 
technical duplicates (n=2) of a biological singlet are shown. 
 
 
 Enhanced enrichment by optimising neutrophil and B cell staining and 
depletion strategies 
Neutrophils contaminating PBMC preparations were enriched by the BDC negative 
selection strategy, likely due to their low CD14 expression. While their granular 
properties typically enables exclusion during analysis by high SSC values, 
abundant contamination would interfere with seeding densities when testing and 
characterising infection. Porcine neutrophils are described in the literature as 
SWC8+, a cell surface marker also found on a subset of T cells and B cells  
(Haverson et al., 1994; Summerfield and McCullough, 1997). SWC8 expression 
was characterised in PBMC before and after BDC enrichment to test if it would 
provide a positive marker for neutrophils and the FSClowSSClowCD172a-lineage- 
population enriched when carrying out negative selection. When analysing these 
populations, neutrophils were removed by SSC and CD172a gating to increase 
confidence of SWC8 assessment in all populations; enriched BDC were assessed 
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for SWC8 expression to validate that using SWC8 as an additional enrichment 
reagent would not deplete cells of interest. 
SWC8 was not detected in any of the BDC subpopulations nor on monocytes 
(Figure 3.5), confirming that using SWC8 in the depletion panel would not remove 
cells of interest. The majority of lineage- lymphocytes enriched in BDC samples 
were revealed to be SWC8+CD1a+ (Figure 3.5 H). Coupled with the lineage-
CD11c+ phenotype observed in lymphocytes in enriched samples (Figure 3.3) this 
supports that lineage-, therefore CD21-, B cells are enriched alongside BDC. These 
are likely also the CD172a-CD1a+ events observed in Figure 3.5 E, due to the 
overlap in CD172alow and lineage- gates. While this explained the poor enrichment 
and staining of lymphocyte subpopulations in previous enrichments, the primary 
goal to improve neutrophil staining was not successful; unexpectedly, only 24% of 
neutrophils were stained by SWC8 mAb (Figure 3.5 G and I), whereas SWC8 
expression was anticipated on 100% of neutrophils.  
 
Luke PM Johnson   Chapter 3 
 
 
 
90 
 
 
 
 
Luke PM Johnson   Chapter 3 
 
91 
 
 
Figure 3.5. Assessment of SWC8 expression on porcine PBMC. SSChighCD172a+ 
neutrophils were excluded from lymphocytes and monocytes (A) in both PBMC samples 
before (B) and after enrichment (C). Lineage-CD172a+ DC subsets in C were gated as 
pDC by CD4 expression (D) and cDC1 and cDC2 by CD1a expression (E). These 
populations were assessed for SWC8 (F) and CD1a expression (G), showing percentages 
of the corresponding population where positive cells are resolvable; neutrophils, DC 
subpopulations and lineage- lymphocytes were compared from enriched sample whereas 
monocytes and lineage+ lymphocytes were compared from PBMC; lineage- lymphocytes 
(H) and neutrophils (I) were further assessed for co-expression. (n=1). 
 
As an alternative strategy, the citrate based anticoagulant Alsever’s solution was 
tested to replace heparin to prevent blood clotting. While different anticoagulant 
treatments are associated with improved outcomes for different goals, Alsever’s is 
also marketed for storage of whole blood for up to 10 weeks, therefore it was 
thought that improved viability may improve BDC yields by reducing any losses 
during processing. As a pilot comparison test, PBMC were isolated from Alsever’s 
solution treated and heparinised blood from one animal 1, 7, and 14 days after 
collection, resting whole blood at 4°C per manufacturer protocol. Yields were 
moderately improved when isolating fresh Alsever’s treated blood over heparinised 
blood, and after storage for 7 days, PBMC yields were reduced by almost a third 
but still viable whereas heparinised blood was haemolysed and did not separate 
by gradient centrifugation after this period (data not shown). Heparinised blood was 
diluted 1:1 in PBS before gradient as normal, and Alsever’s was tested with further 
dilution in PBS or adhering to 1:1 of sample and Alsever’s solution; the latter 
showed moderately improved yields of PBMC.  After 14 days Alsever’s treated 
blood also no longer yielded PBMC. This gave reassurance that PBMC showed 
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overall increased viability from Alsever’s solution-treated blood than heparinised 
blood.  
The transition from heparin to Alsever’s solution also consistently dramatically 
reduced the presence of neutrophils in subsequent PBMC preparations. Figure 3.6 
shows the approximate proportion of neutrophils, lymphocytes and monocytes in 
unstained PBMC isolated from heparinised or Alsever’s solution-treated blood. 
Based on FSC and SSC, the proportion of monocytes and lymphocytes in a 
neutrophil exclusion gate was comparable in PBMC isolated from heparinised 
blood and ungated PBMC from the Alsever’s blood from the same animal. Plotting 
SSC against CD172a was deemed sufficient gating to exclude the minimal 
neutrophils present in freshly processed citrate-treated samples. 
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Figure 3.6. Distribution of PBMC size and granularity after density gradient isolation from 
whole blood anticoagulated using either Alsever's solution or heparin. Blood from a single 
donor animal was collected in Alsever's solution or heparin and PBMC immediately 
isolated and analysed by flow cytometry.  Singlet PBMC from heparin-treated blood are 
presented before (A) and after gating to exclude neutrophils (B); PBMC from citrate-
treated blood gating on all singlets (C). Percentages displayed are frequency of all singlets 
(A and C) and of cells excluding neutrophils (B). Named gates are determined by FSC and 
SSC based on typical back-gating for lymphoid and myeloid markers established in 
previous experiments. Representative data from technical duplicates (n=2) of a biological 
singlet are shown. 
The change in anti-coagulant unexpectedly meant that optimising staining of 
neutrophils for depletion was no longer necessary. While removal of neutrophils by 
whole-blood treatment increased overall efficiency, CD21- B cells were also 
enriched by lineage depletion, a pattern observed increasingly when processing 
blood from slaughter-age pigs sourced from an abattoir instead of the juvenile pigs 
that had been used in early pilot experiments; sourcing blood from slaughtered 
animals was the only logistically viable source of sufficient blood volumes for 
routine BDC enrichment. The resolution of B cell markers was lower in adult 
heparinised blood from adult pigs compared to both heparinised blood from 
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younger pigs and citrate-treated blood from adult pigs; furthermore, fewer CD21+ 
cells were observed in adult blood. This suggested that as pigs age the epitope of 
the selected CD21 mAb is decreasingly expressed on multiple subtypes of B cells, 
which correlates with decreased depletion efficiency when using blood from older 
animals. Unlike Edwards et al. (2017), Braun et al. (2017) used the same clone of 
CD21 mAb, BB6-11C9.6, included in the “lineage” cocktail in the present work. This 
was based on the work of Sinkora et al. (2013) characterising clone BB6-11C9.6 
as binding the most widely expressed epitope of the CD21 B cell marker in swine. 
Subsequent phenotyping with a pool of Igκ and Igλ mAbs as a pan-B cell stain, 
which, unlike mice and cattle, swine use in equal proportions (Butler, 2012), 
revealed that the CD21 mAb did not stain all B cells in older pigs, therefore the 
BB6-11C9.6 clone is not a universal B cell marker. The pooled monoclonal 
antibodies used to detect Igκ and Igλ together (referred to hereafter as IgL) was 
not a feasible addition to the BDC MACS enrichment strategy due to reagent 
availability and high concentration working dilution, but was used to support the 
observation that the enrichment of CD21- B cells was exacerbated in older animals. 
PBMC from juvenile and abattoir animals were co-stained in parallel with CD21 
and antibodies to different B cell receptors (BcR) in order to identify the most 
conserved anti-BcR Ab that could replace or supplement CD21 in the lineage 
cocktail during BDC enrichment and phenotyping (Figure 3.7). IgGH+L polyclonal 
Ab (pAb) is marketed as anti-IgG but the potential for reactivity against both heavy 
and light chains suggested cross-reactivity which is not isotype specific. 
Colleague’s optimisation experiments showed that pAbs against IgMFc, IgA Fc and 
IgGFc stain unique populations of B cells (data not shown), supporting that they are 
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isotype specific. IgL was used as a control condition to identify the proportion of B 
cells that are not stained by CD21 mAb in young and adult animals in a biological 
singlet experiment to confirm that these markers, when stained simultaneously, 
behaved in line with colleague’s work (Figure 3.7 A). 88% of IgL+ cells were also 
CD21+ in the juvenile animal whereas only 64% of IgL+ cells were CD21+ in the 
older animal. Due to the poor resolution of anti-IgL when assessing without a 
second B cell marker, a subset of CD21+ cells appear IgL- in both age animals. The 
total percentages of B cells assessed between staining conditions varies in part 
due to variation in  BcR isotypes stained; IgG+ B cells were anticipated to be less 
abundant than IgM+ B cells, especially in the juvenile pig. Variation in the 
percentages of panels A-D may be due to minor variations of cell distribution 
between samples, as the parent gate is set by FSC and SSC, as IgL was not 
compatible with all co-stains, therefore non-B cells may be present.  IgGFc staining 
showed that a large proportion of CD21+ cells were IgG-. This was anticipated, but 
also appears linked to the poor staining resolution of the pAb; when titrating this 
reagent it was observed that at higher concentrations cross-reactivity could be 
seen with other isotypes of BcR. Again, a greater proportion of BcR stained cells 
were CD21- in the older animal. IgGH+L and IgM staining revealed that almost half 
of BcR stained cells in the older animal were CD21-, with a minority of BcR+ cells 
in the younger animal also CD21-. No CD21+ cells were unstained by IgGH+L 
whereas a CD21+IgM- subpopulation was clearly resolved in both ages. 
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Figure 3.7. Staining of peripheral blood B cells from juvenile and slaughter-age pigs with 
4 different BcR markers and CD21. PBMC from a 4 week (upper row) and 6 month old 
pigs (middle row) were co-stained with CD21 BcR stains: IgGFc (A); IgGH+L (B); IgM (C); or 
IgL (D) pAbs. The frequency of CD21- cells was summarised within BcR+ lymphocytes for 
1 month old (filled bars) and 6 month old (unfilled bars) pigs (E). (n=1). 
To quantify B cells identified by BcR staining that are not detected by CD21, 
staining frequency was summarised within each BcR population (Figure 3.7 E). 
When assessing the frequency of CD21- cells within BcR+ populations the trends 
fit the observations of dot-plots: the pAb binding IgGH+L detects more CD21- B cells 
at both ages than any other Ab tested; in the older animal 55% of IgGH+L+ cells 
were CD21-, whereas 45% of IgL+ and IgM+ cells were CD21-. 
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Multicolour staining of PBMC confirmed that when titrated appropriately anti- 
IgGH+L pAb did not stain CD172a+ cells (data not shown), which was tested due to 
the possibility of Fc receptor binding. It was therefore decided that IgGH+L pAb 
would replace CD21 mAb in the lineage cocktail when both enriching and 
phenotyping BDC samples to improve detection of B cells. 
 
3.3 Susceptibility of BDC subsets to PRRSV-1 
 PRRSV-1 strains used 
Lena and SU1-Bel are both highly pathogenic PRRSV-1.3 strains isolated from 
lung tissues from young pigs in Belarus in 2010. Both strains have been 
characterised as capable of inducing severe clinical signs in juvenile pigs under 
experimental infection settings (Morgan et al., 2013; Weesendorp et al., 2013a), 
however lethality reported in vivo by Lena infection included inadvertent bacterial 
co-infection (Karniychuk et al., 2010). PRRSV-1.1 strain 215-06 was isolated in 
2006 from the serum of a post-weaning piglet showing signs of wasting and poor 
condition on a farm in England and experimentally characterised as inducing a 
greater inflammatory response than prototype PRRSV-1 Lelystad virus but 
regarded as lowly pathogenic when compared to PRRSV-1.3 strains (Morgan et 
al., 2013); it is likely that 215-06’s contribution to the low health status of the 
isolation source was due to co-infection as in PRDC.  
BDC were enriched by single column lineage depletion negative selection from 
freshly isolated PBMC from 3 Babraham gilts and infected immediately after culture 
by inoculating PRRSV-1 at an MOI of 1 for 90 minutes then washing and replacing 
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the inocula with BDC media (IMDM with IL-3). This was necessary to ensure 
viability as virus stock titres required large inocula volumes to achieve this MOI, 
therefore leaving the inocula on for the duration of the time-course would leave the 
cells without fresh media and supplements. Removing the inocula also enabled 
assessment of supernatant for secreted viral progeny if initial infection assessment 
appeared positive. 
Neutrophils were particularly abundant in one of three animals in this experiment 
despite prior optimisations (Figure 3.8). The reduced SSC of cultured neutrophils 
impeded their exclusion in the flow cytometric analysis (using SSC against 
CD172a) as variation in SSC was observed both between animals and between 
time-points. 
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Figure 3.8. Inter-animal variation in neutrophil contamination of PBMC and enriched BDC. 
Dot plots of the preliminary enrichment assessment of PBMC from 3 animals pre- (top row) 
and post- (bottom row) MACS enrichment for BDC. Gating on populations of interest by 
FSC-SSC characteristics based on typical back-gating of cells positive for population 
specific markers. Dot plots of technical singlets of biological triplicate (n=3). 
After the optimisations described previously, the panel used to determine infection 
in enriched BDC are summarised (Table 3.4); the replacement of CD21 and CD14 
mAbs and CADM1 secondary Ab improved confidence in resolving every 
population and the reduction in redundant fluorophores streamlined compensation, 
with the aim of improving the resolution of populations. The gating strategy in this 
experiment used CADM1 to identify cDC1 and cDC2 without CD1a, as described 
in Figure 3.3 and Figure 3.4; as this showed that CD1a was supplemental and not 
essential. While increased phenotyping robustness with more markers would have 
been desirable, the inclusion of unconjugated IgG1 anti-PRRSV N mAb required a 
secondary mAb of limited fluorophore choices. The APC channel was not an ideal 
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tag due to its compensation with Zombie viability dye, and separating dying and 
infected cells would be critical to analysis. Foregoing CD1a, the FITC channel 
(AF488) was available and no other markers were anticipated to show spectral 
overlap into this channel. Lineage was therefore moved to APC to decrease 
compensation with CD4-PerCp-Cy5.5 and CD172a-PE and anti-PRRSV N mAb 
SDOW detected by AF488 tagged anti-IgG1 mAb. 
  
Luke PM Johnson   Chapter 3 
 
101 
 
Table 3.4. Flow cytometric staining panel to assess PRRSV-1 infection of enriched BDC. 
 Marker Tag Clone 
1 Zombie viability 
Near IR 
(APC-Cy7) 
NA 
2 
CD3 Biotin PPT3 
CD8α Biotin 76-2-11 
IgGH+L Biotin Goat polyclonal 
CD14 Biotin REA599 
Streptavidin APC NA 
3 CD172a PE 74-22-15A 
4 CD4 PerCP-Cy5.5 74-12-4 
5 
CADM1 Secondary 3E1 
Anti-IgY BV421 Donkey polyclonal 
6 
PRRSV nucleocapsid Secondary SDOW17 
Anti-IgG1 AF488 RMG1-1 
 
A decrease in surface expression of CD14 immediately after culture and 
inoculation reduced confidence in monocyte resolution from cDC2; CD14 was 
therefore used only as an additional validating marker when possible to 
supplement population determination by gating of CADM1 and CD172a. This 
strategy was viable due to previous comparisons of CADM1 in BDC subsets and 
monocytes.  In early time-points, CD14 gating determination of monocytes 
suggested that CD172ahigh DC were particularly abundant and that monocytes 
were only 12% of FSChighSSClow cells (Figure 3.9 B), whereas alternative gating 
reveals that there were few CADM1+ cells (Figure 3.9 A). By 18 hpi CD14 
expression was strongly detectable in monocytes (Figure 3.9 D). 
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Figure 3.9. Monocyte CD14 expression change after culture in time-course. 
Representative dot plots of uninfected FSChighSSClow MACS enriched cells from pig 2. 
CADM1 and CD172a (A and C) analysis compared to Lineage and CD172a (B and D) 0 
hpi (A and B) and 18 hpi (C and D). CD172a-CADM1- populations were considered 
lymphocytes and excluded from downstream gating. Representative biological singlet 
(n=3). 
 
The detection of infected cells was carried out by detecting intracellular PRRSV N 
protein at 6 hour intervals to detect replication in addition to initial infection. The 
gating strategy for assessing infection is outlined in Figure 3.10. The contaminating 
neutrophils previously described (Figure 3.8) were most present in pig 3, falling 
within the corresponding gate presented in Figure 3.10 A. To control for the varied 
expression of CD14 described above, BDC populations were gated using the 
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CADM1 vs CD172a gating strategy presented in Figure 3.10 B, assessing each for 
presence of PRRSV N protein. An additional validation step was included for cDC1, 
cDC2, and pDC to ensure that N signal was not due to contaminating Lineage+ 
cells stained by CD3, which would be detected by the secondary mAb used to stain 
PRRSV N protein; monocytes did not require this step due to their positive staining 
for Lineage mAb CD14, therefore within the monocyte gate Lineage+PRRSV+ cells 
could be regarded as infected.  
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Figure 3.10. Gating strategy to assess PRRSV-1 infection of BDC subsets. Representative 
dot plots of MACS enriched FSChighSSClow cells; Lena inoculated pig 3 is presented 18 hpi. 
Staining of CD172a and lineage cocktail with gating illustrating overlap in myeloid 
populations (A); gating strategy used to determine downstream populations (B); pDC 
further confirmed by expression of CD4 (C); cDC2 (D), cDC1 (E), and pDC (F) were 
screened for false PRRSV staining introduced by secondary mAb staining CD3 by gating 
on Lineage+PRRSV+ cells, examples shown of pDC (G), and monocytes (H) from which 
Lineage+ cells were not excluded (I). Representative dot plots of technical duplicate (n=3). 
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To observe infection-dependent or -independent losses of BDC subsets, the 
frequency of each population was analysed over time alongside frequency of 
detected PRRSV N. Viability of cDC and pDC showed time-dependent decreases 
and greater variation between biological replicates than between infections (Figure 
3.11 A – C). The relative frequency of all 3 DC subsets appeared particularly low 
for pig 3 due to the increased presence of neutrophils. Pig 2 showed a reduction in 
both cDC2 and pDC over time, with an observable difference in pDC frequency at 
6 hpi in only the SU1-Bel infection condition, however, every infection condition 
clusters together at 12 and 18 hpi, suggesting this may be artefactual. Additionally, 
well-to-well variation appears to account for variation within pig 1 more than the 
infection conditions as cells resuspended and stained 12 hpi show more abundant 
cDC1, cDC2 and pDC than other time-points both before and after. The infection 
rate in Figure 3.11 E – H is determined by gating within individual populations as 
demonstrated in Figure 3.10 E – H, gates set against mock infected samples at 0 
hpi. Background is observable in infection rates, likely due to over-stringent gating 
attempting to avoid biasing flow cytometric analysis towards a negative result; one 
individual event falling within the positive gate gave a 1.2% positive result when 
assessing cDC2 12 hpi by SU1-Bel (Figure 3.11 F). These data supports previous 
findings that pDC are not susceptible to Lena (García-Nicolás et al., 2016) and 
expands on this by confirming that they are neither susceptible to subtype 1 field 
strain 215-06 nor highly pathogenic subtype 3 strain SU1-Bel. cDC subsets also 
show no susceptibility to any strain including Lena, which was reported during the 
course of these studies by Bordet et al. (2018) who characterised the responses 
of parenchyma derived cDC to Lena. 
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Figure 3.11. MACS enriched BDC susceptibility to PRRSV-1 assessed by flow cytometry. 
Each Enriched BDC were infected at MOI=1 immediately after culture and collected for 
flow cytometric staining at 6 hour time-intervals. BDC subsets presented as a percentage 
of FSChighSSClow cells and the frequency of PRRSV-1 N protein+ cells within each of these 
subsets respectively: cDC1 (A and E); cDC2 (B and F); pDC (C and G); monocytes (D and 
H). Thresholds for determining infection were established by gating on mock-infected 
samples within each biological replicate at 0 hpi. Means of cultured technical duplicates 
for each animal are displayed in all panels (n=3). 
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 Enriched BDC cultures do not show cytokine responses in presence 
of PRRSV-1 
Large inter-animal variation was observed when cytokines secreted in enriched 
BDC culture supernatants was quantified by sandwich ELISA. Over the time-
course, there were no significant differences in IFN-α secretion when comparing 
infection conditions or time-points. Assessing 18 hpi only, IFN-α variation in 
response between infection conditions across the biological triplicate are not 
statistically significant despite the large response from pig 3. The strongest 
response increased with infection with PRRSV-1.3 was observed in pig 3 (Figure 
3.12), which was the replicate to have the highest proportion of neutrophils present 
after depletion. Pigs 1 and 2 contained less than 0.5% neutrophils which increased 
to 2% after enrichment whereas pig 3 PBMC were 7% neutrophils which increased 
to 35% after MACS enrichment. To investigate this trend further cytokines were 
assessed (Figure 3.12). TNF-α secretion showed no statistical difference between 
time-points within infection conditions, within each condition, without separating 
time-points, there was a significant difference (P < 0.05) between Lena and SU1-
Bel infection conditions. TNF-α was significantly greater (P < 0.001) than all 
infection conditions at 0 hpi. No inter-infection significance is not present when 
assessing 18 hpi only. Significance cannot be calculated between pig 2 and pig 1 
within infections (circle and square data-points, Figure 3.12 D) due to insufficient 
technical replicates within biological replicates, however, there is a clear trend that 
pig 2 is responding more strongly than pigs 1 and 3 in all conditions other than 
Lena infection; this coincides with an elevated proportion of monocytes present in 
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this animal before and after BDC enrichment, albeit to a lesser extent than the 
neutrophil contamination observed in pig 3.  
IL-8 in culture was consistent across time-points, with significant differences only 
between SU1-Bel samples at 6 hpi and 18 hpi (P < 0.05), suggesting IL-8 did not 
accumulate at any specific stage of culture, despite a general upward trend being 
observable after 6 hpi. IL-8 was significantly lower in Lena inoculated samples than 
mock, 215-06, and SU1-Bel at all time-points; 0 hpi (P < 0.01), 6 hpi (P < 0.005), 
12 and 18 hpi (P < 0.001). 
At 12 hpi, IL-12p40 secretion was significant between mock and both PRRSV-1.3 
strains (P < 0.01) and between 215-06 and both PRRSV-1.3 strains (P < 0.05, not 
shown on graph). SU1-Bel samples were significant between each sequential time-
point (P < 0.05); mock was significant between 6 and 12 hpi and between 12 and18 
hpi (P < 0.05).  
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Figure 3.12. Cytokine response of PRRSV-1 inoculated enriched BDC cultures over-time.  
Enriched BDC were infected at MOI=1 immediately after culture and supernatants 
collected at 6 hour time-intervals; time-point 0 denotes cells at removal of inocula. 
Concentrations of IFN-α, TNF-α, IL-8 and IL-12p40 in culture supernatant after infection 
with PRRSV-1.1 215-06, PRRSV-1.3 Lena and SU1-Bel, and mock infection. Data shown 
are the standard error of the mean of technical duplicates for each biological replicate 
throughout the time-course (A – D), and at 18 hpi only (E – H); bars denote the mean of 
biological triplicates (n=3). Stars denote statistical significance: * P < 0.05, ** P < 0.001, 
*** P < 0.0005, **** P < 0.0001; statistics in panel C show the lowest significance within 
each time-point between Lena and other conditions.  
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3.4 Discussion 
 BDC tropism hypothesis 
Following on the PRRSV-1.3 Lena infected myeloid cell characterisation of Frydas 
et al. (2013) and the enhanced viral clearance and pro-inflammatory responses 
reported in vivo by PRRSV-1.3 SU1-Bel infection, our hypothesis was initially that 
pathogenicity correlated with expanded tropism to DC populations. This hypothesis 
is evidently negative with regards specifically to BDC, having now compared both 
PRRSV-1.3 Lena and SU1-Bel against subtype 1.1 strain 215-06 which were all 
unable to infect freshly isolated BDC and monocytes. 
Interestingly Frydas et al. (2013) provide data reporting monocytes as permissive 
to both LV and Lena, whereas in my hands, monocytes are not susceptible to 
infection immediately after culture. This may be explained by differences in culture 
time pre-infection. Both Frydas et al., and myself removed the infectious inocula 
after an adhesion period of 60 and 90 minutes, respectively, however when testing 
BDC and monocytes, I infected immediately after culture whereas Frydas et al. 
(2013) infected 24 hours after culture, which is reported to alter CD163 expression 
(Fairbairn et al., 2013; Philippidis et al., 2004), perhaps sufficiently to enable 
susceptibility. My initial CD163 phenotyping of myeloid populations in Figure 3.4 
suggests that a subpopulation of monocytes, and to a lesser extent cDC2, express 
CD163 immediately after isolation but at a 50-fold lower level per cell than cryo-
resuscitated AMΦ. Anti-coagulant has been reported to have an impact on CD163 
expression in human samples (Moniuszko et al., 2006), which as the primary entry 
receptor for PRRSV may contribute to variation in literature; the anti-coagulant 
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used is not reported in literature published by the (Frydas et al., 2013) group. The 
assessment of CD163 expression by porcine DC in the recent literature includes; 
CD163- palatine tonsil derived DC subsets (Soldevila et al., 2018); CD1a+CD163low 
dermal DC which cluster functionally and phenotypically resemble cDC2 (Marquet 
et al., 2014). Auray et al. (2016) reported freshly isolated cDC2 to express CD163 
to a lesser extent than monocytes, which correlates with my own findings. Frydas 
et al. (2013) reported that a small proportion of infected cells at the periphery of 
infected clusters are CD163-; no variation is reported in fluorescence intensity of 
imaged cells, therefore these “CD163-” cells could in fact be related to the CD163low 
dermal myeloid cells reported by Marquet et al. (2014). These dermal cells are 
MHC II+CD1a+ CD16+Flt3lowCSF1R+, similar to steady state cDC2, however, unlike 
Langerhans cells and cDC2 they are also CD14+, suggesting a macrophage-like 
phenotype. 
During the course of these studies, work was published by the same group (Xie et 
al., 2017) further characterising the broader tropism of PRRSV-1.3 Lena, using 
immunofluorescence to confirm that a variant of Siglec-1 (CD169), Siglec-10, is 
utilised by Lena and some North American PRRSV-2 strains but not by PRRSV-
1.1 prototype strain Lelystad. The immunofluorescence imaging of porcine spleen 
(from an unspecified pig background) in this paper characterised the co-localisation 
of Siglec-1 and -10 with CD21 in B cell rich areas, discrete from CD163+ regions, 
correlated with further use of in vivo study data (Morgan et al., 2013) by García-
Nicolás et al. (2015) which described a transient depletion of B cells and T cells in 
lymph nodes, likely due to migration to the inflamed lung. In combination with the 
subsequent publication by Xie et al. (2018) that expanded Siglec-10+ refractory cell 
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line permissiveness data to include further Asian PRRSV-2 strains and European 
PRRSV-1 strains including SU1-Bel, this retrospectively suggested that SU1-Bel 
and Lena’s secondary preference for Siglec-10 was the more salient correlate with 
lymphoid inflammation and B cell depletion. Xie et al. (2018) suggest that SU1-Bel 
infects more effectively than Lena using Siglec-10, but that both strains use Siglec-
1 far more effectively than Siglec-10. This suggests a higher affinity for Siglec-1, 
therefore it is likely that Siglec-1+ cells are preferentially infected before Siglec-10+. 
Interestingly SU1-Bel showed a lower infection rate than Lena in the studies 
reported by Xie et al. (2018), correlating with SU1-Bel in vivo data (Morgan et al., 
2013), again suggesting that enhanced replication is not the cause of enhanced 
pathogenicity. 
A comprehensive study on PRRSV-1 modulation of ex vivo cDC was published as 
I carried out my own infection experiments. Bordet et al. (2018) showed that lung 
parenchyma derived cDC1 and cDC2 are not susceptible to PRRSV-1.3 Lena nor 
PRRSV-1.1 strains Lelystad and 13V091, lowly and highly pathogenic PRRSV-1.1 
strains respectively. Lena however induced anti-viral cytokine responses in cDC1. 
This validates my own negative infection data using Lena, supplementing the 
negative results for 215-06 and SU1-Bel. 
 Initial phenotyping panel construction 
The gating strategy used in Bordet et al. (2018) considered cDC2 to be 
CADM1+CD1a+ double positive cells within the CD172a+ populations, which I 
determined were equally identifiable by analysing CADM1 against CD172a without 
CD1a. The addition of CD1a to my infection staining panel would not have 
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expanded the phenotyping of the cells present and would have complicated 
compensation further: re-introducing an additional fluorophore such as BV650 for 
the biotinylated “lineage” group would have increased compensation requirements 
of CD172a-PE and lineage, which was already presenting a challenge in resolving 
monocytes and cDC2. Due to the laser setup, the remaining available fluorophore 
channel for PRRSV detection was APC/AF647, which would reduce confidence in 
separation of infected and dead cells due to a combination of infected cells 
decreasing in viability and the Zombie NIR dye emitting in the APC channel, 
increasingly so when the dye degrades over time when stored before running on 
the cytometer. Short storage was necessary in the time-course experiment in order 
run all samples simultaneously, ensuring identical acquisition settings. Initial work 
to prepare BDC for infection experiments went through several pilot experiments, 
receiving at the outset of my project a staining panel that had several compensation 
difficulties, which in most cases were due to the restricted fluorophore choices on 
conjugated antibodies and secondary Abs were unsuitable due to shared matching 
isotypes. CD14 was initially conjugated to the tandem dye PE-Texas Red (TR), 
which didn’t compensate well with PE due to donor fluorophore emission and the 
compensation being on cells co-expressing CD172a-PE and CD14-PE-TR. A PE-
Vio770 conjugate was used instead due to reduced emission from the PE donor 
dye, as well as increased signal intensity and resolution of the Cy7-equivalent 
Vio770. Before the infection experiments, this was also replaced with biotinylation 
of CD14 in order to group lineage+ CD172a+ double positive cells as monocytes, 
increasing efficiency of the panel. The anti-biotin lineage-staining reagent initially 
used was a BV605 conjugated streptavidin, however, the emission properties of 
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the fluorophore meant that identifying CD172alow cells detected by PE were difficult 
to resolve from the “wide” emission properties of negative populations in the BV605 
channel. BV650 was used as an alternative with narrower emission properties, 
however, when including anti-PRRSV N mAb (SDOW17), streptavidin-APC was 
used as previously described. In an ideal setup, alternatives include directly 
conjugating purified mAb with fluorophores with entirely separation spectral 
properties such as BUV dyes, however the 4-laser cytometer available to us does 
not include a 350nm laser, and conjugation using dyes that are not included in 
commercial conjugation kits is costly. Despite the compensation requirements 
described for Zombie NIR, it was used throughout my project as an alternative to 
other amine reactive dyes such as Live/Dead Aqua due to incompatibility with 
AF405, as well as extensive AMΦ and neutrophil auto-fluorescence in the 400 – 
500 nm range. An alternative attempt to overcome this was using a brighter 
secondary Ab to detect the anti-CADM1 IgY primary Ab. BV421 has increased 
signal intensity & resolution and the fluorophore options were more restricted than 
the Zombie stain. 
In addition to restricted fluorophore choices, the markers used (listed in Table 3.1 
 and Table 3.2) were in several instances selected working around limitations in 
available Abs for flow cytometric staining of live cells, despite the expression of 
surface markers being confirmed in literature by RT-qPCR. For example, Flt3 is a 
receptor found on haematopoietic progenitors and steady-state BDC and no other 
PBMC population and is therefore an ideal target for BDC enrichment; however, 
no commercial research antibodies validated for porcine samples exist against this 
protein and a recombinant tagged ligand reported in literature was not available for 
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use. In some instances, alternative surface markers can be used to overcome 
shortfalls in reactive mAb availability: IL-3 receptor (CD123) is a unique marker for 
pDC, but CD4 staining enables sufficient resolution of CD172a+CD4high pDC from 
CD3+CD4+ T helper cells. 
 Optimising phenotyping of negatively selected cells 
The inclusion of CD11c unexpectedly demonstrated an enrichment compared to 
whole PBMC of CD11c+ lymphocytes when depleting using CD3, CD8α and CD21. 
The finding that porcine B cells include a CD11c+CD21-IgM+ subset (Braun et al., 
2017) had not been published at the time of my BDC enrichment comparisons, 
therefore it was not immediately clear that the majority of the CD172a negative 
cells enriched by negative selection using CD21 as a B cell marker were likely B 
cells. Depletion of this population was subsequently further investigated in order to 
remove a major contaminant of BDC enrichment. Staining of B cells in slaughter 
age landrace-cross pigs did not match the work of Sinkora et al. (2013), who 
characterised CD21 epitopes in swine and informed the choice of CD21 mAb 
subsequently used by many groups. We therefore confirmed whether other CD21 
mAb clones behaved differently in our hands than in the literature. We observed B 
cell staining patterns in available PBMC stocks showing reduced resolution and 
population frequency when staining PBMC from slaughter-age animals compared 
to 6-8 week old piglets. This was carried out by a colleague in parallel to the 
samples in Figure 3.7; clone BB6-11C9.6 was used in initial experiments and 
compared to clones CC51 and B.Ly4 (D. Perry, unpublished data). The finding that 
the proportion of CD21-IgG+ and CD21-IgM+ B cells increased in older animals 
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(Figure 3.7) was also true for IgA+ B cells, which was characterised in a colleague’s 
early optimisation work for B cell analyses that are now published (Goldeck et al., 
2019). Thus CD21 is not a pan-B cell marker and only IgGH+L pAb and IgL mAbs 
bound the highest proportions of lymphocytes and can be considered pan-B cell 
markers. The IgL mAbs were not feasible in the depletion protocol due to the cost 
of these reagents, the requirement for conjugation, and the concentration of mAbs 
required for sufficient staining intensity. As a porcine CD19 mAb does not exist the 
remaining alternative pan-B cell marker in humans and mice is CD79a (Fuentes-
Pananá et al., 2006). This was not tested for MACS enrichment because the only 
available cross-reactive mAb targets a conserved epitope on the B cell receptor 
cytosolic domain, therefore fixation and permeabilisation is required to stain. The 
IgGH+L pAb was therefore taken forward for B cell depletions and staining in the 
“lineage” cocktail, with a notable improvement in the phenotyping of every cell type 
in the sample; now all cells are positive for at least one marker, whereas in pilot 
experiments there were clear populations which were not positively identified by 
any markers. In the infection experiments (Figure 3.11) few cells remained without 
any identifying stain. 
Time-course samples were run on the cytometer simultaneously in order to use 
identical laser and compensation settings, however, changes in cell surface 
markers may also be exacerbated by minor variation in staining mastermixes 
assembled at each time-point; antibodies were always diluted fresh rather than 
risking degradation or complexing of antibodies by the final time-point. This 
necessitated gating strategies grouped by time-point and then establishing the best 
balance of gating parameters between biological replicates. Analysis of the 
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samples collected during the BDC infection time-course was hindered by variation 
in contaminating neutrophil SSC properties between time-points. This meant that 
applying a single gating strategy to all samples was inappropriate, therefore 
separation of cDC2, neutrophils and monocytes required CD172a and CD14 
(lineage) staining. Despite the issue of neutrophils carrying through enrichment 
being largely removed by the replacement of heparin sodium by Alsever’s citrate 
anticoagulant, in one gilt an elevation of and neutrophils was observed while 
isolating PBMC, which were subsequently enriched by MACSorting. Exclusion of 
neutrophils during analysis of freshly isolated cells is typically readily achieved by 
gating out SSChighCD172a+ cells, however as culture time increased neutrophil 
SSC reduced, making it more difficult to separate neutrophils from BDC and 
monocytes. This was an extension of the reduced SSC neutrophils typically 
showed before and after isolating PBMC from whole blood (whole blood data not 
shown). At early time-points, monocyte CD14 expression was low, making it harder 
to separate monocytes from cDC2 due to their similar SSC properties and CD172a 
expression (Figure 3.9). It is likely, but not confirmed, that this was due to CD14 
internalisation during inocula adhesion time, rather than CD14low monocytes being 
inefficiently depleted; CD14 and TLR4 internalisation has been described after 
binding of the LPS-binding domain of CD14 (Kim and Kim, 2014; Poussin et al., 
1998), which resembles the loss of signal seen here when re-staining for CD14 
immediately after inoculation. It is worth noting that neutrophil CD14 expression did 
not increase throughout the time-course and the degree of CD14 downregulation 
has varied between experiments; in previous experiments CD14 was resolvable 
when staining immediately after enrichment when using a fluorophore conjugated 
Luke PM Johnson   Chapter 3 
 
 
 
118 
 
mAb (Figure 3.4) and a biotinylated mAb (Figure 3.3). This effect is consistent 
within the same mAb clone.  
As previously established, the negative selection did not fully deplete the 
neutrophils, likely due to low CD14 expression, which was the original intention of 
testing SWC8 as a depletion marker.  Rather the removal of neutrophils from 
PBMC preparations was improved by replacing heparin with Alsever’s solution as 
an anti-coagulant, which was typically sufficient to render an additional depletion 
reagent unnecessary. The SWC8 mAb tested stained an unexpectedly low 
proportion of neutrophils (Figure 3.5), when staining of all neutrophils by SWC8 
has been described in literature (Bréa et al., 2012). If all neutrophils were stained 
by SWC8 mAb as expected, including SWC8 as a depletion reagent would have 
been complicated by the available mAb being a non-purified, unconjugated, IgM 
clone, thus requiring purification and biotinylation. In order to control for the 
possibility of neutrophil contamination in the future, it may be advisable to include 
SWC8 to stain neutrophils and a marker other than CD14 to stain monocytes, such 
as CD203a (SWC9). The latter is lowly expressed on monocytes until they 
differentiate to a MΦ or DC phenotype but sufficient labelling would enable 
separation from cDC2. CD52 (SWC1) strongly stains monocytes and T cells 
(Leitner et al., 2012), however, its expression is reported on some BDC 
(Summerfield et al., 2003b). Other ideal targets would include XCR1 and CD13 for 
cDC1, but a variety of anti-human mAbs tested were not cross-reactive (data not 
shown).  
Removal of granulocytes by double gradient centrifugation using a series of 
gradients of varied densities, such as described by Mauel et al. (2006) and Menck 
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et al. (2014), was not considered due to the additional processing large volumes 
of blood would be put through, risking further BDC viability losses. 
 BDC infection and responses 
When consolidating my own PRRSV-1 infection data in enriched BDC, I utilised 
blood from exsanguinated Babraham pigs, a highly inbred line derived from a Large 
White commercial background (Schwartz et al., 2018; Signer et al., 1999). This 
was intended to reduce biological variation in my own data and supplemented the 
infection results from Bordet et al. (2018) who used conventionally bred Large 
White sows obtained from a commercial slaughterhouse. Variation was, however, 
observed between animals when cytokine responses were screened. IFN-α was 
the initial antiviral response assessed since pDC (previously known as natural or 
professional IFN producing cells) have been reported to produce significant 
responses to PRRSV-1 (García-Nicolás et al., 2016). Negative results were 
obtained across all time points in all infection conditions for two out of three 
animals, with the exception of 18 hpi by Lena in pig 2; the only time-point at which 
Lena induced a response in any of the three animals. The third animal produced 
an IFN-α response in all infection conditions, which correlated with neutrophils 
being detectable in the PBMC of this animal before MACS enrichment of BDC. 
While monocytes and neutrophils were detectable in the flow analysis of the 
enriched samples neither showed any signal for PRRSV N. This supports the 
previous published finding that co-culture is necessary to induce a pDC response, 
therefore sensing may be possible of phagocytosed or surface-bound virions rather 
than viral progeny, given the absence of any detectable infection. The same 
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publication reported that monocytes are not a source of IFN-α in response to 
PRRSV, rather that sensing of Lena-infected neighbouring MoMΦ is dependent on 
functional exosome secretion or surface integrin expression (García-Nicolás et al., 
2016). The units/mL of IFN-α detected 18 hpi in my ELISA are of a comparable 
magnitude to (Auray et al., 2016). Secreted IL-8 in enriched cultures was 
approximately 10 – 1000-fold greater than that reported by (Auray et al., 2016) after 
individual BDC subset stimulation by TLR agonists; TNF-α secreted here was 100-
fold less than reported pDC, but greater than responses of cDC1 and cDC2; IL-
12p40 secretion was greater than published cDC and control pDC, but 100-fold 
less than stimulated pDC. The significance between 0 hpi mock infection and the 
PRRSV infection conditions is unexpected given the absence of high background 
for all other cytokines tested, however, this likely indicates the presence of TNF-α 
in mock supernatant stocks and the large inoculum volume, which volume-matched 
SU1-Bel as the lowest titre of the three strains used.  
The magnitude of responses observed here was generally comparable to 
published data; Auray et al. (2016) reported a minority of pigs not responding to 
TLR treatments. The magnitude of IFN-α response assessed here was not directly 
comparable to (Auray et al., 2016) as my own ELISA data was quantified in the 
form of U/mL rather than pg/mL. Activated porcine cDC1 are described to produce 
IL-12 and IL-23 (Vu Manh et al., 2015) and cDC1 IL-12p40 response to Lena has 
been confirmed by qPCR (Bordet et al., 2018a); IL-12p40 is the shared subunit 
assessed by sandwich ELISA in my thesis. I did not observe an enhanced IL-12p40 
response in the biological replicate which presented highest frequency of cDC1 
throughout the time-course (Figure 3.11), nor an elevation over basal IL-12p40 
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levels in response to inoculation with Lena; at 18 hpi Lena showed the lowest IL-
12p40 response (Figure 3.12). IL-12, IFN-α, and TNF-α are also associated with 
activated pDC (Guzylack-Piriou et al., 2004); pig 2 presented the highest proportion 
of live pDC at all time-points, and was the highest expresser 18 hpi of TNF-α in 
mock, 215-06 and SU1-Bel infection, and IL-12p40 in 215-06 and SU1-Bel 
inoculated samples.  
The low responses observed in pigs 1 and 2 throughout the time-course suggest 
that the PRRSV-1 strains used here do not directly induce a response when co-
cultured with non-permissive cells; Lena has been specifically characterised as 
unable to induce an IFN-α response from pDC when inoculated as cell-free virus, 
unlike PRRSV-2 strain RVB-581. PRRSV-1 Olot/91 has previously been described 
as able to directly induce pDC IFN-α secretion (Baumann et al., 2013); in the same 
literature cell-free PRRSV-1 has been described as promoting pDC survival, which 
partially correlates with my findings (Figure 3.11), however the increasing 
frequency of pDC in pigs 1 and 2 culture over time is likely exaggerated by the 
decreasing frequency of cDC. 
It is interesting to note that whereas IFN-α secretion was only detectable in pig 3, 
TNF-α was elevated in pig 2 supernatant; pig 1 clustered with the lower responders 
across all cytokines tested, including consistent IL-8 production that was less 
reduced by Lena infection than in pigs 2 and 3. While occasional reduction in 
enrichment efficiency due to neutrophil contamination does not interfere with fresh 
flow cytometric phenotyping, post-infection cytokine detection requires FACSorting 
and re-seeding of specified populations to increase confidence that cytokines are 
produced either by direct BDC responses or interaction with co-cultured cells. 
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FACSorting and re-seeding pDC and monocytes as reported by García-Nicolás et 
al. (2016), was not within the scale of the initial experiments to determine 
fundamental PRRSV-1 susceptibility and permissiveness of BDC subsets. Once a 
confident data-set was in hand confirming a negative infection result it was decided 
to adjust focus from pDC and cDC work that was likely already in progress in other 
groups to instead characterise alternative mechanisms of PRRSV-1.3 
pathogenicity using alternative cell systems.  
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Chapter 4 : In vitro characterisation of PRRSV-1.3 using 
monocyte-derived DCs and macrophages  
4.1 Aims & rationale 
The primary tissue MΦ in context of PRRSV are AMΦ, the canonical initial target 
of infection (Duan et al., 1997). It has been demonstrated that the lung niche can 
be colonised in a self-renewing fashion by monocytes derived from the yolk sac, 
bone marrow or foetal liver (Ginhoux and Guilliams, 2016; Röszer, 2018; Y. Zhao 
et al., 2018). AMΦ have become an established ex vivo system for PRRSV 
infection, due in part to their isolation by lavage with minimal processing (García-
Nicolás et al., 2014a; Gordon, 2003). Monocytes are the precursor to certain 
resident MΦ in the intestines, dermis and heart, but are typically only recruited into 
tissues following inflammation due to injury or infection, where the milieu created 
by cytokine and other immunomodulatory factors drive monocyte differentiation to 
inflammatory MΦ- or DC-like phenotypes (Ginhoux and Jung, 2014); MoDC are 
widely used in the literature as a model for DC in context of both myelotropic virus 
infection and antigen presentation. Infection experiments described in Chapter 3 
(Figure 3.11) agreed with previous reports that monocytes are refractory to 
PRRSV-1 without prior treatment (Frydas et al., 2013; Kavanová et al., 2017b; 
Singleton et al., 2018). Literature supports that monocytes become susceptible to 
PRRSV-1.3 Lena when they are activated or differentiated towards a DC or MΦ 
phenotype (MoMΦ and MoDC) by culture with growth factors. This increase in 
susceptibility correlates with an increase in expression of phagocyte scavenger 
receptor CD163, the indispensable internalisation receptor (Burkard et al., 2017). 
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Infected ex vivo MoDC-like cells described by Bordet et al. (2018) showed reduced 
susceptibility compared to AMΦ and parenchyma MΦ. The reduced susceptibility 
relative to MΦ matches infections of peripheral monocyte in vitro derived MoDC, 
described in literature as an infection model for DC (Rodríguez-Gómez et al., 2015; 
Silva-Campa et al., 2010; Singleton et al., 2016). 
In this chapter, the studies aimed to use the established MoDC/MoMΦ system 
(Sánchez-Torres et al., 2003; Singleton et al., 2016) to evaluate whether the 
enhanced virulence of PRRSV-1.3 strains was associated with augmented 
infection/replication in MoDC and MoMΦ, and/or dysregulated cellular responses.  
By using surface marker staining to phenotypically characterise the cell types, 
studies were conducted to validate the use of monocyte-derived cells as models 
for DC and macrophages, such as AMΦ. AMΦ were first characterised for 
permissiveness and replication kinetics between PRRSV-1 subtypes as the 
canonical target, to validate subsequent characterisations in monocyte-derived 
model cell types. 
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Therefore this chapter aimed to: 
1. Characterise permissiveness and replication kinetics of PRRSV-1.1 and 
PRRSV-1.3 strains in ex vivo AMΦ and in vitro generated MoMΦ and 
MoDC. 
2. Characterise activation states and functional responses to PRRSV-1 
infection by assessing modulation of: 
 Surface protein phenotype 
 Ability to uptake and process antigen 
 Ability to prime T cell proliferation 
 Cytokine responses 
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4.2 Phenotyping of monocyte-derived cells 
Before conducting infection experiments, the phenotype of MoDC and MoMΦ was 
confirmed by flow cytometric staining of surface markers: CD163; CD203a; CD14; 
MHC class II; CD11c. All cells were positive for all markers tested, but expression 
levels varied; for clarity, all marker expression was characterised here as “low” or 
“high” (Figure 4.1). MoDC presented a more homogeneous population, as 
assessed by expression of CD11c, SLA 2, CD14, CD163, and CD203a, whereas 
MoMΦ appeared heterogeneous for SLA 2 expression (Figure 4.1). SLA 2low 
MoMΦ also made up a lower frequency of CD163high and CD14high populations, but 
a slightly greater proportion of higher expressers of CD203a. Applying gating from 
MoMΦ samples illustrates that SLA2high and SLA2low MoDC are both CD203ahigh 
and CD163low.  The frequencies of these populations and the expression per cell, 
assessed by median fluorescent intensity (MFI), were compared between 
biological replicates (Figure 4.2). Due to their homogeneous expression of every 
parameter tested, MoDC were not split into subpopulations; to do so would 
artificially skew the MFI of outliers in the “high” population. 
 
Figure 4.1. Phenotypic surface marker expression on porcine MoMΦ and MoDC. 
Representative live MoMΦ (A – E) and MoDC (F – J) were gated as CD11c+SLA 2high and 
CD11c+SLA 2low (A and F). These populations were further characterised: back-gating 
FSC and SSC (B and G); expression of CD203a (C and H); CD163 (D and I); CD14 (E 
and J). Gates determined in A – E are duplicated in F – J. Representative technical singlet 
(n=3). 
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High expression of CD14, CD163 and CD203a was less frequent in SLA 2 low 
MoMΦ (P < 0.001), with no clear differences in distribution of CD11c. The average 
MFI of each marker was determined for all live MoDC and all SLA 2low and SLA 
2high MoMΦ. MFI relative to the average was presented for each marker, illustrating 
that all 3 populations are comparable for CD11c expression, with relative MFI of 
each subpopulation close to 1 (Figure 4.2 B); the largest difference is between SLA 
2low and SLA 2high MoMΦ (P < 0.05), with no significant difference between SLA 
2low MoMΦ and MoDC nor SLA 2high MoMΦ and MoDC (P 0.33 and 0.47 
respectively). All comparisons between each subset were significant for relative 
MFI of CD14, CD163, CD203a and SLA 2 (P < 0.001). CD14 MFI was lowest in 
SLA 2low MoMΦ, moderately increased in MoDC, and SLA 2high MoMΦ expressing 
almost double the average of the three populations.  SLA 2high MoMΦ were again 
double the mean expression for CD163, with MoDC expression slightly lower than 
SLA 2low MoMΦ. MoDC were the highest expressers of CD203a, expressing 1.5 
times the average an SLA 2high MoMΦ expressing half the average. The relative 
expression of SLA 2 was highest in SLA 2high MoMΦ, approximately 50% above 
MoDC. 
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Figure 4.2. Monocyte-derived cell phenotyping summary. The frequency of subpopulations 
highly expressing corresponding surface markers within SLA 2high and SLA 2low MoMΦ 
subset were compared (A). The MFI for each marker tested was summarised for SLA 2high 
and SLA 2low MoMΦ and MoDC; each marker MFI is relative to the combined average MFI 
of MoMΦ and MoDC (B). Error bars represent standard deviation of the mean of biological 
triplicates (n=3). Statistical significance is denoted as: P < 0.05 *, P < 0.001 ****. 
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4.3 Infection permissiveness and kinetics of PRRSV-1 strain 
replication in antigen-presenting cells 
An expanded range of PRRSV-1.1 and -1.3 strains were used in the 
characterisation of infection of AMΦ and monocyte-derived cells (Figure 2.1). MLV-
DV is a MARC-145 cell adapted commercial vaccine strain closely related to the 
prototype European strain Lelystad virus Ter Huurne (referred to as Lelystad 
hereafter). Olot/91 is a MARC-145 adapted attenuated strain isolated in Spain in 
1991 (Plana et al., 1992). Like 215-06, H2 is a British field strain isolated by APHA 
from a farm with mild clinical signs (Lewis et al., 2010; Morgan et al., 2013). Lena 
is a second PRRSV-1.3 strain, also isolated from samples taken in Belarus and 
described as pathogenic (Karniychuk et al., 2010; Weesendorp et al., 2014a, 
2013a).  
 Alveolar macrophage infection kinetics 
AMΦ stocks from three donor Large White-Landrace crosses and one Babraham 
were used to characterise the infection kinetics of PRRSV-1.1 and 1.3 strains 
(Figure 4.3). Viability of AMΦ remained high over the complete 5 days of culture 
(including the day of seeding when the cells are rested before infection) both when 
cultured in conventional media or treated with mock-infection supernatants, 
suggesting that loss in viability within this time-frame was virus mediated. Viability 
correlated with infection rate, with an observable increase in infection rates within 
each culture and corresponding decrease in viability between 24 hpi and 48 hpi. 
These are the only consecutive time intervals where differences in viability are 
significant, for only H2 (P < 0.01), Lena (P < 0.01), and SU1-Bel (P < 0.05). The 
peak infection rate reached differed greatly between strains; H2 and Lena, PRRSV-
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1.1 and -1.3, respectively, reached almost 100% infection in some replicates 
(Figure 4.3 C), whereas DV and SU1-Bel showed far more limited N protein 
staining within the culture. Despite this difference in infection rate, SU1-Bel, Lena 
and 215-06 caused a comparable reduction in viability. In all strains, the infection 
rate plateaued or declined 48 hpi, coinciding with the decrease in viability, 
suggesting a self-limiting infection due to either neighbouring cells also losing 
viability, or the infected cells sufficiently losing their integrity to become excluded 
by the analysis strategy. Vaccine strain DV caused the least viability loss.  
Attenuated strains DV and Olot/91 reach their peak titre by 24 hpi, earlier than 215-
06, H2 and Lena, decreasing 72 and 96 hpi, suggesting degradation of cell-free 
virus in culture supernatant before experiment sample collection. SU1-Bel also 
peaked 24 hpi, correlating with a lower infection frequency than other strains 24 
hpi. The dotted lines in Figure 4.3 A indicate the lower limit of accurate 
quantification of secreted virus particles based on the first step of the serial dilution 
used in the TCID50 IPX assay. The lower limit was due to the limited supernatant 
available to allocate to the TCID50 assay, due to split prioritisation of assays for 
secreted virus and cytokines. As the assay scoring by the Spearman-Karber 
method is not accurate if any wells in the first dilution step in the series are negative 
for infection the titre cannot be accurately determined below the corresponding 
score. In all cases, intracellular virus titre could not be determined as cells were 
not lysed due to flow cytometric assessment of infection rates. Inferring viral load 
by fluorescent intensity of infected populations did not reveal any variation between 
strains; in all strains virus staining intensity correlated with the infection frequency 
of cells (data not shown). 
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Figure 4.3. Time-course of PRRSV-1.1 and 1.3 strain infection in AMΦ. Infection 
experiment using two wild type (H2 and 215-06) and attenuated (DV and Olot/91) PRRSV-
1.1 strains and two -1.3 strains (Lena and SU1-Bel) at an MOI=0.1. Secreted infectious 
progeny was assessed in culture supernatants by TCID50 assay (A), dotted line 
representing lower limit of accurate quantification; viability of resuspended intact cells 
assessed by membrane permeability dye  (B); intracellular staining for PRRSV 
nucleocapsid within all cell sized events ‘all cells’ (C) and PRRSV staining of cells negative 
for membrane permeability dye ‘live cells’ (D). Error bars represent standard deviation of 
the mean; each biological replicate is the mean of technical duplicate (n=4).  
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 Monocyte-derived cell infection kinetics 
A pilot experiment to assess PRRSV-1.1 and -1.3 infection kinetics in MoMΦ and 
MoDC used the same strains in the AMΦ time-course experiment. 
Secreted viral progeny were below the detectable limit at 6 hpi, suggesting 
complete removal of inocula and that a complete replication cycle of PRRSV had 
not yet occurred. Olot/91 rapidly replicated in both MoMΦ and MoDC, with titres 
equal to or greater than Lena 12 hpi, reaching an earlier plateau than non-
attenuated strains as observed in AMΦ. 
Viability was most reduced at 24 hpi in SU1-Bel infection and least by PRRSV-1.1 
215-06 and H2; however, the media control also showed decreased viability in 
MoMΦ at 24 hpi compared to all other time-points, which suggested some artefact, 
whereas at 48 hpi the trend in strains is reversed but also less resolved. DV 
appeared to cause a lesser reduction in viability until 96 hpi, the only time-point at 
which all strains comparably reduced viability relative to media.  
Unlike AMΦ, MoMΦ and MoDC showed a similar trend in infection frequencies 
between both live and dead intact cells in all strains until 48 hpi. Replication taking 
place between 24 hour intervals likely causes the decreased viability of infected 
cells 72 and 96 hpi (Figure 4.4 D), as infection frequencies continue to rise in cells 
with reduced viability at these later time-points. This effect is more pronounced in 
MoMΦ, which appear more susceptible than MoDC, despite comparable titres of 
secreted progeny. 
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Figure 4.4. Pilot time-course of PRRSV-1.1 and -1.3 infection in MoMΦ and MoDC. Pilot 
infection experiment using two wild type (H2 and 215-06) and attenuated (DV and Olot/91) 
PRRSV-1.1 strains and two -1.3 strains (Lena and SU1-Bel) at an MOI =0.1. Secreted 
infectious virus assessed by IPX TCID50 assay (A), dotted line representing lower limit of 
accurate quantification; viability of resuspended intact cells determined by membrane 
integrity flow staining (B); intracellular staining for PRRSV nucleocapsid within all cell sized 
events (C) and only live cells negative for membrane permeability dye (D). Errors bars 
represent standard error of technical duplicate of biological singlet. 
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Statistics are not presented in Figure 4.4 due to the lack of biological replicates in 
the pilot time-course experiment; conclusions drawn were qualitative to inform the 
decision of the most essential strains to include in the repeat experiments 
summarised in Figure 4.5. Experiment scale was reduced due to the volume of 
PBMC required to generate sufficient monocyte-derived cells for technical 
replicates within every infection condition and the large numbers of AMΦ required 
for progeny titre determination. Lena and SU1-Bel were retained as highly 
pathogenic strains of interest. Olot/91 was retained as an attenuated strain less 
likely to induce inflammatory responses than PRRSV-1.1 field strains, based on in 
vivo data (Morgan et al., 2013). Olot/91 was selected in place of vaccine strain DV 
as DV was unable to induce viraemia in vivo and showed poor infection of AMΦ 
and monocyte-derived cells (Figure 4.3 and Figure 4.4), likely due to extended 
MARC-145 adaptation.  
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Figure 4.5. Time-course of PRRSV-1.1 and -1.3 strain infection in MoMΦ & MoDC. 
Summary of 3 experiments using one attenuated PRRSV-1.1 strain (Olot/91) and two -1.3 
strains (Lena and SU1-Bel) at an MOI=0.1. Secreted infectious virus progeny assessed 
by IPX TCID50 assay, dotted line representing lower limit of accurate quantification (A); 
viability of resuspended intact cells determined by membrane integrity flow staining (B); 
infection rate of live cells determined by ICS for PRRSV N protein (C). Error bars represent 
standard deviation of the mean in technical duplicate, (n=3 separate experiments); each 
biological replicate is the average of technical duplicate for viability and infection data; a 
single technical replicate per animal was analysed for virus titres.  
 
 
Titres of secreted viral progeny in MoMΦ were not statistically different between 
strains at any time-point. Within both Olot/91 and Lena titres, the only consecutive 
time-points with significant differences were between 6-12 and 12-18 hpi (P < 
0.05). Using both Area Under Curve (AUC) and Tukey’s test to assess each 
infection across all time-points showed no statistically significant differences 
between strains. Average titres across all time-points in MoDC culture were 
significant between Olot/91 and SU1-Bel (P < 0.005), and between Lena and SU1-
Bel (P < 0.05). Differences in viability between strains within time-points were not 
significant. 
The infection frequency of MoMΦ at 12 hpi was significantly lower in SU1-Bel than 
Olot/91 (P < 0.005) and Lena at 18 hpi (P < 0.05). Infection frequency of MoDC 
was significant between Olot/91 and SU1-Bel 24 hpi (P < 0.05), and between Lena 
and SU1-Bel 48 hpi (P < 0.05). 
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4.4 Assessment of PRRSV-1 infection of MoDC and MoMΦ by 
confocal microscopy 
Confocal microscopy was used as a qualitative technique to supplement flow 
cytometry by assessing infection using visualising distribution of PRRSV structural 
and non-structural proteins. Confocal microscopy illustrated that AMΦ are more 
regular in morphology than MoMΦ and MoDC; elongation typical of chemotaxis 
was observed more frequently in monocyte-derived cultures than AMΦ, and 
vacuole-like structures were observed in MoMΦ more than AMΦ, regardless of 
infection condition. MARC-145 adapted PRRSV-1.1 vaccine strain DV appeared 
by flow cytometry to infect all myeloid cell types barely above media and mock 
controls (Figure 4.3). Frequencies of infected cells broadly correlated when 
experiments included flow cytometry and confocal microscopy in parallel. When 
assessing infection by confocal N protein was detectable by 12 hpi (data not 
shown) and was clearly visible at a low frequency at 24 hpi (Figure 4.6, Figure 4.7, 
Figure 4.8). Staining intensity generally appeared lower in DV than all other strains 
in every primary cell type, however staining of PRRSV N protein was always bright 
and diffuse throughout the cytoplasm. Quantification of viral load by fluorescent 
intensity was restricted to flow cytometry MFI, which consistently correlated with 
infection frequency in all strains and did not suggest any alternative trends in 
replication rate within each cell (data not shown).  
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Figure 4.6. Confocal microscopy of PRRSV-1 infected AMΦ. Representative images of 
cells 24 hours after inoculation with PRRSV-1 strains at an MOI=1: MARC-145 adapted 
PRRSV-1.1 DV (A) and Olot/91 (B); PRRSV-1.1 British field strains 215-06 (C) and H2 
(D); PRRSV-1.3 field strains Lena (E) and SU1-Bel (F). DNA in blue, actin in red, PRRSV 
N protein in green. Scale bar 25 µm. (n=1). 
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Figure 4.7. Confocal microscopy of PRRSV-1 infected MoMΦ. Representative images 24 
hpi at MOI=1: MARC-145 adapted PRRSV-1.1 DV (A) and Olot/91 (B); PRRSV-1.1 British 
field strain 215-06 (C) and H2 (D); PRRSV-1.3 field strains Lena (E) and SU1-Bel (F). DNA 
in blue, actin in red, PRRSV N protein in green. Scale bar 25 µm. (n=1). 
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Figure 4.8. Confocal microscopy of PRRSV-1 infected MoDC. Representative images of 
cells 24 hpi at MOI=1: MARC-145 adapted PRRSV-1.1 DV (A) and Olot/91 (B); PRRSV-
1.1 British field strains 215-06 (C) and H2 (D); PRRSV-1.3 field strains Lena (E) and SU1-
Bel (F). DNA in blue, actin in red, PRRSV N protein in green. Scale bar 25 µm. (n=1). 
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4.5 Modulation of surface marker expression on MoDC and MoMΦ in 
response to PRRSV-1 infection 
Surface markers associated with macrophage/DC activation were stained 24 hpi 
with a range of PRRSV-1 strains. As described previously, CD163 is a key entry 
receptor for PRRSV and therefore of direct relevance to susceptibility infected and 
neighbouring cells. The TLR4 co-receptor CD14 has been characterised as being 
downregulated in MoDC differentiation and maturation compared to MoMΦ, which 
upregulate compared to monocytes (Bordet et al., 2018b; Soldevila et al., 2018). 
In humans CD14 and CD16 are described as showing varied expression between 
peripheral classical and alternative monocyte subsets (Canelli et al., 2017), a 
dichotomy that has been reported in pigs with variation between breeds (Fairbairn 
et al., 2013). In humans these subsets have been described to yield M1 and M2 
MoMΦ with varied activation states (Boyette et al., 2017), however phenotyping of 
my MoMΦ derived from mixed monocytes described previously (Figure 4.2) 
revealed intra-culture heterogeneity that did not clearly correlate with M1 and M2.  
CD16 is associated with granulocytes, macrophages, monocytes, eosinophils, and 
the most abundant Fcγ receptor on monocyte-derived cells, correlating with its role 
in enhanced phagocytosis of foreign antigens opsonised by antibodies. CD16 has 
been linked to antibody-dependent enhancement (ADE) of PRRSV infection (Gu 
et al., 2015; Yoon et al., 1996) and antibody dependent, complement-mediated cell 
lysis (Costers, 2006). The expression of CD16 enables infection of non-permissive 
cell lines lacking major entry receptors, therefore modulation of CD16 in 
neighbouring cells may contribute to enhancing infection in pathogenic strains such 
as SU1-Bel, or strains such as Lena that within this project have replicated more 
efficiently than lowly pathogenic strains. 
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Observations were made accepting the caveat that the relative expression 
between infected cell populations cannot confirm whether the differences observed 
are a correlate of susceptibility or a consequence of direct infection or co-culture 
with infected cells. As in previous phenotypic analyses, only live cells were included 
due to downregulation of surface proteins in non-viable cells regardless of infection 
state; changes observed in infected dead cells could not be therefore determined 
as due to infection. Infection frequency was found to be comparable between live 
and dying cells at this time interval after infection at MOI=1 (Figure 4.9 A – C).  
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Figure 4.9. Surface marker expression in infected and bystander cells. Infection 
frequencies were determined for each cell type (A – C) for live cells (blue) and dead cells 
(red) 24 hpi at MOI=1. Relative expression of CD163 (D – F), CD14 (G – I), and CD16 (J 
– L) in live infected (red) and live uninfected (blue) cells for each infection condition on 
AMΦ (D, G, J), MoMΦ (E, H, K), and MoDC (F, I, L). In panels D – L each data point is 
the fold-change median fluorescent intensity (MFI) of live cells relative to the average MFI 
of uninfected media controls (dotted line). Error bars represent standard deviation of the 
mean in technical duplicates (n=3). 
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Each biological replicate was calculated as the fold change from the average of the 
control samples for the corresponding marker; a fold-change of 1 denotes MFI in 
the given sample identical to the average of the uninfected controls. In all cell types 
and surface markers variation around the mean of the media controls was 
extremely limited, with only CD163 staining in MoDC showing observable variation 
of controls comparable to the infected samples. Uninfected cells within each well 
likewise showed very limited variation (blue data points, Figure 4.9 F). 
In AMΦ, MoMΦ and MoDC CD163 expression was lower in infected and uninfected 
bystanders in samples inoculated with DV, Olot/91, and H2. This trend was also 
observed in CD14 expression on AMΦ and MoMΦ and CD16 expression on all cell 
types; variation was however increased in MoMΦ in DV and H2 conditions, with a 
slight increase above average in H2 infected cells. 215-06, Lena and SU1-Bel 
generally clustered but MFI relative to mock varied between cell types and surface 
markers in a manner that did not correlate with infection rate; 215-06 infection was 
lowest in AMΦ (Figure 4.9 A), but showed the highest increase in MFI of CD163, 
CD14 and CD16 (Figure 4.9 D, G, J). There is no consistent pattern between 
CD163 expression and infection rates, however greater CD163 in MoMΦ in 215-
06, Lena, and SU1-Bel suggests higher expression of CD163 correlates with 
susceptibility, which is expected. Frequencies of PRRSV N+ cells were 
unexpectedly similar when comparing live cells and dead cells; when analysing 
samples the debris exclusion gate showed intact cells comprised a far higher 
percentage of singlets in media controls and samples with lower infection rates, 
suggesting that strains with high infection rates with Lena caused greater CPE and 
many infected cells may have been destroyed prior to or during processing cells, 
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lifting and staining before fixation. It was not clear why infection frequency of SU1-
Bel in MoDC was lower than every other infection except DV in live & dead cells; 
when gating only on live cells SU1-Bel was only significantly lower than Lena and 
H2 (P < 0.05). In AMΦ 215-06 was significantly lower than H2 and Lena (P < 0.05) 
in both live and dead, and in MoMΦ Lena was significantly higher than DV and 
Olot/91 (P < 0.01 and 0.05, respectively) when analysing live cells only, and also 
SU1-Bel when including dead cells (P < 0.05).  
AMΦ samples inoculated with 215-06 significantly elevated CD163 expression 
compared to mock (P < 0.05). Infected MoMΦ were significantly different between 
215-06, Lena and SU1-Bel and DV, H2, Olot/91, and media (P < 0.05 – 0.001 
across conditions). Of these, Lena was the most significantly different between 
infected and uninfected cells; 215-06 P < 0.01, Lena P < 0.005, SU1-Bel P < 0.05. 
In MoDC all conditions’ uninfected cells were significantly different only to media. 
All conditions infected samples except for 215-06 and H2 were significant 
compared to the average media control, and no conditions were significant 
compared to one another; however, infected Olot/91, H2 and 215-06 appeared to 
downregulate to a lesser extent than uninfected cells, unlike in Lena and SU1-Bel. 
215-06 was the only condition to significantly elevate CD14 expression in both 
infected and uninfected AMΦ. In MoMΦ 215-06 and SU1-Bel were significant 
compared to all other conditions in infected and uninfected cells, and between 
uninfected Lena and uninfected SU1-Bel cells. Within MoMΦ this trend is 
consistent across markers, 215-06, Lena and SU1-Bel increasing compared to 
media and Lena showing the greatest difference between infected and uninfected 
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cells.  In MoDC 215-06 and SU1-Bel are significantly elevated compared to media 
only in uninfected cells.  
CD16+ populations of live cells appears almost entirely absent in AMΦ, therefore 
the expression levels observed increased in 215-06 and Lena infected cells are 
effectively the only samples where signal clearly exceeded background auto-
fluorescence. Trends in CD16 were similar to CD163 in all cell types, broadly 
similar magnitudes of changes in expression. AMΦ showed very low frequencies 
of CD16, unlike their monocyte-derived counterparts, presenting an increased 
expression in infected and uninfected cells in 215-06. AMΦ basal MFI of CD16 was 
approximately half that of MoMΦ and comparable to MoDC. MoMΦ similar 
expression across infection conditions; H2 and Lena showed a decreased 
expression in uninfected cells, whereas infected 215-06, Lena, and SU1-Bel were 
significant compared to media DV, Olot/91 and H2. Infected and uninfected cells 
in Lena samples were significant in AMΦ and MoMΦ (P < 0.01 and P < 0.005 
respectively). MoDC expressed CD16 similarly in both infected and uninfected 
cells, with differences only visible in Lena and SU1-Bel samples downregulated 
compared to all other conditions, significant only between DV and 215-06 in 
infected cells (P < 0.05).  
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4.6 Assessment of the effect of PRRSV-1 infection on endocytic and 
phagocytic activity of MoDC and MoMΦ 
Activation states in response to infection were further characterised by functional 
assays. APC ability to process intact or degraded antigen is integral to their primary 
function and their maturation state; MΦ activated by IFN-γ secreted by Th1 cells 
are reported to digest phagocytosed material and decrease antigen uptake (Jungi 
et al., 1989). Decreased endocytic or phagocytic activity may therefore indicate 
maturation in response to PRRSV-1 infection. Furthermore, PRRSV entry is via 
clathrin-mediated endocytosis.  Therefore, it could be expected that endocytic 
activity upregulation in neighbouring cells would be advantageous to PRRSV 
infection. IFN-γ is used frequently in literature to drive MΦ polarisation towards an 
M1 phenotype (Franzoni et al., 2017; García-Nicolás et al., 2014a). OVA and OVA-
DQ were used to characterise antigen uptake and processing, respectively, in 
monocyte-derived cells after maturation by treatment with cytokines that are 
typically produced systemically in response to infection. TNF-α is a classical 
inflammatory response which induces vasodilation and increases vascular 
permeability, aiding recruitment of lymphocytes and neutrophils in vivo, and IFN-α, 
a primary activating cytokine secreted in response to viral MAMPs. 
Fluorescently conjugated ovalbumin (OVA) was used to assess receptor-mediated 
endocytosis activity, and quenching agent DQ conjugated OVA to assess 
downstream processing. DQ quenches tagged BODIPY-FL dyes, causing 
fluorescence to only emit after proteolytic hydrolysis of the OVA-DQ. Each assay 
was carried out at 37°C and on ice for to control for passive cell binding and uptake, 
ensuring responses were due to metabolically active processes. This was carried 
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out without infection to investigate healthy cells. OVA-DQ showed lower variation 
and background than OVA, with clear distributions of low and high fluorescent 
populations at both temperatures, with an upward shift in distribution of positive 
events in the 37°C sample (Figure 4.10). As such, OVA-DQ was taken forward for 
assessments of infected cells. 
 
Figure 4.10. Antigen uptake and processing by MoDC after treatment with cytokines. 
Differentiated MoDC were cultured for 24 hours with 20 ng/mL, 10 ng/mL IFN-α, or both, 
before using fluorescently tagged OVA with or without DQ quenching. Error bars represent 
standard deviation of the mean (n=3). 
In addition to OVA-DQ, 2 µm diameter carboxylate-modified microspheres were 
used to assess phagocytic activity of PRRSV-1 infected MoDC and MoMΦ. Each 
assay was again carried out at 37°C and on ice. Downregulation of endocytic or 
phagocytic activity could be indicative of functional maturation, or alternatively 
subversion of these major functional pathways by PRRSV-1. Comparing infected 
cells to uninfected bystanders and to media/mock control treated cells provided 
additional insight into whether the response is specifically modulated as a 
consequence of infection.  
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OVA-DQ uptake frequency of live cells (Figure 4.11 A) was compared to MFI of 
processed OVA-DQ to confirm that frequency of uptake correlates with intensity, 
inferring that the OVA-DQ signal correlates with frequency and not a dramatic shift 
within infected cells only, as the largest reductions in uptake and signal intensity 
correlate with infection frequency of strains (C). Since infection frequency was not 
affected by the temperature condition of the assay and minimal OVA was observed 
at 4°C, only 37°C was further assessed for OVA-DQ intensity per cell in infected 
and uninfected cells within each condition (D). It appeared that uptake was reduced 
in bystander cells as well as infected cells irrespective of the PRRSV-1 strain. 
Signal intensity per cell reduction of OVA-DQ in infected samples compared to 
mock correlated with infection rate (C and D), suggesting that bystanders and 
infected cells alike are inhibited by infection of the culture. Viability was moderately 
reduced in infected conditions as typically observed 24 hpi, and not reduced in LPS 
and CpG treatments, with no difference observed between temperature conditions 
(data not shown).  
 
 
Figure 4.11. Endocytosis and processing of fluorescently conjugated OVA-DQ by PRRSV-
1 infected MoDC and MoMΦ. Cells were incubated for 1 hour with OVA-DQ either at 37°C 
(red points) or on ice (blue points) 24 hpi (MOI=1) before assessment of resuspended cells 
by flow cytometry: frequency of live cells processed OVA-DQ (A); MFI of OVA-DQ+ live 
cells (B); infection frequency of live cells (C); MFI of infected and uninfected live cells 
processed OVA-DQ at 37°C only (D). Error bars represent standard deviation of the mean 
of technical duplicates (n=3); individual data-points (pig 1, circle; pig 2, square; pig 3, 
triangle) were assayed in parallel in each temperature condition. Statistical significance is 
denoted as: P < 0.05 *, P < 0.01 **, P < 0.005 ***, P < 0.001 ****. 
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Background of phagocytosis uptake in 4°C controls was far higher in MoMΦ than 
MoDC (Figure 4.12 A), an effect which is mitigated by assessing MFI instead 
(Figure 4.12 B). Observing the data-set in this way showed a significant increase 
in phagocytosis by LPS-treated and mock-infected MoMΦ compared to untreated 
cells. Phagocytic uptake was almost entirely absent in PRRSV-1 infected MoMΦ.  
Despite the comparatively lower uptake suggested by fluorescent intensity, as a 
frequency of live cells uptake was reduced but resolvable in infected conditions 
(Figure 1.20 D). Reductions in microsphere uptake again correlated with infection 
rate; Lena in both cell types was significantly higher than both 215-06 and SU1-Bel 
(Figure 1.20 C). As in the OVA-DQ assay, this correlated with a decreased MFI in 
both bystander as well as infected cells within each infection condition compared 
to mock. In MoMΦ there were no statistically significant or observable differences 
between PRRSV+ and PRRSV- cells, whereas in MoDC there was a difference in 
215-06 only (Figure 1.20 D). Interestingly, in MoDC, the reductions in uptake were 
far greater in pigs 2 and 3, whereas for all 3 animals the uptake was normal in 
media and CpG controls, albeit to a lower load in pig 3. 
Figure 4.12. Phagocytosis of fluorescently conjugated microspheres by PRRSV-1 infected 
MoDC and MoMΦ. Cells were incubated for 3 hours with 2 µm carboxylate microspheres 
either at 37°C (red points) or on ice (blue points) 24 hpi (MOI=1) before assessment of 
resuspended cells by flow cytometry: frequency of live cells phagocytosed microspheres 
(A); MFI of microspheres (B); infection frequency of live cells (C); MFI of infected and 
uninfected live cells phagocytosed microspheres at 37°C only (D). Error bars represent 
standard deviation of the mean in technical duplicate (n=3); individual data-points (pig 1, 
circle; pig 2, square; pig 3, triangle) were assayed in parallel in each temperature condition. 
Statistical significance is denoted: P < 0.05 *, P < 0.01 **, P < 0.005 ***, P < 0.001 ****. 
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4.7 Assessment of the effect of PRRSV-1 infection on the T cell 
stimulatory potential of MoDC and MoMΦ 
The ability of MoDC to prime lymphocyte proliferation is a key feature of their use 
as a model DC system. I conducted a pilot experiment to test their proliferative 
capacity in an allogeneic system using PBMC stained with Tag-it Violet™ 
Proliferation and Cell Tracking Dye (Tag-it). To evaluate the effect of PRRSV-1 
infection, MoDC and MoMΦ were infected 24 hours prior to the addition of 
allogeneic PBMC. Assessing the proportion of proliferated cells within each major 
conventional T cell subset revealed differences in T cell responses. Proliferation 
was most observed in CD4+CD8+ T cells (Figure 4.13 C), with proliferation induced 
by mock treated monocyte-derived cells stronger than Lena or SU1-Bel infected 
APC, which clustered more closely to the baseline response induced by autologous 
MoDC. Proliferation was consistently lower in autologous MoDC co-cultured 
lymphocytes, with an elevation of proliferation observable in CD4 T cells in SU1-
Bel infected MoMΦ and MoDC but not autologous MoDC nor in Lena infection, 
suggesting Lena decreasing allogeneic responses. The likelihood of this is 
tempered by the low MoMΦ induced CD4 proliferation in mock infection. Minor 
differences were observed in CD8 T cell proliferation, with mock infected again 
priming a stronger allogeneic response. CD4CD8 T cells proliferated significantly 
more when stimulated by mock infected allogeneic MoDC than Lena (P < 0.05) or 
SU1-Bel infected (P < 0.05). 
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Figure 4.13. Allogeneic lymphoproliferation induced by PRRSV-1 infected and uninfected 
MoDC and MoMΦ. Allogeneic MoMΦ (blue), allogeneic MoDC (red), and autologous 
MoDC (green) were mock infected or infected with PRRSV-1 Lena and SU1-Bel (MOI=1) 
and after 2 hours, the inocula were removed and replaced with CD14-depleted, Tag-it 
Violet-labelled allogeneic PBMC at a responder:stimulator cell (R:S) ratio of 5:1 (responder 
n=3). After 5 days culture, cells were harvested, stained with Zombie dead cell stain and 
mAbs to CD3, CD4 and CD8α and analysed by flow cytometry. Proliferative responses 
were assessed as the % live, Tag-itlow cells for naïve CD4 (CD3+CD4+CD8a-) (A), antigen-
experienced CD4 (CD3+CD4+CD8a+) (B) and CD8 (CD3+CD4-CD8a+) (C) T cells. Error 
bars represent standard error of the mean of technical triplicate in biological singlet. 
The pilot experiment suggested that Lena and SU1-Bel may be inhibiting 
proliferation priming by MoDC. The experiment was therefore repeated with a 
biological triplicate of stimulator cells, again in addition to autologous stimulating 
cells, with a biological singlet of responder cells. MoDC consistently induced a 
greater degree of proliferation than MoMΦ for all three T cell populations (Figure 
4.14), with limited proliferation induced by allogeneic MoMΦ above autologous 
controls. Within MoMΦ there appeared to be increased responses in SU1-Bel 
infection allogeneic stimulations. Differences were significant (P < 0.05) between 
SU1-Bel and all other conditions for CD8 T cells; between SU1-Bel and media and 
SU1-Bel and Lena for antigen-experienced CD4 T cells; between SU1-Bel and 
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Lena for naïve CD4 T cells. No conditions showed significance in MoDC mixed 
cultures, with a range of responses observed between replicates. Trends in MoDC 
priming of CD8 T cells did not correlate with infection, rather pig 1 (circle) stimulated 
a stronger response in all conditions than pigs 2 (square) and 3 (triangle). This 
trend was similar in CD4CD8 T cells, however pig 1 did not induce proliferation 
when infected by SU1-Bel. 
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Figure 4.14. Percentage of lymphocyte subsets induced to proliferate by co-culture with 
PRRSV-1 infected allogeneic APC. MoMΦ (A) and MoDC (B) were untreated or inoculated 
with mock inocula, PRRSV-1 Lena, and SU1-Bel (MOI=1) and after 2 hours, the inocula 
were removed and replaced with CD14-depleted, allogeneic (red symbols) and autologous 
(blue symbols) lymphocytes stained with Tag-It Violet proliferation dye at an R:S of 5:1 
(responder n=3).  After 5 days culture, cells were harvested, stained with Zombie dead cell 
stain and mAbs to CD3, CD4 and CD8α and analysed by flow cytometry. Proliferative 
responses were assessed as the % live, Tag-itlow cells for naïve CD4 (CD3+CD4+CD8a-), 
antigen-experienced CD4 (CD3+CD4+CD8a+) and CD8 (CD3+CD4-CD8a+) T cells. Error 
bars represent standard deviation of the mean of biological triplicate; each data point is 
the mean of technical triplicates. Statistical significance is denoted as * = P < 0.05. 
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4.8 Macrophage and MoDC cytokine responses to PRRSV-1 infection 
 Assessment of PRRSV-1 infected AMΦ pro-inflammatory cytokine 
responses over time 
IL-1β and TNF-α were assessed in infected AMΦ culture supernatant to determine 
if pro-inflammatory cytokine responses in vitro were similar to that reported in the 
lungs and lymph nodes of pigs during infection by SU1-Bel (Amarilla et al., 2015; 
Morgan et al., 2013) and Lena (Weesendorp et al., 2014a, 2013b). Supernatants 
were taken from infection data presented in Figure 4.3. 
IL-1β accumulated in the culture consistently until 48 hpi, after which time it 
decreased, secreting exclusively in response to SU1-Bel; the only quantifiable 
measurements were at 12 hpi, when all other strains were below mock (Figure 
4.15). SU1-Bel was significantly different to all other conditions within 18 hpi (P < 
0.01) and 24, 48, 72, and 96 hpi (P < 0.001). TNF-α showed a clear response to 
mock but not media, above that of 215-06 but below responses to SU1-Bel. No 
other strain induced TNF-α secretion until 96 hpi when a minimal response was 
detected. TNF-α responses appeared to develop within 6 hpi, before the first 
secretion of infectious progeny, peaking at 12 hpi and progressively declining. It is 
not clear if this immediate response is due to treatment during the 90 minute 
inoculation, as the inocula were not assessed within this experiment. Wide error 
bars represent variation in the peak TNF-α responses between animals, with mock 
treatment immediately declining in some replicates, and at least one replicate 
increasing between 6 and 12 hpi. Changes between time-intervals were significant 
for IL-1β only for SU1-Bel between 24 and 48 hpi (P < 0.05). TNF-α secretion was 
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significant within 215-06 between 6 and 48 hpi significant (P < 0.01) and within 
SU1-Bel between 6 and 24 hpi (P < 0.05) and between 6 and 48 hpi (P < 0.05). 
SU1-Bel induction of TNF-α secretion was significant compared to all other 
conditions within 6, 12, 18, 24, 48, 72, and 96 hpi (P < 0.001). 215-06 was 
significant compared to all conditions except mock at 6 and 12 hpi (P < 0.001) and 
to a lesser extent at 18, 24, 48, 72, and 96 hpi (lowest significance P < 0.01). 
 
Figure 4.15. Cytokine secretion by AMΦ in response to PRRSV-1 infection.  IL-1β (A) and 
TNF-α (B) in AMΦ culture supernatants after infection with 6 PRRSV-1 strains at MOI=0.1. 
Error bars represent the standard deviation of the mean in technical duplicate (n=3).  
SU1-Bel was confirmed to induce to IL-1β secretion at a range of time-points in line 
with infection and viability; AMΦ appeared to lose the ability to secrete IL-1β when 
viability was decreased. TNF-α followed a flat trend which responses to SU1-Bel 
peaking within 12 hours of infection, suggesting an immediate response to virus 
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before replication has occurred. As this response did not elevate further over time 
in this low MOI experiment (MOI=0.1) it could be inferred that either cell-free virus 
was detected or that infected cells rapidly triggered TNF-α secretion in 
neighbouring cells. 
 
 Multiplex analysis of MoMΦ and MoDC cytokine secretion in response 
to PRRSV-1 
Monocyte-derived cells were compared to AMΦ to validate that they respond 
comparably despite their different compartmental origin. In a pilot experiment, a 9-
parameter fluorescent bead assay was used to identify cytokines for investigation. 
Chemically inactivated PRRSV-1 inocula were included in this assay to compare 
responses to virus particles and supernatants in the absence of replication. 
Inactivation of infectious virus stocks was carried out by beta-propiolactone (BPL) 
treatment. The supernatants tested were taken from one replicate of the data-set 
characterising phenotypic surface marker changes in response to infection (Figure 
4.9 and Figure 4.16); this replicate was also assessed by confocal microscopy 
(Figure 4.6, Figure 4.7, and Figure 4.8). 
The 9 porcine analytes tested were: IFN-α, classical primary anti-viral response; 
IFN-γ, Th1/MΦ activating cytokine; IL-1β, pro-inflammatory product of 
inflammasome activation; IL-4, Th2 activation cytokine; IL-6 and TNF-α, pro-
inflammatory cytokines; IL-8, chemokine associated with neutrophils; IL-12p40, the 
common subunit found in IL-12 and IL-23; and IL-10, immunomodulatory cytokine 
associated with Tregs. 
Luke PM Johnson   Chapter 4 
 
161 
 
SU1-Bel induced a range of inflammatory cytokines more than every other strain; 
in most cases all other strains down-regulated relative to mock except for IL-8, 
where 215-06 and Lena also upregulated (Figure 4.16). IL-8 values at the top of 
the y axis were reduced to the upper limit of accurate quantification (ULQ). 
In MoDC this trend was less clear, but SU1-Bel broadly induced the greatest 
responses, most readily observed when summarising cytokine data in Figure 4.17.  
Several cytokines were barely detectable within the assay. IL-12p40 secretion was 
restricted to MoMΦ mock and SU1-Bel infected over the lower limit of accurate 
quantification (LLQ). No MoDC infection samples were above the LLQ for IFN-α, 
and several cytokines were so low as to likely be of limited biological relevance: 
supernatants that contained IL-6, IL-12p40, IL-4, IFN-α and IFN-γ were no higher 
than 60 pg/mL; in several of these cytokines the lower limit of quantification is 
observable in the scale of responses. IL-4 results for MoDC are off-scale as the 
culture supernatant included IL-4 as a growth factor during infection. Responses 
were lower in BPL-inactivated virus inoculations than live infections in both MoMΦ 
and MoDC for most significantly present cytokines; IL-8, IL-1β, and TNF-α. IL-10 
was slightly elevated in BPL-SU1-Bel infection. BPL-treated “infections” induced 
lower responses in MoMΦ and MoDC than live virus, particularly IL-1β and IL-
12p40, with a less clear difference in lowly expressed cytokines such as IFN-α, 
IFN-γ, IL-6, and IL-4. The magnitude of response in several of these cytokines is 
close to the lower limit of detection, suggesting a very low response relative to 
biologically relevant thresholds.   
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Figure 4.16. Monocyte-derived cell cytokine responses to PRRSV-1 infection analysed by 
Luminex. MoMΦ (blue) and MoDC (red) supernatants collected 24 hpi at MOI=1 before 
assessment with the Luminex 9-plex kit. Infections used either mock-treated virus stocks 
(circles) or beta-propiolactone (BPL) inactivated stocks (triangles). All y axes are pg/mL of 
corresponding secreted cytokine. Dotted lines indicate lower limit of accurate quantification 
in assay as determined by interpolation software. (n=1). 
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In all cases cytokine production was decreased when inoculating with inactivated 
virus. Relative secretion of each cytokine was normalised within each cell type, and 
summarised in Figure 4.17. Presented in this format, MARC-145 adapted DV and 
Olot/91 are the lowest inducers of cytokine responses in MoMΦ and SU1-Bel is the 
highest inducer in all infectious conditions. Lowly expressed IFN-α and IFN-γ, and 
more highly secreted IL-10, inactivated SU1-Bel is the greatest inducer. 
In MoDC IFN-α, IFN-γ, and IL-12p40 are consistent across infection conditions and 
BPL-inactivated inocula treated conditions. SU1-Bel is broadly the greatest 
cytokine inducer when using inactivated virus as well as infectious stocks, with the 
exception of IL-12p40 in MoMΦ. Inactivated virus induces similar IL-8 to infectious 
virus in both cell types. 
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Figure 4.17. Monocyte-derived cell normalised cytokine responses to infection. Relative 
cytokine expression is normalised to the highest concentration detected for each cytokine 
within each cell type in infectious and BPL-inactivated infection conditions; each row 
presenting corresponding cytokines and each column presenting corresponding infection 
conditions. As in the individual cytokine data, infections were carried out on differentiated 
cells at an MOI=1 and supernatants collected 24 hpi before assessment with the Luminex 
9-plex kit (n=1). 
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 MoMΦ & MoDC cytokine secretion over time after infection 
Further cytokine assessment of monocyte-derived cultures was informed by 
Luminex data. The supernatants from the monocyte-derived cell infection time-
courses (Figure 4.5) were analysed for secreted TNF-α and IL-1β by sandwich 
ELISA to further assess differences in responses to PRRSV-1.1 and -1.3 strains 
(Figure 4.18).  
Trends in TNF-α response over time were comparable between MoMΦ and MoDC 
within each experiment, however the extent of response was greater in MoDC. 
Olot/91 and Lena produce responses comparable to mock treatment in only one of 
three separate experiments (Figure 4.18 B); in all experiments these responses 
were lower than SU1-Bel. Responses to SU1-Bel were varied in scale, but typically 
elevated over other conditions by 6 hpi and plateaued by 48 hpi. Supernatants 
were not available in the second experiment at 96 hpi due to a logistical 
complication. 
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Figure 4.18. Monocyte-derived cell secretion of TNF-α in response to PRRSV-1 infection 
over time. Secreted TNF-α quantified over time in MoMΦ (left column) and MoDC (right 
column) after infection with an attenuated PRRSV-1.1 strain (Olot/91) and two -1.3 strains 
(Lena and SU1-Bel)  at MOI=0.1. Rows A – C illustrate separate experiments (n=3) with 
different donor pigs; error bars, where present, are standard error of the mean of technical 
duplicates infected and assessed independently by sandwich ELISA.  
IL-β was assessed in parallel to TNF-α. Unlike TNF-α, responses were generally 
not elevated significantly compared to other conditions 6 hpi (Figure 4.19), with a 
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delay observable to peak response correlating with peak infection rates in cultures 
(Figure 4.5). 
 
Figure 4.19. Monocyte-derived cell secretion of IL-1β in response to PRRSV-1 infection 
over time. Secreted IL-1β quantified over time in MoMΦ (left column) and MoDC (right 
column) after infection with an attenuated PRRSV-1.1 strain (Olot/91) and two -1.3 strains 
(Lena and SU1-Bel)  at MOI=0.1. Rows A – C illustrate separate experiments (n=3) with 
different donor pigs; error bars, where present, are standard error of the mean of technical 
duplicates infected and assessed independently by sandwich ELISA.  
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4.9 Discussion 
The initial hypothesis of the project was that the increased pathogenicity of 
PRRSV-1.3 strains, such as SU1-Bel, correlates with an expanded DC tropism, 
compared to lowly pathogenic PRRSV-1.1 field strains. Recently  published studies 
concur with my findings that BDC are not susceptible to PRRSV-1 (Bordet et al., 
2018a). Using lung parenchyma derived DC phenotyped by CD11c, MHC II (SLA 
2), CADM1 and CD1a, Bordet et al. (2018a) determined cDC2 to be entirely 
negative for CD163 expression. The same study also demonstrated that pro-
inflammatory responses are elicited in cDC1 in the presence of PRRSV-1.3 Lena, 
assessing cytokine secretion and T cell stimulation which correlated with in vivo 
data from Weesendorp et al. (2013). 
This chapter characterised monocyte-derived cell infection to expand their use as 
a model for AMΦ and DC functional responses to PRRSV-1.3 infection, as 
described  by (Singleton et al., 2018, 2016). AMΦ, MoMΦ and MoDC showed 
greater responses to Lena and SU1-Bel than PRRSV-1.1 strains. Infection time-
courses confirmed susceptibility to all strains tested and validated further 
characterisation at 24 hpi. Endocytosis and phagocytosis was decreased further 
by Lena than SU1-Bel, despite increased CD163 expression in Lena infected AMΦ 
and MoMΦ. MoDC showed decreased CD163 expression in all infection 
conditions, which would correlate with decreased phagocytosis. Endocytosis was 
downregulated further in MoMΦ than MoDC, and downregulation greater in 
uninfected cells than infected cells, perhaps due to increased activation as 
indicated by CD14 and CD16 expression. Interestingly, 215-06 clustered with SU1-
Bel and Lena for phenotypic changes, and with SU1-Bel for endocytosis wherein 
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increased Lena infection rates were a stronger correlate. 215-06 and SU1-Bel 
clustered together more than Lena or any lowly pathogenic strain when 
characterising pro-inflammatory cytokine responses, which generally correlated 
over time with infection frequency of live cells within cultures. Lena also clustered 
away from SU1-Bel when characterising T cell priming capacity; MoDC showed 
greater priming capacity, which was decreased by SU1-Bel only when assessing 
CD4CD8 T cells, whereas MoMΦ showed increased T cell subset priming when 
infected by SU1-Bel. This suggests that SU1-Bel activated monocyte-derived cells 
more than other strains such as Lena, which exhibited a greater replication rate, 
suggesting a greater degree of activation and therefore lesser immune evasion by 
SU1-Bel. 
All observations made in responses to infection assessed by flow cytometry were 
restricted to live cells as determined by membrane permeability dyes as previously 
described. When comparing surface marker expression on infected and uninfected 
cells, late-apoptotic Zombie+ cells consistently show reduced marker expression 
regardless of infection state. Apoptosis markers such as Annexin V and TUNEL 
would have enabled resolution of early apoptotic populations from late apoptotic 
populations, however the buffer dependent staining was not readily compatible with 
intracellular staining for PRRSV proteins. Pilot stains using Annexin V and 
membrane permeability dyes without infection staining reported the anticipated 
increase in both early apoptosis and late apoptosis (data not shown) in infected 
samples compared to media controls. Investigations were not carried out to 
increase compatibility of buffers with co-staining of surface markers or endocytosis 
and phagocytosis assays, where changes in pH would be particularly relevant. 
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When assessing cytokine responses secreted proteins were quantified by 
sandwich ELISA, rather than blocking secretion of proteins at each time-point post 
infection. This would have complicated accurate reporting of time intervals, and 
would not have quantified production within the cell populations’ positive for 
cytoplasmic cytokine. Blocking of protein secretion pathways may also have had a 
negative impact on viral replication. Furthermore, several mAbs tested for porcine 
cytokine reactivity were not successful.  
 MoMΦ & MoDC surface marker expression in response to PRRSV-1 
The phenotypic markers characterised without infection suggest a split population 
in MoMΦ cultures: SLA2highCD11c+CD14highCD163highCD203alow and 
SLA2lowCD11c+CD14lowCD163lowCD203ahigh. Such a heterogeneity of MoMΦ is not 
described in literature, including published titrations of MoMΦ differentiation 
treatments (Franzoni et al., 2017), where CD163, CD203a and SLA 2 MoMΦ 
expression was dramatically increased above monocytes whereas CD14 and 
CD16 expression was comparable.  
MoDC showed increased CD14 expression in infected cells to media controls, 
however MFI is clearly lower in MoDC than in MoMΦ, matching the literature 
(Singleton et al., 2016). The expression of CD14 was consistently reduced in 
infected MoMΦ compared to uninfected bystanders, a pattern most clearly 
resolved in Lena infected samples, which was also true of AMΦ. 
MoDC have been reported to vary in their function when derived from CD163+ or 
CD163- peripheral monocytes; the former presented a more homogeneous 
population expressing higher levels of SLA 2, CD80/86, and CD203a (Chamorro 
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et al., 2004). My own assays used MACSorted CD14+ monocytes, and it was not 
directly assessed how heterogeneous these cells were for CD163 or markers of 
classical, intermediate and non-classical populations (Chamorro et al., 2004; 
Fairbairn et al., 2013); when titrating mAbs partial expression of each marker was 
observed. Franzoni et al. (2017b) reported relative expression of CD163 and SLA 
2 on activated MoMΦ subset: M1 increased SLA 2 expression (MFI) but not 
frequency over M2 and non-activated MoMΦ; M2 expressed lower but not less 
frequent CD163 than M1 and non-activated MoMΦ. This would correlate with the 
SLA 2highCD163high and SLA 2lowCD163low MoMΦ populations in my own data 
resembling M1 and M2, respectively, however, these two populations were not 
clearly observable in infected samples (data not illustrated, data-set in Figure 4.9) 
When assessing AMΦ and monocyte-derived cell surface marker expression in the 
context of PRRSV-1 infection, CD163 expression was elevated in MoMΦ 
compared to AMΦ, and both were elevated above fresh monocytes (direct 
comparison data not shown, monocyte CD163 expression presented in Figure 3.4) 
correlates with previous literature (Kavanová et al., 2017b). CD163 expression on 
MoDC was approximately half that of MoMΦ and AMΦ in media controls and 
reduced further in all infection conditions, whereas in infected AMΦ and MoMΦ 
215-06 and Lena and increased by a factor of 2 – 5, and SU1-Bel in MoMΦ only 
(MFI not presented; data-set in Figure 4.9). MFI in DV, Olot/91 and H2 infected 
samples were comparable for CD163, CD14 and CD16 in all cell types. This 
difference in CD163 did not appear to cause a difference in infection rates in 
experiments that used MOI=1 24 hpi, such as characterising surface marker 
changes (Figure 4.9), however during the time-course (Figure 4.4) MoDC showed 
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lower infection frequencies and SU1-Bel infected lowly in MoMΦ  as well as MoDC. 
While the total infection rate did not correlate with changes in CD163, it may 
contribute to the delayed replication and cytokine responses observed over time in 
MoDC compared to MoMΦ. 
Surface markers previously compared in vitro in literature are reported to be 
unchanged by PRRSV-1.1 Lelystad on AMΦ, but were reduced by Lena infection  
(Weesendorp et al., 2013b). CD163, SLA 2, CD80/86 were reduced in frequency 
but the only marker that was clearly downregulated in all Lena infected cells was 
CD14. In this publication, phenotypic change coincided with increased late-
apoptosis detection, decreasing confidence that these changes are independent 
of viability. A similar trend was reported in bone marrow-derived DC, with 
decreased frequency of CD14, CD163 and SLA 1 in infected cells. Chung et al. 
(2018) reported CD172a and SLA 2 downregulation in cells infected by PRRSV-2 
SD23983 has been observed in AMΦ and MoMΦ by 12 hpi.  CD163 
downregulation has been reported in vivo (Rodríguez-Gómez et al., 2019), 
however the observation that CD163 expression was decreased in infected AMΦ 
does not conclusively demonstrate that the frequency of CD163 expressing cells 
is reduced post-infection, nor that expression decreases within non-infected cells; 
the structure of my own experimental analysis were structured to investigate the 
latter aspect. 
When phenotyping these populations in media controls all cells were deemed 
positive for expression, with the exception of AMΦ expressing CD16, which could 
not be resolved above background auto-fluorescence. To determine this, gates 
were set against unstained samples for markers detected by conjugated antibodies 
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and against cells stained without primary antibody when determining baseline 
signal for the corresponding secondary antibody. Using MFI instead of frequency 
allowed partial compensation for an inherent limitation of quantifying low 
expression levels that correspond to dim fluorescent signal. MoMΦ and MoDC 
have previously been reported as expressing comparable CD16 (Kyrova et al., 
2014), whereas I found MoDC expressed approximately half as much as MoMΦ. 
AMΦ expression of CD16 was lower than MoMΦ or MoDC, with positive 
populations resolvable above auto-fluorescence background at a low frequency; 
however, reductions in surface marker expression compared to media controls 
were clear in PRRSV-1.1 strains except 215-06, which presented the lowest 
infection rate in live cells. The infection rate in the surface marker assessment 
experiment was higher in live cells and lower in dead cells than the infection time-
course experiments. This is likely due to the MOI increasing from 0.1 to 1. The 
highly similar infection frequencies of live and dead cells in the phenotyping 
experiment may be explained by inviable infected cells being excluded as shrunken 
cell debris at this MOI 24 hpi. The increased pathology in PRRSV-1.3 strains 
reported in pregnant sows may correlate with antibody-dependent cell mediated 
cytotoxicity inducing CD16+ NK cell endometrial invasion as part of the natural 
response to control PRRSV infection (Karniychuk and Nauwynck, 2013); the trend 
of down-regulation in lowly pathogenic PRRSV-1.1 and up-regulation in strains 
associated with enhanced inflammation (215-06, Lena, SU1-Bel) may therefore be 
partially a consequence of CD16 modulation, however the advantages conferred 
to the virus life cycle selecting for this evolution are not obvious. 
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 In vitro PRRSV-1 replication and host-response kinetics 
Titres of virus obtained from AMΦ 48 and 72 hpi in the time-course (Figure 4.3) 
were generally lower than the titres obtained when propagating virus stocks, which 
were collected from AMΦ 60 hpi at MOI=0.1. This is despite each cryopreserved 
batch of AMΦ being screened for viability and permissiveness. Additional minor 
variation in batches included peripheral blood contamination in the lungs during 
lavage; while red blood cells can be lysed during the primary cell cryopreservation 
protocol, leukocytes present were not excluded, therefore despite their typically 
high enrichment for resident macrophages, all AMΦ cultures were to varying 
extents mixed cultures. When the source of the sample is unique, such as during 
a vaccine trial, combined density gradient protocols may be used to separate 
lymphocytes from monocytes, however, when collecting large stocks of cells 
minimal processing was favoured and peripheral blood cell contamination was 
regarded as a marker for stressed animals or inappropriately handled tissues. 
Assessing the impact of lymphocyte or granulocyte presence in AMΦ cultures was 
beyond the remit of this project, therefore stocks were not used if over 20% of cells 
(based on forward and side scatter when counting cells using a flow cytometer) 
appeared to be lymphocytes or granulocytes, since this correlates with inflamed 
lungs and may not be representative of a healthy ex vivo system. Animal to animal 
variation was partially controlled by including the batch of AMΦ used to propagate 
these stocks as the fourth biological replicate when assessing infection frequency, 
and using another of the biological replicates as the stock of primary cells for 
TCID50 assays. Differences in titre in the time-course experiment compared to the 
propagated stocks may be explained by the propagation protocol including freeze-
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thaw lysis to release cell-associated virus particles, whereas in the time-course 
cells were resuspended for flow cytometric assessment; at later time points almost 
all cells contained virus (see Figure 4.3C).  
Attenuated strains DV and Olot/91 reach their peak titre by 24 hpi, earlier than 215-
06, H2 and Lena. The consistent decline in titre observed after this peak may 
indicate cell-free virus particles degrading at 37°C between peak titre and 
experiment end-time and supernatant collection; the half-life of PRRSV at 37°C is 
3 hours (Bloemraad et al., 1994), therefore after 24 hours the titre of cell-free virus 
likely halved approximately 8 times. This effect will be exaggerated in my results 
due to the use of 24 hour intervals for the final 3 time-points; this was decided due 
to the volume of TCID50 assays and primary cells required. The reduction in 
infection may be due to reduced culture pH impeding re-infection of cell-free virus; 
pH changes from 7 to 6 are sufficient to reduce infection rates and pH reductions 
are associated with inflammatory macrophage responses (Riemann et al., 2016), 
correlating with infected AMΦ cultures showing greater media discolouration than 
media controls.  
During the time-course experiments, infection rates typically showed greater 
variation between experiments and animals than secreted viral progeny due to the 
requirement of intact cells during processing in order to accurately quantify 
infection by flow cytometry. Detecting intracellular antigen necessitates washing 
cells in a centrifuge multiple times: while lifting adherent cells, when washing to 
remove media and PBS/EDTA, when washing unbound Zombie viability stain, 
when washing fixative, when permeabilising the cells, washing excess primary and 
secondary antibodies, and finally when fixing the cells a second time before 
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resuspending to run the sample. If a cell’s membrane integrity is significantly 
decreased before it is fixed it is less likely after extensive handling to be distinct 
from shrunken debris during analysis. 
Permissiveness has been reported to vary between breeds, with Landrace derived 
AMΦ being less permissive than those isolated from Large White-Pietrain 
crossbred animals (Lewis et al., 2010). The majority of animals we had access to 
during this study were sourced from a local abattoir and were therefore Large 
White-Landrace crosses; Large White derived inbred line Babraham animals were 
used as described previously during BDC susceptibility assessment and abattoir 
sourced PBMC were used for MoMΦ and MoDC growth-curves. AMΦ growth-
curves used cells sourced from varied backgrounds where possible to control for 
variation: two juvenile outbred pigs, one adult outbred pig, and one adult Babraham 
were assessed by flow cytometry; supernatants from one less juvenile outbred pig 
were assessed by ELISA and viral titre. No abattoir sourced AMΦ remained for 
comprehensive growth-curve characterisation, however comparable 
permissiveness was observed when assessing batches of AMΦ from different ages 
in parallel using established PRRSV-1 stocks; as described previously variability 
between animals is notable in AMΦ (Kapetanovic et al., 2013b; Reiner et al., 2010). 
It was hoped that monocyte-derived cells would show reduced inter-animal 
variation due to the comparative sterile compartment of peripheral blood compared 
to lung lavages. This was subsequently supported by (Bordet et al., 2018b) who 
reported lung parenchyma derived MΦ show less variation than AMΦ. The same 
publication also demonstrated that parenchyma isolated MoDC infected ex vivo 
show limited susceptibility to Lena and not at all to PRRSV-1.1 FL13 and Lelystad, 
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unlike lavaged AMΦ. I observed greater infection rates in my own in vitro MoDC 
experiments, which was in turn lower than infection rates reported by (Frydas et 
al., 2013), who demonstrated total infection of cultures 48 hpi by both Lena and 
Lelystad virus. These infection rates were more similar to my own Lena infection 
of MoMΦ, where approximately 75% of cells were infected 18 hpi, whereas Olot/91 
infection was closer to 50% of cells. The monocyte differentiation and infection 
protocol used in this paper was similar to my own, including MOI, so it is not clear 
why my Lena infection rates were lower. These infection rates appear lower still 
when assessing PRRSV N frequency in live cells only – the dramatic reduction in 
infection rate 48 hpi drops even lower when excluding dying cells, suggesting that 
the infection “burns out”, whether by damaging the only permissive cells or by 
inducing a strong activated non-permissive state in remaining uninfected 
neighbouring cells. In MoMΦ, which as described highly expressed CD163, high 
infection of Lena and lower infection of PRRSV-1.1 is similar to infection reported 
by (Ogno et al., 2019b), who included Lelystad and PR11 as lowly pathogenic 
strains. To investigate the effect of CD163, expression was assessed with and 
without infection to validate whether bystander cells change in susceptibility when 
neighbouring cells become infected (Figure 4.9). CD163 expression was found to 
be increased in MoMΦ infected by 215-06, Lena and SU1-Bel compared to 
uninfected MoMΦ, with slight elevations of CD163 in uninfected bystanders 
compared to media controls only in 215-06 and SU1-Bel. This trend was observed 
to a lesser extent in AMΦ, wherein SU1-Bel resembled media controls and Lena 
infected cells expressed greater CD163 than bystander cells. In MoDC all infection 
conditions showed a reduction in CD163 compared to media controls. This 
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suggests that PRRSV-1 is not able to upregulate CD163 to improve infection rates; 
it may be inferred that CD163high cells are more susceptible, and that CD163 
decreases in response to infection in line with decreased viability during infection.  
 Confocal microscopy assessment of viral load and localisation 
The elongated morphology of MoMΦ observed by confocal microscopy suggested 
an increased activation state, correlating with greater fold-changes in surface 
markers in infection compared to media than AMΦ and MoDC, including CD14 
(Figure 4.9). Changes in CD14 and morphology have previously been described 
and specifically compared between human and pig, demonstrating association with 
polarisation (Cui et al., 2018), however the images included in this report suggest 
murine M-CSF may more efficiently induce the migratory M2 phenotype than 
human M-CSF, as used in my studies and throughout literature (Franzoni et al., 
2017; Lacey et al., 2012). The abundant vacuole-like structures observed in MoMΦ 
were not further characterised in this project; they have been described previously 
as enhancing PRRSV replication by hijacking of autophagy pathways, as reviewed 
by (Richards and Jackson, 2013). Actin protrusions were visible in all 3 cell types 
when staining with phalloidin, characteristic of MΦ and DCs. Giant cells have been 
reported in porcine responses to Haemophilus parasuis (Kavanová et al., 2017b), 
a bacteria associated with PRRSV co-infections in porcine respiratory disease 
complex (PRDC); these cells resembled the multinuclear phenomenon observed 
in my monocyte-derived cultures, particularly in PRRSV infected samples. 
NSP-1β and dsRNA staining were typically perinuclear, resembling endoplasmic 
reticulum localisation in MARC-145 stained by ER-tracker (data not shown), 
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whereas N protein staining was diffuse throughout the cytoplasm in all infection 
conditions in all cell types (AMΦ, MoMΦ, MoDC, and MARC-145 cells) imaged at 
12 hpi and 24 hpi. Assessments of inter-strain replication characteristics using 
NSP-1β and NSP7 mAbs were intended to be validated in flow cytometry at time-
intervals, however, the mAbs tested worked effectively in MARC-145 cells but not 
AMΦ in this assay format. 
 Endocytic and phagocytic activity of MoMΦ & MoDC after PRRSV-1 
infection 
OVA-DQ was used alongside microspheres to assess the endocytic and 
phagocytic activity of monocyte-derived cells after PRRSV-1 infection. 2 µm 
microspheres were selected as being a comparable order of magnitude to micro-
vesicles (50 – 1000 nm) (Crescitelli et al., 2013) and apoptotic bodies (800 – 5000 
nm); due in part to findings that apoptotic bodies can be transported to the lymph 
nodes in PRRSV infected animals (Bertho et al., 2005). While not specifically 
investigated, the assessment of phagocytosis of exosome-sized particles is 
relevant with the discovery that PRRSV proteins and virions can be transported by 
exosomes (Montaner-Tarbes et al., 2016; Wang et al., 2018), and that exosomes 
and microvesicles can be integral to TLR and RIG-I like receptor (RLR) induced 
responses to viral RNA in MΦ and DCs (Kouwaki et al., 2017).  African swine fever 
virus (ASFV) was included as a collaboration with colleagues at TPI, increasing 
confidence in PRRSV-1 specific responses, since ASFV is also a highly pro-
inflammatory myelotropic virus. Virulent and attenuated ASFV strains OURT88/1 
and OURT88/3 were tested in parallel to PRRSV-1 infections when carrying out 
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the OVA-DQ and carboxylate microsphere uptake assays (data not shown). 
Neither strain reduced uptake or processing as observed with PRRSV-1, appearing 
more comparable to mock controls. OURT88/1 showed a slight reduction 
compared to OURT88/3, which was only significant when excluding PRRSV-1 
infection from analysis.  Alongside ASFV, control treatments included LPS for 
MoMΦ and CpG for MoDC. No further treatments were included as priming with 
IFN-α and TNF-α showed no change in endocytosis (Figure 4.10), which was 
tested in parallel for changes in susceptibility to PRRSV-1 and no changes 
observed except for a reduction in viability regardless of infection (data not shown). 
Alternative priming using IFN-γ, TNF-α, and equine pro-inflammatory cytokines IL-
6, IL-1β and PGE2 has previously been reported to not alter endocytosis or 
phagocytosis (Singleton et al., 2016); background in 4°C MoDC phagocytosis 
samples was comparable in my own results and Singleton et al. IFN-γ activation of 
MΦ has also been shown to reduce susceptibility to PRRSV-1 (García-Nicolás et 
al., 2014a), likely due to activation state, which is known to influence susceptibility 
(Duan et al., 1997). 
Trends in reduction of endocytic and phagocytic uptake correlated with infection 
rates, with the exception of MoDC within the phagocytosis assay. 215-06 infected 
MoDC were almost entirely positive for microsphere phagocytosis, whereas Lena 
and SU1-Bel infected MoDC were more comparable to the bystander cell’s uptake, 
as was the case in all infections in MoMΦ. The reduced uptake of Lena inoculated 
samples MoMΦ compared to 215-06 corresponds with ex vivo AMΦ analysis of 
juvenile Large White pigs infected by PRRSV-1.1 Finistere and Lena (Renson et 
al., 2018). This study confirmed AMΦ made up a reduced proportion of BAL cells 
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in the first 2 weeks of infection, with TNF-α peaking in BALF coinciding with 
greatest reduction of microsphere MFI. 
 Capacity of PRRSV infected monocyte-derived cells to prime 
allogeneic lymphocytes 
Antigen-primed MoDC are used as autologous therapeutic vaccines for cancer in 
humans (Nesselhut et al., 2015; Santin et al., 2000). The ability of monocyte-
derived APC to induce lymphocyte proliferation is typically reported as lower than 
cDC, however cross-presentation capacity of MoMΦ and MoDC has been 
confirmed in humans (Tang-Huau et al., 2018) and reported for monocytes in swine 
(Edwards et al., 2017). Bordet et al. (2018) used both cDC and MoDC-like cells 
isolated ex vivo to observe cytokine responses associated with polarised T cell 
responses. Their assessment was made by qRT-PCR of mixed cultures rather than 
phenotyping cells by flow cytometry, therefore my data is complementary. 
Soldevila et al. (2018) reported that tonsillar cDC1 and cDC2-like populations were 
most effective at stimulating CD8 T cell proliferation and that both cDC subsets and 
CD14+ cells comparably stimulated CD4 T cells. PRRSV-2 infected MoDC have 
been reported to induce allogeneic T cells to proliferate significantly less than 
uninfected MoDC (Flores-Mendoza et al., 2008), a trend which was only replicated 
in my work by CD4+CD8+ T cells when MoDC were infected with SU1-Bel and not 
by Lena. CD4+CD8+ and CD4+CD8- T cells have been reported to inhibit spread of 
infection by destroying PRRSV-2 infected MoMΦ (Chung et al., 2018), both cell 
types I observed an increase in proliferation by SU1-Bel infected MoMΦ compared 
to Lena infected MoMΦ and media controls (Figure 4.14). The destruction of 
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infected cells reported here correlates with the decreased viability I observed 
during my own assays, wherein the monocyte-derived cells showed dramatically 
reduced viability in allogeneic mixed cultures and not in un-mixed controls. 
Activation of both MΦ and CD8 T cells is associated with TNF-α production. TNF-
α detection was attempted by intracellular flow staining to confirm which 
populations were the source of secreted cytokine, however the 5-day duration of 
the proliferation assay was not compatible with this; it is likely that either all 
produced cytokine was secreted by this time, or that viability is decreased in the 
cells producing cytokines continuously for several days. Secreted cytokine was 
assessed by sandwich ELISA, comparing supernatants from lymphocyte and MΦ 
from each animal cultured alone against supernatants from allogeneic mixed 
cultures. More TNF-α was present in MoMΦ control cultures that did not have 
allogeneic lymphocytes overlaid, correlating with decreased viability of MoMΦ and 
MoDC in mixed cultures. This suggests that lymphocytes were inhibiting MoMΦ 
and MoDC responses. Two out of three allogeneic reactions produced no 
detectable TNF-α in media and mock controls and in response to Lena infection, 
SU1-Bel induced a negligible quantity. The third reaction produced a larger 
response from controls and a comparatively reduced response to SU1-Bel, with 
again no response to Lena. Responses were in all cases greater in MoMΦ alone 
compared to mixed allogeneic culture. If viability were decreased in infected MoMΦ 
due to T cell mediated cytotoxicity it could be expected to detect inflammatory 
cytokines such as TNF-α, however this was not the case. Lymphocytes-alone 
showed only detectable TNF-α when “inoculated” with SU1-Bel; infection 
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conditions were duplicated in single-cell controls however infection was not 
anticipated. 
 Pro-inflammatory cytokine responses to PRRSV-1.3 infection 
The MoMΦ differentiation treatments reported by Franzoni et al. (2017) did not 
result in differences in cell surface phenotype, but a difference in cytokine 
production was reported. 50 ng/mL human M-CSF yielded lower basal expression 
of IL-10, IL-12 and IL-1RA compared to higher growth factor concentrations or 
culture with porcine serum, which supports my own use of this differentiation 
strategy. This report also demonstrated that cytokine responses of polarised 
MoMΦ were greater in M1 than M2 cultures; polarisation treatment for M2 
consisted of IL-4 in addition to M-CSF. GM-CSF has been used previously to 
generate MoMΦ (Lacey et al., 2012), and IL-4 and GM-CSF were the strategy for 
differentiated MoDC phenotype as in my own studies. The MoDC pro-inflammatory 
cytokine responses to PRRSV-1 characterised in these studies were comparable 
to MoMΦ, despite variations in their morphology and surface marker relative 
expression. This is a reminder that monocyte-derived cells occupy a spectrum of 
antigen-presenting cells akin to the variety of MΦ and DCs occupying the dermal 
environment and tonsils (Marquet et al., 2014; Soldevila et al., 2018), some 
subsets of which blood DC are representative. Furthermore, basal cytokine 
secretion in monocyte-derived cells has been described to higher when monocytes 
are isolated by adherence rather than CD14 MACS selection (Elkord et al., 2005). 
The fluorescent magnetic bead Luminex kit availability was restricted due to its 
high expense, so supernatants from limited replicates of infected monocyte-derived 
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cells were taken forward; these were prioritised over AMΦ as monocyte-derived 
cells are anticipated to be a cleaner model system than AMΦ which, as previously 
described, contain varying degrees of environmental antigens. Viral stocks of SU1-
Bel contained more pro-inflammatory cytokines due to their origin of infected AMΦ 
that produced a pro-inflammatory response to infection. 
The TNF-α response AMΦ to 215-06 and mock infection matches low but 
detectable clinical signs in vivo elevated over vaccine strains. The total lack of 
response induced by Lena is unexpected, given the pro-inflammatory cytokines 
reported in BALF from in vivo infections (Weesendorp et al., 2014a),  however the 
same authors also reported AMΦ infected by Lena in vitro show no increase over 
uninfected controls of secreted IL-1β, IL-10, and TNF-α (Weesendorp et al., 
2013b). The same authors also report Lena secreted less IL-1β than controls in 
bone marrow-derived DC generated in vitro, correlating with the MoDC data 
presented here (Figure 4.15 and Figure 4.19). It may be that Lena requires co-
infection to induce lethal inflammation in vivo, as the prematurely euthanized 
animals in the (Karniychuk et al., 2010) study were found to have multiple bacterial 
infections. This would be typical of PRRSV-1, which does not always cause 
obvious clinical signs in the absence of bacterial and viral pathogens associated 
with PRDC. 
The risk of introducing artefact into host response assessments in monocyte-
derived cells by inoculating with pro-inflammatory cytokines was exacerbated by 
the lower titre of SU1-Bel compared to Lena necessitating larger inocula volumes 
for a given MOI. Mock infection volumes were matched to the largest inocula 
volume used in each experiment to ensure that any response elevated above mock 
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infection is not artefact due to a large inoculation volume. When assessing cytokine 
responses inocula were washed off after 90 minute adhesion time to remove 
cytokines present in the inocula to ensure that the cells have sufficient whole media 
for the duration of the infection, to remove the cytokine treatment of the cells that 
is inevitably occurring during inoculation, and to remove the residual cytokines so 
that only proteins secreted post-treatment are collected at the end time. Further 
controls were made to compare live infectious virus to inocula containing non-
infectious virions by chemical inactivation by BPL (Figure 4.16). Chemical 
inactivation was used instead of heat inactivation in order to preserve the structure 
of the virions, to control for changes in host response being due to host-virus 
binding interactions. Colleagues in my group have used scanning electron 
microscopy to show that Olot/91 virus particles are intact after BPL-treatment and 
appear comparable to untreated virus. This may be validated by detecting external 
membrane-bound virus by after high MOI inoculation with inactivated virus, 
however when detecting live infectious virus by this method it is not possible to 
resolve surface bound virus from the cytoplasm and the membrane, as stained by 
phalloidin, which binds the cytoskeleton component actin. To control for chemical 
and processing artefact introduced by the inactivation of virus, sandwich ELISAs 
were used to compare IL-1β and TNF-α levels in BPL treated inocula to mock 
treated inocula and freshly thawed untreated inocula; levels of pro-inflammatory 
cytokines in supernatants were comparable, indicating that treatment was not 
altering cytokine concentration in the infectious virus stocks (data not shown). 
Freshly thawed untreated inocula, BPL treated inocula, and mock treated inocula 
were also assessed by IPX on AMΦ for titre; no difference was observed between 
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mock treated and freshly thawed aliquots of virus stocks, and all BPL-treated 
samples showed no signs of infection. PRRSV inactivated by heat-treatment has 
previously been reported to lack the down-regulating capacity of infectious North 
American PRRSV-2 strains in monocyte-derived cells cultured with autologous 
lymphocytes (Charerntantanakul et al., 2006). In this project chemical inactivation 
was selected in place of heat inactivation in order to preserve virion structure 
(transmission electron microscopy was used by colleagues to confirm virions were 
intact) and prevent denaturation of cytokines.  
IL-12p35, the subunit unique to IL-12, has been previously described as secreted 
by cDC1 in response to culture with Lena (Bordet et al., 2018a). IL-12p40, the 
subunit shared with IL-23, was detected above 10 pg/mL only in SU1-Bel infected 
MoMΦ, suggesting a minimal response; 215-06 and mock treatments induced 
production marginally above the quantifiable threshold of the assay. Secretion was 
detectable to an even lesser extent in MoDC treated with mock, DV, 215-06 and 
SU1-Bel, regardless of virus inactivation. IL-12p40 is of interest due to its role in 
Th1 induction by activated MΦ (Abdi and Singh, 2015). IL-12 in synergy with TNF-
α and other pro-inflammatory cytokines can stimulate IFN-γ production and 
NK/CD8 cytotoxicity(Henry et al., 2008), which is salient to the CD8 lung infiltration 
observed in SU1-Bel infection (Morgan et al., 2013). (Bordet et al., 2018a) also 
reported cDC1 secretion of IL-8, a response I compared to my own BDC data 
previously. In the MoDC model system, production of IL-8 was lower than MoMΦ 
in all conditions other than SU1-Bel 24 hpi, where the assay was saturated at an 
accurate quantification of 3 ng/mL. In MoMΦ, this upper limit was also reached by 
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215-06 and Lena infection, broadly correlating with strains that report inflammation 
in vivo, unlike DV, Olot/91 and to a lesser extent H2.  
IL-6 responses were greater in MoDC than MoMΦ, with highest concentrations in 
SU1-Bel followed by 215-06 cultures. Interestingly, BPL-treatments were 
increased in Olot/91 and minimally reduced in Lena. This pro-inflammatory 
cytokine activates cytotoxic T cells and recruits monocytes to sites of inflammation. 
IL-6 can also inhibit T cell apoptosis and the development of Tregs. Associated 
with immediate pro-inflammatory response, IL-6 was used alongside TNF-β as an 
immediate response marker by Zhang et al. (2013) to detect pro-inflammatory 
responses that do not require prior priming with MAMPs. This became of particular 
interest when I further assessed AMΦ supernatants for IL-1β and TNF-α at time-
intervals after infection. IL-1β secretion was low in all conditions other than mock 
and SU1-Bel when initially assessed. As a chemoattractant for granulocytes and 
lymphocytes, IL-β was also detected by Amarilla et al. (2015) in the inflamed lungs 
and lymph nodes of SU1-Bel infected animals. This cytokine was significant in in 
vivo reports of Lena in lymph nodes and bronchoalveolar lavage fluid compared to 
prototypic Lelystad virus (Weesendorp et al., 2014a); qRT-PCR assessment of 
cytokine responses in blood  7 days post-infection showed that Lena induced 
stronger IL-12, IFN-γ, IL-10, IL-1β and TNF-α responses than Lelystad, but the 
increased response was not resolvable 3 days post-infection (Weesendorp et al., 
2013a). This may explain why even in the concentrated in vitro system, responses 
to Lena were not clearly elevated 1 day post-infection, however my in vitro studies 
of BDC and non-differentiated monocytes suggested that Lena was typically down-
regulating rather than up-regulating inflammatory responses. 
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Due to the extent of IL-1β and TNF-α responses these were assessed at multiple 
time-points after infection in monocyte-derived cells. These cytokine time-courses 
were repeated with strains of interest, using Olot/91 as a lowly pathogenic subtype 
1 strain, SU1-Bel as a highly pro-inflammatory subtype 3 strain, and Lena as an 
alternative subtype 3 strain that did not induce pro-inflammatory responses in vitro. 
These time-courses are presented as infection rates (Figure 4.5) and secreted 
TNF-α and IL-1β (Figure 4.18 and Figure 4.19). Secreted cytokines correlated with 
infection frequency of live cells; two out of three experimental repeats correlated 
particularly closely with infection frequency and secreted viral titres, with responses 
peaking 24 hpi and reducing between 48 and 72 hpi. The 24 hour interval is 
sufficient time for 2 – 3 replication cycles of PRRSV, therefore the exponential 
spread of virus through the well after 12 hpi is to be expected if all strains replicate 
at comparable rates. Previous reports suggest PRRSV internalisation after 4 hours 
and secretion of virus by 8 hours (Nauwynck et al., 1999); I selected a 6 hour 
interval anticipating detectable levels of uncoated virus 6 hpi intracellularly and in 
supernatants 12 hpi onwards, however flow cytometry was not sufficiently sensitive 
to quantify infection 6 hpi, unlike qRT-PCR in literature (W. Zhang et al., 2018). 
Previous reports analysing at 4 hour intervals observed infectious virus 8 hpi 
minimally elevated over 4 hpi, increased over 10-fold between 8 and 12 hpi, and 
further increased 16 hpi (W. Zhang et al., 2018). This matches my TCID50 data of 
supernatants: unquantifiable 6 hpi and positive 12 hpi, dramatically increased 18 
hpi, correlating with approximately 8 hour replication cycles.  
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In summary, the replication and impact of PRRSV-1 was characterised in 
monocyte-derived cells and AMΦ. Attenuated PRRSV-1.1 DV and Olot/91 peaked 
in infection frequency earlier than field strains, inducing no pro-inflammatory 
cytokine responses. British PRRSV-1.1 215-06 induced more inflammation than 
H2, PRRSV-1.3 Lena replicated most efficiently in all cell types but induced no 
inflammatory responses, unlike SU1-Bel for which the inverse was true. 215-06, 
Lena and SU1-Bel all increased CD14 and CD163, whereas only Lena significantly 
reduced endocytosis, however this also correlated with infection frequency of live 
cells. SU1-Bel was the only strain to upregulate T cell priming in infected MoMΦ 
and downregulate priming of MoDC.  
Pro-inflammatory responses in monocyte-derived cells were followed up by 
investigating the mechanism of response via inflammasome-specific inhibition, 
induction and priming by microbe associated molecular patterns. RNA-Seq of 
MoMΦ and MoDC was carried out to identify further genes of interest alongside 
previously identified inflammatory responses, to identify correlates of pathogenicity 
given the lack of pro-inflammatory cytokines observed in vitro in response to 
infection by Lena. 
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Chapter 5 : Further investigations of the PRRSV-1.3 SU1-Bel 
induced pro-inflammatory response 
Aims & rationale 
Functional data described in Chapter 4 confirmed that PRRSV-1.3 SU1-Bel 
induces greater pro-inflammatory cytokine responses and T cell proliferation than 
PRRSV-1.3 Lena and low pathogenicity PRRSV-1.1 strains in MoDC and MoMΦ, 
and greater pro-inflammatory cytokine responses in AMΦ, whereas Lena induced 
greater changes in MoDC/MoMΦ surface markers and antigen uptake. This data 
suggested that different mechanisms may be responsible for the increased 
virulence of SU1-Bel and Lena (Weesendorp et al., 2013b, 2013a). Additionally, 
multiplex cytokine assay data suggested that the ability of SU1-Bel to induce a 
range of pro-inflammatory cytokines is severely reduced after chemical 
inactivation, suggesting that infectious or replicative virus is required either to 
activate host PRRs or to modulate the host response towards a pro-inflammatory 
phenotype.  
The activation of the transcription factor NF-κB is strongly associated with pro-
inflammatory responses to viral infection. This can be induced by activation of the 
IL-1 receptor, therefore, autocrine and paracrine release of IL-1β. The release of 
IL-1 is induced by pyroptosis via the inflammasome, which occurs in response to 
priming by MAMPS and DAMPs, the latter of which may be released from 
neighbouring cells which were sufficiently stressed to rupture before apoptosis 
could sufficiently control the cell death pathways. NLRP3 expression has been 
reported in porcine lymph nodes (Tohno et al., 2011), peripheral cDC1 (Auray et 
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al., 2016), and alveolar macrophages immortalised with SV40 large T antigen (Lin 
et al., 2014; Weingartl et al., 2002). NLRP3 has been observed to be significantly 
modulated in PBMC during vaccination with PRRSV-1 MLV Porcilis (Islam et al., 
2016). PRRSV-2 RNA has been reported to activate the inflammasome via the 
PRR dead-box helicase 19A (DDX19A) in AMΦ (J. Li et al., 2015). The authors 
demonstrated that DDX19A directly bound HP-PRRSV-2 HuN4 (2006 Chinese 
outbreak strain) RNA but did not directly bind synthetic MAMP analogues such as 
Poly I:C. HP-PRRSV-2 strains SDA2 and HuN4 induced IL-1β and TNF-α to 
comparable levels as LPS priming and ATP treatment, unlike the comparatively 
lower virulence 1995 prototype Chinese PRRSV-2 strain CH-1a, and the MARC-
145 attenuated variant of HuN4. DDX19A knockdown was shown to reduce HuN4 
replication, suggesting that IL-1β maturation is a by-product of a modified 
replication cycle in specific HP-PRRSV strains; if CH-1a replication were 
dependent on DDX19A it is likely that it would trigger NLRP3 activation in a similar 
manner to HuN4. Cytokine induction by viral RNA was described to be dose-
dependent and peaked 3 – 6 hours post-transfection, which correlates with the time 
that PRRSV takes to replicate after endocytosis. 
NSP11 has been demonstrated to inhibit NLRP3 activation in an endoribonuclease 
dependent fashion in PRRSV-2 (Wang et al., 2015), therefore the induction of 
inflammasome by SU1-Bel, observed by IL-1β secretion described in Chapter 4, 
could indicate a loss of inhibitory function rather than a gain of activating function. 
Two further Chinese HP-PRRSV-2 strains isolated in 2006, WUH3 and JS-1, have 
been reported to induce inflammasome-mediated IL-1β secretion; NLRP3 activity 
was dependent on the TLR4/MyD88 signalling pathway and activated by viral total 
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RNA and viral 5’ UTR RNA, respectively (Bi et al., 2014; Sun et al., 2019). The 
finding that PRRSV-2 strains emerging in geographical and temporal isolation to 
North American strain FL12 have also mutated to induce inflammasome activation 
supports assessment of inflammasome activity in pathogenic PRRSV-1 which 
induce IL-1β compared to low pathogenicity strains. PRRSV-1 strains tested in 
Chapter 4 that did not induce pro-inflammatory responses are nevertheless known 
to cause respiratory and reproductive pathology in vivo, therefore this may be an 
alternative mechanism of pathogenicity utilised by PRRSV-1.3; modulation of 
NLRP3 by viral infection has been increasingly reported in recent years.  
Viroporin activity has been described to induce NLRP3 activation in other porcine 
diseases, such as CSF (Lin et al., 2014). PRRSV E protein has been characterised 
as a viroporin, which shares properties with numerous RNA viruses (reviewed by 
Yu et al., 2017); E protein co-localises on the virus membrane with the GP3/4/5 
heterotrimer, is not essential for viral progeny transport from the endoplasmic 
reticulum to the cell surface, but is essential for infectivity (Wissink et al., 2005). Its 
ion channel-like role is associated with un-coating and viral genome delivery into 
the cytoplasm (Lee and Yoo, 2006) and enhances viral egress (Du et al., 2010). E 
protein (ORF2b) is conserved in Nidovirales, which infect a wide range of hosts 
including humans (SARS-CoV), chickens (infectious bronchitis virus), horses 
(EAV), monkeys (SHFV), and insects (Nam Dinh virus) (Nga et al., 2011), and pigs 
(PRRSV). SARS-CoV E protein has been demonstrated to preferentially bind 
membranes in the endoplasmic reticulum Golgi apparatus intermediate 
compartment (ERGIC) and the Golgi apparatus (Nieto-Torres et al., 2015), which 
may correlate with reports that PRRSV-2 strain interferes with homeostasis of the 
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ER which results in stress granule formation (W.-Y. Chen et al., 2018). The same 
strain has been used in studies demonstrating PRRSV-2 can induce IL-1β by E 
protein mediation of intracellular K+ and Ca2+ levels, independent of but enhanced 
by prior NF-κB activation by LPS treatment (K. Zhang et al., 2013). These 
publications used, an infectious clone of a PRRSV-2 strain isolated in Iowa in 1997 
(Vu et al., 2015), as well transfected E protein mRNA to determine that the product 
of ORF2b is responsible for inflammasome activation. 
Based on the interactions of viruses with inflammatory pathways described above, 
and the diverse functional responses demonstrated by Lena and SU1-Bel, it was 
anticipated that SU1-Bel and Lena may be interacting with the pro-inflammatory 
signal transduction via different mechanisms. This was explored in further detail by 
RNA-Seq, to gain an insight into genes which are not readily identifiable by 
functional phenotyping. Assessing the relative modulation by each strain provided 
assessment of divergent mechanisms of pathogenicity; transcriptomics enabled 
assessment of all genes simultaneously that might normally require qPCR for 
individual mRNA targets or western blots for assessment of protein post-
translation. RNA-Seq to assess Lena infection has previously been reported in 
AMΦ, comparing to prototype strain Lelystad (Badaoui et al., 2014), and proved 
effective at identifying the downregulating activity of inflammation by Lena relative 
to Lelystad, despite strong induction of IFN pathways, supporting a downstream 
downregulation of IFN treatment, or sufficiently rapid replication to overcome the 
effects of ISG activation. Badaoui et al. discovered that Lena downregulated 
pathways associated with DC activating of NK cells compared to Lelystad infection. 
Based on these studies, an RNA-Seq experiment was designed to further 
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characterise the macrophage response to Lena and SU1-Bel using the monocyte-
derived model system to reduce inter-animal variation. 
Furthermore, available porcine macrophage cell lines were tested at this stage of 
the project. These cells were compared to AMΦ for susceptibility by 
immunofluorescence and flow cytometry and have informed future avenues of in 
vitro PRRSV-1 research. 
The objectives addressed within this chapter were: 
1. To evaluate the significance of inflammasome activation in pro-inflammatory 
cytokine induction by PRRSV-1.3 infection  
2. To compare the mechanisms of pathogenicity by assessing transcriptomes 
of MoMΦ infected by PRRSV-1.3 strains Lena and SU1-Bel 
3. To characterise novel cell line systems for future application in 
characterising PRRSV-1.3 pro-inflammatory activation 
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5.1 Characterisation of MΦ inflammatory response mechanisms to 
PRRSV-1.3 
 Comparison of sequences of candidate inflammasome activating 
gene in lowly pathogenic and highly pathogenic PRRSV-1 strains  
PRRSV-2 E protein has been reported to induce pro-inflammatory responses in 
AMΦ after LPS priming, supporting an inflammasome mediated route of pro-
inflammatory cytokine secretion (K. Zhang et al., 2013). Sequences of PRRSV-1 
strains isolated in Europe, USA, and Asia were assessed by relatedness of ORF2b 
to test whether clustering correlated with pathogenicity more greatly than by 
subtype (Figure 5.1) SU1-Bel ORF2b clustered most closely with Lena, AUT14-
440 (Austria), HLJB1 (China), and Cresa2982 (Spain). The two adjacent clades 
consist of 87129 (UK) and FJQEU14 (China); 13V117, 07V063 (both Belgium), 
Cresa3249, and Cresa3256 (both Spain). 13V117 and 07V063 replicate more 
efficiently than lowly pathogenic strains (Frydas and Nauwynck, 2016), and 
07V063 in particular has been described as pathogenic PRRSV-1.1 (Frydas et al., 
2015). The clustering of AUT14-440 and SU1-Bel is interesting as AUT14-440 and 
AUT13-833 have been described as being phylogenetically closer to HP-PRRSV-
2 than PRRSV-1 in terms of NSP2 deletions and ORF5 sequences, despite their 
isolation in Austria, where PRRSV-2 does not circulate;  AUT14-440, the more 
pathogenic of these two strains, is more closely related to SU1-Bel (Sinn et al., 
2016). Other than Lena, these described strains are all PRRSV-1.1, including those 
originating in China such as HLJB1, which is reported to be a recombination of 
Amervac and a Chinese field strain (Chen et al., 2017). FJQEU14 is reported as 
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pathogenic and to contain discontinuous amino acid deletions usually associated 
with HP-PRRSV-2 as well as novel deletions (Liu et al., 2017). 
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Figure 5.1. Phylogenetic tree of ORF2b sequences in PRRSV-1 strains. 51 sequences 
were aligned using the Neighbour-Joining MEGA6. The optimal tree with the sum of branch 
length = 1.547 is shown. The tree is drawn to scale, with branch lengths in the same units 
as those of the evolutionary distances used to infer the phylogenetic tree; evolutionary 
distances are in the units of the number of base substitutions per site. Red symbols 
indicate strains used in these studies, and Lelystad, the prototype PRRSV-1 strain. Where 
publicly available, accession numbers are listed prior to the strain name (with the exception 
of Cresa isolates); the country of origin is listed after the strain name. Phylogenetic tree 
shared by Dr Jean-Pierre Frossard, APHA. 
The predicted amino acid sequences encoded by ORF2b were compared between 
the strains used in Chapter 4 to assess associations between E protein 
sequence/structure and pro-inflammatory cytokine responses, using prototype 
strain Lelystad as a reference sequence (Figure 5.2 A). All strains characterised 
differed from Lelystad at one position: A27V, except Lena, which exhibited A27I. 
The 27th amino acid appeared to border the N-terminal side of the transmembrane 
region (Figure 5.2 B). Further deviation from the reference sequence partially 
correlated with inflammatory cytokine responses observed; only 215-06 and SU1-
Bel induced pro-inflammatory cytokine responses above mock, whereas DV 
Porcilis, H2, and Lena induced no cytokine response above media controls. 
Outside of positon 27, Olot/91 and H2 have 100% identity and DV (Porcilis) only 
one amino acid substitution in a unique location. 215-06 and SU1-Bel share one 
amino acid change at the C-terminal end. SU1-Bel showed the most changes, at 5 
substitutions. Both of the substitutions observed in Lena are shared with SU1-Bel 
and were not observed in any of the subtype 1 strains. Transmembrane helical 
protein topology modelling software TMHMM did not demonstrate any clear 
changes in predicted structure between SU1-Bel and Lelystad sequences; the 
L47F modification appeared to increase the confidence that the 48th positon is part 
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of the transmembrane domain, as denoted by height of the red bar (Figure 5.2 B 
and C). This may be due to the rigid aromatic side chain in phenylalanine, unlike 
leucine.   
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Figure 5.2. Analysis of PRRSV-1 ORF2b encoded amino acid sequences. Amino acid 
alignment of E protein from PRRSV-1 strains in this study using Lelystad as the reference 
sequence, dots representing no change from reference, DV referred to as Porcilis (A). The 
seven amino acid sequences were aligned using MegAlign Version 13.0. DNASTAR and 
kindly shared by Dr Jean-Pierre Frossard, APHA. TMHMM posterior probabilities 
modelling of transmembrane structures in ORF2b protein sequences from Lelystad (B) 
and SU1-Bel (C); the y-axis denotes modelling confidence within each position; red bars 
indicate transmembrane regions, blue indicates intracellular regions, and pink indicates 
extracellular regions. 
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ORF2b is only 70 amino acids long, therefore creating a percentage alignment 
score exaggerated differences caused by minimal modifications: SU1-Bel was the 
most divergent from Lelystad at 7% different; Lena and 215-05 both 4.3% different; 
DV 2.9% different; H2 and Olot/91 1.4% different. All amino acid substitutions did 
not present any changes in charge or polarity, which correlated with no clear 
changes in modelling of transmembrane domains. In the absence of identification 
of a confirmatory change in the viral protein, in vitro investigations focused on 
downstream cellular outputs of NLRP3 inflammasome activation, characterising 
whether LPS priming (therefore NF-κB signalling) modified this in AMΦ and MoMΦ. 
 LPS pre-treatment increases inflammatory response to subsequent 
PRRSV-1.3 SU1-Bel infection and decreases viability and viral load 
AMΦ were initially investigated as the classical model of PRRSV infection to 
compare SU1-Bel infections to previously published work which had used PRRSV-
2, and to previous infection response data collected in this project. SU1-Bel was 
newly propagated in the batch of AMΦ used to propagate Lena in order to equalise 
backgrounds in virus stocks. This new stock (P4B) was the second propagation 
from the original third passage stock of SU1-Bel, whereas the first stock (P4A) was 
used thus far. A wide range of LPS treatments are reported in PRRSV-2 literature 
(Kim et al., 2014; J. Li et al., 2015), therefore a working concentration sufficient to 
prime cells to subsequent PRRSV-1 infection was determined. Two treatment 
times were tested, in line with the upper and lower extents of treatments reported 
by the manufacturer and in literature for MCC950 (Perera et al., 2018; van Hout et 
al., 2017) and nigericin (Nomura et al., 2015; Perregaux and Gabel, 1994). All cells 
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were treated with media containing LPS for 90 minutes prior to inoculation, with 
inocula diluted in media containing LPS. After inoculation, culture media was 
replaced with media without LPS (“LPS-prime”) or with the same concentrations 
again of LPS (“LPS-continuous”). Supernatants and cells were collected 24 hours 
after inoculation. 
AMΦ infected by SU1-Bel P4B showed increased IL-1β responses 18 hpi when 
pre-treated with LPS but limited secretion above mock in un-treated cells (Figure 
5.3 B). There was no observable difference in IL-1β secretion between LPS-prime 
and LPS-continuous, regardless of infection condition. Infection frequencies of 
SU1-Bel were not significantly different between LPS primed and continuously 
treated cells. Comparable infection frequencies in all conditions (Figure 5.3C) were 
observed, but the decreased N-protein MFI correlating with increasing LPS 
concentrations suggested lower viral load (Figure 5.3 D), despite viability not 
changing significantly in LPS-prime treatments (Figure 5.3 A). Viability showed a 
moderate downward trend correlating with increasing LPS treatment, increased in 
SU1-Bel infected samples compared to mock.  
Within 10 ng/mL treatments, mock LPS-prime and SU1-Bel LPS-prime were 
significantly less viable than SU1-Bel LPS-continuous (P < 0.05). Within 100 ng/mL 
treatments, mock LPS-prime relative to SU1-Bel LPS-continuous and SU1-Bel 
LPS-prime relative to mock LPS-continuous were significant (P < 0.05), as was 
SU1-Bel LPS-prime relative to SU1-Bel LPS-continuous (P < 0.01). Within 1 µg/mL 
treatments, mock LPS-prime was significant relative to SU1-Bel LPS-continuous 
(P < 0.05). SU1-Bel LPS-prime was significant compared to mock LPS-continuous 
and SU1-Bel LPS-continuous (both P < 0.005). Within 10 µg/mL, mock LPS-prime 
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was significant relative to SU1-Bel LPS-continuous (P < 0.01), and SU1-Bel LPS-
prime was significant compared to mock LPS-continuous and SU1-Bel LPS-
continuous (both P < 0.001). Mock infections were significantly different between 
LPS-prime and LPS-continuous samples only at 1 and 10 µg/mL (P < 0.01 and P 
< 0.005 respectively). 
LPS-prime pre-treatment did not show statistical significance in N protein MFI 
between titration steps but a downward trend in N protein MFI with increasing LPS 
concentration was observed. N protein MFI was significantly different between LPS 
treatments within the LPS-continuous samples; media only was significant 
compared to 100 ng/mL (P < 0.05), 1 µg/mL (P < 0.01) and 10 µg/mL (P < 0.01). 
10 ng/mL was also significant compared to 10 µg/mL (P < 0.05). Infection 
frequencies were not significantly different between prime and continuous 
treatment at any LPS concentration (Figure 5.3 C). IL-1β secretion was significantly 
different between 10 µg/mL LPS-priming relative to 10 ng/mL priming and media 
controls in SU1-Bel infected samples (P < 0.05) (Figure 5.3 B). IL-1β secretion was 
significantly different between 10 µg/mL relative to 100 ng/mL within LPS-
continuous treatment (P < 0.05), 10 ng/mL (P < 0.01), and media control (P < 0.01). 
Within the 10 µg/mL treatments only, LPS-continuous SU1-Bel infection was 
significantly different (P < 0.05) compared to prime-only and continuously-treated 
mock infected samples. Statistics were not carried out on titres of secreted viral 
progeny due to a single sample per condition being assessed (Figure 5.3 G), 
however, differences in titre were not greater than observed inter-assay variation 
(~0.5 Log10); titres in the wells pre-treated with media in the LPS-prime and LPS-
continuous treatment plates did not match, therefore a robust observation of the 
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upward or downward trend in treated samples TCID50 cannot be made. The TCID50 
scale presented was representative of the range of titres obtained from AMΦ and 
MoMΦ supernatants throughout LPS-priming and MCC950 treatment experiments 
in this chapter. The only readout that negatively correlated with the increased IL-
1β secretion after priming was reduced virus load per cell, as inferred by MFI of N 
protein. SU1-Bel P4B did not induce IL-1β above mock without LPS treatment in 
AMΦ, however, the base-line response of mock samples was higher than observed 
in previous experiments (Figure 4.19). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3. Impact of LPS priming on AMΦ response to PRRSV-1.3.  AMΦ were pre-
treated by a titration of LPS for 90 minutes before and during inoculation at MOI=1, for 3 
hours total, replacing with fresh media (prime) or replenishing LPS treatments after 
inoculation (continuous). Supernatants and cells were collected 24 hpi and stained for 
viability (A); infection, presented as frequency of live cells (B) and MFI of PRRSV N (C); 
and quantification of secreted IL-1β in culture supernatant (D). Panels B and G are 
technical singlet. Error bars in panels A and C-F are the standard error of the mean of 
technical duplicates (n=1); where error bars are not visible the error range was too small 
to plot. Statistical significance is denoted by *.  
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 Determination of effective concentrations of NLRP3 inducer and 
inhibitor in AMΦ 
An inhibitor of NLRP3 was tested with a view to assessing whether SU1-Bel 
induction of IL-1β is dependent on the inflammasome. MCC950 inhibits ASC 
(adapter protein) oligomerisation with NLRP3, potentially by direct interaction with 
the mitosis check-point protein NEK7 (Perera et al., 2018; Shi et al., 2016). An 
activating compound of NLRP3 was tested in parallel as a positive control in order 
to test the inhibitor in a controlled setting. Nigericin is a potassium ionophore 
derived from Streptomyces hygroscopicus which has been reported to trigger 
NLRP3 via pannexin-1 signalling (Nomura et al., 2015; Qu et al., 2011). This 
response is described to be dependent on prior priming by MAMPs such as LPS, 
therefore a NLRP3 activating and inhibiting titration series was conducted on AMΦ, 
pulsing cells before treatment with fresh media with and without LPS prime. Culture 
supernatant and cells were collected at 3 and 24 hours after commencement of 
LPS treatment. 1 µg/mL LPS was selected from the previous experiment as 
sufficient to prime AMΦ. Due to the wide concentration ranges described by the 
manufacturer, nigericin was titrated across the MCC950 dilution series; a checker-
board dilution series of co-treatment was used to assess toxicity (Figure 5.4) and 
inflammasome activation, using IL-1β as a readout (Figure 5.5). Due to the scale 
of the experiment, samples were assessed in singlet to initially assess overall 
trends.  
Samples were collected 3 and 24 hours post-treatment to compare treatment times 
associated with priming cells compared to continuous co-treatment at the time 
interval used during infections. Viability in treated AMΦ was high in all treatment 
Luke PM Johnson   Chapter 5 
 
207 
 
conditions after 3 hours and clearly reduced after 24 hours, regardless of LPS 
priming (Figure 5.4 A and C). After 24 hours, nigericin treatments between 8 - 64 
µM consistently reduced viability more greatly than treatments of 0.5 - 4 µM. 
Viability trended downwards with increasing concentrations of MCC950; only the 
lowest concentration tested showed the majority of analysed cells were viable 
(Figure 5.4 B and D). Between 108 - 27,648 nM MCC950 treatments, viability was 
flat for two nigericin treatments, decreasing further at 110,592 nM and 442,368 nM. 
Viability of AMΦ was lower when treated with lower concentrations of nigericin 
without LPS priming compared to primed cells, however, in lower nigericin 
treatments cells were more viable in LPS primed samples. Treatment of higher 
concentrations of MCC950 did not preserve cell viability in high concentrations of 
nigericin, suggesting a direct toxicity effect in both cases, rather than the 
anticipated “rescue” of cells from pyroptosis, if MCC950 treatment was able to 
counteract nigericin treatments. 
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Figure 5.4. Titration of inflammasome pathway inducer and inhibitor in AMΦ.  AMΦ were 
treated throughout culture with varied concentrations of nigericin and MCC950, 
concentration indicated by colour and x-axis, respectively, and resuspended for flow 
staining after 3 hours (A and C) and 24 hours (B and D); cells were assessed for viability 
by membrane permeability dye. Before nigericin and MCC950 treatments, cultures were 
primed by 1 µg/mL LPS for 3 hours (A and B) or received media without LPS (C and D). 
(n=1). 
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A cross-section of supernatants from these treated samples were taken forward for 
quantification of IL-1β; the two highest concentrations of MCC950 were not taken 
forward as this concentration was deemed toxic after 24 hours and therefore non-
applicable to future cell culture. IL-1β secretion in response to nigericin treatment 
was completely dependent on LPS pre-treatment (Figure 5.4 C and D). Nigericin 
induced responses after 3 hours treatment that were comparable to SU1-Bel in 
previous experiments (Figure 4.19) and increased by 24 hours treatment. A slight 
downward trend was observed in IL-1β secretion with increasing MCC950 
treatment at 3 hours, whereas at 24 hours inter-sample variation obscured this 
trend; higher concentrations of nigericin showed clearer trends than 2 µM 
treatment, which increased in secretion at greater concentrations of MCC950. The 
inability of MCC950 to more fully counteract the activity of nigericin was likely due 
to their different sites of interaction with the inflammasome. The magnitude of the 
response induced by nigericin after 24 hours treatment may have also not been 
possible to overcome by MCC950. 
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Figure 5.5. Secretion of IL-1β in AMΦ after inflammasome induction and inhibition. Cells 
were treated throughout culture with varied concentrations of nigericin and MCC950, 
concentration indicated by colour and x axis, respectively, and supernatants were 
collected after 3 hours (A and C) and 18 hours (B and D); supernatants were stored and 
quantified by sandwich ELISA in parallel. Before nigericin and MCC950 treatments 
cultures were primed by 1 µg/mL LPS for 3 hours (A and B) or received media without 
LPS (C and D). Error bars are standard error of the mean of technical duplicates (n=1). 
Since cytokine levels in LPS treated cultures were two orders of magnitude greater than 
untreated cultures the responses are therefore presented with a different y-axis scaling. 
MCC950 was taken forward for testing with PRRSV-1.3 infection, with a view to 
assessing whether it could inhibit the magnitude of the IL-1β response induced by 
infection, and to indirectly characterise the interaction of SU1-Bel with the 
inflammasome, having demonstrated that during simultaneous treatment after prior 
priming, the equilibrium of NLRP3 induction and inhibition is weighted towards 
activation. 
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 Inhibiting the inflammasome reduces AMΦ susceptibility to SU1-Bel 
and viral load 
Having established toxic ranges of MCC950 in the context of an NLRP3 inducer, 
an upper limit was selected for treatment and a dilution series of treatments 
prepared with infection of SU1-Bel P4B in AMΦ from two animals without additional 
priming; priming was omitted to assess SU1-Bel-mediated IL-1β as in Chapter 4 
(Figure 4.19). Viability was consistently high across MCC950 treatments, with a 
slight decrease in pig 2 in all treated conditions, decreased further by SU1- infection 
(Figure 5.6 A). IL-1β was secreted to detectable levels only by pig 1 when mock 
and SU1-Bel infected, the cause of which is not clear. A downward trend was 
observed in IL-1β in response to MCC950 treatments, but no treatment conditions 
were significantly different (Figure 5.6 B). The downward trend was also observed 
in infection frequencies of both animals (Figure 5.6 C). The decrease in infection 
frequency of live cells was significant in pig 1 between 0, 60, and 300 nM MCC950 
treatments and 1500, 7500, and 37500 nM treatments, increasing in significance 
(300 nM and 1500 nM P < 0.05, 300 nM and 37500 nM P < 0.001). The MFI of 
PRRSV N protein staining decreased more greatly than infection frequency at 
increased MCC950 treatments (Figure 5.6 D), suggesting that viral load was lower 
when cells were treated with at least 1500 nM MCC950, and in turn indicating 
decreased replication. The decrease in MFI was not statistically significant, likely 
due to variation in technical replicates within each biological replicate. In pig 2, the 
MFI trend corresponded with the infection frequency, however it is not immediately 
visible due to the different order of magnitude of MFI in the two animals. To 
determine whether the decrease in live infected cells was due to decreasing 
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viability as observed in LPS priming (Figure 5.6), the frequency and MFI was 
plotted for live and dead cells combined in the analysis, but both were found to be 
highly similar to only including live cells (Figure 5.6 E and F). Observations of viral 
progeny titre were limited by replicates, however, there was a slight upward trend 
in titre in the biological replicate that showed greater IL-1β response and reduced 
MFI in response to MCC950, and a decrease in the second animal at the highest 
dose of MCC950. This does not strongly support that MCC950 impacts replication 
at these doses, however, the decrease in viral load and infection frequency 
indicates some degree of restriction on SU1-Bel infection when NLRP3 is inhibited. 
It is unknown why the second biological replicate in this experiment showed limited 
IL-1β responses and a lower infection frequency, as this AMΦ stock was used 
extensively for titre determination of PRRSV titres in supernatants from previous 
experiments and included in the time-course experiment in Chapter 4. 
Furthermore, differences between inflammatory responses to SU1-Bel infection 
and mock-infection observed in the time-course experiments were substantially 
larger than described here. 
Figure 5.6. Impact of NLRP3 inhibition on AMΦ response to PRRSV-1.3. AMΦ were pre-
treated by a titration of NLRP3 inhibitor for 3 hours before infection at MOI=1, replacing 
with fresh media after inoculation. Supernatants and cells were collected 24 hpi and 
stained for viability (A); secreted IL-1β in culture supernatant quantified (B); infection, 
presented as frequency and MFI within live cells only (C and D) and all cells (E and F). 
Panels B and G are technical singlet. Error bars in panels A and C-F are the standard error 
of the mean of technical duplicates, biological replicates are plotted separately (n=2); 
where error bars are not visible the error range was too small to plot. Statistical significance 
is denoted as * = P < 0.05, ** = P < 0.01, *** P < 0.005, **** P < 0.001. 
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 LPS priming enhances inflammasome activation in PRRSV-1.3 SU1-
Bel infected MoMΦ  
It was established that SU1-Bel replication in AMΦ was not significantly altered by 
priming cells for inflammasome activation, despite decreased viral loads and 
increased IL-1β secretion. NLRP3 inhibition significantly altered infection 
frequency, but to an extent that was not readily observable. Inhibition instead of 
priming also correlated with decreased viral load and increased IL-1β response, 
which was unexpected as NLRP3 inhibition was expected to be upstream of IL-1β 
maturation. Viral replication was again not clearly affected by inflammasome 
treatment, with greater inter-animal variation than inter-treatment variation. This 
variation was thought to be due to the environment-facing differences in AMΦ 
stocks. As monocyte-derived cells had proven to be a highly susceptible model, it 
was hoped that the sterile origin of the monocyte culture and previous literature of 
MoMΦ polarisation by LPS treatment would provide a robust system for 
inflammasome investigation. The LPS and MCC950 titration treatments were 
therefore repeated to enable comparison. When treating with LPS, only the pre-
infection prime treatment was included due to similarity in prolonged and pre-
treatments in AMΦ, and pre-treatment more closely resembled methods reported 
in literature. 
LPS treatment did not change viral load within infected cells; MFI correlated with 
infection frequency, suggesting that decreases in MFI of populations was due only 
to changes in infection frequency. When gating on live cells the infection frequency 
decreased with increasing LPS concentration (Figure 5.7 B) to a greater extent 
than viability (Figure 5.7 A). The infection frequency of both live and dead cells was 
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therefore checked, and infection rates were unchanged across LPS treatments 
(Figure 5.7 C). This suggested that susceptibility was unchanged, but that a greater 
proportion of infected cells were decreasing in viability by 24 hpi in greater 
concentrations of LPS treatment. This correlated positively with IL-1β secretion 
(Figure 5.7 E) but not secretion of viral progeny (Figure 5.7 D); the trend in the 
cross-section of supernatants assessed suggested an increase in virus replication 
in increased LPS treatments, which may explain the greater loss of viability in these 
cultures. While only live cells are typically included in flow cytometric analysis, 4 
populations were clearly resolved as live infected, live uninfected, dead infected, 
and dead uninfected. 
Together, this suggests that IL-1β secretion correlates with increased SU1-Bel P4B 
infection and replication, which coincides with more rapid loss of viability. This trend 
does not explain the decrease in IL-1β observed in low-concentration LPS 
treatments, and the non-significant increase in SU1-Bel infected cultures compared 
to mock infected.  
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Figure 5.7. Impact of LPS priming MoMΦ on PRRSV-1.3 SU1-Bel infection responses. 
MoMΦ were primed for 3 hours pre-infection with the corresponding concentration of LPS 
in complete media, resuspended and stained 24 hpi at MOI=1 with PRRSV-1.3 SU1-Bel. 
Viability assessed by membrane permeability dye (A); infection frequency within only live 
cells (B) and within all intact cells (C); quantification of secreted viral progeny (D) and IL-
1β (E) in culture supernatant. Error bars represent standard error of the mean of technical 
duplicates (n=1); where error bars are not visible the error range was too small to plot. 
Panel D is technical singlet without no error bars. 
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 Inflammasome inhibition reduces PRRSV-1.3 SU1-Bel P4B 
replication in MoMΦ but does not change host response or viability 
The NLRP3 inhibitor MCC950 was titrated in SU1-Bel P4B infected MoMΦ using 
comparable treatment concentrations to those in AMΦ. Unlike in LPS-treated cells, 
no trend emerged between infection frequency, viability, and MCC950 
concentration. The MFI of viral N protein correlated with infection frequency, 
suggesting viral load was again unchanged in MoMΦ cultures, unlike in AMΦ 
(Figure 5.6). 
There was no statistically significant differences between MCC950 treatments in 
viability of infected, mock-infected, or media control MoMΦ (Figure 5.8 A). A small 
downward trend was observed in infection frequencies of MoMΦ treated with 
increased concentrations of MCC950, however inter-animal variation led to no 
significance (Figure 5.8 B). This trend was not observed when including dead cells 
in analysis (Figure 5.8 C), as in LPS treatments. There was no clear correlation 
between infection frequency and IL-1β secretion; IL-1β in mock infected samples 
increased in the presence of MCC950, and the 1500 nM condition was both the 
highest for live cell infection frequency and lowest for IL-1β secretion (Figure 5.8 
E). Interestingly, despite the unchanged infection frequency and IL-1β response, 
secreted viral progeny was significantly lower in MCC950 treated conditions (P < 
0.05) (Figure 5.8  D).  
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Figure 5.8. Impact of NLRP3 inhibition on MoMΦ response to PRRSV-1.3. MoMΦ were 
pre-treated by a titration of NLRP3 inhibitor for 3 hours before infection at MOI=1, replacing 
with fresh media after inoculation. Supernatants and cells were collected 24 hpi and 
stained for viability (A); infection frequency within only live cells (B) and within all intact 
cells (C); quantification of secreted virus progeny (D) and IL-1β (E) in culture supernatant. 
Error bars represent standard deviation of the mean in technical singlet (n=3). Statistical 
significance is denoted as * = P < 0.05. 
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 NLRP3-specific inhibitor rescues cell viability by reducing infection 
rate and IL-1β induction of PRRSV-1.3 
The minimal IL-1β response observed by SU1-Bel P4B, above mock and media 
treatments, without prior LPS priming suggested that SU1-Bel P4B was not 
behaving in the same manner as SU1-Bel P4A. During initial inflammasome-
oriented experiments, low IL-1β responses of untreated infected samples were 
considered anomalous; however, the repeated absence of elevated IL-1β secretion 
in response to SU1-Bel P4B, despite very high infection frequency in MoMΦ, 
suggested that there was a systemic cause. This was initially suspected to be due 
to changes in lot number of the M-CSF growth factor included in MoMΦ culture, 
however when NLRP3 inhibition was repeated in MoMΦ comparing both passages 
of SU1-Bel and Lena, a strong IL-1β response to SU1-Bel P4A infection was 
observed. This was abrogated by MCC950 used at a higher concentration than 
previous experiments, and increased viability compared to mock-treated samples 
(Figure 5.9). This “rescue” effect was observable in all infection conditions and not 
in mock samples, where viability was comparable in all replicates with and without 
MCC950. While this trend was clearly visible, no conditions were significantly 
different between treated and mock treated: mock P=0.1, Lena P=0.098, SU1-Bel 
P4A P=0.24, SU1-Bel P4B P=0.42. Viability was also not significantly different 
between infection conditions within treated and mock treated samples (Figure 5.9 
A). Infection frequencies within live cells followed the inverse trend, suggesting that 
MCC950 treatment decreased susceptibility of MoMΦ to PRRSV-1.3. The only 
condition with a significant difference between treated and mock treated was SU1-
Bel P4B (P < 0.01) (Figure 5.9 B). Infection frequencies between strains were not 
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significantly different, with significance observed only between all strains and the 
background of mock infection. IL-1β secretion was significantly different between 
SU1-Bel P4A and both Lena (P < 0.01) and SU1-Bel P4B (P < 0.05) in MCC950 
treated samples only (Figure 5.9 C). Differences were observed between treated 
and mock treated samples in a comparable trend to infection frequencies: lower 
secreted cytokine concentrations in treated culture supernatants than mock treated 
samples, but significant only in SU1-Bel P4A (P < 0.05). Within biological 
replicates, trends were consistent with positive correlations between cytokine 
secretion and infection frequency, and negative correlation with viability. Due to 
logistical limitations, supernatants from this infection were not able to be assessed 
for viral titre determination and quantification of additional cytokines. 
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Figure 5.9. PRRSV-1.3 infection of MoMΦ with and without inflammasome inhibitor. 24 hpi 
at MOI=1 cells were resuspended and stained for membrane permeability dye (A), PRRSV 
N (B), and supernatants quantified for secreted IL-1β (C). Cells were treated for 2 hours 
before infection and after inocula washes with 200 µM MCC950 (+) or a mock treatment 
of media containing an equal volume of DMSO (-). Error bars are standard deviation of the 
mean in technical singlet (n=3), each in technical singlet. Statistical significance is denoted 
as * = P < 0.05, ** = P < 0.001.  
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The side-by-side comparison of SU1-Bel P4A and P4B confirmed that low pro-
inflammatory cytokine responses observed in response to P4B in previous 
experiments was due to consistent differences in response to P4A and P4B. To 
identify whether the increased responses to P4A may be due to bacterial priming 
of infected cells during stock propagation, a Limulus amebocyte lysate (LAL) test 
was carried out to detect LPS in PRRSV-1 stocks and supernatants from cultures 
of the AMΦ batches used to propagate these stocks; LPS could be expected to be 
present in low levels in alveolar lavages due to the external facing environment of 
the lungs. 215-06 and both SU1-Bel passages contained ~18 ng/mL LPS (Table 
2.1). The supernatants of the batch used to propagate H2, 215-06, Lena and SU1-
Bel P4B, as well as the batch used to propagate SU1-Bel P4A, contained 
detectable but negligible quantities of LPS; this suggests that the LPS present in 
PRRSV-1 stocks were not necessarily due to the batch of AMΦ used.  
Table 5.1. Quantification of LPS in supernatants from PRRSV-1 infectious stocks and 
culture supernatant from AMΦ stocks used to propagate the corresponding stocks. Units 
are ng/mL of LPS in the corresponding stocks. 
PRRSV-1 stock 
AMΦ stock culture 
supernatant 
Mock 3.8 
0.7 
H2 0.4 
215-06 17.8 
Lena 0.2 
SU1-Bel P4B 18.8 
SU1-Bel P4A 16.9 0.7 
Olot/91 0.2 NA 
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5.2 MoMΦ transcriptome analysis: comparing PRRSV-1.3 SU1-Bel to 
PRRSV-1.3 Lena and mock 
Total RNA was extracted from replicate wells of PRRSV-1.3 and mock infected 
MoMΦ from three pigs. The whole transcriptome was compared between infection 
conditions and between each infection and mock infected cells to characterise 
trends in infection that were not apparent from previous functional assays. SU1-
Bel P4A was the infectious stock taken forward to RNA-Seq due to its ongoing use 
at the time in assessments of monocyte-derived cell functional responses to 
infection. Based on previous infections, the 24 hpi time-point at MOI=1 was 
selected as a balance of viability, infection frequency, and replication, as 
determined by flow cytometry and TCID50, respectively. Cells were lysed in TRIzol 
reagent in situ to prevent introduction of artefact by resuspending and centrifuging 
cells, an imbalance that would be exacerbated by less viable cells being less 
adherent and therefore spending greater time resuspended in EDTA. 
Before isolation of MoMΦ RNA for RNA-Seq, RNA isolation was optimised using 
readily available AMΦ. AMΦ were lysed in TRIzol 24 hours after seeding, and 
lysates processed by three different RNA isolation protocols. Cell lysates in TRIzol 
were separated by centrifugation and the upper, aqueous phase, collected. The 
aqueous phase was mixed with equal volumes of ethanol and taken forward for 
purification using RNeasy Kit columns, Monarch Total RNA columns, or alcohol 
precipitation. Purified RNA was analysed by heat denaturing and gel 
electrophoresis to assess the RNA quality by the abundance of differentially sized 
ribosomal RNA to calculate an RNA integrity number (RIN). Samples isolated by 
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NEB Total RNA Kits displayed larger ribosomal RNA peaks and smaller peaks 
associated with fragmented RNA debris (Figure 5.10).  
 
 
 
Figure 5.10. Representative electrophoretic histograms of extracted cellular RNA analysed 
by Bioanalyser 2100. Representative histograms of samples processed by different RNA 
isolation protocols after TRIzol aqueous phase collection: alcohol precipitation (A); Qiagen 
RNeasy Kit (B); NEB Total RNA Kit (C); ladder control (D). The y axis denotes relative 
abundance, determined by fluorescence intensity, and the x axis denotes time (seconds). 
The relative position of peaks corresponds with predicted ribosomal RNA: 25 nucleotide 
lower marker in all samples and the ladder (1); fragmented RNA debris (2); mRNA (3); 
18S ribosomal RNA (4); 28S ribosomal RNA – in the ladder the corresponding marker size 
is indicated (5).  
The decreased presence of fragmented RNA relative to the strong 18S and 28S 
peaks in NEB Total RNA Kit generated a correspondingly higher RIN compared to 
samples isolated by alcohol precipitation or processed by the Qiagen RNeasy kit. 
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The total yield of RNA was quantified using a Qubit and compared to the RIN to 
inform the optimal strategy moving forward (summarised in Table 5.2). 
Table 5.2. Comparison of RNA quality and quantity from varied RNA isolation methods. 
Isolation strategy 
RNA index 
number 
Total RNA 
(µg) 
Alcohol 
precipitation 
1 NA 3.21 
2 NA 3.60 
3 6.6 2.09 
RNeasy 
column 
1 NA 0.17 
2 8.8 0.13 
3 8.2 0.08 
NEB column 
1 7.8 2.00 
2 7.8 2.65 
3 7.7 2.70 
Three parallel strategies were tested for the purification of TRIzol-phase isolated RNA; the 
aqueous phase of RNA isolated from 1x106 AMΦ was mixed with ethanol and taken 
forward to each corresponding protocol in technical triplicate.  
Based on the best-balance of RNA quality and quantity, and factoring in the 
logistics of processing multiple samples simultaneously, the NEB Total RNA Kit 
was selected for isolation of MoMΦ RNA taken forward to RNA-Seq analysis. 
 Validation of RNA-Seq data and confirmation of sample quality 
To validate that samples going forward to RNA-Seq were sufficient quality and 
consistent with previous results, and to provide comparative functional data for 
transcriptomics, supernatants were assessed for secretion of pro-inflammatory 
cytokines and viral progeny. Cells cultured in parallel were assessed for viability 
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and infection frequency. Viability and infection frequency was determined in control 
wells seeded and infected in parallel to the samples treated with TRIzol. Viability 
of resuspend cells appeared higher in pig 2 than pigs 1 and 3 regardless of infection 
condition, however replicates allocated to this assessment were limited (Figure 
5.11 A). The infection frequency was assessed to infer whether trends between 
SU1-Bel and Lena may be dependent on different infection frequencies. Pigs 1 and 
3 were comparable, based on previous inter-well and inter-experiment variation. 
Flow cytometric staining suggested an absence of infection in pig 2 by SU1-Bel, 
however, infection was confirmed when assessing supernatants by IPX; as inocula 
was washed away after 90 minutes infection time any virus present was secreted 
progeny. Lena and SU1-Bel titres were significantly different (P < 0.05) in pig 2 
only and PRRSV was confirmed to be absent in mock samples (Figure 5.11 C). IL-
1β and TNF-α sandwich ELISA of sample supernatants confirmed cell responses 
correlated with transcriptomic data; IL-1β as upregulated in SU1-Bel and Lena 
relative to mock by LogFC 7.2 and 9.9, respectively. In SU1-Bel the upregulation 
matches the large secretion of IL-1β observed in pig 1, with almost no transcripts 
detected in mock inoculated samples, whereas the transcript count does not tally 
with Lena’s downregulation of secreted IL-1β. A similar trend was observed in TNF-
α, with LogFC 2.5 in SU1-Bel relative to mock and LogFC 5.2 in Lena relative to 
mock. The ELISA also confirmed that trends were comparable to MOI=0.1 growth-
curve data obtained in Chapter 4 (Figure 4.17 and Figure 4.18) and MOI=1 
experiments comparing Lena and SU1-Bel in this chapter (Figure 5.9). In all three 
animals Lena appeared to downregulate IL-1β and TNF-α compared to mock 
(Figure 5.11 D and E). The secreted IL-1β was significant (P < 0.001) between 
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SU1-Bel and mock in only pig 1, and significant compared to SU1-Bel infected pigs 
2 and 3 (P < 0.001); pigs 2 and 3 were unexpectedly low secretors of IL-1β 
compared to previous experiments. Pig 1 was significant compared to pig 3 within 
mock treated samples (P < 0.01). TNF-α secretion was significantly different 
between Lena and SU1-Bel in all three pigs (P < 0.005, P< 0.001, P < 0.01, 
respectively). SU1-Bel was significant compared to mock only within pig 2 (P < 
0.01). Mock was significant compared to Lena only within pig 1 (P < 0.05). There 
was no significant inter-animal variation of TNF-α, however, the elevation observed 
in response to SU1-Bel was significant only within pig 2 (P < 0.01). 
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Figure 5.11. MoMΦ RNA-Seq sample infection confirmation and validation of cytokine 
response.  Samples cultured and infected simultaneously to cells taken to RNA-seq library 
prep were resuspended and stained 24 hpi for viability (A) and PRRSV N (B). 
Supernatants taken directly from RNA-Seq sample cultures 24 hpi were assessed by IPX 
for secreted viral progeny (C) and sandwich ELISA for secreted IL-1β (D) and TNF-α (E). 
Individual data-points in A and B represent single wells. Error bars in C – E are standard 
error of the mean of technical triplicates (n=3). Statistical signifiance is denoted by *.  
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 Inter-sample variation assessed by hierarchical clustering 
To observe an initial overview of sample clustering by infection condition and by 
biological replicate, a multidimensional scaling graph (MDS) of the 200 most 
variable genes, as determined by counts per gene, was generated using R (Figure 
5.12). The scaling of MDS varies depending on the analysis parameters, however, 
the distance between conditions implies relative relatedness. Pig 1 clustered away 
from pigs 2 and 3 in both mock and SU1-Bel conditions, whereas pigs 2 and 3 
clustered together in SU1-Bel conditions. The opposite (x) axis suggests clustering 
of mock, then SU1-Bel, then Lena, in a gradient of dissimilarity (Figure 5.12).  
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Figure 5.12. Multidimensional scaling representation of most variable genes in mock, SU1-
Bel and Lena infected MoMΦ. The 500 most variable genes from each sample were 
assessed to determine overall clustering of conditions relative to infection condition and 
biological replicate; axes represent relative similarity rather than measurable parameters. 
SU1 denotes infection with SU1-Bel P4A, LV denotes infection with Lena. MDS was 
created and shared by the Core Sequencing Group (TPI). 
The 50 most differentially expressed genes were plotted in a heat-map to further 
visualise clustering of pigs and infection conditions. This was to aid visualisation of 
clustering of genes between animals and conditions; several genes were 
significant by pair-wise comparisons but showed large inter-animal variation, 
therefore the hierarchical clustering of the x-axis grouped animals and infection 
conditions dependent on the genes included. Hierarchical clustering suggested a 
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closer clustering of pig 2 infected with Lena and mock, and pig 3 infected by Lena 
and SU1-Bel (Figure 5.13). The most variable genes were included in this heat-
map, as determined by the false discovery rate (FDR), which factors the LogFC 
with the P value across triplicates for each gene. An FDR < 0.05 was considered 
significant.  
 
Figure 5.13. Heat map of significantly different genes between mock, SU1-Bel and Lena 
infected MoMΦ. Genes presented here were selected as present in significantly different 
pathways determined by over-representation tests. Colour denotes the count of the 
corresponding gene, colour-scale normalised across all genes and all samples. Graphic 
was created and shared by the Core Sequencing Group (TPI). 
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Moving forward with analysis of genes between each infection condition, statistical 
significance was determined across biological triplicate. All genes in pairwise 
comparisons with an FDR of < 0.05 were included: 88 genes in mock vs SU1-Bel, 
370 genes in mock vs Lena, and 293 genes in SU1-Bel vs Lena. A preliminary 
characterisation of the clustering of significantly different genes was visualised by 
Venn diagram (Figure 5.14). 28 genes were unique to SU1 vs mock, equating to 
5.8% of the total significant genes from all pair-wise comparisons, whereas 141 
genes were unique to Lena vs mock, equating to 29.3%. This suggests that Lena 
induced additional responses compared to SU1-Bel.  
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Figure 5.14. Venn diagram of two-way comparisons of significant genes between mock, 
SU1-Bel and Lena infected MoMΦ. Each circle represents the number of genes 
significantly different (FDR < 0.05) within each pair-wise comparison. The percentage in 
each section represents the proportion of the total genes entered across all three pair-wise 
comparisons. Figure generated using Venny 2.1.0 (Oliveros, 2007). 
 
 
  
Luke PM Johnson   Chapter 5 
 
 
 
234 
 
Venn diagrams highlighted that Lena was modulating more genes than SU1-Bel 
relative to mock, but assessing the significant gene lists in this format did not factor 
in differential gene expression as in the heat-map above, i.e. it was not confirmed 
whether Lena infection inhibited genes that are activated by mock treatment, or 
whether Lena induced greater responses within these genes than SU1-Bel. The 
differential gene expression was summarised for the most upregulated and 
downregulated genes between SU1-Bel and Lena infected MoMΦ (Table 5.3). 
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Table 5.3. Significantly different genes between Lena and SU1-Bel infection. 
Most variable genes in response to 
infection by SU1-Bel relative to Lena* 
Upregulated Downregulated 
5.4 NR0B1 -6.5 RRAD 
5.1 CDCP1 -6.3 EGR4 
4.8 IL12B -4.5 NTN4 
4.8 IL23A -4.2 ARC 
4.7 AMCF-II -4.2 HES4 
4.6 IL19 -4.0 EGR1 
4.5 RFLNA -4.0 JARID2 
4.3 CLDN1 -3.9 CD2 
4.3 CD163 -3.8 HEATR9 
4.3 CHI3L2 -3.8 BCR 
4.2 UPB1 -3.7 ANKRD33B 
4.0 XDH -3.7 DUSP2 
3.9 S100A9 -3.6 DAPK2 
3.8 RETN -3.6 TSEN2 
3.8 S100A12 -3.6 SGMS2 
3.8 PPBP -3.5 NR4A1 
3.8 S100A8 -3.5 FOS 
3.6 GPRC5B -3.4 PTGS2 
3.6 MSC -3.3 CACNA1E 
3.6 IL6 -3.3 UNC93A 
3.6 RHCG -3.3 RAB34 
3.5 CEMIP -3.2 TLR8 
3.5 SERPINB2 -3.2 TXLNB 
3.4 PLA2G2D -3.2 PTGER3 
3.4 GREM1 -3.2 CD93 
*The 25 most variable genes were determined by largest and smallest LogFC 
values, which are log2 scale. Genes with an FDR > 0.05, genes which were not 
annotated, and viral ORFs are excluded. 
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 Assessment of enriched pathways identified by significant genes 
Genes that were significantly differentially expressed in each pair-wise infection 
comparison were assessed for enrichment of associated pathways. This analysis 
aimed to reduce bias and increase pattern recognition of pathways relevant to 
virus-host interaction by making comparisons using multiple bioinformatics 
databases; none are specific to porcine genes. The GO over-representation 
analysis suggested that cytokine activity, cytokine receptor binding, receptor ligand 
activity, and receptor regulator activity were significant in all three pair-wise 
comparisons (Figure 5.15).  
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Figure 5.15. GO over-representation test of significantly different genes between mock, 
SU1-Bel and Lena infected MoMΦ. Pathway enrichment test of genes from each pair-wise 
comparison, separated into columns. Genes of FDR < 0.05 were included in the analysis. 
Gene ratio indicates the proportion of all genes within each pair-wise comparison, i.e. 
larger circles represent larger proportions of genes within each column; 0.15 denotes 15%. 
P adjust denotes confidence that a pathway is significant within the analysis. Graphic was 
created and shared by the Core Sequencing Group (TPI). 
 
Of the 36 different pathways recognised by GO, three of these were unique to 
infection by Lena: TLR binding, receptor for advanced glycation end-products 
(RAGE) receptor binding, and core promoter binding (summarised Table 5.4). Two 
further pathways were identified as significant in every pair-wise comparison, 
suggesting that SU1-Bel and Lena modulate the pathway via different mechanisms 
or to different extents: receptor-regulatory activity and cytokine activity. The ligand 
for RAGE, high mobility group protein (from gene HMGBP), cross-referenced in 
the pair-wise comparisons and found to be over-expressed by Lena relative to both 
SU1-Bel and mock infection, but not to a significant degree (FDR=0.08 and 0.1, 
respectively). 
  
Luke PM Johnson   Chapter 5 
 
 
 
238 
 
Table 5.4. Genes in significant pathways as determined by GO enrichment test. 
Pathway † Comparison 
Gene 
ratio 
Genes associated with pathway 
TLR binding 
Lena vs mock  4/164 S100A8 S100A9 TLR1 TLR6 
Lena vs SU1-Bel 3/136 S100A8 S100A9 TLR1  
RAGE 
receptor 
binding 
Lena vs mock 
Lena vs SU1-Bel 
3/164 
3/136 
S100A8 S100A9 S100A12 
Core 
promoter 
binding 
Lena vs mock 
Lena vs SU1-Bel 
4/164 
4/136 
GADD45A MYC KLF10 FOS 
Receptor 
regulator 
activity 
Lena vs mock 13/164 
EDN1 EBI3 AREG CXCL6 
TNFSF9 LIF VGF NRG1 PPBP 
IL15 IFNB1 LTB TNF 
Lena vs SU1-Bel 12/136 
EBI3 IL23A IL12B CXCL6 VGF 
IL6 IL19 IL18 NRG1 PPBP 
GREM1 CXCL8 
SU1-Bel vs mock 15/79 
EDN1 JAG1 CSF3 AREG IL23A 
HBEGF IL12B INHBA LIF IL6 
IL33 ADM IL12A IFNB1 TNF 
Cytokine 
activity 
Lena vs mock  11/164 
EDN1 EBI3 AREG CXCL6 
TNFSF9 LIF NRG1 IL15 IFNB1 
LTB TNF  
Lena vs SU1-Bel 10/136 
EBI3 IL23A IL12B CXCL6 IL6 
IL19 IL18 NRG1 GREM1 CXCL8 
SU1-Bel vs mock 12/79 
EDN1 CSF3 AREG IL23A IL12B 
INHBA LIF IL6 IL33 IL12A IFNB1 
TNF 
† Only pathways with a Q value (FDR adjusted P value) < 0.05 were presented here. The 
gene ratio refers to the number of genes associated with the pathway as a proportion of 
the total number of genes input as significant from each comparison. 
 
The Reactome database was next utilised as an alternative source to complement 
and validate findings from GO. Reactome analysis recognised 81 pathways, 68 of 
which were modulated by SU1-Bel relative to mock (Figure 5.16). 
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Figure 5.16. Reactome over-representation test of significantly different genes between 
mock, SU1-Bel and Lena infected MoMΦ. Pathway enrichment test of genes from each 
pair-wise comparison are separated into columns. Genes of FDR < 0.05 were included in 
the analysis. Gene ratio indicates the proportion of all genes within each pair-wise 
comparison, i.e. larger circles represent larger proportions of genes within each column; 
0.15 denotes 15%. P adjust denotes confidence that a pathway is significant within the 
analysis. Graphic was created and shared by the Core Sequencing Group (TPI). 
Only 5/81 over-represented pathways correlated with infection exclusively by Lena 
or by SU1-Bel (Table 5.5). With the exception of the IL-10 signalling family, these 
were all related to signalling downstream of TLR activation, which corresponds with 
inflammasome investigations described above which support that SU1-Bel P4A 
alone primed MΦ in a manner similar to P4B after LPS-priming. The pathways 
over-represented indicated that SU1-Bel was stimulating signalling of TLR7/8/9 
pathways via MyD88 and TRAF6 to induce inflammatory cytokines, whereas Lena 
modulated TLR signalling. Further pathways that were enriched by both Lena and 
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SU1-Bel infection include: TLR1:TLR2 cascade, TLR6:TLR2 cascade, TLR4 
cascade, TLR9 cascade, MyD88:MAL cascade, IL-4 and IL-13 signalling, and 
signalling by interleukins; the lattermost of which included up to 17 genes.  
Table 5.5. Genes in significant pathways as determined by Reactome enrichment test. 
Pathway † Comparison 
Gene 
ratio 
Genes associated with 
pathway 
Interleukin-10 
family signalling 
SU1-Bel vs Lena 4/103 IL12B IL6 IL18 CXCL8 
SU1-Bel vs mock 8/64 
CSF3 IL12B CCL20 CD80 LIF 
IL6 IL12A TNF 
MyD88 dependent 
cascade initiated 
on endosome 
SU1-Bel vs Lena 6/103 
MAP3K1 RPS6KA5 TLR8 
S100A12 FOS CD14 
SU1-Bel vs mock 6/64 
RPS6KA5 NFKBIA TLR8 
MAP3K8 S100A12 FOS 
Regulation of TLR 
by endogenous 
ligand 
Lena vs mock 5/110 
S100A8 S100A9 CD14 TLR1 
TLR6 
Lena vs SU1-Bel 4/103 S100A8 S100A9 CD14 TLR1 
TLR7/8 Cascade / 
TLR9 Cascade 
SU1-Bel vs Lena 6/103 
MAP3K1 RPS6KA5 TLR8 
S100A12 FOS CD14 
SU1-Bel vs mock 6/64 
RPS6KA5 NFKBIA TLR8 
MAP3K8 S100A12 FOS 
TRAF6 mediated 
induction of NF-kB 
and MAP kinases 
upon TLR7/8 or 9 
activation 
SU1-Bel vs Lena 6/103 
MAP3K1 RPS6KA5 TLR8 
S100A12 FOS CD14 
SU1-Bel vs mock 6/64 
RPS6KA5 NFKBIA TLR8 
MAP3K8 S100A12 FOS 
† Only pathways with a Q value (FDR adjusted P value) < 0.05 were presented here. The 
gene ratio refers to the number of genes associated with the pathway as a proportion of 
the total number of genes input as significant from each comparison. 
 
Genes that were categorised as associated with pathways by over-representation 
tests were summarised for their relative expression within each sample (Figure 
5.17). This aided the resolution of upregulated and downregulated genes between 
conditions, visualising which genes were only moderately or up to 10-fold up or 
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downregulated by Lena or SU1-Bel relative to mock consistently across replicates, 
unlike LogFC values which were calculated combining all three pigs. Limited genes 
were visibly lower in mock than both Lena and SU1-Bel, such as IL-15, IFNB1, 
TNF, and transcription factor FOS. Downregulation by Lena and upregulation by 
SU1-Bel was clear in cytokines IL-12, IL-23, IL-6, IL-18, and IL-19. A similar trend 
was evident in CD14, NRG1, JAG1, LIF, GREM1, MMP2, TLR1, TLR6, and the 
S100 family. Three S100 genes in particular were almost 10-fold lower than SU1-
Bel samples.  
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Figure 5.17. Relative expression of genes associated with pathways as determined by GO 
and Reactome. The relative expression within each gene (row) is denoted for each sample 
(column) by the corresponding colour gradient, normalised to the highest sequence count 
across samples within each gene. Genes were included if determined to be related to 
pathway modulation in a strain-specific manner. 
 
5.3 Cell lines investigated as model system to overcome inter-animal 
variation in assays and virus propagation 
 CΔ2+ cell line permissiveness assessed by immunohistochemistry 
CΔ2+ cells were investigated as a model for primary AMΦ in order to provide a 
consistent cell line for IPX assays and virus propagation. They are reported to be 
a spontaneously immortalised MoMΦ-like cell line, as monocytes treated with M-
CSF (Chitko-McKown et al., 2013). Their morphology more closely resembles 
fibroblasts than macrophages, therefore their phenotype for multiple markers was 
assessed alongside CD163, the major PRRSV-1 binding receptor. Due to their size 
and morphology appearing more fibroblast-like they were seeded in flat bottom 96 
well plates at the same density as MARC-145 (2x104/well) rather than the 
1x105/well that AMΦ are seeded at. They showed no permissiveness to PRRSV-1 
entry as assessed by immunohistochemistry (Figure 5.18). The lack of 
susceptibility correlated with a lack of CD163 expression (Figure 5.19), despite 
their myeloid lineage being confirmed by expression of CD172a and low 
expression of macrophage marker CD203a. 
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Figure 5.18. Assessment of CΔ2+ cell permissiveness to PRRSV-1. IPX assay used to 
quantity cell line and primary cell permissiveness to PRRSV-1 infection and replication. 
Infectious stocks of known-titre PRRSV-1 strains were serially diluted onto the 
corresponding cell types and assessed by peroxidase immunohistochemistry staining. 
Dotted line indicates lower limit of accurate quantification. Error bars represent standard 
error of the mean of two separate experiments using different passage number CΔ2+ and 
MARC-145, and two separate AMΦ batches (n=2). 
The negative titre assessment in Figure 5.18 is representative of the inability to 
detect PRRSV-1 by IPX staining in any dilution step of the titration series during 
the TCID50 assay. This equates to a lack of susceptibility at a wide range of MOI 
as the starting dilution in this assay for a virus stock previously scored as 1x107 
TCID50/mL is equivalent to an MOI of approximately 5; this value is not exact virus 
stock titres are determined in the AMΦ batch it was grown in, and will yield a 
different titre dependent on the cell batch titrated onto due to inter-animal variation. 
The phenotype was confirmed by flow cytometric assessment of markers 
associated with MΦ to investigate the lack of susceptibility observed by 
immunohistochemistry. Staining was carried out in parallel on AMΦ to confirm 
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relative expression of corresponding markers (data not shown).Strong CD172a 
staining and low CD203a staining suggested a myeloid lineage, but no signal was 
detected for MHC II, CD14, CD1a, CD83 or CD163, which are all expressed to 
differential levels on AMΦ and monocyte-derived cells. The absence of MHC II and 
CD1a suggests a lack of antigen-presentation phenotype, and the absence of 
CD83 and CD14, and low CD203a staining, supports a non-MΦ origin. The 
negative staining for CD163 supports the lack of susceptibility observed when 
directly comparing known-titre stocks on CΔ2+ cells and AMΦ. 
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Figure 5.19. Representative phenotypic analysis of CΔ2+ cells by flow cytometry. Cells 
were resuspended after growing to 90% confluency and assessed by flow cytometry: 
CD172a (A); CD203a (B); CD163 (C); SLA II (D); CD14 (E); CD1a (F); CD83 (G). Red 
populations are stained for the corresponding marker, blue populations are stained with 
secondary antibody only; both populations show events within the live cell gate (n=1). 
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 Novel liver derived MΦ cell line permissiveness and cytokine 
responses 
In collaboration with Dr Gyorgy Fejer at Plymouth University and colleagues at TPI, 
myeloid progenitor cells were isolated from porcine foetal liver tissue and cultivated 
in recombinant porcine GM-CSF, giving rise to a continuously replicating non-
transformed cell line. These novel cells (referred to as porcine Max Planck Institute 
cells, poMPI) were tested for susceptibility and permissiveness in a limited scale 
infection experiment; due to initial slow cell growth after transportation, the sample 
size of each infection condition is limited to n=1. An MOI of 3 was used to increase 
confidence that any susceptibility would be detected by fluorescent microscopy. 
SU1-Bel P4A, as characterised in Chapter 4, was used alongside Lena and MARC-
145 adapted Olot/91.  
PRRSV -1 Olot/91 N protein staining intensity per cell was lower than SU1-Bel and 
Lena, which was not consistent with AMΦ and monocyte-derived cell infections 
where Olot/91 typically had comparable viral loads. The brightness of the staining 
of SU1-Bel and Lena infections throughout the entire cytoplasm of the infected cells 
suggests that replication had occurred after initial entry, which was confirmed by 
carrying out an IPX TCID50 assay to quantify secreted progeny; this was possible 
due to washing away inocula after adhesion. 
IL-12, IL-8, and TNF-α were screened to compare responses of poMPI cells to 
monocyte-derived cells and AMΦ. Media and mock wells washed in the same 
manner as infected wells, therefore media in all wells was present for 24 hours 
before collection. The magnitude of cytokine responses to SU1-Bel P4A was 
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comparable to monocyte-derived cells (Figure 4.16), however the basal response 
of IL-8 in untreated media control poMPI was higher than monocyte-derived cells. 
Progeny assessed by TCID50 (Figure 5.20 G) correlated with intensity of 
immunofluorescent staining (Figure 5.20 B). Lena replicating more efficiently than 
SU1-Bel correlated with my experience propagating PRRSV-1 in AMΦ. Statistics 
were not possible on these samples due to the unavailability of replicates, however 
the trend that SU1-Bel induces greater cytokine responses than other strains fits 
the inflammatory responses described previously in AMΦ and monocyte-derived 
cells (Figure 4.15 and Figure 4.19). 
 
 
 
 
Figure 5.20. Assessment of porcine foetal liver derived MΦ (poMPI) cell line 24 hpi with 
PRRSV-1. Immunofluorescent microscopy: actin in red and PRRSV N protein in green: 
mock infected (A); Olot/91 (B); Lena (C); SU1-Bel (D). Supernatants collected 24 hpi were 
assessed by sandwich ELISA for secreted IL-8 (E), IL-12p40 (F), TNF-α (G) and by IPX to 
titre secreted viral progeny (H). Scale bar denotes 75 µm. Each data-point is technical 
singlet from a single passage of the cell line (n=1). 
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5.4 Discussion 
 Characterisation of PRRSV-1.3-mediated IL-1β responses in MΦ 
The work in this chapter was conducted to investigate the pro-inflammatory 
responses to SU1-Bel observed in Chapter 4. LPS-priming of AMΦ and MoMΦ 
before infection with SU1-Bel P4B partially recreated IL-1β responses to SU1-Bel 
P4A observed in time-course experiments (Figure 4.19), whereas without priming 
SU1-Bel P4B produced an unexpectedly low response compared to mock 
treatment (Figure 5.8). IL-1β secretion in response to SU1-Bel, and basal levels in 
controls, was reduced by inhibition of the NLRP3 inflammasome, supporting the 
hypothesis that SU1-Bel induced pyroptosis. Using RNA-Seq to identify additional 
correlates supported cytokine data that Lena infection was immunosuppressive to 
MoMΦ, despite an active type I IFN response, and highlighted that SU1-Bel P4A 
induced a conversely active state. Subversion of the MyD88/NF-κB pathway by 
Lena was strongly indicated by pathway analyses, suggesting that the mechanism 
of pathogenicity for Lena has evolved toward immunosuppression and replication, 
whereas conversely SU1-Bel replication was impeded by inflammasome inhibition. 
Infection treatments were normalised by generating virus stocks from the same 
batch of AMΦ, however SU1-Bel P4A was generated before receiving Lena, H2 
and DV, and the stock used to produce SU1-Bel P4A was exhausted by this time. 
The age of the pigs from which AMΦ were sourced was also investigated as a 
factor for the increased pro-inflammatory responses of P4A. The permissiveness 
of AMΦ from different backgrounds has been published to varying degrees both 
recently (Gray et al., 2019) and when propagation of PRRSV-1 was less 
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established (Duan et al., 1997). The latter study informed my initial propagation 
optimisations and correlated with personal observations when handling AMΦ over 
the course of this project, particularly regarding reducing activation of AMΦ as 
described above. With the limited AMΦ available to me from various aged animals, 
I newly propagated multiple SU1-Bel and Lena passages in parallel before 
subsequent infection of MoMΦ and MoDC alongside SU1 P4A and P4B, assessing 
IL-1β and TNF-α in culture supernatants 24 hpi by ELISA. Unfortunately in this 
experiment all strains showed limited IL-1β responses compared to mock, including 
SU1-Bel stock P4A. The P4A batch was used in subsequent tests and confirmed 
to still be highly pro-inflammatory in MoMΦ and MoDC compared to other strains, 
therefore the cause for the low responses is unknown. The experiment propagating 
new stocks in parallel was not repeated due to insufficient AMΦ availability from 
the same source as P4A. 
Pro-inflammatory cytokine responses were observed in response to SU1-Bel P4A 
across all biological replicates used in the AMΦ time-course experiments, one of 
which was the stock later used to propagate SU1-Bel P4B. To control for the pro-
inflammatory induction of SU1-Bel P4A I would have ideally included the same 
stock used for propagating SU1-Bel P4A in the AMΦ time-course in Chapter 4, but 
the stock was already depleted. The AMΦ stock which was later used to propagate 
SU1-Bel P4B showed a strong pro-inflammatory response to SU1-Bel P4A in the 
time-course (Figure 4.16), and inflammasome priming and inhibition experiments 
(Figure 5.3, pig 1 in Figure 5.6) causing further confusion as to the reason for the 
difference in phenotype between P4A and P4B stocks of SU1-Bel. A LAL test was 
used to detect the bacterial component LPS, which could be expected to be 
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present at low levels in the lung due to the external facing environment. P4A and 
P4B were both propagated from the same intermediate passage of SU1-Bel 
(passage 3, “P3”) which was itself propagated on the same batch of AMΦ as P4A. 
The stock used to propagate SU1-Bel P4B was used to generate mock and 
propagate H2, Lena, and 215-06. 215-06, SU1-Bel P4A and SU1-Bel P4B were 
comparably positive within the LAL test, and the mock supernatant was moderately 
positive; H2 was not positive (Table 2.1). This suggested a correlation between 
LPS presence and pro-inflammatory cytokine secretion characterised between 
strains in Chapter 4, and between passages in Figure 5.8; SU1-Bel P4A used the 
largest inoculum volume and P4B used the lowest volume due to increased stock 
titre. This was partially controlled by matching mock inoculum volume to the highest 
infectious volume and washing all inocula off after 90 minutes adhesion time. The 
highest concentration of LPS quantified in stocks was, however, lower than any 
concentration which primed an increased response to infection with SU1-Bel P4B 
in both AMΦ and MoMΦ (Figure 5.3 and Figure 5.7). Furthermore, in the literature, 
priming MΦ is generally not carried out with less than 1 µg/mL LPS when treating 
for less than 3 hours (B. Li et al., 2015; J. Li et al., 2015; Park et al., 2015; K. Zhang 
et al., 2013). It therefore cannot be confirmed that the low level LPS presence is 
responsible for the increased pro-inflammatory cytokine responses observed in 
AMΦ and monocyte-derived cells when infected by SU1-Bel P4A and 215-06 
relative to H2, DV, Olot/91 and Lena. Cytokines present in infectious stocks were 
more likely to contribute, as stocks were produced by infection of AMΦ which 
themselves generated a pro-inflammatory response to SU1-Bel infection; DV and 
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Olot/91, propagated in simian MARC-145, contained no LPS and no cytokines 
which the porcine-specific ELISA reagents could detect.  
Other than virus inactivation as described in Chapter 4, purifying infectious stocks 
would be the ideal solution to control for inocula-mediated responses separate to 
infection; IL-1β was present in all PRRSV-1.3 stocks. Non-MARC-145 adapted 
strains were not purified due to problems of scale; when colleagues purified Olot/91 
high titres and large starting volumes were required (~1010 TCID50) due to losses 
throughout the protocol. Generating such a quantity of virus was limited primarily 
by the need for abundant highly susceptible AMΦ, cultured at a scale that would 
not amplify low level contamination. Amicon centrifugal filter units with a 100 kDa 
cut-off were trialled as a smaller-scale approach than sucrose gradients to partially 
purify and concentrate virus stocks. Multiple centrifugations were required in 
sequential columns due to rapid blocking of columns by proteins and debris in the 
stocks, which in several instances lead to concentration of cytokines as well as 
concentration of virus. In some cases, IL-1β presence in the retained fractions was 
reduced by approximately 75%, however 80% of infectious virus was lost, 
rendering changes redundant and returning to the problem of scale; virus was likely 
either destroyed or trapped in the filter membranes. In the interests of time 
optimising this process was not further investigated; approaches would have 
included trialling tangential flow microfiltration or affinity chromatography and 
subsequent dialysis of virus. Reducing FBS in AMΦ culture when propagating virus 
stocks may have improved column purification efficiency by reducing membrane 
blocking by protein aggregation, however balancing cell viability during early 
infection and propagation would be a major factor given the already high level of 
Luke PM Johnson   Chapter 5 
 
 
 
254 
 
variation observed between cell batches; propagation of PRRSV-1 in primary 
porcine AMΦ is well established, with variation reported between animals 
(Kommadath et al., 2017). 
PRRSV-2 is routinely propagated in literature in the MARC-145 cell line without 
comment on changes to virulence, however extensive passaging has been 
demonstrated to reduce HP-PRRSV-2 induction of pro-inflammatory cytokines (J. 
Li et al., 2015; Zhang et al., 2011), likely related to mutations in E protein and GP2 
- GP5 (An et al., 2011). ORF2b sequence alignments demonstrated that there are 
very few variations between PRRSV-1.1 strains and PRRSV-1.3 strains. Single 
amino acid changes can, however, make significant changes to virus-host 
interaction depending on the impact on protein interaction; only 3 amino acid 
changes in GP2a (ORF2) are necessary to enable MARC-145 cell ingress in tested 
PRRSV-2 field strains (Xie et al., 2019). Mutations in pathogenic coronaviruses in 
ORF2b have been reported to attenuate pathogenicity in coronaviruses (Nieto-
Torres et al., 2015). The relatedness of ORF2b between PRRSV-1 strains not 
included in this project suggested pathogenicity influenced clustering more than 
geographical origin (Figure 5.1). The phylogenetic tree would have been enhanced 
by inclusion of further pathogenic PRRSV-1 strains of interest, such as pathogenic 
PRRSV-1.1 Finistere and PR40 and subtype 2 strains, however these were not 
available at the time. Further PRRSV-2 strains were not included as previous 
studies have confirmed ORF2b relatedness of Chinese PRRSV-2 strains to 
PRRSV-2 prototype VR-2332 (An et al., 2011), which was an outlier in the 
phylogenetic analysis. Regions of ORF2b where SU1-Bel differ from lowly 
pathogenic PRRSV-1.1 strains present similarities in amino acid sites where amino 
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acid sequences of this ORF have been compared previously in literature, in HP-
PRRSV-2 strains CH-1a and HuN4 compared to their attenuated variants, CH-1aR 
and HuN4-F112, respectively (An et al., 2011). These regions are either side of the 
transmembrane region at positons 10 and 48; I observed variation between SU1-
Bel and lowly pathogenic PRRSV-1 strains at positions 10 and 47 (Figure 5.2). 
The remedial pathway of the endoplasmic reticulum unfolded protein response has 
been reported to be impeded by both North American and Chinese PRRSV-2 
strains, driving stress granule formation and the apoptotic pathway of the unfolded 
protein response (W.-Y. Chen et al., 2018). Stress granule formation has been 
described to suspend translation of host mRNA until a stress response has passed. 
Infectious RNA must therefore overcome the suspension of translation in order to 
replicate by phosphorylating eukaryotic initiation factor 2 α (eIF2α) directly or via 
protein kinase R (PKR), which prevents tRNA complex formation (reviewed by 
Miller, 2011). The triggering of stress granule formation by PRRSV-2, as previously 
characterised for other Nidoviruses such as Middle East respiratory syndrome 
(MERS) CoV (Nakagawa et al., 2018), suggests that pathogenic PRRSV is able to 
replicate despite cessation of host translation. Chen et al. (2018) describe that if 
AMΦ are exposed to additional priming MAMPs after 6 hpi, and not earlier, that the 
unfolded protein response drives an inhibiting instead of an activating response, 
which results in reduced TNF-α production; this supports alternative inhibitory 
functions of Lena, rather than SU1-Bel inflammation being dependent on a unique 
interaction with the ER. 
The “potential” for IL-1β secretion can be inferred by the quantity of pro-IL-1β 
remaining in cells before and after activation, as demonstrated by (Kim et al., 2014; 
Luke PM Johnson   Chapter 5 
 
 
 
256 
 
J. Li et al., 2015). pro-IL-1β was not characterised in this project; as pro-IL-1β is 
cleaved in the cytoplasm a western blot of lysed cells would be necessary to 
compare pro-IL-1β and IL-1β levels after treatments, which would require seeding 
cells for western blot in parallel to cells allocated to flow cytometry. Cell lysates 
may be of value if the priming of MΦ from different backgrounds were to be 
assessed, or confirmation that all pro-IL-1β had been converted to IL-1β by 
PRRSV-1 infection, as (Kim et al., 2014) describe when assessing bone marrow-
derived MΦ treated with nigericin. It has been demonstrated that pro-IL-1β can also 
be detected by immunofluorescence in human monocyte-derived cells (Fernandez 
et al., 2014), therefore this technique may be transferrable to flow cytometry 
depending on cross-reactive mAbs. This would enable quantification and resolution 
of pro-IL-1β+ and IL-1β+ populations alongside other phenotypic or activation 
markers. Assessing pro-IL-1β  populations after infection with a range of PRRSV-
1 with known sequences may aid amino acid sequence correlation with 
pathogenicity; viral proteins other than E are associated with NF-κB activation, 
such as N, which has been described as upregulated by Canadian PRRSV-2 strain 
PA8 in a recently developed MΦ cell line (Ke et al., 2019). This may be particularly 
relevant if alternative inhibitors were introduced to confirm the step of SU1-Bel-host 
interaction; direct interaction of PRRSV-2 has been reported by co-
immunoprecipitation  (J. Li et al., 2015). MCC950 inhibits ASC (adapter protein) 
oligomerisation with NLRP3, potentially by direct interaction with the mitosis check-
point protein NEK7 (Perera et al., 2018; Shi et al., 2016). Nigericin triggers 
caspase-1 activation, and subsequent IL-1β processing, through pannexin-1, an 
ATP transmembrane protein (Nomura et al., 2015; Qu et al., 2011). The inhibitor 
Luke PM Johnson   Chapter 5 
 
257 
 
therefore acts downstream of the inducer, however, it did not completely abrogate 
action of the inducer. Alternative inhibitors that could be investigated in the future 
include β-hydroxybutyrate, which indirectly blocks ASC oligomerisation by 
preventing K+ efflux (Youm et al., 2015), which would be in direct competition with 
nigericin. 
Dead infected cells were compared to live infected cells in experiments titrating 
LPS priming before infection to investigate the correlation of lower viral load and 
lower viability at higher LPS media concentrations. Dead infected cells showed 
reduced PRRSV N protein MFI compared to live cells, regardless of LPS treatment 
concentration and duration; only live infected cells showed a decrease in PRRSV 
N MFI correlating with LPS concentration. The stimulation of AMΦ used here is 
lesser than those reported in some literature; prolonged LPS treatments have been 
reported as necessary to induce responses (J. Li et al., 2015), however excessive 
activation of AMΦ has been reported to decrease permissiveness to PRRSV-1 
(Duan et al., 1997). It is possible that inhibition of NLRP3 is the de facto state of 
lowly pathogenic PRRSV-1, and SU1-Bel has in fact lost inhibitory ability. This 
could be investigated by priming cells, infecting with multiple PRRSV-1.1 and -1.3 
strains, with and without activating agents such as nigericin to assess whether 
PRRSV infection can overcome the activating capacity of nigericin. Carrying out 
these comparisons with and without inhibitors at alternative steps of the 
inflammasome signalling pathway would assist characterisation of the interaction 
step; DDX19A has been reported to directly detect HP-PRRSV-2 RNA, as 
determined by co-immunoprecipitation. 
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Other groups have since published work on IL-1β and PRRSV-2 co-infection (Sun 
et al., 2016), more recently characterising inhibition of PRRSV-2 induced NLRP3 
inflammasome(Sun et al., 2019). Interestingly this group transfected the 5’ 
untranslated region (UTR) rather than ORF2b, requiring 4 µg of RNA per 2x106 
AMΦ to induce a response above that of LPS alone (1 µg/mL) for IL-1β, TNF-α, IL-
8 and IL-6 expression. Relative IL-1β expression was estimated by western blot, 
rather than quantifying secreted protein by ELISA as carried out in my own 
analyses and Zhang et al. (2013). During my studies, antibodies were tested for 
cross-reactivity in flow cytometric intracellular assessment of cytokines, however 
clones tested for IL-8, IL-12p40, IL-10, IL-18 and IL-1β were not successful.  
Alternative compounds to inhibit specific inflammasomes would be the next logical 
step to confirm in vitro that NLRP3 was the only inflammasome triggered by SU1-
Bel P4A and 215-06. Transcriptomics served as an efficient alternative to 
investigate this, albeit within the discussed limitations detection only of de novo 
transcription and not post-translational modifications of pro-proteins. 
 Analysis of the transcriptome of MoMΦ infected by PRRSV-1.3 strains 
SU1-Bel and Lena 
Significance was determined in pair-wise comparisons of each infection condition 
by FDR < 0.05. Differences were then sorted by the LogFC value, which presented 
differences in RNA reads in a log2 scale; no genes with FDR < 0.05 had a LogFC 
value between -1 and 1. LogFC values here are referred to here as upregulated or 
downregulated by an integer > 1, therefore fold changes are described as positive 
values. Initial clustering by MDS and heat-map (Figure 5.12) suggested that pig 1 
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clustered away from pigs 2 and 3. Pig 1 PBMC were isolated from adult Babraham 
blood, whereas pigs 2 and 3 were sourced from the same collection at an abattoir. 
Clustering was nevertheless observed to be greater between infection conditions 
than pig source for many genes (Figure 5.13). 
All PRRSV ORFs were upregulated in Lena compared to SU1-Bel; only ORF2b 
and ORF1b were significant. In ascending order of differential expression: ORF4 
(LogFC 1.6), ORF6, ORF7, ORF5, ORF1a, ORF2a, ORF2b, and ORF3 (LogFC 
2.5). This correlated with an increased infection frequency of cells as determined 
by flow cytometry (Figure 5.11). ORF1b transcription was upregulated the inverse, 
at LogFC 23.9 in SU1-Bel relative to Lena, suggesting significantly increased 
transcription of this viral gene. ORF1b is approximately 25% larger than ORFs 2 – 
7 combined, encoding NSPs 8 – 12, including the RNA dependent RNA 
polymerase and helicase domains. It is unexpected that ORF1b differs from the 
others ORFs, especially due to the decreased infection frequency observed in 
SU1-Bel and the comparable secreted progeny, therefore this statistical anomaly 
may be due to the analysis of sub-genomic mRNA associated with ORF1b.  
Limited NLR genes (transcribing the NALP inflammasome proteins) were mapped 
within all conditions; NLR family pyrin domain containing proteins (NLRP) 3 and 
12, and NLR family CARD domain containing proteins (NLRC) 3 and 5 were 
present in analyses. The absence of NLRC4 and AIM2 corresponds with the 
reported absence of these pathways in pigs (Dawson et al., 2017; Sakuma et al., 
2017). NLRP3 was upregulated in SU1-Bel relative to mock, but not quite within 
significance thresholds (LogFC 1.2, FDR=0.053); ELISA data suggested that 1 of 
3 biological replicates did not secrete IL-1β in this experiment, which would explain 
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the shortfall in robust statistics. The only NLR gene significantly different between 
conditions was NLRP12; NLRP12 was significantly downregulated in Lena relative 
to SU1-Bel and mock (LogFC 2.7 and 2.6, respectively). The assembly of the active 
inflammasome likely was not contingent on transcription post-infection; similarly, 
the only caspases with a LogFC integer greater than 1 were caspase-14 in SU1-
Bel relative to mock (FDR=0.25) and caspase-10 in Lena relative to mock 
(FDR=0.3). IL-1β and IL-1β receptor accessory protein were significantly 
upregulated in SU1-Bel relative to mock and Lena. Cullin 1 has been reported to 
inhibit NLRP3, however CUL1 was not significant between SU1-Bel P4A and Lena. 
Potassium channels are essential to caspase activation by reducing potassium 
levels; potassium voltage-gated channel (KCN) subfamily H and J were 
significantly downregulated (LogFC 2.8 and 2.9, respectively) by SU1-Bel relative 
to Lena – this is the inverse of what might be expected if SU1-Bel P4A is able to 
prime cells for caspase activation. S100 family genes were upregulated by SU1-
Bel relative to mock and downregulated by Lena relative to mock (Figure 5.17). 
The association of S100 proteins with Ca2+ sensing may imply a role in calcium-
dependent anti-viral responses, as described in hepatitis C virus infection (Tani et 
al., 2013); calcium efflux has been described as integral to inflammasome 
activation (Katsnelson et al., 2015). These genes were also associated with the 
RAGE receptor binding pathway, which triggers DNA binding and chromatin 
remodelling (van Zoelen et al., 2011), and monocyte-derived cell adhesion, 
chemotaxis, and pro-inflammatory response induction in alarmin responses 
(Bertheloot and Latz, 2017; Donato et al., 2013; Xia et al., 2018). Downregulation 
by Lena was observed in multiple transcription factors associated with DNA 
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remodelling and TWIST1, JAG1, GREM1 suggests broad dysregulation of cellular 
metabolism, despite the absence of pro-inflammatory induction. Further pro-
inflammatory responses observed by transcriptomics included IL-18, which was 
anticipated based on caspase-1 activity inferred by IL-1β data, and IL-6, 
corresponding with Luminex data in Chapter 4 (Figure 4.16). Both responses were 
also described in (K. Zhang et al., 2013) when characterising PRRSV-2 E protein 
RNA activation of NLRP3. 
CD163 transcription was downregulated in Lena relative to mock and unchanged 
in SU1-Bel relative to mock, suggesting a decrease in phagocytic activity in Lena 
only, however previous flow cytometric assessment of surface markers suggested 
that SU1-Bel and Lena comparably upregulated CD163 in infected cells compared 
to mock (Figure 4.9). Functional assessment of phagocytosis of microspheres was 
downregulated in both infection conditions compared to mock, not significantly 
more so in Lena than SU1-Bel (Figure 4.12). The reason for this inconsistency 
between flow assessment of phagocytic, transcription of surface proteins, and 
functional assessment is not immediately clear. CD14 was downregulated in Lena 
relative to both mock and SU1-Bel (LogFC 3.0 and 3.1 respectively), whereas 
surface marker staining described (Figure 4.9) suggested that CD14 expression is 
increased relative to mock, more so in SU1-Bel than Lena infection. TLR4 is an 
LPS sensor co-localising with CD14 for MyD88 signal transduction. TLR4 
expression was not significantly different in SU1-Bel relative to mock, whereas it 
was downregulated in Lena relative to mock (LogFC 1.4) and SU1-Bel (LogFC 1.2). 
TLR4 has been reported in literature to be integral to MyD88/NF-κB induction of 
NLRP3 expression in response to PRRSV-2, supported by reductions in IL-1β 
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expression and secretion when TLR4 is inhibited by siRNA before infection (Bi et 
al., 2014; Sun et al., 2019). This may be indicative of MyD88/NF-κB involvement 
in the priming signal, rather than the viral stimulus which induces NLRP3. Bi et al. 
(2014) used siRNA rather than biologically-derived compounds, such as MCC950, 
to support that PRRSV mediated IL-1β secretion is NLRP3 dependent, therefore 
this work is complementary. TLR1, TLR4, TLR6 were significantly downregulated 
in Lena relative to both SU1-Bel and mock (LogFC 2.7, 1.4, 2.4, respectively, 
relative to mock). This is the inverse of observations reported in lung tissue from 
CH-1a PRRSV-2 infected animals (Xiao et al., 2010). TLR2 associates with TLR1 
and TLR6 (Farhat et al., 2008), however TLR2 was not significant in any pair-wise 
comparisons. Together, this supports that SU1-Bel P4A does not prime the 
inflammasome by upregulating TLR expression, and that Lena downregulates this 
response. The only other TLR to be significant in data-set was TLR8, which was 
downregulated in SU1-Bel relative to both Lena and mock (LogFC 3.2 and 1.7 
respectively). TLR8 is associated with endosomal detection of ssRNA, therefore 
modulation could be a replicative advantage via immune evasion, however, Lena 
replicated comparably to SU1-Bel in 2 animals and 10-fold more in 1 animal. 
Furthermore, SU1-Bel more effectively evading intracellular PRRs does not readily 
fit with in vivo reports that SU1-Bel is more rapidly cleared by an enhanced immune 
response (Morgan et al., 2013). dsRNA and ssRNA sensors TLRs 3, 7 and 9 were 
not significant in any comparison. AMΦ infected in vitro by Lena in literature have 
been reported in literature to show no change in TLR3 and TLR7 expression, 
whereas Lelystad increased these markers (Badaoui et al., 2014).  
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The finding that E protein interacts with α-tubulin in MARC-145 (Zhang and 
Zakhartchouk, 2017) was of note to the finding in my RNA-Seq data that 
sphingomyelin synthase was upregulated by Lena infection relative to SU1-Bel and 
mock (LogFC 3.6 and 4.0, respectively); sphingomyelin has been reported to be 
integral to pDC type I IFN production in response to infected MoMΦ (García-
Nicolás et al., 2016). Sphingomyelin has been reported to be necessary for infected 
MΦ to induce IFN-α induction in neighbouring pDC via adhesion-molecule 
mediated cell-cell contact and an intact cytoskeleton (García-Nicolás et al., 2016). 
IFN-β was very highly upregulated in both Lena and SU1-Bel relative to mock 
(LogFC 9.9 and 7.2 respectively). IFN-β has been previously confirmed in literature 
as upregulated by both PRRSV-1.1 and -1.3, with prototype PRRSV-1.1 Lelystad 
reported to increase greater type I IFN transcription than Lena (Badaoui et al., 
2014). The same authors were the first to describe IFN-αω, likely due to its recent 
annotation. Interestingly, transcripts for the gene encoding IFN-ω (IFNV) were not 
mapped in my data-set, whereas IFN-αω was significant; highly upregulated in both 
Lena and SU1-Bel relative to mock (LogFC 8.9 and 5.9 respectively). The 
increased interferon induction by Lena relative to SU1-Bel observed here does not 
correlate with the immunosuppressive responses observed by ELISA when 
quantifying pro-inflammatory cytokines in culture supernatants. This difference is 
not explained by infection frequency of QC samples; however, titres of secreted 
Lena progeny were 10-fold higher than SU1-Bel in pig 2 (Figure 5.11 C). TNF-α 
was however downregulated in Lena compared to SU1-Bel, correlating with reports 
by Badaoui et al. (2014) that Lena induces less TNF-α than other PRRSV-1 strains 
despite its highly pathogenic characterisation in vivo (Karniychuk et al., 2010). The 
Luke PM Johnson   Chapter 5 
 
 
 
264 
 
induction of TNF-α and IL-10 has previously been used to classify Spanish 
PRRSV-1.1 strains (Gimeno et al., 2011). Despite its previous appearance in 
Luminex data, IL-10 was not significantly different in either infection. IL-19, a 
member of the IL-10 family, was non-significantly upregulated in SU1-Bel relative 
to mock and significantly upregulated relative to Lena (LogFC 4.6), suggesting a 
slight downregulation by Lena relative to mock. IL-33 was upregulated by SU1-Bel 
relative to both mock and Lena (LogFC 2.2 and 2.4 respectively). IL-19 and IL-33 
have both been implicated in inflammatory autoimmune disorders in the skin (Witte 
et al., 2014), bone (Hofmann et al., 2015), and liver (Neumann et al., 2018). IL-33 
utilises the IL-1R as a co-receptor on numerous immune cells for pro- and anti-
inflammatory roles, which may be influenced by the downregulation of IL-1R 
accessory protein observed in Lena relative to mock and SU1-Bel (LogFC 2.2 and 
2.8, respectively). IL-1R signalling also leads to IL-23, which is associated with 
inflammation in the context of autoimmunity and infection; C. difficile has been 
reported to induce IL-23 production via IL-1R signalling, which was abrogated by 
removal of extracellular K+ (Cowardin et al., 2015). IL-12p40, the subunit shared 
between IL-12 and IL-23, and IL-23p19 were both significantly upregulated by SU1-
Bel relative to Lena (both LogFC 4.8) and less upregulated relative to mock (LogFC 
2.8 and 3.3, respectively). IL-12p35 was significantly different to mock (LogFC 3.0), 
implying that IL-12 is expressed non-significantly more by mock than Lena infected 
samples and that IL-23 is expressed significantly more during SU1-Bel infection 
than both mock and Lena infection. This corresponds to secretory IL-12p40 data 
previously collected, which suggested that Lena downregulated relative to mock 
whereas SU1-Bel increased secretion (Figure 4.16). IL-23 is reported to contribute 
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to autoimmunity in the skin by induction of Th17 cells (Fotiadou et al., 2018; Witte 
et al., 2014) and in a broader setting, NK cell activation of ADCC and NK cell IFN-
γ secretion (Ziblat et al., 2018). While IL-23 was not upregulated in Lena, IL-15 
upregulation relative to mock (LogFC 3.5) suggests that Lena infected MoMΦ 
cytokine responses may exacerbate NK cell activity in vivo (M. Zhang et al., 2018), 
however, allogeneic leukocyte reaction in Chapter 4 did not support direct 
stimulation in vitro. 
Several other lymphocyte activating genes were included in this transcriptomics 
data-set. CD2 was upregulated by Lena relative to SU1-Bel and mock infection. 
CD2 is associated expression on T cells binding CD58 on macrophages during 
MHC mediated activation (Selvaraj et al., 1987); CD58 was absent from this data-
set therefore comparisons could not be made. CD2 is not associated with 
macrophages but contaminating lymphocytes were not observed in any replicates 
when seeding, infecting, or collecting cells, therefore the degree of significance in 
CD2 transcription (LogFC 3.8) appears robust. With further regards to T cell 
interaction, CD86 was downregulated non-significantly relative to mock (LogFC 
1.2, FDR=0.15) and to SU1-Bel (LogFC 1.2, FDR=0.18) but CD80 was significantly 
upregulated by Lena (LogFC 3.1) more so than by SU1-Bel infection (LogFC 1.1); 
CD80 and CD86 typically provide an activating signal to T cells as a heterodimer 
(reviewed by Sharma et al., 2019). CD72, the ligand for T cell and B1 B cell subset 
associated CD5, was downregulated (LogFC 1.5) by Lena and unchanged by SU1-
Bel infection. This suggests an imbalance in T cell activation capacity. PD-L1 and 
PD-L2, molecules that bind PD-1 on T cells in an immunosuppressive fashion 
(Zhang et al., 2015), were not significant in any conditions. CD80 and PD-L1 have 
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been reported to form a heterodimer that blocks immunosuppressive PD-1:PD-L1 
and CD80:CD152/CTLA4 interactions but allows activating CD80:CD28 
interactions (Zhao et al., 2019). The upregulation of CD80 and unchanged PD-L1 
therefore implies a pro-activation phenotype induced particularly by Lena.  
Further downregulating activity induced by Lena was observed in the complement 
system, including properdin and factor H, which act as positive and negative 
regulators, respectively. Properdin is downregulated and factor H upregulated in 
Lena relative to SU1-Bel and mock. CD93 was highly upregulated in Lena relative 
to mock and SU1-Bel. CD93 is a C-type lectin transmembrane receptor expressed 
on a wide range of leukocytes, belonging to the same family as endosialin and 
thrombomodulin; the latter of which binds thrombin and regulates complement C3b 
inactivation, further supporting complement interaction. This suggests Lena may 
interact with the complement pathway uniquely compared to SU1-Bel. CD93 has 
been described as the C1q receptor, which has been shown to decrease 
complement enhanced phagocytosis when blocked by mAb, however its function 
is thought to be also related to intracellular adhesion and clearance of apoptotic 
cells (reviewed by Thielens et al., 2017); CD93 has been found to interact with 
moesin, which plays a key role in cytoskeleton restructuring during phagocytosis 
(Zhang et al., 2005). The finding that CD93 was significantly upregulated by Lena 
relative to mock (LogFC 4.5) and SU1-Bel (LogFC 3.2) is therefore at odds with 
the increase in complement inhibition suggested by increased Factor H and 
decreased properdin and C1 proteins; this implies CD93 is performing an 
alternative role to complement membrane attack complex formation. While 
functional data of endocytosis and phagocytosis presented in Chapter 4 suggested 
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that Lena inhibited uptake of antigen in both infected and uninfected cells more 
than SU1-Bel and 215-06, this trend also correlated with overall infection frequency 
within these experiments. Despite reported cross-talk between C1qR and 
inflammasome in the prevention of macular degeneration (Doyle et al., 2012), C1q 
has also been reported to inhibit inflammasome activation during phagocytosis of 
apoptotic bodies (Benoit et al., 2012). The increase of CD93 correlated with 
upregulation of pro-apoptotic pathways and inhibition of pro-inflammatory 
pathways. This was supported by increased transcription of DNA repair protein 
XRCC4, involved in non-homologous end joining DNA repair, and two AP-1 FOS 
transcription factor genes which are related to JNK kinase mediated pro-
inflammatory cytokine induction. The primary transcription factors related to pro-
inflammatory gene transcription, CREB5, AP-1 and NF-κB, appeared to be 
inhibited by Lena more extensively than SU1-Bel.  Nuclear receptor subfamily 4 
group A member (NR4A) genes 1, 2, and 3 are NF-κB related AP-1 inhibiting 
transcription factors (Liu et al., 2019), which were upregulated relative to mock 
more greatly by Lena than by SU1-Bel: Lena relative to SU1-Bel LogFC 3.5, 2.5 
(both FDR < 0.05) and 1.6 (FDR=0.32), respectively. NR4A1 and NR4A3 were also 
significant in SU1-Bel relative to mock (LogFC 2.3 and 1.6, respectively). Both 
Lena and SU1-Bel significantly upregulated relative to mock MAP3K8 (Raf) (LogFC 
3.1 and 1.6, respectively), which phosphorylates ERK1/2, p38, and IKK, the 
transcription factors immediately upstream of CREB, AP-1 and NF-κB (reviewed 
by O’Neill et al., 2013). This would suggest both viruses should be inducing strong 
anti-viral responses in addition to IFN-β, therefore Lena may be inhibiting this 
action at an alternative location of the pathway. Degradation of CREB-binding 
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proteins has been reported to modulate type I IFN responses via NSP1 in Canadian 
PRRSV-2 (Kim et al., 2010), and by porcine viruses in the same order; porcine 
epidemic diarrhoea virus is reported to degrade CREB-binding protein by NSP1, 
without interfering with IRF3 (Q. Zhang et al., 2016). Inflammasome activation by 
PRRSV-2 has been shown to be contingent on ERK1/2 and p38 signalling, with no 
reduction in response to JNK inhibitors (Bi et al., 2014). The same authors 
demonstrated that IL-1β secretion is entirely knocked down by caspase-1 
inactivation, and reduced by NLRP3 and ASC siRNA, but mRNA levels of IL-1β 
were not affected. NF-𝜅B inhibition caused a reduction in PRRSV mediated 
transcription of NLRP3, ASC, and caspase-1, implying that PRRSV activation of 
the inflammasome is detectable at the transcriptional level as well as the post-
translational level. Reactome analysis of my data suggested over-representation 
by Lena of pathways relating to TRAF6 and MyD88-mediated induction of NF-kB 
and MAP kinases, associated with TLR7/8 or TLR9 activation. 
To confirm whether modulation of CD93 and complement proteins are biologically 
relevant to Lena pathogenicity in vitro, follow up work could include incubation of 
infected cells with active and inactivated recombinant porcine complement proteins 
or serum. Work similar to this has previously been conducted using Lelystad virus, 
which has been described as unable to induce antibody-dependent complement-
mediated cell lysis (ADCML) (Costers, 2006), however Lena and SU1-Bel were not 
included in their study. Other than C1qr, no complement markers appeared to be 
upregulated in the RNA-Seq data-set; however, CD16, which has been described 
to aid CR3 binding to iC3b (Preynat‐ Seauve et al., 2004), was upregulated in AMΦ 
and MoMΦ neighbouring those infected by 215-06 and SU1-Bel (Figure 4.9). This 
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may suggest uninfected bystander cells are induced to increase expression of Fc 
receptors to facilitate antibody-dependent enhancement (ADE) of infection (Gu et 
al., 2015). Alternatively, CD16 upregulation may be part of the host defence that is 
increased in strains that are associated with increased clinical signs in vivo (215-
06, Lena, and SU1-Bel), whereas H2 and attenuated DV and Olot/91 showed 
minimal changes. These changes were also observed for the primary entry 
receptor CD163, which may lead to increased susceptibility or increased 
phagocytic activity in response to neighbouring infected cells decreasing in 
viability, irrespective of apoptosis being virus driven. Transcripts were not 
increased for CD16 in the samples taken to RNA-Seq, suggesting upregulation is 
based on shuttling of intracellular proteins to the surface after activation rather than 
de novo transcription, similar to CD83 expression in monocyte-derived cells as 
described by Cao et al. (2005). Surface phenotyping was not carried out of cells 
taken to RNA-Seq, therefore these observations are made across different 
experiments. Assessment of surface markers is complicated by increasing 
infection frequency potentially increasing early apoptosis that was not excluded by 
membrane staining. Matching infection frequency or MOI between samples was a 
trade-off, however the potential that Lena’s increased infection frequency is due to 
more efficient replication was included as a factor in this experiment, which may 
have contributed to the inconsistency between transcriptomic data and flow 
cytometric surface staining. 
SU1-Bel P4A enhanced both NLRP3 dependent and independent inflammatory 
cytokine responses, which correlates clearly with reported in vivo inflammation. 
These data suggest that Lena downregulates pro-inflammatory pathways, 
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including the inflammasome, to evade antiviral responses by upregulating 
complement proteins and inhibiting pro-inflammatory transcription factors, but 
cannot prevent apoptosis of heavily infected MoMΦ. Reduction of phagocytosis 
may be a beneficial evolution to reduce destruction of neighbouring infected cells, 
or may be a by-product of activation of apoptosis pathways. This does not 
immediately correlate with reported in vivo inflammation, however, several markers 
associated with cell activation are upregulated in Lena which correlates with NK 
mediated pathology described in utero (reviewed by Karniychuk and Nauwynck, 
2013). Neutrophil infiltration of lung in sows (Weesendorp et al., 2014a) may be 
exacerbated by the rate of Lena infection increasing apoptosis (Labarque et al., 
2003), and T cell activation as suggested by CD80 upregulation (Zhao et al., 2019). 
 Model immortalised/self-renewing macrophage systems 
A sub-clone of the 3D4 porcine lung derived MΦ cell line, 3D4/21, has been used 
in literature to characterise inflammasome activation in response to aerosolised 
particulate contaminations in swine nurseries, including pre-treatment with 
MCC950, the same inhibitor as in my own experiments (Tang et al., 2019), 
suggesting that this porcine AMΦ model system is relevant for investigations of 
pro-inflammatory responses to PRRSV if sufficiently susceptible. However, 3D4/21 
cells have only been shown to be permissive to PRRSV-1 and -2 infection after 
transfection with CD163 (Lee et al., 2010) and not without (Weingartl et al., 2002). 
CD163 transfected 3D4/21 cells have also been used in ADE studies, with 
confirmed FcγII and FcεRI expression (Shi et al., 2018), and used to assess 
priming MΦ pathways; lentiviral-expressed HP-PRRSV-2 NSP-1β was shown to 
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upregulate NF-κB (Xin et al., 2018). This may prime pro-inflammatory cytokine 
production in a similar manner to LPS treatment described here infection (Figure 
5.3 and Figure 5.7). This cell system would therefore be a boon to future studies 
for stock propagation and characterisation of priming and PRRSV-1.3 infection. 
A permissive myeloid cell line would also be an ideal way to propagate and titre all 
PRRSV-1 stocks in a consistent setting; the finite cells from an alveolar lavage and 
inter-animal variation of these stocks was felt throughout this project. 
MARC-145 cells are widely used to propagate PRRSV-2, anecdotally requiring 
fewer passages than PRRSV-1 to enable adaptation. Adaptation may be linked to 
expression of simian orthologues of entry receptors such as CD163 (Caì et al., 
2015); PRRSV-2 RNA is reportedly detectable in BHK cells transfected with simian 
vimentin (Kim et al., 2006). In literature authors sometimes refer to MARC-145 as 
permissive to PRRSV-1 without any reference of passaging or selection (Provost 
et al., 2012), however after initial susceptibility appeared negligible in my hands 
(illustrated in Figure 5.18) I did not attempt to passage my stocks in order to negate 
the risk that selecting for adaptation may alter mechanisms of pathogenicity. 
In addition to the 3D4/21 cells described above, recombinant PRRSV-permissive 
cell lines have shown promise increasingly in recent years. MARC-145 have shown 
increased permissiveness to field isolates after transfection with porcine CD163 
(Wu et al., 2018), which may require reduced adaptation of the virus strains, 
although this is unconfirmed; the PRRSV mutations responsible for enabling 
tropism to non-transfected MARC-145 have since been identified (Xie et al., 2019). 
Another swine kidney epithelial cell line, PK15 (L. Zhang et al., 2016), and murine 
alveolar and peritoneal macrophages (L. Li et al., 2017) have also been shown to 
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be permissive after transfection with porcine CD163. The recently developed 
commercial lung MΦ ZMAC cell line has also been described as susceptible to 
PRRSV-2 comparably to AMΦ (W.-Y. Chen et al., 2018) and able to propagate 
vaccine strain Prime Pac more effectively than MARC-145 (Calzada-Nova et al., 
2012).  
Despite this range of cell lines that were published within the timescale of my 
project, transfecting a cell line was not a priority within our research group and the 
ZMAC cell line was not available. Primary AMΦ were therefore used, serving as a 
representative cell system that was relatively accessible from juvenile animals. A 
non-transfected cell line that is reportedly monocytic in lineage, CΔ2+, was 
obtained for testing. This line has previously been described as expressing the 
appropriate mononuclear phagocytic associated receptors suggesting 
susceptibility to PRRSV (Chitko-McKown et al., 2013). Cells were cultured in 50 
ng/mL M-CSF as MoMΦ were previously been generated, however the 
concentration used in the original reporting of the cell line is unclear due to the use 
of non-purified supernatant from L929 cells. The expression of monocytic lineage 
surface markers was improved in the literature by including M-CSF, but expression 
of markers tested were not enhanced in our hands by passaging with M-CSF. The 
lack of any infection seen when titrating known-titre PRRSV-1 stocks onto CΔ2+ 
cells correlated with a healthy morphology observed at all time-points of the 
infection assessment, unlike permissive AMΦ and MARC-145 infected 
simultaneously which showed clear CPE at the highest steps of the titration, which 
equate to higher MOI. The proportion of CD172a+ cells was higher in our hands 
than reported, but CD163 and CD14 showed no expression at all, contrasting with 
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AMΦ (data not shown). This cell line has been described by others as 20% CD14+ 
and 10% MHC II+ (Sánchez et al., 2017); these relatively low frequencies were 
higher still than in my own assessments. This publication also assessed WSL cells, 
isolated from wild boar lung and reported to be ASFV susceptible; however, low 
CD163 expression and poor permissiveness to wild-type ASFV strains suggests 
that they are unlikely to be permissive to PRRSV. No publications assessing WSL 
cell susceptibility to PRRSV-1 were available at the time of writing.  
A novel cell line generated by collaborators near the conclusion of my project 
(poMPI) showed promising susceptibility and permissiveness in the limited pilot 
experiment. Lena produced more progeny than SU1-Bel, matching previous AMΦ 
and monocyte-derived cell data. Olot/91 replicating less efficiently in these cells 
was surprising; while the side-by-side comparison of CΔ2+ cells, AMΦ and MARC-
145 in Figure 5.18 matched this, comparable titres were observed during time-
course experiments (Figure 4.5). Despite the limited replicates available thus far, 
the cytokine responses correlating with infection are promising for the future 
application of these cells, supporting the hypothesis that these cells will form a 
representative model for AMΦ. Beyond characterising host responses this would 
provide benefits to rescuing and amplifying stocks of viral field isolates, as reported 
in non-myeloid cell lines that have been transfected to enable permissiveness (Wu 
et al., 2018; L. Zhang et al., 2016). 
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Chapter 6 : Concluding discussion 
These studies initially sought to test the hypothesis that the increased 
pathogenicity of PRRSV-1.3 reported in vivo is due to an expanded tropism of 
steady-state dendritic cells. Blood-derived cDC2 were found to express low levels 
of the key PRRSV entry receptor CD163, however neither cDC2 nor cDC1 nor pDC 
were found to be non-susceptible to Belarusian PRRSV-1.3 strains as well as a 
British PRRSV-1.1 that has been reported to induce increased clinical signs 
compared to vaccine strains. Basal cytokine responses of cultured enriched DC 
suggested modulation only by Lena, which downregulated rather than upregulated 
tested cytokines. The inverse was observed when expanded characterisations 
were carried out in AMΦ and monocyte-derived cells; Lena clustered with lowly 
pathogenic strains in inducing low inflammatory responses, whereas SU1-Bel 
induced a large response above mock which correlated over time with peak 
infection infrequency of live cells, however, replication of SU1-Bel was consistently 
lower than attenuated and lowly pathogenic strains, while Lena replicated to the 
greatest extent. Infection frequency also correlated with decrease in endocytic and 
phagocytic function of monocyte-derived cells, whereas the capacity to prime 
allogeneic lymphocytes correlated instead with specific strains; SU1-Bel appeared 
to inhibit MoMΦ priming, whereas MoDC priming was greater and less consistently 
modulated by infection. Changes in surface markers associated with phagocytosis 
and polarisation were only significantly altered from mocks in pathogenic strains, 
with upregulation observed in both infected and uninfected bystander cells in AMΦ 
and MoMΦ, whereas markers on MoDC downregulated in the same strains. The 
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pro-inflammatory IL-1β response observed was reduced at the 24 hpi interval in 
MoMΦ when cells were pre-treated with an NLRP3 inhibitor, as was viral load per 
cell and titre of infectious progeny, whereas this effect was less observed in AMΦ, 
which did not clearly decrease in SU1-Bel P4B titre with NLRP3 inhibition. The 
pathogenicity of SU1-Bel was found to be decreased in a new passage of virus 
stock, which was restored when cells were pre-treated with LPS, providing the 
inflammasome a priming signal. This suggested that inflammasome induction was 
beneficial to PRRSV-1.3 replication, therefore co-culture with bacterial PAMPs was 
beneficial. Despite this, bacterial levels were consistent between PRRSV-1 stocks 
and AMΦ batches used. Transcriptomics was used to identify further co-markers 
of pathogenicity in MoMΦ; data supported markers assessed by flow cytometry 
and associated with phagocytosis, and suggested several unidentified genes that 
were modulated, particularly by non-inflammasome inducing Lena. The 
inflammatory activity downregulation by Lena observed in vitro corresponded with 
inhibition of the complement pathway and pro-inflammatory cytokines, both 
inflammasome-dependent and independent, despite extensive infection. This 
suggested that Lena was able to downregulate host responses more efficiently 
than SU1-Bel, despite both inducing clinical signs in vivo associated with systemic 
inflammation. This supports that SU1-Bel pathogenicity is due to enhanced 
immune responses, which leads to enhanced viral clearance, whereas the cause 
of inflammation in response to Lena in vivo is due to expanded lymph node tissue 
infection.  
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6.1 Primary cell sources 
PBMC stocks from the same animals were used in each experiment where 
possible to reduce inter-experiment variation. The first replicate in the MoMΦ RNA-
Seq data-set was used in the LPS and MCC950 titrations using SU1-Bel P4B 
(Figure 5.7 and Figure 5.8), and the experiment comparing SU1-Bel P4A and P4B 
with and without MCC950 (Figure 5.9). Pigs 2 and 3 in the RNA-Seq data-set were 
included in the growth-curves in Chapter 4 (Figure 4.5). The second replicate was 
also included as one of the replicates in the MCC950 titration experiment (Figure 
5.8). PBMC stock availability did not in all cases allow using the same stocks when 
follow-up experiments were designed. To preserve prioritised stocks, pilot 
biological singlet experiments were often conducted using alternative stocks, 
however, in several instances the pilots were sufficiently informative that they were 
not repeated to avoid depleting cell stocks. 
Blood from regular donors would greatly control biological variation; assess a herd 
by generating monocyte-derived cells from a range of animals and assessing 
variation in permissiveness and responses. An additional advantage to this would 
be further characterising the immunological background of these animals, unlike 
the abattoir sourced samples where weight, gender, diet, prior infections are all 
approximate. While a reduction in inter-animal variation was hoped for using 
peripheral monocytes rather than AMΦ, due to the comparatively sterile blood 
compartment, responses to LPS across breeds and species. Additionally, MoMΦ 
and bone marrow derived MΦ cluster away from AMΦ, potentially fulfilling an 
intermediate niche to lung MΦ and MoDC (Kapetanovic et al., 2012). It was initially 
hoped that the increased cell numbers available from porcine femurs and reduced 
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risk of adventitious microbial contamination, relative AMΦ lavaged from lungs, 
would allow a more efficient virus stock production platform. In contrast to the 
results obtained with PRRSV-1, this approach has previously been applied to 
African swine fever virus (ASFV) a myelotropic virus that can also be propagated 
in AMΦ (Lithgow et al., 2014; Sánchez-Torres et al., 2003). It was posited that an 
unidentified pig serum component or recombinant M-CSF should drive the 
differentiation of bone marrow precursors towards a macrophage phenotype 
(Kapetanovic et al., 2012) with an accompanying expression of the PRRSV 
receptor CD163 and co-receptor CD169 (Delputte et al., 2007; Singleton et al., 
2016). Whilst the expression of these specific markers was not evaluated, BMC 
cultures were stained with CD172a, a specific myeloid marker, and results showed 
an unexpectedly low proportion of cells, correlating with low titres obtained from 
supernatants after inoculation with PRRSV-1.1. Due to the inconclusive initial 
findings in bone marrow cultures, sourcing AMΦ and PBMC stocks was instead 
prioritised.  
6.2 Cell lines and virus stock background 
Due to the unavailability of a permissive porcine myeloid cell line for propagation 
at the outset of the project, batches of AMΦ were allocated to propagation of 
PRRSV strains, however, cryovials of permissive AMΦ stocks were held in reserve 
for IPX assessments. In order to assess inter-animal variation, propagating each 
strain in several AMΦ stocks in parallel was partially investigated in an attempt to 
characterise the pathogenicity of the initial 4th passage of SU1-Bel (P4A) compared 
to the later passage (P4B) which did not induce inflammasome activity (Figure 5.9). 
An alternative may have been to accept the inherent variation between AMΦ stocks 
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and increase volume by pooling infectious stocks harvested from several parallel 
propagations. This may have created a sufficiently large stock to make purification 
protocols viable, or it may have standardised backgrounds of stocks by combining 
backgrounds. Were volumes of stocks sufficient, purification would have removed 
supernatant proteins including inflammatory cytokines, however, losses during 
purification protocols required a larger starting volume than was obtainable from 
available primary cell stocks. Concentration of stocks when concentrating 
cytokines as well as virus was partially investigated and deemed redundant due to 
the co-concentration of cytokines. An advantage to concentrating virus titres would 
be that inocula could be diluted in larger volumes of fresh media. While this would 
not have removed the treatment of the pro-inflammatory cytokines, it may have 
been sufficient to support an unstressed state in the cultured cells. 
This project began with the use of representative attenuated, PRRSV-1.1 and -1.3 
strains: Olot/91, 215-06, and SU1-Bel, respectively. Olot/91 was supplemented by 
the commercial vaccine strain DV, 215-06 was supplemented with a second British 
field isolate H2, and SU1-Bel supplemented by a second highly pathogenic 
Belarusian isolate Lena. My studies of monocyte-derived cells would have been 
further complemented by inclusion of highly pathogenic PRRSV-1.1 and -1.2 
strains, however, it transpired that similar work was submitted for review by another 
group during the third year of my project, now published (Ogno et al., 2019b). This 
report expanded previously published work by the same group (García-Nicolás et 
al., 2014b) using polarised MoMΦ to demonstrate that highly pathogenic strains 
tested were able to overcome reduced susceptibility induced by IFN-γ treatment 
compared to tested lowly pathogenic PRRSV-1.1 strains. Repeating portions of 
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this work in PRRSV-2 would be relevant if correlates were clearly identified in the 
PRRSV-1 strains characterised thus far. Inflammasome activation is the primary 
readout of interest identified throughout these studies, as proliferation, 
phagocytosis and phenotyping assays did not reveal clear trends to suggest the 
mechanism of pathogenicity of SU1-Bel and Lena over PRRSV-1.1 strains tested. 
Were this expanded upon and the interacting pathways of pro-inflammatory 
response triggering confirmed it would be relevant to repeat this work in as wide a 
range of well-characterised strains as possible in order to confidently assess the 
conservation of the correlate of pathogenicity. 
6.3 Recombinant approaches to PRRSV infection 
The application of yeast-2-hybrid screens with PRRSV have been published by 
other groups (Song et al., 2018) and are ongoing in colleague’s work to investigate 
NSP-host interaction. When a candidate gene is identified it could be over or under 
expressed in recombinant infectious plasmids, using the monocyte-derived cell 
system as a representative model for AMΦ and DC, or an alternative susceptible 
porcine myeloid cell line as described previously. This system would enable 
controlled assessment of pathogenicity markers, such as by swapping the ORF2b 
sequences of Olot/91 and SU1-Bel and assessing gain or loss of function to induce 
pro-inflammatory responses after infection. An alternative initial target for 
sequence exchanging would be NSP2 - a 30 amino acid discontinuous deletion in 
NSP2 is the traditional hallmark of HP-PRRSV-2 (Tian et al., 2007). The deletion 
in HP-PRRSV-2 has been proven to not be solely responsible for the elevation in 
pathology (Zhou et al., 2009), however individual amino acid substitutions in GP4 
have been reported to correlate with HP-PRRSV-2 strains (Wang et al., 2016). 
Luke PM Johnson   Chapter 6 
 
 
 
280 
 
Deletions in this region have been described in Lena relative to Lelystad (Van 
Doorsselaere et al., 2012), and this region showed multiple further deletions in 
SU1-Bel compared to Lena, the longest of which was 11 amino acids long. Smaller 
deletions in this region have been described in pathogenic PRRSV-1.1 strains 
(Canelli et al., 2017; Frydas, 2015), therefore the complete genome of SU1-Bel 
P4A generated by transcriptomics could be compared to previous passage 
sequences to identify further correlating SNPs.  
A representative PRRSV-1.1 and PRRSV-1.3 virus was under development by 
collaborators throughout my PhD, with a focus on integrating a GFP tag to remove 
the need for staining to detect virus progeny in IPX and virus neutralisation antibody 
test (VNT) assays, however, this system was not available within the time-scale of 
my project. Transfection or electroporation are anecdotally difficult in primary cells 
such as AMΦ, however, the poMPI replicating cell line should prove a more robust 
tool. siRNA transfection has been reported to be a viable strategy in bovine 
monocyte-derived cells (Jensen et al., 2014). The observation that chemically 
inactivated PRRSV induced a lower pro-inflammatory response suggests that live 
virus is required, but does not confirm whether a similar response could be elicited 
by detection of intracellular replication deficient virions, such as transfection of a 
recombinant cell egress-deficient virus into AMΦ or monocyte-derived cells. 
Transfecting recombinant virus into non-myeloid cell lines (such as PK-15, SK6, 
BHK) may enable propagation of stocks with no cell-derived background, however 
this would require a high transfection efficiency if using cells where cell-to-cell 
spread of virus progeny was limited. MARC-145 propagated strains presumably 
contained simian cytokines which did not react with porcine reagents when stocks 
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were assessed for background by Luminex as MARC-145 are not IFN deficient (Q. 
Zhang et al., 2016). Olot/91 and DV were propagated in MARC-145 and all field 
strains were propagated in AMΦ in order to reduce the risk of inadvertently 
attenuating wild-type strains or reverting attenuated strains to virulence; reversion 
of MARC-145 passaged vaccine strains have been reported in Western Europe 
when the Amervac vaccine strain reverted (Nielsen et al., 2001), and in China when 
attenuated HP strain JXA1-R reverted (Jiang et al., 2015). PRRSV-1.3, attenuated 
and wildtype PRRSV-1.1 strains were assessed in AMΦ and MARC-145 alongside 
the candidate CΔ2+ cell line, both before and after passaging all three strains in 
AMΦ. There was a 10-fold drop in Olot/91 titre after passaging in AMΦ. This 
correlates with sub-optimal culturing conditions as the strain is adapted to MARC-
145 cell line growth. Curiously, SU1-Bel was unable to infect MARC-145 cells, 
whereas wild-type subtype 1 215-06 was able to, albeit replicating to lower titres 
than in AMΦ (Figure 5.18); vaccine strain DV was previously observed to be 
completely unable to infect AMΦ as determined by immunohistochemistry. This 
finding did not concur with the more sensitive imaging approach of confocal 
microscopy (Figure 4.6) and flow cytometry (Figure 4.3), which suggested 
comparable viral load and reduced infection frequency. This was interesting 
because MARC-145 is regularly used to screen PRRSV-2 field isolates (Wu et al., 
2018), despite evidence that porcine cells remain a superior option (de Abin et al., 
2009), and I anticipated tropism in PRRSV-1.3 to be wider, not more restricted, 
than PRRSV-1.1. 
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6.4 Alternative characterisations of MΦ and DC infection using 
phenotyping reagents 
Within MARC-145, actin protrusions have been demonstrated to facilitate direct 
cell-to-cell transfer of PRRSV virions in the absence of several viral GP, with 
mitochondria migration rescuing infected cells (Guo et al., 2016). AMΦ have been 
reported to not show the same degree of cell-to-cell transfer of virus as in cell lines 
(Panasiuk et al., 2018), due perhaps to healthy AMΦ seeding densities precluding 
abundant cell contact. Confocal microscopy in this project demonstrated actin 
filaments visible extending between infected cells and uninfected cells resembled 
tunnelling nanotubes rather than filopodia described by (Eugenin et al., 2009). 
Within the assessments completed I did not investigate whether protrusions were 
indicative of migration towards infected cells specifically; migration was observed 
in a minority of cells by light microscope in media and mock infection control 
samples in all AMΦ and MoMΦ experiments. There is an association in literature 
with migration and activation/polarisation (Ruytinx et al., 2018); live cell culture 
imaging may enable characterisation of variation in cell migration in controls 
compared to different infection conditions. Confocal microscopy of monocyte-
derived cells and AMΦ showed PRRSV N present within the cytoplasm and not at 
the cell surface when cells were stained 24 hpi (Figure 4.6, Figure 4.7, and Figure 
4.8). NSP mAbs were hoped to be used to assess replication stages by flow 
cytometry, however, they did not prove effective in this application. Pilot tests of 
these mAbs by confocal microscopy suggested perinuclear, not surface staining 
(data not shown), agreeing with the findings of Costers et al. (2006) that PRRSV 
proteins are not transported to the surface independently of progeny virions. NSP 
mAbs could be used to assess replication efficiency by staining cells at fixed time-
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intervals to determine whether the MFI or localisation of each NSP manifests at 
different hours post infection between strains such as Lena which appeared to 
replicate rapidly, and SU1-Bel, which appeared to replicate slowly. Assessing 
TCID50 from lysed cells would confirm infectious viral particle synthesis correlation, 
after the initial time-points. A low MOI would be needed to avoid swamping of 
qPCR/TCID50 readouts, however, high MOI would facilitate detection by confocal. 
The TCID50 would only be relevant after a complete replication cycle has elapsed, 
whereas NSPs would be detectable sooner after viral internalisation and un-
coating. 
CD83, traditionally a marker for DCs, was detected within MoMΦ. CD83 has been 
reported as comparably expressed within human monocytes, MoMΦ and MoDC 
when staining intracellularly, with increased surface expression after activation by 
treatment with LPS (Cao et al., 2005). The finding that Lena upregulated CD83 
transcription compared to mock and SU1-Bel suggests an activation response 
similar to the published response to LPS treatment. There is minimal literature 
regarding CD83 expression on MΦ. CD83 was excluded from pathway analysis 
due to the FDR across replicates being slightly above significance threshold 
(FDR=0.053). If the number of available samples were no object then further 
sequencing replicates and biological replicates would increase confidence in 
statistics. The use of CD83 mAb to phenotype mCD83 by flow cytometry would 
enable investigations of MoDC activity as described by (X. Chen et al., 2018), 
where increased membrane bound CD83 and secreted CD83 were both assessed 
to characterise activation. The mAb used in literature was no longer available at 
the time of writing and alternative mAbs tested showed non-specific binding to cells 
Luke PM Johnson   Chapter 6 
 
 
 
284 
 
based on size, regardless of cell type. Future characterisations would benefit from 
additional phenotyping reagents. Fluorescently tagged FTL3 (CD135) ligand would 
enable robust resolution of steady-state DC from monocytes and monocyte-
derived cells. XCR1 would positively identify cDC1, which were gated negatively 
by CD1a or relatively lower expression of CD172a as described in chapter 4. 
Several antibodies were tested for cross-reactivity to XCR1, however none were 
successful. The XCR1 ligand tagged mCherry described by (Deloizy et al., 2016) 
was kindly shared with us, however our tests did not clearly resolve cDC1 from 
cDC2 or pDC. The reagent was not included in subsequent publications by the 
collaborating group (Bordet et al., 2018a); it can be inferred that the CADM1 gating 
strategy adopted was deemed sufficient. 
6.5 Further genes of interest identified by transcriptomics 
Several genes controlling the complement pathway were modulated by infection. 
SU1-Bel and Lena significantly decreased properdin expression relative to mock, 
whereas factor H was increased only by Lena; properdin stabilises the C3b 
complex and factor H inhibits C3b bound only to host cells (reviewed by Janeway 
et al., 2001). C1qc and C1qa were downregulated significantly by Lena and non-
significantly by SU1-Bel; both infections also non-significantly downregulated C1qr 
and C1qb. The various genes comprising C1q molecules were first characterised 
for their role in classical activation of complement, however, C1q has been 
associated with phagocytic clearance of immune complexes (reviewed by Thielens 
et al., 2017). This suggests a dysregulation of antigen-antibody complex 
associated complement formation, increased in Lena compared to SU1-Bel. The 
comparatively decreased CD163 transcripts in Lena infected MoMΦ strongly 
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support decreased phagocytic activity, which was in line with functional data 
collected (Figure 4.11and Figure 4.12). Treating early or late apoptotic 
lymphocytes and MoMΦ mixed cultures with C1q has been shown to reduce 
NLRP4, NLRP10, and NLRP3 activity, and increased NLRP12 activity compared 
to MoMΦ cultured with lymphocytes in the absence of C1q (Benoit et al., 2012). A 
direct comparison with their data-set could not be made due to an absence of 
several genes in my mapped data; NLRC3, NLRC5, NLRP3 and NLRP12 were the 
only NLR genes mapped, however, the upregulation of C1q receptor, CD93, in the 
Lena-infected MoMΦ (Table 5.3) This appeared to a be a factor in complement 
genes as well, as complement 7 was absent from the SU1-Bel relative to mock 
pair-wise comparison, factor I was absent from SU1-Bel relative to mock and SU1-
Bel relative to Lena, and complement C4a was absent from SU1-Bel relative to 
mock and Lena relative to mock comparisons. CD91 has been described as a 
modulator of C1q, however it was absent from pair-wise comparison data, likely 
due to gene mapping confidence, and therefore could not be assessed. The 
strategy for optimising mapping of porcine genes without a complete reference 
genome was not part of the investigation of this project, however discussion with 
collaborators who conducted the bioinformatics analyses suggests that de novo 
assembly may be a viable alternative (described by Huang et al., 2016). 
Infections of samples taken to bulk RNA-Seq were synchronised within live cells 
as far as possible by removing inocula after virus adhesion and selecting an 
appropriate time interval and MOI, however, titres of virus stocks dictated an upper 
limit of MOI=1. Flow assessment suggested that infection was below 100%, 
therefore the total RNA extraction contained RNA from cells at various stages of 
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primary and secondary infection; bulk transcriptomics can only provide insight into 
the average expression of each gene across infection states within each sample. 
Single cell RNA-Seq would map the transcriptome of each individual cell, enabling 
assessment of correlations in gene expression at each stage of infection. tSNE 
plots would enable clustering of apoptotic vs pyroptotic pathways in early infections 
and cells containing replicated virus from each strain. The primary logistical 
limitation of single cell RNA-Seq is cost and accessibility of viable cells; the latter 
would be a factor in steady-state DC. Were an unlimited budget available, 
modulated pathways in different monocyte-derived cell types could be compared 
to BDC subsets to identify mechanisms of highly pathogenic PRRSV strain 
interaction with susceptible and non-susceptible cells, as cDC1 are reported to 
respond to cDC1. Sorting susceptible and non-susceptible cells after infection in 
mixed culture would enable characterisation of cells in response to activation by 
neighbouring infected cells, however resuspending cells prior to single cell 
separation would likely reduce viability and introduce artefact. Furthermore, 
functional assays may suffice as readouts to mixed culture experiments, such as 
ELISpots to sensitively quantify activity of monocyte-derived cells in response to 
infection without needing to resuspend cells. Sandwich ELISA an efficient 
alternative to this in the course of this project as culture supernatants could be 
taken for assessment by multiple ELISA types. ELISpots would not be effective for 
mixed cultures, such as further mixed allogeneic reactions or identifying infected 
and bystander responses, therefore flow cytometry would be preferable, however, 
mAbs tested for reactivity with inflammatory cytokines IL-1β, IL-18, IL-10, IL-12 and 
IL-8 showed poor resolution.  
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The increased proliferation of T cells by MoMΦ infected by SU1-Bel relative to Lena 
(Figure 4.14) correlated with IL-23 secretion observed by Luminex (Figure 4.16) 
and by transcriptomics (Figure 5.17), as IL-12p40 is associated with T cell priming 
by antigen-presenting cells. If SU1-Bel is the greater inducer of pro-inflammatory 
cytokines and T cell proliferation, this does not support the working hypothesis at 
the conclusion of Chapter 5, which is that Lena is inhibitory of numerous pro-
inflammatory cytokines and therefore inflammation in vivo is a result of T cell and 
NK cells activation increased in Lena infection more greatly than SU1-Bel. To 
assess the downregulating capacity of Lena compared to SU1-Bel, the final 
inflammasome experiment would be followed up with further combinations of 
conditions: each infection condition with and without inflammasome inhibitors, LPS 
priming, and positive control treatment, assessing further pro-inflammatory 
cytokines dependent and independent of the inflammasome. Determining the 
TCID50 of Lena and SU1-Bel, alongside a low pathogenicity strain, in response to 
co-treatment with inflammasome inducers would clarify whether the mechanism is 
beneficial or deleterious to PRRSV-1.3 replication.  
It is anticipated that differences and similarities between PRRSV-1.3 strains, and 
British PRRSV-1.1, will be elucidated by an ongoing RNA-Seq experiment in 
MoDC, following up the initial transcriptomics in MoMΦ. The MoDC transcriptomics 
will use matching strains in the previous experiment to facilitate comparison to the 
MoMΦ data-set, and will include both SU1-Bel P4A and P4B, as well as a low 
pathogenicity PRRSV-1.1 strain included in Chapter 4, 215-06. Due to logistical 
limitations these samples were not processed and analysed by the time of writing 
this thesis, but the data will address the question of SU1-Bel P4B behaving more 
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similarly to Lena. Furthermore, total RNA sequencing will enable alignment of the 
complete genomes of all strains tested, enabling identification of SNPs or deletions 
in NSPs that may have occurred between my own passages and the originally 
published sequences; sequencing conducted within this project targeted only 
ORF5 for confirmation of strain identity. 
In conclusion, both PRRSV-1.3 strains characterised induced significant IFN-β, 
and not IFN-α, responses and one SU1-Bel passage tested utilised inflammasome 
activation through an unconfirmed mechanism, whereas Lena downregulated pro-
inflammatory cytokine responses, potentially via induction of apoptosis instead of 
pyroptosis. 
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Chapter 7 Appendices 
7.1 Optimisation of monocyte-derived cell culture use of round 
bottom culture plates 
In literature monocyte-derived cells are routinely cultured and differentiated in petri 
dishes and flat bottom multi-well tissue culture plates. Singleton et al., (2016) report 
using a 48 well plate format. In order to carry out flow staining on my samples the 
cells were ultimately transferred to round bottom 96 well plates for processing. To 
increase cell recovery efficiency, culturing cells at the appropriate density directly 
into 96 well plates was explored, resuspending and staining cells in situ. Since 
round bottom plates were not typically reported in use in literature an infection 
experiment compared monocyte-derived cells in 96 well flat bottom and round 
bottom plates to confirm that permissiveness to PRRSV-1 infection remained 
consistent. An increase in event counts was observed in both MoMΦ and MoDC 
(Figure 7.1 A and E). This correlated with a decrease in the percentage of viable 
cells collected (Figure 7.1 B and F). This corresponded with an increase of virus 
detected in all intact cells (Figure 7.1 C and G) and to a lesser extent, virus detected 
in live cells only (Figure 7.1 D and H). This strongly suggested that resuspended 
round bottom cultures contained a complete mixture of cells present (live, dead, 
infected, uninfected), whereas cells with reduced viability (particularly infected 
cells) failed to resuspend efficiently in flat bottom plates, therefore viable, less 
infected, cells were collected preferentially from the flat bottom culture system.  
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Figure 7.1. Flat bottom or round bottom culture impact on monocyte-derived cells. MoM0Φ 
(A-D) and MoDC (E-H) were cultured in either flat bottom 96 well tissue culture plates and 
transferred to round bottom plates for flow cytometry staining and analysis, or cultured 
directly in round bottom 96 well plates and stained in situ. The total number of intact cells 
collected by cytometer (A and E); the viability of intact cells determined by membrane 
permeability dyes (B and F); the infection rate of all intact cells determined by ICS for N 
protein (C and G); infection rate gating only on live cells (G and H). (n=1). 
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7.2 Allogeneic leukocyte reaction checkerboard 
The selection of animal combinations to be taken forward for allogeneic leukocyte 
reactions with monocyte-derived cells was based on low basal responses to self-
cells and detectable reaction to the non-self-cells, quantified by total proliferation 
as determined by proliferation dye labelling of cells before addition to mixed culture. 
Animal D was taken forward as the proliferating responder (R) and animals A, B, 
and F as stimulators (S). While Animal E showed strong responses to animals A 
and B (Figure 7.2), it showed comparable responses to itself as it did to the other 
animals available; a biological triplicate of stimulating animals was desired. 
 
Figure 7.2. Proliferated cells in different combinations of mixed leukocyte reactions. 2x105 
cells from each animal were cultured simultaneously at a 1:1 responder:stimulator (R:S) 
ratio before collection after 5 days (R:S pairs n=1, total n=6).  
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7.3 Lists of statistically significant genes from transcriptomics 
Table 7.1. All significant genes in transcriptomics data-set comparing SU1-Bel to Lena. 
Genes from MoMΦ are sorted by FDR; only genes FDR < 0.05 were included here. Where 
external gene name is absent it was not confidently annotated by the mapping software. 
Ensembl gene ID LogFC FDR 
External 
gene name 
Orf1b 23.90 3.12E-37 NA 
ENSSSCG00000011298 5.11 1.37E-17 CDCP1 
ENSSSCG00000001841 3.55 2.38E-09 RHCG 
ENSSSCG00000008522 3.99 4.01E-09 XDH 
ENSSSCG00000010060 4.25 5.76E-09 UPB1 
ENSSSCG00000034376 3.59 5.76E-09  
ENSSSCG00000003226 2.97 2.70E-08  
ENSSSCG00000033146 4.26 1.67E-07 CD163 
ENSSSCG00000012199 5.36 1.67E-07 NR0B1 
ENSSSCG00000015839 3.21 2.19E-07 NRG1 
ENSSSCG00000002764 -3.11 4.19E-07 SMPD3 
ENSSSCG00000006796 4.26 4.81E-07 CHI3L2 
ENSSSCG00000012278 2.93 6.42E-07 CFP 
ENSSSCG00000024377 3.03 6.42E-07 RPS6KA5 
ENSSSCG00000037579 3.80 7.27E-07 PPBP 
ENSSSCG00000008957 4.71 8.97E-07 AMCF-II 
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Ensembl gene ID LogFC FDR 
External 
gene name 
ENSSSCG00000021206 2.82 8.97E-07 IL1RAP 
ENSSSCG00000002829 3.34 1.71E-06 MMP2 
ENSSSCG00000027480 -2.53 2.15E-06 KLF10 
ENSSSCG00000035760 4.51 2.15E-06 RFLNA 
ENSSSCG00000017044 4.82 4.48E-06 IL12B 
ENSSSCG00000013498 2.22 4.92E-06 EBI3 
ENSSSCG00000022446 2.33 5.22E-06 SEL1L3 
ENSSSCG00000007700 3.12 5.73E-06 HIP1 
ENSSSCG00000026583 3.31 6.47E-06 TLR1 
ENSSSCG00000036423 2.31 8.50E-06 CCDC50 
ENSSSCG00000033457 3.60 9.55E-06  
ENSSSCG00000027726 2.21 1.31E-05 DLL1 
ENSSSCG00000003251 2.68 1.53E-05 NLRP12 
ENSSSCG00000036060 -6.48 1.64E-05 RRAD 
ENSSSCG00000033183 3.84 1.64E-05  
ENSSSCG00000033520 4.79 2.11E-05 IL23A 
ENSSSCG00000004670 2.23 2.73E-05 C15orf48 
ENSSSCG00000032857 3.83 3.09E-05 S100A12 
ENSSSCG00000014136 2.27 3.28E-05 VCAN 
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Ensembl gene ID LogFC FDR 
External 
gene name 
ENSSSCG00000015299 2.77 3.54E-05 STEAP4 
ENSSSCG00000005965 -2.38 3.56E-05 MYC 
ENSSSCG00000031023 3.68 3.56E-05  
ENSSSCG00000031356 -2.62 3.97E-05 HES1 
ENSSSCG00000039053 -2.61 4.10E-05 VGF 
ENSSSCG00000006296 2.47 4.25E-05 ATP1B1 
ENSSSCG00000006588 3.93 4.34E-05 S100A9 
ENSSSCG00000035249 -2.93 4.66E-05 GADD45G 
ENSSSCG00000006001 3.28 5.52E-05 ENPP2 
ENSSSCG00000007864 3.64 6.14E-05 GPRC5B 
ENSSSCG00000029096 3.34 6.14E-05 HRH2 
ENSSSCG00000022197 2.64 6.14E-05 HS6ST1 
ENSSSCG00000006590 3.78 6.54E-05 S100A8 
ENSSSCG00000028552 -2.20 6.60E-05 BHLHE41 
ENSSSCG00000006734 -2.63 6.60E-05 CD101 
ENSSSCG00000008870 2.46 7.15E-05 GUCY1B1 
ENSSSCG00000000504 -2.30 1.06E-04 PTPRB 
ENSSSCG00000011928 2.31 1.33E-04 CCDC80 
ENSSSCG00000014369 3.07 1.33E-04 CD14 
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Ensembl gene ID LogFC FDR 
External 
gene name 
ENSSSCG00000037168 3.19 1.41E-04 TMEM92 
ENSSSCG00000039658 1.86 1.41E-04  
ENSSSCG00000015894 2.27 1.51E-04 DPP4 
ENSSSCG00000036064 2.38 1.74E-04 CALHM6 
ENSSSCG00000015370 3.36 1.87E-04 TWIST1 
ENSSSCG00000039416 2.35 2.12E-04 CXCR4 
ENSSSCG00000027404 -3.26 2.16E-04 UNC93A 
ENSSSCG00000015653 4.62 2.32E-04 IL19 
ENSSSCG00000012118 -3.21 2.35E-04 TLR8 
ENSSSCG00000015926 -2.75 2.50E-04 ABCB11 
ENSSSCG00000034039 2.23 2.50E-04 SLC11A2 
ENSSSCG00000040047 2.21 2.51E-04 TMEM151B 
ENSSSCG00000007116 -3.16 2.72E-04 CD93 
ENSSSCG00000023852 3.30 2.99E-04 CCL17 
ENSSSCG00000006736 -3.91 3.32E-04 CD2 
ENSSSCG00000001064 -2.04 3.46E-04 GMPR 
ENSSSCG00000031999 2.31 4.00E-04 GPR18 
ENSSSCG00000031092 3.33 4.07E-04  
ENSSSCG00000000896 -4.49 4.41E-04 NTN4 
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Ensembl gene ID LogFC FDR 
External 
gene name 
ENSSSCG00000032599 -3.05 4.91E-04  
ENSSSCG00000004891 3.32 5.24E-04 SERPINB7 
ENSSSCG00000010052 -3.81 5.75E-04 BCR 
ENSSSCG00000034846 -2.64 5.75E-04  
ENSSSCG00000037066 -2.04 6.15E-04 GADD45A 
ENSSSCG00000001061 -3.95 8.78E-04 JARID2 
ENSSSCG00000040808 5.01 9.51E-04  
ENSSSCG00000015784 2.90 9.95E-04 ACSL1 
ENSSSCG00000038965 -4.20 1.02E-03 ARC 
ENSSSCG00000015477 2.83 1.05E-03 CHIT1 
ENSSSCG00000028148 -2.71 1.06E-03 DMD 
ENSSSCG00000017014 1.84 1.06E-03 PANK3 
ENSSSCG00000016184 3.06 1.14E-03  
ENSSSCG00000016918 1.62 1.15E-03 MAP3K1 
ENSSSCG00000011713 -2.96 1.15E-03 P2RY12 
ENSSSCG00000031106 3.42 1.31E-03 PLA2G2D 
ENSSSCG00000029482 1.84 1.35E-03 CHST15 
ENSSSCG00000020970 3.58 1.35E-03 IL6 
ENSSSCG00000030388 2.86 1.37E-03 UPP1 
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Ensembl gene ID LogFC FDR 
External 
gene name 
ENSSSCG00000015930 -2.34 1.42E-03 DHRS9 
ENSSSCG00000004236 3.05 1.49E-03 PKIB 
ENSSSCG00000015037 2.52 1.60E-03 IL18 
ENSSSCG00000023796 2.74 1.68E-03  
ENSSSCG00000000656 2.12 1.73E-03 CLEC2B 
ENSSSCG00000006197 1.90 1.82E-03 SULF1 
ENSSSCG00000010241 2.35 1.82E-03 TET1 
ENSSSCG00000006187 3.61 2.05E-03 MSC 
ENSSSCG00000015543 -3.34 2.06E-03 CACNA1E 
ENSSSCG00000004179 2.61 2.13E-03 VNN2 
ENSSSCG00000032594 1.59 2.14E-03  
ENSSSCG00000013102 2.63 2.14E-03 MS4A7 
ENSSSCG00000000655 1.98 2.25E-03 KLRF1 
ENSSSCG00000008954 2.70 2.53E-03  
ENSSSCG00000004180 3.56 2.55E-03  
ENSSSCG00000002383 -3.46 2.57E-03 FOS 
ENSSSCG00000040648 2.81 2.62E-03 CCL11 
ENSSSCG00000038643 -2.83 2.69E-03 KLF11 
ENSSSCG00000011563 2.04 2.75E-03 FANCD2 
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Ensembl gene ID LogFC FDR 
External 
gene name 
ENSSSCG00000032601 1.78 2.80E-03 RASSF2 
ENSSSCG00000015753 3.27 2.83E-03 ANGPT2 
ENSSSCG00000007439 2.75 2.83E-03 CDH22 
ENSSSCG00000008953 2.98 2.83E-03 CXCL8 
ENSSSCG00000008187 -2.87 2.83E-03 KIAA1211L 
ENSSSCG00000039758 1.84 2.83E-03  
ENSSSCG00000037466 1.92 2.83E-03  
ENSSSCG00000004280 -2.81 2.97E-03 RIMS1 
ENSSSCG00000004509 1.74 3.05E-03 LIPG 
ENSSSCG00000016618 -2.88 3.15E-03 CPED1 
ENSSSCG00000010603 1.92 3.26E-03 NEURL1 
ENSSSCG00000035971 -3.69 3.42E-03 DUSP2 
ENSSSCG00000029160 -3.09 3.42E-03  
ENSSSCG00000010437 2.15 3.55E-03 PAPSS2 
ENSSSCG00000039609 -3.74 3.60E-03 ANKRD33B 
ENSSSCG00000032372 -1.81 3.60E-03 ZFP90 
ENSSSCG00000036364 -6.31 3.77E-03 EGR4 
ENSSSCG00000022149 2.34 3.99E-03 RMI2 
ENSSSCG00000003788 -3.19 4.05E-03 PTGER3 
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Ensembl gene ID LogFC FDR 
External 
gene name 
ENSSSCG00000011102 2.15 4.11E-03 NRP1 
ENSSSCG00000011580 -3.62 4.11E-03 TSEN2 
ENSSSCG00000028662 -2.87 4.37E-03 PDE3A 
ENSSSCG00000024001 2.18 4.43E-03 PLXNA1 
ENSSSCG00000006392 1.96 4.47E-03 IGSF8 
ENSSSCG00000009111 3.04 4.71E-03 SYNPO2 
ENSSSCG00000035650 2.42 4.89E-03  
ENSSSCG00000011672 1.48 5.01E-03 RASA2 
ENSSSCG00000011204 -2.81 5.25E-03 KCNH8 
ENSSSCG00000038414 -3.00 5.25E-03  
ENSSSCG00000004952 -2.46 5.34E-03 SMAD3 
ENSSSCG00000033657 3.39 5.36E-03 GREM1 
ENSSSCG00000006911 -2.85 5.85E-03 TGFBR3 
ENSSSCG00000039175 1.46 6.25E-03 MARCHF6 
ENSSSCG00000027684 -1.89 6.60E-03 TRIM63 
ENSSSCG00000000891 1.67 6.69E-03 LTA4H 
ENSSSCG00000027992 2.08 6.69E-03 MST1R 
ENSSSCG00000002009 1.66 6.69E-03 PCK2 
ENSSSCG00000005437 -2.87 6.69E-03  
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Ensembl gene ID LogFC FDR 
External 
gene name 
ENSSSCG00000024596 -2.78 6.83E-03 NOCT 
ENSSSCG00000013145 -1.92 6.87E-03 DTX4 
ENSSSCG00000032108 3.30 6.94E-03  
ENSSSCG00000032395 -3.01 7.47E-03  
ENSSSCG00000027865 1.72 7.56E-03 GALC 
ENSSSCG00000010974 -2.93 7.61E-03 CNTFR 
ENSSSCG00000013101 2.67 7.61E-03  
ENSSSCG00000000994 -2.45 7.66E-03 GMDS 
ENSSSCG00000038911 -2.76 7.66E-03 KLF2 
ENSSSCG00000000600 -2.37 7.68E-03 EPS8 
ENSSSCG00000023956 -2.78 7.80E-03 NEDD9 
ENSSSCG00000023174 1.94 8.38E-03 USP53 
ENSSSCG00000038929 3.55 8.39E-03 CEMIP 
ENSSSCG00000035420 -4.17 8.39E-03 HES4 
ENSSSCG00000017706 -3.83 8.65E-03 HEATR9 
ENSSSCG00000040839 -2.48 8.98E-03  
ENSSSCG00000002350 -1.76 9.33E-03 ELMSAN1 
ENSSSCG00000006774 -1.67 9.53E-03 PPM1J 
ENSSSCG00000014286 2.91 9.75E-03 SOWAHA 
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Ensembl gene ID LogFC FDR 
External 
gene name 
ENSSSCG00000015446 1.54 9.85E-03 PNPLA8 
ENSSSCG00000034000 2.46 9.91E-03  
ENSSSCG00000008443 1.69 1.00E-02 EPAS1 
ENSSSCG00000009152 -3.55 1.01E-02 SGMS2 
ENSSSCG00000004057 -2.40 1.01E-02 SYTL3 
ENSSSCG00000038471 -2.69 1.03E-02 NUAK2 
ENSSSCG00000004195 2.48 1.04E-02 ARG1 
ENSSSCG00000014336 -4.04 1.07E-02 EGR1 
ENSSSCG00000035863 -1.68 1.09E-02 PLIN2 
ENSSSCG00000009012 1.85 1.12E-02 TMEM154 
ENSSSCG00000002821 2.11 1.14E-02 CCL22 
ENSSSCG00000008326 2.84 1.17E-02 TGFA 
ENSSSCG00000032980 -3.03 1.17E-02  
ENSSSCG00000038811 -2.35 1.22E-02 MOB3B 
ENSSSCG00000011670 1.86 1.29E-02 PXYLP1 
ENSSSCG00000040449 -1.37 1.29E-02 ABHD12 
ENSSSCG00000004053 -2.50 1.29E-02 TAGAP 
ENSSSCG00000005311 1.66 1.33E-02 CD72 
ENSSSCG00000004193 -1.92 1.43E-02 ENPP1 
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Ensembl gene ID LogFC FDR 
External 
gene name 
ENSSSCG00000012634 1.38 1.44E-02 DOCK11 
ENSSSCG00000032861 -1.52 1.45E-02 NUAK1 
ENSSSCG00000026478 -1.65 1.45E-02 PADI2 
ENSSSCG00000007140 1.38 1.45E-02 SMOX 
ENSSSCG00000039214 3.83 1.45E-02  
ENSSSCG00000015755 1.50 1.47E-02 AGPAT5 
ENSSSCG00000005163 -2.69 1.48E-02 IFNB1 
ENSSSCG00000012050 -1.77 1.48E-02 RCAN1 
ENSSSCG00000007100 -2.31 1.51E-02 SLC24A3 
ENSSSCG00000022200 -3.00 1.54E-02 SYT17 
ENSSSCG00000021588 -3.62 1.58E-02 DAPK2 
ENSSSCG00000038903 -2.34 1.63E-02  
ENSSSCG00000026592 2.23 1.69E-02 TLR6 
ENSSSCG00000008339 1.68 1.73E-02 GFPT1 
ENSSSCG00000037087 3.35 1.73E-02 PRRT4 
ENSSSCG00000016866 -2.04 1.77E-02 GHR 
ENSSSCG00000024793 1.92 1.77E-02 PORCN 
ENSSSCG00000001710 -2.26 1.77E-02 RUNX2 
ENSSSCG00000013575 3.84 1.86E-02 RETN 
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Ensembl gene ID LogFC FDR 
External 
gene name 
ENSSSCG00000040904 4.31 1.87E-02 CLDN1 
ENSSSCG00000008959 2.92 1.88E-02 CXCL2 
ENSSSCG00000000291 2.51 1.88E-02 GPR84 
ENSSSCG00000006059 -2.25 1.88E-02 NCALD 
ENSSSCG00000004890 3.47 1.88E-02 SERPINB2 
ENSSSCG00000005083 1.29 1.91E-02 DHRS7 
ENSSSCG00000004071 -2.69 1.91E-02  
ENSSSCG00000004143 -3.20 2.00E-02 TXLNB 
ENSSSCG00000016338 -2.49 2.03E-02 PER2 
ENSSSCG00000013784 -1.86 2.03E-02 DNAJB1 
ENSSSCG00000039062 -2.50 2.03E-02  
ENSSSCG00000016991 -2.46 2.06E-02 DUSP1 
ENSSSCG00000016959 2.13 2.10E-02 MARVELD2 
ENSSSCG00000034879 -2.25 2.12E-02 MAML2 
ENSSSCG00000032366 1.27 2.13E-02 MOB3A 
ENSSSCG00000004279 1.36 2.13E-02 OGFRL1 
ENSSSCG00000016928 2.05 2.13E-02 RAB3D 
ENSSSCG00000002814 2.24 2.17E-02 ADGRG3 
ENSSSCG00000016431 -2.59 2.18E-02 GALNTL5 
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Ensembl gene ID LogFC FDR 
External 
gene name 
ENSSSCG00000005688 2.56 2.18E-02 PTGES 
ENSSSCG00000032622 1.55 2.18E-02 PPP3CC 
ENSSSCG00000015871 -2.50 2.25E-02 NR4A2 
ENSSSCG00000005533 2.19 2.25E-02 PTGS1 
ENSSSCG00000006987 -2.58 2.25E-02 SLC7A2 
ENSSSCG00000017769 -3.25 2.25E-02 RAB34 
ENSSSCG00000000515 -2.28 2.25E-02 TRHDE 
ENSSSCG00000033445 -2.66 2.25E-02  
ENSSSCG00000000882 -2.15 2.25E-02 ANKS1B 
ENSSSCG00000032715 1.35 2.25E-02 CERS6 
ENSSSCG00000031321 -3.51 2.25E-02 NR4A1 
ENSSSCG00000028056 -2.08 2.25E-02 ZFP36 
ENSSSCG00000040779 1.98 2.25E-02  
ENSSSCG00000007730 -2.47 2.42E-02 CALN1 
ENSSSCG00000011076 -2.12 2.54E-02 OTUD1 
ENSSSCG00000036768 -1.64 2.56E-02 PRAG1 
ENSSSCG00000040275 1.44 2.60E-02 HEBP1 
ENSSSCG00000024015 1.45 2.63E-02 FADS1 
ENSSSCG00000039821 1.90 2.70E-02 GPRIN3 
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Ensembl gene ID LogFC FDR 
External 
gene name 
ENSSSCG00000035037 -1.89 2.70E-02  
ENSSSCG00000005503 1.21 2.71E-02 TLR4 
ENSSSCG00000006290 -1.67 3.04E-02 SLC19A2 
ENSSSCG00000032284 1.39 3.06E-02 CCND3 
ENSSSCG00000015823 1.37 3.06E-02  
ENSSSCG00000021557 2.40 3.09E-02 SULT1A3 
ENSSSCG00000034812 -2.34 3.13E-02 EFCAB8 
ENSSSCG00000015434 1.31 3.13E-02  
ENSSSCG00000015362 1.66 3.14E-02 TSPAN13 
ENSSSCG00000025293 1.22 3.18E-02 HLTF 
ENSSSCG00000009567 1.34 3.18E-02 RASA3 
ENSSSCG00000016521 -2.06 3.23E-02 DGKI 
ENSSSCG00000033574 -2.05 3.33E-02 CFAP54 
ENSSSCG00000039947 -2.89 3.33E-02 KCNJ2 
ENSSSCG00000022405 1.84 3.36E-02 P2RX1 
ENSSSCG00000017046 -2.15 3.36E-02 EBF1 
ENSSSCG00000022473 -2.97 3.40E-02 A4GNT 
ENSSSCG00000036622 2.10 3.42E-02  
ENSSSCG00000015579 -3.42 3.44E-02 PTGS2 
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Ensembl gene ID LogFC FDR 
External 
gene name 
ENSSSCG00000021259 1.54 3.59E-02 CDA 
ENSSSCG00000027607 2.07 3.65E-02 IER3 
ENSSSCG00000010455 -2.22 3.85E-02 SLC16A12 
ENSSSCG00000006155 -2.91 3.90E-02 ZBTB10 
ENSSSCG00000035577 -2.25 3.92E-02  
ENSSSCG00000004221 1.29 3.93E-02 HINT3 
Orf2b -2.29 3.93E-02 NA 
ENSSSCG00000031255 -2.76 3.93E-02  
ENSSSCG00000037580 1.26 3.93E-02 ITPRIPL1 
ENSSSCG00000040701 -1.29 3.95E-02 GYPC 
ENSSSCG00000002669 2.43 3.97E-02 CRISPLD2 
ENSSSCG00000004094 -1.93 4.07E-02 PPP1R14C 
ENSSSCG00000023784 1.43 4.07E-02 SEMA3C 
ENSSSCG00000000571 -3.01 4.13E-02 ABCC9 
ENSSSCG00000004121 1.22 4.18E-02 FBXO30 
ENSSSCG00000005203 2.39 4.18E-02 IL33 
ENSSSCG00000024134 -2.18 4.18E-02 MGLL 
ENSSSCG00000017389 1.36 4.18E-02 RAMP2 
ENSSSCG00000016093 -2.12 4.29E-02  
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Ensembl gene ID LogFC FDR 
External 
gene name 
ENSSSCG00000015872 1.29 4.29E-02 GPD2 
ENSSSCG00000017261 1.36 4.30E-02 ARSG 
ENSSSCG00000037949 2.75 4.36E-02  
ENSSSCG00000038082 -1.72 4.41E-02 TRAF6 
ENSSSCG00000008823 2.34 4.45E-02 SLC10A4 
ENSSSCG00000017770 -3.01 4.47E-02 PROCA1 
ENSSSCG00000034087 2.07 4.55E-02 TNFSF15 
ENSSSCG00000010893 -2.25 4.72E-02  
ENSSSCG00000037900 -2.09 4.72E-02 CCND1 
ENSSSCG00000010464 -2.52 4.92E-02 PPP1R3C 
ENSSSCG00000010402 -2.19 4.92E-02 ZFAND4 
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Table 7.2. All significant genes in transcriptomics data-set comparing SU1-Bel to mock. 
Genes from MoMΦ are sorted by FDR; only genes FDR < 0.05 were included here. Where 
external gene name is absent it was not confidently annotated by the mapping software. 
Ensembl gene ID LogFC FDR 
External gene 
name 
ENSSSCG00000005163 7.24 2.52E-44 IFNB1 
ENSSSCG00000024140 6.42 1.69E-11   
ENSSSCG00000015014 2.21 4.89E-11 ZC3H12C 
Orf2b 7.52 1.12E-10 NA 
ENSSSCG00000002383 2.96 2.17E-10 FOS 
ENSSSCG00000031616 4.83 4.41E-09 FOSB 
ENSSSCG00000033520 3.27 1.25E-07 IL23A 
ENSSSCG00000017488 2.60 2.74E-07 CSF3 
ENSSSCG00000003155 2.08 5.55E-07 PPP1R15A 
ENSSSCG00000021504 5.93 6.18E-07 
IFN ALPHA 
OMEGA 
ENSSSCG00000014336 3.31 1.52E-06 EGR1 
ENSSSCG00000004369 1.69 7.98E-06 PRDM1 
ENSSSCG00000016991 1.61 8.47E-06 DUSP1 
ENSSSCG00000031321 2.34 8.74E-06 NR4A1 
ENSSSCG00000003521 3.67 1.00E-05   
ENSSSCG00000008664 2.27 1.26E-05 FAM84A 
ENSSSCG00000008963 2.63 1.38E-05 AREG 
ENSSSCG00000011951 2.02 1.38E-05 NFKBIZ 
ENSSSCG00000035971 1.72 3.09E-05 DUSP2 
ENSSSCG00000001404 2.52 5.13E-05 TNF 
ENSSSCG00000039622 3.97 5.13E-05   
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Ensembl gene ID LogFC FDR 
External gene 
name 
ENSSSCG00000004154 1.95 1.34E-04 TNFAIP3 
ENSSSCG00000007067 1.59 1.87E-04 JAG1 
ENSSSCG00000008954 1.51 3.14E-04   
ENSSSCG00000016254 2.74 3.33E-04 CCL20 
ENSSSCG00000022689 1.62 4.98E-04 GADD45B 
ENSSSCG00000022128 2.13 4.98E-04   
ENSSSCG00000007964 1.63 4.98E-04   
ENSSSCG00000007470 2.76 4.98E-04 RIPOR3 
Orf3 8.32 6.00E-04 NA 
ENSSSCG00000035077 1.51 6.58E-04 INHBA 
ENSSSCG00000014362 1.22 8.16E-04 HBEGF 
Orf4 8.34 8.16E-04 NA 
ENSSSCG00000004041 2.86 8.16E-04 SLC22A1 
Orf2a 8.18 8.28E-04 NA 
ENSSSCG00000035598 2.08 1.33E-03 EDN1 
Orf6 8.36 1.64E-03 NA 
ENSSSCG00000012118 -1.71 1.78E-03 TLR8 
ENSSSCG00000037132 1.40 1.79E-03 POU2F2 
Orf5 8.37 1.79E-03 NA 
ENSSSCG00000003805 1.25 2.15E-03 PDE4B 
Orf1a 7.93 2.15E-03 NA 
ENSSSCG00000001097 1.81 2.15E-03   
ENSSSCG00000040277 2.68 2.15E-03   
ENSSSCG00000017706 2.84 2.40E-03 HEATR9 
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Ensembl gene ID LogFC FDR 
External gene 
name 
ENSSSCG00000005385 1.55 2.51E-03 NR4A3 
ENSSSCG00000011298 1.66 2.81E-03 CDCP1 
ENSSSCG00000014156 1.54 3.29E-03 ARRDC3 
ENSSSCG00000031255 2.42 3.48E-03   
ENSSSCG00000038929 2.34 3.61E-03 CEMIP 
Orf7 8.36 3.72E-03 NA 
ENSSSCG00000037815 1.17 4.00E-03 ZC3H12A 
ENSSSCG00000004918 2.48 4.34E-03 ALPK2 
ENSSSCG00000027607 1.17 5.59E-03 IER3 
ENSSSCG00000029388 2.70 5.80E-03 PDE2A 
ENSSSCG00000033183 1.53 6.43E-03   
ENSSSCG00000011899 1.16 6.47E-03 CD80 
ENSSSCG00000005203 2.20 6.47E-03 IL33 
ENSSSCG00000039514 -1.25 7.47E-03 ID3 
ENSSSCG00000029260 2.52 7.48E-03 NDNF 
ENSSSCG00000023057 1.79 7.77E-03 LMO1 
ENSSSCG00000027646 1.41 7.77E-03 TIPARP 
Orf1b 7.81 7.88E-03 NA 
ENSSSCG00000017044 2.77 8.80E-03 IL12B 
ENSSSCG00000031023 2.79 1.15E-02   
ENSSSCG00000010581 2.17 1.18E-02 PSD 
ENSSSCG00000016925 1.12 1.18E-02 PLK2 
ENSSSCG00000004125 0.99 1.18E-02 STX11 
ENSSSCG00000031346 -1.22 1.34E-02 CMKLR1 
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Ensembl gene ID LogFC FDR 
External gene 
name 
ENSSSCG00000004509 1.10 1.34E-02 LIPG 
ENSSSCG00000020705 1.65 1.37E-02 MAP3K8 
ENSSSCG00000002829 1.38 1.43E-02 MMP2 
ENSSSCG00000034812 1.77 1.57E-02 EFCAB8 
ENSSSCG00000011730 2.97 1.96E-02 IL12A 
ENSSSCG00000008881 1.07 1.96E-02 RAPGEF2 
ENSSSCG00000039419 1.00 2.43E-02 SLCO4A1 
ENSSSCG00000008870 1.13 2.73E-02 GUCY1B1 
ENSSSCG00000009237 -1.17 3.31E-02 HPSE 
ENSSSCG00000026043 1.83 3.31E-02 TGM3 
ENSSSCG00000000291 1.15 3.83E-02 GPR84 
ENSSSCG00000018007 2.10 3.83E-02 MYH3 
ENSSSCG00000024596 1.34 3.95E-02 NOCT 
ENSSSCG00000010603 1.36 4.35E-02 NEURL1 
ENSSSCG00000001952 1.37 4.35E-02 NFKBIA 
ENSSSCG00000009320 1.47 4.41E-02 FLT1 
ENSSSCG00000013408 1.16 4.46E-02 ADM 
ENSSSCG00000023522 1.47 4.74E-02 TGM2 
ENSSSCG00000033606 2.22 4.97E-02 HIST1H2AC 
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Table 7.3. All significant genes in transcriptomics data-set comparing Lena to mock. 
Genes from MoMΦ are sorted by FDR; only genes FDR < 0.05 were included here. Where 
external gene name is absent it was not confidently annotated by the mapping software. 
Ensembl gene ID LogFC FDR External gene name 
ENSSSCG00000005163 9.93 8.25E-18 IFNB1 
Orf2b 10.40 1.07E-17 NA 
ENSSSCG00000024140 9.20 4.15E-10   
ENSSSCG00000008522 -4.38 2.13E-09 XDH 
ENSSSCG00000000504 3.34 4.78E-09 PTPRB 
ENSSSCG00000033146 -4.87 8.08E-09 CD163 
ENSSSCG00000031616 7.62 1.48E-08 FOSB 
ENSSSCG00000007864 -4.29 1.90E-08 GPRC5B 
ENSSSCG00000023852 -4.42 2.82E-08 CCL17 
ENSSSCG00000011298 -3.45 2.80E-07 CDCP1 
ENSSSCG00000002383 6.42 2.80E-07 FOS 
ENSSSCG00000034376 -3.51 2.96E-07   
ENSSSCG00000010060 -4.03 2.96E-07 UPB1 
ENSSSCG00000003226 -2.98 4.49E-07   
ENSSSCG00000028552 2.61 5.25E-07 BHLHE41 
ENSSSCG00000034846 3.54 5.25E-07   
ENSSSCG00000017706 6.67 8.93E-07 HEATR9 
ENSSSCG00000035249 3.42 1.46E-06 GADD45G 
ENSSSCG00000007116 4.49 1.46E-06 CD93 
ENSSSCG00000021504 8.87 1.76E-06 IFN ALPHA OMEGA 
ENSSSCG00000031356 3.57 2.29E-06 HES1 
ENSSSCG00000032599 3.86 2.73E-06   
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Ensembl gene ID LogFC FDR External gene name 
ENSSSCG00000034812 4.11 2.88E-06 EFCAB8 
ENSSSCG00000006464 -4.30 3.05E-06 NTRK1 
ENSSSCG00000006001 -3.31 3.89E-06 ENPP2 
ENSSSCG00000031255 5.18 4.00E-06   
ENSSSCG00000014336 7.35 6.97E-06 EGR1 
ENSSSCG00000035971 5.40 7.41E-06 DUSP2 
ENSSSCG00000024596 4.12 1.46E-05 NOCT 
ENSSSCG00000027646 3.31 1.80E-05 TIPARP 
ENSSSCG00000018007 3.84 1.80E-05 MYH3 
ENSSSCG00000022054 5.11 1.80E-05   
ENSSSCG00000037579 -3.35 1.95E-05 PPBP 
ENSSSCG00000016991 4.07 2.19E-05 DUSP1 
ENSSSCG00000004053 3.71 2.37E-05 TAGAP 
ENSSSCG00000036364 9.96 2.80E-05 EGR4 
ENSSSCG00000033606 4.84 3.10E-05 HIST1H2AC 
ENSSSCG00000036064 -2.65 4.54E-05 CALHM6 
ENSSSCG00000036060 5.94 5.84E-05 RRAD 
ENSSSCG00000017769 5.11 6.11E-05 RAB34 
ENSSSCG00000006796 -3.30 6.37E-05 CHI3L2 
ENSSSCG00000031321 5.85 9.02E-05 NR4A1 
ENSSSCG00000035420 5.04 9.80E-05 HES4 
ENSSSCG00000001841 -2.78 1.01E-04 RHCG 
ENSSSCG00000015543 3.96 1.18E-04 CACNA1E 
ENSSSCG00000000571 4.78 1.19E-04 ABCC9 
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Ensembl gene ID LogFC FDR External gene name 
ENSSSCG00000003155 4.80 1.19E-04 PPP1R15A 
ENSSSCG00000035760 -4.07 1.32E-04 RFLNA 
ENSSSCG00000029096 -3.44 1.32E-04 HRH2 
ENSSSCG00000000994 3.23 1.42E-04 GMDS 
ENSSSCG00000015014 4.21 1.48E-04 ZC3H12C 
ENSSSCG00000021206 -2.19 1.58E-04 IL1RAP 
ENSSSCG00000017770 5.23 1.58E-04 PROCA1 
ENSSSCG00000013101 -3.00 1.64E-04   
ENSSSCG00000016618 3.71 1.64E-04 CPED1 
Orf3 10.01 1.64E-04 NA 
ENSSSCG00000011928 -2.36 1.81E-04 CCDC80 
ENSSSCG00000029388 4.59 1.83E-04 PDE2A 
Orf2a 10.03 1.83E-04 NA 
ENSSSCG00000008957 -3.39 2.15E-04 AMCF-II 
Orf4 9.92 2.22E-04 NA 
ENSSSCG00000005437 3.60 2.22E-04   
ENSSSCG00000015839 -3.18 2.54E-04 NRG1 
ENSSSCG00000000515 3.15 2.87E-04 TRHDE 
ENSSSCG00000001404 5.25 3.17E-04 TNF 
ENSSSCG00000023796 -2.79 3.33E-04   
ENSSSCG00000028148 3.04 3.37E-04 DMD 
ENSSSCG00000020705 3.06 3.48E-04 MAP3K8 
ENSSSCG00000021588 4.92 3.48E-04 DAPK2 
Orf1a 9.74 3.48E-04 NA 
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Ensembl gene ID LogFC FDR External gene name 
ENSSSCG00000014369 -3.05 3.92E-04 CD14 
ENSSSCG00000004041 3.76 3.92E-04 SLC22A1 
ENSSSCG00000004670 -1.89 4.29E-04 C15orf48 
Orf6 10.06 4.29E-04 NA 
ENSSSCG00000037757 3.26 4.37E-04 C4orf45 
Orf5 9.97 4.72E-04 NA 
ENSSSCG00000016690 3.72 4.78E-04 CREB5 
ENSSSCG00000017507 3.85 4.91E-04   
ENSSSCG00000022473 4.38 5.47E-04 A4GNT 
ENSSSCG00000010052 4.40 5.71E-04 BCR 
ENSSSCG00000010581 4.56 5.77E-04 PSD 
ENSSSCG00000001061 4.13 6.18E-04 JARID2 
ENSSSCG00000013102 -2.72 6.77E-04 MS4A7 
ENSSSCG00000010455 2.87 6.77E-04 SLC16A12 
ENSSSCG00000039062 3.06 7.19E-04   
ENSSSCG00000005385 3.14 7.19E-04 NR4A3 
ENSSSCG00000034264 4.36 7.61E-04   
ENSSSCG00000022149 -2.54 7.80E-04 RMI2 
ENSSSCG00000015926 2.65 8.40E-04 ABCB11 
ENSSSCG00000022370 3.18 9.12E-04 TNFSF9 
Orf7 10.06 9.22E-04 NA 
ENSSSCG00000000204 2.98 9.58E-04 PRPF40B 
Orf1b 10.07 1.09E-03 NA 
ENSSSCG00000029160 3.46 1.09E-03   
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Ensembl gene ID LogFC FDR External gene name 
ENSSSCG00000034286 4.54 1.09E-03   
ENSSSCG00000033457 -2.81 1.10E-03   
ENSSSCG00000022200 4.25 1.11E-03 SYT17 
ENSSSCG00000016866 2.56 1.17E-03 GHR 
ENSSSCG00000028662 3.36 1.20E-03 PDE3A 
ENSSSCG00000030388 -3.04 1.22E-03 UPP1 
ENSSSCG00000008187 2.90 1.31E-03 KIAA1211L 
ENSSSCG00000035598 3.98 1.31E-03 EDN1 
ENSSSCG00000032395 3.83 1.32E-03   
ENSSSCG00000038903 2.91 1.40E-03   
ENSSSCG00000003251 -2.63 1.41E-03 NLRP12 
ENSSSCG00000031874 3.52 1.49E-03 REM2 
ENSSSCG00000027405 2.89 1.65E-03 RF00004 
ENSSSCG00000010402 3.11 1.65E-03 ZFAND4 
ENSSSCG00000022446 -1.91 1.66E-03 SEL1L3 
ENSSSCG00000032781 3.40 1.66E-03 SRSF12 
ENSSSCG00000011580 4.30 1.66E-03 TSEN2 
ENSSSCG00000015299 -2.40 1.67E-03 STEAP4 
ENSSSCG00000028056 2.54 1.79E-03 ZFP36 
ENSSSCG00000034879 2.74 1.94E-03 MAML2 
ENSSSCG00000015370 -2.86 2.06E-03 TWIST1 
ENSSSCG00000006105 4.20 2.11E-03 GEM 
ENSSSCG00000015550 4.53 2.29E-03 RGS16 
ENSSSCG00000015579 4.93 2.32E-03 PTGS2 
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Ensembl gene ID LogFC FDR External gene name 
ENSSSCG00000039053 2.02 2.36E-03 VGF 
ENSSSCG00000023956 3.27 2.45E-03 NEDD9 
ENSSSCG00000034634 3.21 2.58E-03 ssc-mir-6782 
ENSSSCG00000016517 3.60 2.64E-03 SVOPL 
ENSSSCG00000015525 2.94 2.68E-03 TOR3A 
ENSSSCG00000003799 3.46 2.68E-03 IL12RB2 
ENSSSCG00000001405 3.81 2.68E-03 LTB 
ENSSSCG00000023837 -2.20 2.69E-03 WFDC1 
ENSSSCG00000016521 2.60 2.69E-03 DGKI 
ENSSSCG00000022689 2.87 2.69E-03 GADD45B 
ENSSSCG00000003788 3.28 2.69E-03 PTGER3 
ENSSSCG00000009152 4.04 2.69E-03 SGMS2 
ENSSSCG00000034000 -2.65 2.71E-03   
ENSSSCG00000019556 3.63 2.86E-03 RF00100 
ENSSSCG00000006187 -3.31 2.88E-03 MSC 
ENSSSCG00000027480 1.85 2.90E-03 KLF10 
ENSSSCG00000004090 2.40 2.96E-03 ZBTB2 
ENSSSCG00000021581 3.30 3.00E-03 CLCN2 
ENSSSCG00000039977 2.62 3.09E-03   
ENSSSCG00000027404 2.56 3.27E-03 UNC93A 
ENSSSCG00000005636 2.62 3.28E-03 SLC25A25 
ENSSSCG00000028720 2.78 3.29E-03 NXN 
ENSSSCG00000023396 2.94 3.29E-03 LIX1 
ENSSSCG00000035037 2.34 3.29E-03   
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Ensembl gene ID LogFC FDR External gene name 
ENSSSCG00000026583 -2.74 3.45E-03 TLR1 
ENSSSCG00000011204 3.13 3.47E-03 KCNH8 
ENSSSCG00000000896 4.02 3.61E-03 NTN4 
ENSSSCG00000012278 -2.31 3.63E-03 CFP 
ENSSSCG00000006736 3.77 3.67E-03 CD2 
ENSSSCG00000015871 2.99 3.81E-03 NR4A2 
ENSSSCG00000003891 4.01 3.83E-03 CYP4A24 
ENSSSCG00000009348 3.54 3.84E-03 STARD13 
ENSSSCG00000007700 -2.41 3.98E-03 HIP1 
ENSSSCG00000039175 -1.53 4.04E-03 march1 
ENSSSCG00000009334 2.22 4.04E-03 HSPH1 
ENSSSCG00000040973 2.92 4.06E-03 HYDIN 
ENSSSCG00000008443 -1.77 4.09E-03 EPAS1 
ENSSSCG00000032911 3.28 4.09E-03 DUSP8 
ENSSSCG00000038414 3.01 4.36E-03   
ENSSSCG00000021557 -2.78 4.53E-03 SULT1A3 
ENSSSCG00000006588 -2.70 4.72E-03 S100A9 
ENSSSCG00000014921 -3.34 4.85E-03 PRSS23 
ENSSSCG00000011714 2.38 4.85E-03 MED12L 
ENSSSCG00000006296 -1.83 4.86E-03 ATP1B1 
ENSSSCG00000027525 1.42 4.97E-03 DHCR24 
ENSSSCG00000009051 3.46 5.07E-03 IL15 
ENSSSCG00000039947 3.59 5.07E-03 KCNJ2 
ENSSSCG00000016885 2.56 5.07E-03 ITGA1 
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Ensembl gene ID LogFC FDR External gene name 
ENSSSCG00000038911 2.92 5.07E-03 KLF2 
ENSSSCG00000004939 3.00 5.35E-03 MEGF11 
ENSSSCG00000016301 2.81 5.45E-03 SAG 
ENSSSCG00000004369 3.61 5.45E-03 PRDM1 
ENSSSCG00000038706 -2.03 6.05E-03 C1QC 
ENSSSCG00000037066 1.72 6.22E-03 GADD45A 
ENSSSCG00000037494 2.38 6.22E-03 SPTBN4 
ENSSSCG00000032857 -2.46 6.28E-03 S100A12 
ENSSSCG00000013784 2.04 6.62E-03 DNAJB1 
ENSSSCG00000017983 2.30 6.62E-03 PER1 
ENSSSCG00000004057 2.47 6.62E-03 SYTL3 
ENSSSCG00000002350 1.76 6.65E-03 ELMSAN1 
ENSSSCG00000015071 2.54 6.72E-03 SIK3 
ENSSSCG00000005965 1.76 6.73E-03 MYC 
ENSSSCG00000040961 2.64 6.73E-03 LIF 
ENSSSCG00000006590 -2.59 7.04E-03 S100A8 
ENSSSCG00000010974 2.98 7.18E-03 CNTFR 
ENSSSCG00000004142 2.18 7.37E-03 CITED2 
ENSSSCG00000025672 3.64 7.41E-03   
ENSSSCG00000008664 3.30 7.84E-03 FAM84A 
ENSSSCG00000037168 -2.84 7.90E-03 TMEM92 
ENSSSCG00000038471 2.80 8.02E-03 NUAK2 
ENSSSCG00000008963 2.88 8.19E-03 AREG 
ENSSSCG00000004236 -2.69 8.21E-03 PKIB 
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Ensembl gene ID LogFC FDR External gene name 
ENSSSCG00000011076 2.33 8.38E-03 OTUD1 
ENSSSCG00000030359 2.34 8.38E-03 ARHGEF3 
ENSSSCG00000036423 -1.61 8.42E-03 CCDC50 
ENSSSCG00000035172 2.63 8.75E-03   
ENSSSCG00000009667 2.74 8.87E-03   
ENSSSCG00000026592 -2.41 9.12E-03 TLR6 
ENSSSCG00000027745 -1.40 9.12E-03 ABCG1 
ENSSSCG00000016691 2.37 9.17E-03 JAZF1 
ENSSSCG00000004071 2.99 9.17E-03   
ENSSSCG00000008881 3.11 9.52E-03 RAPGEF2 
ENSSSCG00000004869 2.88 9.62E-03 CNDP1 
ENSSSCG00000034039 -1.79 9.64E-03 SLC11A2 
ENSSSCG00000022500 2.98 9.97E-03 IL20RB 
ENSSSCG00000012050 1.74 1.03E-02 RCAN1 
ENSSSCG00000009410 2.29 1.03E-02 RUBCNL 
ENSSSCG00000013498 -1.55 1.03E-02 EBI3 
ENSSSCG00000024674 3.31 1.03E-02 ABL2 
ENSSSCG00000038082 1.99 1.06E-02 TRAF6 
ENSSSCG00000016093 2.46 1.06E-02   
ENSSSCG00000001347 2.01 1.06E-02 PPP1R10 
ENSSSCG00000027865 -1.77 1.07E-02 GALC 
ENSSSCG00000007100 2.28 1.10E-02 SLC24A3 
ENSSSCG00000038562 2.99 1.19E-02 RND1 
ENSSSCG00000039609 3.46 1.24E-02 ANKRD33B 
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ENSSSCG00000010840 2.41 1.25E-02 RGS7 
ENSSSCG00000015930 2.17 1.26E-02 DHRS9 
ENSSSCG00000022197 -1.72 1.26E-02 HS6ST1 
ENSSSCG00000005503 -1.38 1.29E-02 TLR4 
ENSSSCG00000034213 2.69 1.34E-02 ACER2 
ENSSSCG00000020725 2.61 1.40E-02 ERBB3 
ENSSSCG00000025436 3.86 1.40E-02 ILDR1 
ENSSSCG00000022128 2.91 1.40E-02   
ENSSSCG00000004891 -2.60 1.42E-02 SERPINB7 
ENSSSCG00000006197 -1.68 1.45E-02 SULF1 
ENSSSCG00000028706 2.93 1.45E-02 MORN1 
ENSSSCG00000004332 2.59 1.45E-02 BACH2 
ENSSSCG00000002917 2.06 1.46E-02 NFKBID 
ENSSSCG00000038811 2.49 1.46E-02 MOB3B 
ENSSSCG00000036693 2.59 1.46E-02 ZNF658 
ENSSSCG00000007067 3.13 1.46E-02 JAG1 
ENSSSCG00000002764 2.34 1.47E-02 SMPD3 
ENSSSCG00000039821 -1.97 1.47E-02 GPRIN3 
ENSSSCG00000029458 1.97 1.47E-02 SLC16A2 
ENSSSCG00000035212 1.89 1.47E-02 KLF6 
ENSSSCG00000031912 2.62 1.56E-02   
ENSSSCG00000026044 2.20 1.56E-02 FDFT1 
ENSSSCG00000037466 -1.74 1.57E-02   
ENSSSCG00000011951 3.00 1.58E-02 NFKBIZ 
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ENSSSCG00000005948 2.79 1.58E-02 TG 
ENSSSCG00000011181 3.03 1.59E-02 NEK11 
ENSSSCG00000009053 3.03 1.59E-02 RNF150 
ENSSSCG00000024001 -1.95 1.59E-02 PLXNA1 
ENSSSCG00000004143 3.29 1.60E-02 TXLNB 
ENSSSCG00000033333 2.31 1.64E-02 FER1L6 
ENSSSCG00000012680 2.39 1.64E-02 GPC3 
ENSSSCG00000007730 2.60 1.65E-02 CALN1 
ENSSSCG00000014156 2.65 1.67E-02 ARRDC3 
ENSSSCG00000024249 2.40 1.69E-02 GABRR2 
ENSSSCG00000025996 2.58 1.73E-02 MTUS2 
ENSSSCG00000006734 2.04 1.74E-02 CD101 
ENSSSCG00000032416 1.86 1.74E-02 RGS1 
ENSSSCG00000027992 -2.10 1.81E-02 MST1R 
ENSSSCG00000000882 2.38 1.85E-02 ANKS1B 
ENSSSCG00000039880 -2.22 1.91E-02   
ENSSSCG00000017014 -1.44 1.91E-02 PANK3 
ENSSSCG00000008385 1.85 1.91E-02 PUS10 
ENSSSCG00000026232 2.22 1.91E-02 FAM184B 
ENSSSCG00000003137 2.25 1.91E-02 PLEKHA4 
ENSSSCG00000035577 2.44 1.93E-02   
ENSSSCG00000016338 2.44 2.00E-02 PER2 
ENSSSCG00000040648 -2.23 2.01E-02 CCL11 
ENSSSCG00000040828 1.77 2.02E-02   
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ENSSSCG00000015894 -1.70 2.02E-02 DPP4 
ENSSSCG00000003476 2.62 2.05E-02   
ENSSSCG00000030680 2.79 2.06E-02 TCF7 
ENSSSCG00000002811 2.26 2.07E-02   
ENSSSCG00000011599 2.67 2.11E-02 GRIP2 
ENSSSCG00000017389 -1.45 2.15E-02 RAMP2 
ENSSSCG00000039118 3.20 2.17E-02   
ENSSSCG00000009132 2.19 2.23E-02 ENPEP 
ENSSSCG00000040839 2.51 2.24E-02   
ENSSSCG00000014136 -1.58 2.27E-02 VCAN 
ENSSSCG00000002001 2.04 2.28E-02 REC8 
ENSSSCG00000025879 2.20 2.35E-02 SCRT1 
ENSSSCG00000015512 2.92 2.35E-02 PAPPA2 
ENSSSCG00000013100 -2.60 2.44E-02   
ENSSSCG00000033445 2.68 2.46E-02   
ENSSSCG00000006059 2.22 2.51E-02 NCALD 
ENSSSCG00000018061 1.72 2.52E-02   
ENSSSCG00000013753 2.50 2.55E-02 IER2 
ENSSSCG00000009237 -1.60 2.56E-02 HPSE 
ENSSSCG00000009567 -1.46 2.56E-02 RASA3 
ENSSSCG00000026705 1.72 2.56E-02 NVL 
ENSSSCG00000011899 3.12 2.56E-02 CD80 
ENSSSCG00000029380 1.67 2.58E-02 ZFP2 
ENSSSCG00000033452 1.56 2.63E-02   
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ENSSSCG00000006481 2.13 2.63E-02 GPATCH4 
ENSSSCG00000037452 -2.48 2.71E-02 HTR2A 
ENSSSCG00000027726 -1.28 2.81E-02 DLL1 
ENSSSCG00000032372 1.45 2.81E-02 ZFP90 
ENSSSCG00000037766 2.09 2.82E-02 NR3C2 
ENSSSCG00000038406 2.15 2.87E-02   
ENSSSCG00000004565 2.60 2.87E-02 CA12 
ENSSSCG00000004902 2.54 2.88E-02 RNF152 
ENSSSCG00000034164 2.26 2.90E-02   
ENSSSCG00000002829 -1.96 2.90E-02 MMP2 
ENSSSCG00000005269 3.10 2.95E-02 TRPM6 
ENSSSCG00000009012 -1.91 2.95E-02 TMEM154 
ENSSSCG00000006774 1.58 2.95E-02 PPM1J 
ENSSSCG00000030877 1.78 2.96E-02 FRMPD4 
ENSSSCG00000017204 2.41 2.98E-02 ITGB4 
ENSSSCG00000036846 2.89 3.02E-02   
ENSSSCG00000010437 -1.73 3.08E-02 PAPSS2 
ENSSSCG00000010607 2.06 3.11E-02 COL17A1 
ENSSSCG00000006155 2.95 3.11E-02 ZBTB10 
ENSSSCG00000002821 -1.58 3.15E-02 CCL22 
ENSSSCG00000005222 4.01 3.19E-02 SLC1A1 
ENSSSCG00000029482 -1.54 3.22E-02 CHST15 
ENSSSCG00000003112 2.05 3.28E-02   
ENSSSCG00000005311 -1.50 3.28E-02 CD72 
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ENSSSCG00000000647 1.79 3.28E-02 OLR1 
ENSSSCG00000038946 2.76 3.31E-02 SLC17A8 
ENSSSCG00000004121 -1.26 3.31E-02 FBXO30 
ENSSSCG00000001076 2.68 3.31E-02 RNF144B 
ENSSSCG00000026454 2.09 3.32E-02 PMAIP1 
ENSSSCG00000032601 -1.45 3.35E-02 RASSF2 
ENSSSCG00000010464 2.82 3.42E-02 PPP1R3C 
ENSSSCG00000023478 -1.59 3.51E-02 SLC46A1 
ENSSSCG00000023127 2.69 3.62E-02   
ENSSSCG00000017551 2.08 3.63E-02 FAM117A 
ENSSSCG00000033672 2.62 3.68E-02 HIST1H1E 
ENSSSCG00000017876 2.19 3.69E-02 CYB5D2 
ENSSSCG00000037580 -1.23 3.72E-02 ITPRIPL1 
ENSSSCG00000021702 2.37 3.72E-02 XRRA1 
ENSSSCG00000024428 1.70 3.76E-02 CHRNA9 
ENSSSCG00000004361 2.19 3.76E-02 GRIK2 
ENSSSCG00000039754 -2.64 3.83E-02   
ENSSSCG00000026349 -2.26 3.83E-02 ALDH3B2 
ENSSSCG00000003524 -1.88 3.83E-02 C1QA 
ENSSSCG00000011102 -1.85 3.87E-02 NRP1 
ENSSSCG00000016431 2.45 3.91E-02 GALNTL5 
ENSSSCG00000004094 1.91 4.04E-02 PPP1R14C 
ENSSSCG00000009111 -2.82 4.05E-02 SYNPO2 
ENSSSCG00000010224 1.77 4.10E-02 EGR2 
Luke PM Johnson   Appendices 
 
 
 
366 
 
Ensembl gene ID LogFC FDR External gene name 
ENSSSCG00000010894 1.54 4.11E-02 TP53BP2 
ENSSSCG00000029507 1.89 4.19E-02 RASGEF1B 
ENSSSCG00000040815 1.99 4.19E-02 DUSP5 
ENSSSCG00000014080 1.19 4.26E-02 HMGCR 
ENSSSCG00000004154 2.65 4.26E-02 TNFAIP3 
ENSSSCG00000038101 2.14 4.28E-02   
ENSSSCG00000010839 2.25 4.29E-02   
ENSSSCG00000024793 -1.75 4.29E-02 PORCN 
ENSSSCG00000008339 -1.37 4.32E-02 GFPT1 
ENSSSCG00000031346 -1.51 4.33E-02 CMKLR1 
ENSSSCG00000028677 2.35 4.43E-02   
ENSSSCG00000037288 2.07 4.46E-02 YPEL1 
ENSSSCG00000032980 2.60 4.47E-02   
ENSSSCG00000008326 -2.59 4.47E-02 TGFA 
ENSSSCG00000007140 -1.21 4.47E-02 SMOX 
ENSSSCG00000001952 2.42 4.52E-02 NFKBIA 
ENSSSCG00000012915 2.56 4.52E-02 CLCF1 
ENSSSCG00000040445 2.35 4.56E-02 RND3 
ENSSSCG00000039416 -1.63 4.62E-02 CXCR4 
ENSSSCG00000001710 1.93 4.64E-02 RUNX2 
ENSSSCG00000014882 1.40 4.65E-02 RSF1 
ENSSSCG00000000951 -2.06 4.70E-02   
ENSSSCG00000006290 1.57 4.70E-02 SLC19A2 
ENSSSCG00000004896 1.57 4.70E-02 PHLPP1 
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ENSSSCG00000032705 1.62 4.70E-02 USP42 
ENSSSCG00000002341 2.19 4.70E-02 PAPLN 
ENSSSCG00000022312 2.22 4.70E-02 RHPN2 
ENSSSCG00000031106 -2.55 4.85E-02 PLA2G2D 
ENSSSCG00000030165 1.83 4.85E-02 MAFF 
ENSSSCG00000040779 -2.01 4.92E-02   
ENSSSCG00000008263 1.89 4.92E-02 M1AP 
ENSSSCG00000008768 2.19 4.92E-02 ARAP2 
ENSSSCG00000012026 3.08 4.92E-02 ADAMTS1 
ENSSSCG00000017427 -2.16 4.94E-02 HAP1 
ENSSSCG00000001064 1.40 4.97E-02 GMPR 
ENSSSCG00000015487 2.60 4.98E-02 TNFSF18 
ENSSSCG00000015487 2.60     
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